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Background: Pain is a primary clinical concern for most people. Pain is the most common reason for 
seeking any form of health assistance be it medical, dental, physiotherapeutic or alternative disciplines. 
Pain threshold is defined as the lowest application of a stimulus that is perceived as pain. 
Experimental pain studies use a range of pain challenges including electrical, heat or cold, ischaemic 
and pressure. Some carry a higher potential risk of tissue injury or the sensations experienced are less 
acceptable to subjects. Pressure pain threshold (PPT), measured by a simple mechanical algometer is 
an attractive alternative well-suited for non-invasive repeated measurements on multiple sites not 
limited to limbs over short time intervals in a relaxed setting. Since 2000, the University of 
Technology Sydney had conducted eight PPT studies and collected over 47,500 baseline PPT 
measurements on 262 healthy subjects at 24 regional sites with three or four PPT readings for each 
site at each session of four to eight occasions of at least one week apart. Research Study One included 
seven studies with over 32,000 pre-intervention PPT measures on 235 healthy subjects at 17 sites with 
three PPT measures at each occasion for four consecutive occasions. These data were being analysed 
to develop comprehensive epidemiological profiles that assess relationships between PPT with subject 
variables (gender, age, BMI) and duration of temporal sessions. Research Study Two assessed the 
PPT at two affected and two non-affected sites of 20 patients with lateral epicondylitis. Research 
Study Three examined the inter-device reliability between mechanical and electronic algometers at six 
sites of 17 subjects. 
Aims: Research Study One explored the temporal stability of possible relationships between subject 
variables of gender, age and BMI, the duration of temporal sessions with the regional PPT at each 
measurement site. Research Study Two assessed the regional PPT measures at LI10 and LI11 of the 
affected and non-affected elbows for subjects with lateral epicondylitis. Research Study Three 
examined the inter-device reliability of a mechanical and an electronic algometers of same 
measurement parameters: circular rubber plunger of 1cm2 and force application rate of 1kg/s. 
Methods: Research Study One: All studies used the same protocol including the same model 
algometer, tip dimensions, application rates, rest interval between measurement cycles and at least 
seven days between each of four data collection visits. Regional PPT measurement sites included sites 
on head, neck and limbs. Data analyses used GLM and the alternative non-parametric tests wherever 
applicable. Research Study Two: A double blind randomised controlled trial that involved PPT 
measurements at two affected and two non-affected acupoints LI10 and LI11. Research Study Three: 





alternatively at six sites on hands. Subjects were blinded with a curtain drawn across the neck to the 
type of algometer being applied at each site. 
Results: Research Study One: For all 17 sites, the regional PPT for males was significantly higher 
than for females for each visit and each measurement cycle in general and in Intervention and Control 
groups. No significant differences between mean PPT and median PPT, and between the means of 
PPTmean and PPTmedian for each gender at all 17 measurement sites. The mean and median PPT among 
reading cycles within gender were generally stable for both genders independent of temporal visits. 
Irrespective of gender, most sites showed significant increase in means of PPTmean and PPTmedian over 
temporal sessions in general and in Intervention but not the case in Control. The Pearson correlation 
coefficients of PPT with age and BMI for both genders at all measurement sites were generally weak 
(<0.35 in magnitude). Stepwise multiple regressions models had PPTmean or PPTmedian in Visit 1 related 
to solely gender in all sites except bilateral LI20 with age and gender and PC6L with BMI only.  
Research Study Two: Generally significant increase of mean PPT at non-affected and affected sites in 
Acupuncture than Sham Laser and in males than females. Research Study Three: The mean PPT of 
mechanical algometer did not differ with that of electronic algometer at all six measurement sites. 
Conclusions: Research Study One: Data analysis on PPT to be completed separately by gender. 
Experimental design for PPT between subjects should ensure a matched gender ratio across groups. 
Washout period to be extended. Research Study Two: The males received higher PPT than females 
whilst both genders showed higher PPT from acupuncture treatment than the sham laser in lateral 
epicondylitis. Research Study Three: Both mechanical and electronic algometers provided valid and 
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Table 2.1: Coding of search phrases. 
Table 3.1: The 24 regional measurement sites at which PPT measures were 
taken on healthy adults. The sites are labelled according to the body side, 
anatomical location, relation to TCM channel (only applicable to acupoint) and 
WMS segmental region.  Note the term cun relates to a TCM measurement unit. 
Table 3.2: The regional PPT measurement sites in previous studies (a to f) and 
the present study (g).   
Table 3.3: The definition of 17 regional PPT measurement sites used in 
Research Study One. Note: All images showing all 17 PPT locations are of the 
author himself.                                           
Table 3.4: The four regional measurement sites at which PPT measures were 
taken on adults with lateral elbow pain. The sites are labelled according to the 
body side, anatomical location, relation to TCM channel and/or WMS 
segmental region. 
Table 4.1: The distribution of subjects by gender (F=Female, M=Male) in each 
measurement site in the order from head to toe. 
Table 4.2: The overall mean PPT and median PPT at each measurement site by 
gender.  
Table 4.3: The comparison of mean PPTmean (or mean PPTmedian) between 
genders by repeated measures ANOVA by GLM with F statistics (in all cases, 
p<0.003 except GB12R with p=0.004).  
Table 4.4: The p-values of repeated measures ANOVA and the Median Test on 
PPT by reading, independent of visits. In all cases, p>0.05. 
Table 4.5: The distribution of age and BMI by gender in each measurement site. 





































Table 4.7: The Pearson product moment correlation coefficient (R) between the 
PPTmean and age, PPTmean and BMI, age and BMI. Only PPTmean of Visit 1 were 
considered. Highlighted in red are the coefficients of highest correlation among 
all sites.  
Table 4.8: The Pearson product moment correlation coefficient (R) between the 
PPTmedian and age, PPTmedian and BMI, age and BMI. Only PPTmedian of Visit 1 
were considered. Highlighted in red are the coefficients of highest correlation 
among all sites.  
Table 4.9a: The stepwise multiple regression models of PPTmean with age and 
BMI.  
Table 4.9b: The stepwise multiple regression models of PPTmedian with age and 
BMI. 
Table 4.10: The number of subjects by BMI-group by gender at PC6L. 
Table 4.11: The mean (SD) of PPTmean of PC6L in Visit 1 and the results of 
one-way ANOVA on PPTmean and PPTmedian between Healthy Weight and 
Overweight by gender. The asterisk indicates p<0.05. 
Table 4.12: The adjusted mean (SE) of PPTmean of PC6L in Visit 1 and the 
results of univariate ANOVA on PPTmean and PPTmedian between Healthy Weight 
and Overweight by gender. In all cases, p>0.05. 
Table 4.13: Comparisons of means of PPTmean and PPTmedian between treatment 
groups of females where * indicates p<0.003 (Bonferroni correction) and + for 
p<0.05 for comparisons in overall visits and 1 in Visit 1 only. 
Table 4.14: Comparisons of means of PPTmean and PPTmedian between treatment 
groups of males where * indicates p<0.003 (Bonferroni correction) and + for 
p<0.05 for comparisons in overall visits and 1 in Visit 1 only. 
Table 4.15: The frequency distribution of subjects in each BMI group by 
treatment by gender for PC6L. 
Table 4.16: Comparisons of means of PPTmean and PPTmedian at PC6L of Healthy 
Weight between treatment groups by gender. The GLM revealed no significant 





































Table 4.17: The means of PPTmean and PPTmedian of PC6L of Control in Visit 1 
and the results of univariate ANOVA on PPTmean and PPTmedian between BMI 
groups (HW, OW and OB of females, HW and OW of males) by gender. The 
asterisk * indicates p=0.045<0.05. Bonferroni adjustment removed this 
statistical significant difference. 
Table 4.18: The adjusted means of PPTmean of PC6L of Control in Visit 1 and 
the results of univariate ANOVA on PPTmean and PPTmedian between BMI groups 
(HW, OW and OB of females, HW and OW of males) by gender. In all cases, 
p>0.05. 
Table 4.19a: The results of one-sample t-test on absolute difference between 
POST PPTmean and PRE PPTmean with Bonferroni correction (p<0.003). 
Table 4.19b: The results of one-sample t-test on absolute difference between 
POST PPTmedian and PRE PPTmedian with Bonferroni correction (p<0.003). 
Table 4.19c: The results of one-sample t-test on relative difference between 
POST PPTmean and PRE PPTmean with Bonferroni correction (p<0.003). 
Table 4.19d: The results of one-sample t-test on relative difference between 
POST PPTmedian and PRE PPTmedian with Bonferroni correction (p<0.003). 
Table 4.20: The mean (SE) PPT and the F statistics of GLM on PPT between 
genders. In all cases, p<0.05. 
Table 4.21: The mean (SE) of PPT and the results from GLM on PPT between 
pre and post intervention sessions. Statistical significant differences are marked 
with italic (p<0.05). 
Table 4.22: The mean (SD) of PPT and the p-values of Friedman test on PPT 
between sessions for (a) Acupuncture and (b) Sham Laser. The asterisk * 
denotes significant decrease in PPT from PRE to POST. 
Table 4.23: The p-values of Friedman test on PPT between LI10 Non-affected 
and LI10 Affected by session by gender for Acupuncture and Sham Laser. The 
asterisk indicates statistical significant change (* for increase, * for decrease) in 
PPT from non-affected to affected site. 
Table 4.24: The p-values of Friedman test on PPT between LI11 Non-affected 
and LI11 Affected by session by gender for Acupuncture and Sham Laser. The 






































Table 4.25: The p-values of Mann-Whitney U test on PPT between treatment 
groups. The asterisks * indicate statistical significant higher PPT in Sham Laser 
group. 
Table 4.26: The results from one-sample T test on percentage of PPT from 
baseline mean PPT on Week 1. The asterisk * indicates statistical significant 
increase and * for significant decrease in PPT. 
Table 4.27: The p-values of Mann-Whitney U test on percentage change in PPT 
from its baseline mean between treatment groups. The asterisks * indicate 
statistical significant difference between treatment group. 
Table 4.28: The p-values of Friedman test on percentage change in PPT 
between sessions. The asterisk * denotes significant decrease in percentage 
change in PPT from PRE to POST. 
Table 4.29: The p-values of Friedman test on percentage change in PPT 
between non-affected and affected LI10 and LI11. The asterisk indicates 
statistical significant change (* for increase, * for decrease) in percentage 
change in PPT from non-affected to affected site. 
Table 4.30: The results from paired samples t tests on PPT at six regional PPT 
measurement sites. 
Table 4.31: The results from paired samples t tests on PPT by measurement 
cycle at six regional PPT measurement sites. 
Table 4.32: The mean intra-device and inter-device coefficients of variance at 































Figure 1.1a: A mechanical algometer. 
Figure 1.1b: An electronic algometer. 
Figure 2.1: Flow chart for the number of articles in ProQuest and MEDLINE 
by period of publication and availability as reviewed articles for search phrases 
A1, A2, A3, A4, B1, B2, B3, B4, C1, C2, C3, C4 and C5. 
Figure 3.1: Regional PPT measurement sites used in UTS PPT studies on 
healthy adults. Figure adapted from Rogers and Rogers 1999. Some sites 
involved left and right sides as listed in Table 3.1. 
Figure 3.2: The Wagner Pain Test™ Model FPK Algometer.  
Figure 3.3: Left: Measuring PPT by an electronic algometer at LI10 of the left 
hand. The subject    immediately pressed the pedal to record the data into the 
computerised system (Tracker Software Version 5) when the PPT was perceived. 
Right: The electronic algometer (Tracker Freedom R ). 
Figure 3.4: Display of the application rate as a guide to consistent applied rate 
and records of reading which were transmitted immediately when the paddle 
was activated.  
Figure 4.1: The boxplots for 17 measurement sites by gender, showing the 
lower and upper fences, interquartiles, outliers, median, mean (red dot) with 
standard deviation (red double arrows), width of box proportional to the square 
root of the sample size, skewness and the notched boxplots. 
Figure 4.2: The bar graphs of overall mean PPT, overall median PPT, mean 
PPTmean and mean PPTmedian by gender by site.   
Figure 4.3: The mean PPT for three measurement cycles at 17 regional sites by 
gender, independent of visit. 
Figure 4.4: The median PPT for three measurement cycles at 17 regional sites 
by gender, independent of visit. 
Figure 4.5: The 95% confidence interval (CI) of overall mean and median PPT 
by regional site and sessions (V1, V2, V3, V4) shown separately by gender. The 



































Figure 4.6: The means of PPTmean and PPTmedian by gender, regional site and 
session. The GLM on PPTmean and PPTmedian between visits revealed some 
significant increases (*) in the means of PPTmean and PPTmedian and a decrease (*) 
in mean PPTmean across temporal intervals of V1 to V2, V3 and V4. Bonferroni 
corrections yielded only sites marked with red arrow. 
Figure 4.7: Percentage of the 17 regional measurement sites that showed 
statistical significant increase in the means of PPTmean and PPTmedian at interval 
sessions of V1 to V2, V1 to V3, and V1 to V4 for females (blue) and males 
(green). Bonferroni corrections reduced the percentages to at most 6%. 
Figure 4.8: Distribution of age and BMI by gender for the study subjects. 
Figure 4.9a: The scatterplots of PPTmean and PPTmedian with age. 
Figure 4.9b: The scatterplots of age and BMI. 
Figure 4.9c: The scatterplots of PPTmean and PPTmedian with BMI (kg/m2). 
Figure 4.10: The adjusted means of PPTmean and PPTmedian by gender at LI20L 
and LI20R in four visits with age as covariate. The ANCOVA by GLM on 
PPTmean and PPTmedian between visits revealed no significant differences in the 
adjusted means across temporal intervals of V1 to V2, V3 and V4. 
Figure 4.11: The adjusted means of PPTmean and PPTmedian by gender at PC6L in 
four visits with BMI as covariate. The ANCOVA by GLM on PPTmean and 
PPTmedian between visits revealed no significant differences in the adjusted 
means across temporal intervals of V1 to V2, V3 and V4. 
Figure 4.12 The bar graphs of mean PPTmean of PC6L across four consecutive 
visits by selected BMI groups by gender.  
Figure 4.13: The mean PPT for three measurement cycles at 17 regional sites 
by treatment group by gender, independent of visit. 
Figure 4.14: The median PPT for three measurement cycles at 17 regional sites 
by treatment group by gender, independent of visit. 
Figure 4.15: The means of PPTmean by treatment, gender, regional site and 
session. The GLM on PPTmean between visits revealed some significant 
increases (*) in the means of PPTmean across temporal intervals of V1 to V2, V3 
and V4 whilst Bonferroni correction yielded a more conservative result with 







































Figure 4.16: Percentage of the 17 regional measurement sites that showed 
statistical significant increase in the means of PPTmean at interval sessions of V1 
to V2, V1 to V3, and V1 to V4 for females (blue) and males (red) for 
intervention before and after Bonferroni corrections. 
Figure 4.17: The mean of PPTmedian by treatment, gender, site and session. The 
GLM on PPTmedian between visits revealed some significant increases (*) in the 
means of PPTmedian across temporal intervals of V1 to V2, V3 and V4 whilst 
Bonferroni correction yielded a more conservative result with p<0.003 (denoted 
by *). 
Figure 4.18: Percentage of the 17 regional measurement sites that showed 
statistical significant increase in the means of PPTmedian at interval sessions of 
V1 to V2, V1 to V3, and V1 to V4 for females (blue) and males (red) for 
intervention before and after Bonferroni corrections. 
Figure 4.19: By treatment group by gender, the adjusted means of PPTmean and 
PPTmedian by gender at LI20L and LI20R in four visits with age as covariate. The 
ANCOVA by GLM on PPTmean and PPTmedian between visits revealed nine 
significant differences (p<0.05 for + and p<0.025 for *) in the adjusted means 
across temporal intervals of V1 to V2, V3 and V4. 
Figure 4.20: By treatment by gender, the adjusted means of PPTmean and 
PPTmedian at PC6L in four visits with BMI as covariate. The ANCOVA by GLM 
on PPTmean and PPTmedian between visits revealed four significant increases in the 
adjusted means across temporal intervals of V1 to V2, V3 and V4. 
Figure 4.21: The bar graphs of mean PPTmean and mean PPTmedian of PC6L at 
Control across four consecutive visits by selected BMI groups by gender.  
Figure 4.22: The means of absolute differences and the means of relative 
differences for PPTmean and PPTmedian. The marker x indicates no significant 
differences (p>0.05) presence in the mean differences from zero with 
Bonferroni correction (p<0.003). 
Flow chart 4.1: Flow charts for sequence of data analyses in Sections 4.1 to 4.3. 





































Flow chart 4.3: Flow charts for sequence of data analyses in Sections 4.7 to 4.9. 
Flow chart 4.4: Flow charts for sequence of data analyses in Sections 4.10 to 
4.11. 
Flow chart 4.5: Flow charts for sequence of data analyses in Section 4.12 and 
4.13. 
Flow chart 4.6: Flow charts for sequence of data analyses in Sections 4.14 to 
4.17. 
Figure 4.23: The mean PPT at both sessions by occasion by gender. The error 
bar shows the 95% confidence interval. 
Figure 4.24: The mean PPT between sessions for each site by treatment by 
gender in intervention weeks and the one-month follow-up. Friedman test 
revealed three significant decreases (*) in mean PPT between sessions. 
Figure 4.25: The mean PPT between LI10 Non-affected and LI10 Affected by 
treatment by gender in each occasion. The asterisk indicates statistical 
significant change in PPT (* for increase, * for decrease) from non-affected to 
affected site. 
Figure 4.26: The mean PPT between LI11 Non-affected and LI11 Affected by 
treatment by gender in each occasion. The asterisk indicates statistical 
significant change in PPT (* for increase, * for decrease) from non-affected to 
affected site. 
Figure 4.27: The mean PPT between treatment groups at non-affected and 
affected LI10 and LI11 for females. Mann-Whitney test revealed no statistical 
significant differences between the two groups. 
Figure 4.28: The mean PPT between treatment groups at non-affected and 
affected LI10 and LI11 for males. Mann-Whitney test revealed four statistical 
significant differences (*) between the two groups in Week 1. 
Figure 4.29: The percentage change in PPT from the baseline mean PPT on 
Week 1 for each gender. The asterisk * indicates statistical significant increase 
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Chapter 1: Introduction 
 
1.1 Background 
Pain is a primary clinical concern for most people. Pain is the most common reason for seeking 
any form of health assistance be it medical, dental, physiotherapeutic or alternative disciplines. 
While pain is a phenomenon (Bäcker et al 2010) experienced by virtually everybody, a 
comprehensive definition remains elusive. This reflects the complex nature of the pain 
experience. Some descriptions focus upon the frequent association between pain and actual or 
potential damage to human tissues (Ogimoto et al 2002; Christidis et al 2005; Fernandez-de-las-
Penas et al 2006b; Rolke 2006) where it provides an ‘alarm or early warning function’. By 
contrast, others are concerned with emotional hurt where the experience, while cognitively 
intense (Isselée et al 1997; Ishitani et al 2005), occurs in the absence of tissue injury (Williams 
et al 2004; Vedolin et al 2009). 
 
However, all manifestation share the common underlying characteristic that pain is a brain event 
and is perceived (Williams et al 2004; Zhang et al 2009) or experienced (Katz et al 1999) solely 
by the conscious brain. This means that all pain is subjective and its interpretation in terms of 
quality and intensity is influenced by the individual sufferer’s past experiences and expectations 
(Katz et al 1999) as well as the current physiological state (Vedolin et al 2009). The study of 
pain has become a primary concern for understanding both human physiology and clinical 
disease states (Isselée et al 1997) as evidenced by the longstanding publication of prestigious 
journals such as Pain and The Clinical Journal of Pain. 
 
1.2 Pain models 
The origin of pain was drafted by the French philosopher and mathematician Réne Descartes 
(1596-1650) in a linear causality model which claimed the mechanical transmission of pain 
stimulus in a passive and unidirectional manner to the brain just like the pulling at other end of 
the robe connected to the doorbell and caused the instant stroke of a doorbell (Melzack and Wall, 
1965; Bäcker et al 2010). This concept of pain perception evolved into the specificity theory and 
pattern theory which were basis to the gate control theory emerged in 1965 (Melzack and Wall, 
1965; Melzack 1996; Wall 1996; Wolff 1996). This theory proposed that pain phenomena were 
determined by interactions among three spinal cord systems. The nociceptive stimulus 
information was transmitted and modulated many times in its path from the receptor to the brain 





instead of unidirectional. This model has great impact to pain research and was further 
incorporated with the systems theory that evolved in the 1980s in which a stimulus did not 
directly provoke an event but modified an existing active system. It was the physical and 
biochemical conditions and activities within the individual, and not the direct external stimulus 
alone that was responsible for the pain sensation. The level of pain sensation was determined by 
the interplay between the pain-inhibiting and pain-promoting mechanisms (Bäcker et al 2010). 
This has potentially explained at a neuronal level the working of acupuncture by aiding the 
individual’s own pain inhibiting mechanisms to alleviate pain via local analgesic and anti-
inflammatory action (Wu et al 2002; Zijlstra et al 2003; Rong et al 2005; Zhao 2008; Kim et al 
2011; Leung 2012; Hadianfard et al 2014).  
 
Whilst the above theories have difficulties in explaining some of the biopsychosocial factors 
that related to pain (e.g. phantom limb), Melzack and Wall revised and associated the gate 
theory with additional components involving psychological factors (e.g. stress, anxiety, memory) 
into the recently evolved neuromatrix theory (Melzack  1993, 1996; Wolff 1996; Melzack 1999; 
Leskowitz 2000) that focus on the well-being of an individual as a balance of mind, body, spirit 
and environment (Melzack 2001; Wheat et al 2007; Kim et al 2011; Lee et al 2013; Cheng et al 
2014) and has drawn growing interest into the field of complementary and alternative medicines 
as seen in Australia (Leach et al 2014; Steel et al 2014). However, of interest is the application 
of the model in the study of PPT (Bittar et al 2005; Oosterwijck et al 2011; Jay et al 2014). The 
UTS PPT studies had at certain extent explored PPT in relations to the biopsychosocial 
elements (Li et al 2005; Zaslawski 2006; Yuan 2002; Szabo 2007). 
 
1.3 Measuring pain 
Pain remains difficult to define and to measure because its experience is multidimensional as 
well as variable in intensity. A major advance came from the work of Melzack and colleagues at 
McGill University (Melzack 1975) that led to the development of the widely accepted McGill 
Pain Questionnaire (MPQ), that has been shown to measure the experience of pain both reliably 
and validly (Melzack and Wall 1988; Katz and Melzack 1999). The MPQ continues to be used 
widely to monitor quality and intensity of pain over time and to determine the effectiveness of 
analgesic interventions. This versatile instrument takes into account three dimensions of the 
pain experience dubbed sensory, affective and evaluative. Its extensive use in many studies 
internationally has clearly shown that it is possible to reliably assess pain both in the clinical 






The MPQ has been used to measure pain tolerance (Edwards et al 2001) defined as: the lowest 
stimulus level at which the subject withdraws or asks to have the stimulus stopped (Melzack and 
Wall 1988) as well as the less confronting pain threshold: the lowest stimulus value at which the 
person reports that the stimulus feels painful (Gazerani et al 2006). For obvious reasons, 
experimental pain studies that make use of measures of pain tolerance present ethical concerns. 
Therefore, most experimental pain studies focus on the measurement of experimental pain 
thresholds, in view of the potential for tissue damage.  
 
However there are two separate aspects to pain measurement and the MPQ only addresses one, 
which is quantifying the actual pain experience. The other aspect is the reliable quantification of 
the intensity of the pain inducer or challenger that is being delivered and is the province of 
dolorimetry. A dolorimeter is an instrument designed to deliver a stimulus capable of inducing 
pain in a controlled manner so that the stimulus can be gradually increased and reliably 
measured. Different dolorimeters have been developed to deliver different qualities of stimuli 
for example heat, electrical and pressure. Measuring pain threshold and tolerance are two of the 
main endpoints studied in dolorimetry. 
 
In 1884, Goldscheider described experimental procedures for eliciting pain thermally by placing 
hot objects on the skin or immersing a limb in hot water (Hardy et al 1940). In 1940, a more 
refined method that also used thermally induced pain was developed by Hardy and colleagues. 
Regarded as the first dolorimeter, their device was designed to deliver a quantified and variable 
thermal stimulus to elicit pain (Hardy et al 1940, 1947). The stimulus was the intensity of heat 
projected from a 1000 watt light bulb that was focused through a lens onto a blackened area on 
the subject’s skin and applied for a constant interval (three seconds).  The intensity of the 
radiation was controlled and varied using a rheostat. If no pain was experienced, the intensity of 
the light was increased and after 30 to 60 seconds the test was repeated. This procedure was 
repeated until the subject reported feeling pain at the end of the exposure and was equated to the 
pain threshold. Using the same three subjects (the experimenters themselves) this was found to 
be relatively constant over many months both within and between the three subjects. By 
increasing the thermal intensities, the group developed a pain scale, called the Hardy-Wolff-
Goodell Scale, with ten gradations or dols. However, the thermal method was inappropriate for 
determining pain tolerance due to potential and actual tissue injury, such as blistering associated 






A different approach to temperature induced pain that does not have the risk of tissue damage is 
the pain induced by immersion in very cold water, commonly known as the cold pressor test. 
For example, Krishnan et al (2012) used two specifically designed cylindrical temperature-
controlled water baths with a thermo-regulator in which the subject’s forearm and hand were 
immersed for cold pain threshold and cold pain tolerance measurements.  
 
Ischaemic pain has also been employed as the challenge. For example, Krishnan et al (2012), 
using a blood pressure cuff on the subject’s arm, increased the cuff pressure to 20mmHg above 
the subject’s systolic pressure. Subjects then performed a handgrip exercise on an elastic ball in 
time with the rate of the beat of a metronome while the pressure at the cuff was maintained.  
During the exercise period each subject immediately signalled when they first detected 
(experienced) pain and then, when they could no longer tolerate the pain. Both endpoints were 
recorded in seconds by the researcher. 
 
Electrical stimulation has been widely used in pain measurement studies although it brings with 
it a suite of application and quantification hurdles often related to the variable conductivity of 
the skin, the need for two electrodes and variable electrode dimensions (Maresca et al 1983, 
Krishnan et al 2012). The development of TENS devices facilitated ready availability of a 
highly adaptable, compact and portable stimulation source and a delivery mode that could be 
controlled by the subject, thereby eliminating measurement error stemming from the response 
time of the individual applying the stimulus.  
 
Pressure represents yet another pain challenge and mechanical devices to produce pain 
experimentally, had been developed by von Frey (1897) and Eddy (1932), as reported by Hardy 
et al (1940). The first dolorimeter that measured pain threshold produced by application of 
pressure was developed by Gluzek in 1944. The patient’s leg was stabilised on a leg rest and 
gradually increasing pressure was applied to the tibia until it was reported to produce pain. The 
pressure pain thresholds were reported to range 500 to 2700 grams of applied pressure.  
 
This method has evolved into what is more widely known as algometry.  An algometer (Figure 
1.1a) is an instrument for measuring the intensity of pain-inducing stimuli. In the clinical and/or 
experimental setting, algometers are widely used to quantify the pressure and/or force required 
to elicit either a pressure induced pain threshold or tolerance in subcutaneous and underlying 
tissues. In the experimental setting, both threshold (Chung 1992; Cathcart et al 2006, 2008) and 





(PPT) is defined as the minimum force per unit area that induces discomfort or pain whereas 
pressure pain tolerance is the maximum force per unit area a person can tolerate without 
excessive effort (Fischer 1986). 
 
The algometer is a spring loaded pressure gauge, attached to a rubber-tipped stylus and a force 
dial which reads in pounds or kilograms. When in use, the flat, circular rubber tip (areas ranging 
from 0.5 to 1.5 cm2; UTS PPT studies used 1cm2) of the plunger is placed perpendicular to the 
subject’s skin and pressure steadily applied until the subject reports that the pain threshold (or 




Figure 1.1a: A mechanical algometer. Figure 1.1b: An electronic algometer. 
 
Nowadays, there are both mechanical (Figure 1.1a) and electronic (Figure1.1b) algometers used 
for clinical practices and experiments. The electronic algometer has been described by some as 
an improved version of the mechanical algometer, because it removes measurement error 
stemming from the response time of the individual applying the pressure. However, it loses the 
flexibility of the manual method in situations where multiple body sites are to be measured and 
remeasured in a short period of time.  
 
In brief, dolorimetry research has led to development of dolorimeters designed to deliver and 
measure a range of pain challenges. Many experimental studies on pain thresholds involve 
measurements of electrical pain thresholds (Maresca et al 1983; Krishnan et al 2012; Li et al 
2013), thermal pain thresholds (Hwang et al 2012; Li et al 2013) and ischaemic pain thresholds 
(Frölich et al 2012). PPT was chosen for the present research because of a series of 
characteristics that made it most appropriate. However no matter which pain challenger is 
selected, there are both advantages and limitations. Importantly it must be emphasised that the 





Pain challengers Limitations  
Electrical pain Requires sophisticated and isolated power source. 
Needs meticulous preparation to ensure reliable electrical contact 
(Lund et al 2005). 
Time consuming and irritating for the participant (Lund et al 2005). 
Difficult to prepare multiple measurement sites. 
Many subjects dislike electrical sensations. 
Ischaemic pain Measurements are restricted to limbs (Roche et al 1984). 
Onset and termination are gradual and appears to be a practice effect 
with repetition (Barlas, 2000). 
Repeated measurements are time consuming (Panza et al 1995). 
Thermal pain Comparisons between heat and cold stimuli are difficult to interpret 
due to large inter-individual variations in baseline thermal, heat or 
cold, pain threshold (Johnson et al, 1989).  
Measurements of heat and cold pain threshold tend to be limited at 
the superficial nervous tissue while clinical pain cases concern the 
underlying deeper tissues. 
Cold induced pain threshold only applied on localised body region 
(Ashton et al 1984). 
Pressure pain Measuring tip may skid off when pressure applied was increased, at a 
bony or uneven site. 
Difficulty in maintaining the direction of the applied pressure at the 
rubber tip of the plunger perpendicular to the surface of the 
measuring site throughout each measurement. 
 
For the present program a single form of pain challenge was used in order to develop an 
epidemiological profile for healthy subjects for this quality of painful experience. Among the 
challengers listed, pressure pain measured with an algometer, emerges as the most appropriate 
in situations where:  
 multiple measurement sites are involved; 
 repeated measurements over a short time interval are required; 
 sites are not limited to the limbs; 
 risk of pain or injury are virtually absent for pain threshold measurement; 
 preparation of sites is minimally intrusive or time consuming; 
 portable and not restricted to a laboratory or clinic setting; 
 compliance by subject and return for follow up sessions is necessary;  
 possible stress associated with sophisticated settings of other challengers can be avoided. 
 
These were the conditions that described the long running program of research into pain 
threshold commenced at the University of Technology, Sydney (UTS). In the Department of 
Medical and Molecular Biosciences (DMMB) of the Faculty of Science at UTS, since 2001 
(Zaslawski 2001), a series of seven studies has made extensive use of PPT in healthy subjects. 





subjects (127 females, 108 males), at a total of 24 body sites, with three or four recordings for 
each site on each of four to eight occasions at interval of at least one week apart.  
 
Of particular interest in this thesis was the temporal session of one week apart in which there 
was a considerable concern on the stability of the pre-intervention PPT after baseline session. 
Any significant variability of subsequent PPT should be handled carefully while interpreting 
post-intervention PPT. 
 
1.4 PPT database from previous UTS studies 
Obviously these extensive records comprise a comprehensive database concerning PPT in 
healthy subjects. In addition, among the studies, many of the measurement sites were the same. 
The six previous PPT studies have generated an extensive database of baseline PPT measures at 
a range of 24 sites on 150 healthy subjects represented by mostly younger adults (78 females, 72 
males) with mean age 30 years, age range 17 to 70 years (Zaslawski et al 2001, 2003, 2006; 
Yuan 2002; Li et al 2005, 2008; Szabo 2007). In each study, the key demographics of the 
subjects such as gender, age, weight and height were reported. For each subject, baseline PPT of 
three to four measures at each study site were collected on at least four separate occasions 
spaced a minimum of one week apart. In addition identical protocols and algometry instruments 
and procedures were used for all studies facilitating the pooling of data into arguably the most 
comprehensive database of PPT measures available. 
 
Since each study using a within subjects repeated measures experimental design, the numbers of 
subjects were too small to consider significant patterns or relationships between PPT and 
subject variables such as gender, age, and the body mass index (BMI). However, since all the 
data have been made available for the present research, they are now able to be combined.  
 
The data were still limited since subjects aged above 35 were rarely included in these studies. If 
useful epidemiological data were to be developed, the age range needed to be extended by 
recruitment of additional subjects. An expansion of the database of subjects to include ages 
distributed between 35 and 65 will permit subdivisions for each measurement sites into smaller 
but representative groups by gender, age and BMI, so meaningful results may be drawn from 
data analysis.  
 
A large database of healthy subjects will comprehensively contribute a great deal of the PPT 





disease states. This is because, as pain is quantifiable, subjects with disease states might have 
some representations of discomfort at their physiological sites with respect to PPT measures. 
For example, an injured site may have a lower or higher baseline PPT reading as compared to 
the normal site, and this might vary after an intervention and over a period of time. 
 
1.5 Study aims 
Research Study One: An extended study on the regional PPT of subjects aged between 35 and 
65 years replicating the same protocols of type of algometer, size of measuring tip, rate of 
applied force, three measurement cycles and four occasions with at least one week apart on 
some existing sites as the previous PPT studies at UTS. 
General aim: To examine the temporal stability of possible relationships between subject 
variables of gender, age and BMI with the regional PPT. 
This general aim comprised of 18 specific aims. 
 
Research Study Two: A pilot study on selected sites on subjects with lateral elbow pain. 
General aim: To examine the regional PPT measures at LI10 and LI11 between the affected 
and non-affected elbow for subjects with lateral epicondylitis. 
This general aim comprised of nine specific aims. 
 
Research Study Three: Examination of the reliability of PPT readings obtained between 
mechanical and electronic algometers of a specific measuring size and rate. 
General aim: To examine the consistency of PPT measures at each study site obtained by 
mechanical and electronic algometers. 
This general aim comprised of two specific aims. 
 
1.6 Format of thesis 
Chapter 1: Introduction 
Introduced the background of pain study, the evolution of pain models and various types of pain 
challengers used in quantifying pain. Detailed the choice of using algometers in measuring 
pressure pain threshold in UTS PPT studies and the need of Research Study One in extending 
the age range. Research Study Two as a pilot study in extending PPT measurement on disease 
state study and Research Study Three explored the possibility of combining PPT data obtained 







Chapter 2: Literature review 
The elements in the common protocol of UTS PPT studies were reviewed. These included  the 
type of algometers,  the various size of measuring plunger, the rate of application of pressure, 
the operator’s experience and training, test-retest interval, health states and the age and body 
mass index of subjects. 
 
Chapter 3: Methods 
The experimental research designs and procedures and the statistical models for each study were 
described. 
 
Chapter 4: Results 
This chapter reported the results from three research studies. The results were systematically 
presented in Sections 4.1 to 4.19 for Research Study One, followed by Sections 4.20 to 4.28 for 
Research Study Two, then in Sections 4.29 and 4.30 for Research Study Three.  
 
Chapter 5: Discussion and conclusion 
Each research study was discussed and concluded separately. Research Study One was 
discussed in Sections 5.1 to 5.6, followed by Research Study Two in Section 5.7 and Research 
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Chapter 2: Literature review 
 
Of interest in the literature review is the scope of the PPT research involving the type of 
algometer used,  the various size of measuring tip on the plunger, the rate of application of 
pressure, the operator’s experience and training, test-retest interval, diseases or conditions 
measured using PPT measures, and the subject variables in age and body mass index.   
 
2.1 Systematic search of PPT articles 
A systematic search of the UTS e-database on category of Health was undertaken to identify 
studies using the key phrase “pressure pain threshold” or “pain pressure threshold”. The search 
was then refined by including secondary keywords such as “algometer or algometry” and other 
search phrases as coded in Table 2.1. Figure 2.1 provides the flow chart for number of articles 
stored in the two main databases, namely ProQuest and MEDLINE, according to period of 
publication and availability as reviewed articles for search phrases as described in Table 2.1.  
 
Code Search phrases 
A1 "pressure pain threshold" or "pain pressure threshold" 
A2 A1 and ("algometer" or "algometry") 
A3 A2 and ("mechanical algometer" or "hand-held algometer" or "handheld algometer") 
A4 A2 and "electronic algometer" 
B1 A2 and tip 
B2 A2 and rate 
B3 A2 and ("reliability" or "validity") 
B4 A2 and (training or trained or operator) 
C1 A2 and "age group" 
C2 A2 and "body mass index" 
C3 A2 and (intervals or occasion)  
C4 A2 and ("retest" or "test-retest" or "re-test" or "re-measured") 
C5 A2 and (disease or injury) 







Figure 2.1: Flow chart for the number of articles in ProQuest and MEDLINE by period of publication 
and availability as reviewed articles for search phrases A1, A2, A3, A4, B1, B2, B3, B4, C1, C2, C3, C4 
and C5. 
 
As of 31.12.2014, based on the key search phrase of “pressure pain threshold” or “pain pressure 
threshold”, ProQuest had collected 1260 reviewed articles, whilst MEDLINE reported a total of 
629 since 1984. Search phrases on types of algometers based on phrases such as “electronic 
algometer” or “mechanical algometer” or “hand-held algometer” or “handheld algometer” 
revealed a limited number of studies as the specific models of the algometer were commonly 
used in the reports instead of the above general terms. ProQuest has larger collections that deal 
with features regarding algometers as shown in second level that reported outcome from search 
phrases B1, B2, B3 and B4. Of 408 articles in ProQuest, 99 (24.3%) reported size of plunger tip, 
204 (50%) the rate of the application of pressure, 197 (48.3%) concerned the training of 





162 reports returned in MEDLINE, ten studies (6.2%) reported size of plunger tip, 15 (9.3%) 
the rate of the application of pressure, 22 (13.6%) the training of operators and eight (4.9%) 
involved the reliability or validity of algometry. With search phrases of C1, C2, C3 and C4, the 
third level shows that there were very limited publications about the age group (16 in ProQuest 
and one in MEDLINE) and body mass index (36 in ProQuest and three in MEDLINE). 
However, there were 176 (43.1%) and 59 (14.5%) articles for “intervals or occasion” and 
("retest" or "test-retest" or "re-test" or "re-measured") respectively in ProQuest but a relatively 
smaller number of 15 (9.3%) and six (3.7%) in MEDLINE. The publications related to disease 
states or injuries included 239 (58.6%) reported in ProQuest and 24 (14.8%) in MEDLINE. The 
above comparisons reveal that ProQuest has collected more reviewed articles than MEDLINE in 
the field of PPT study in all search phrases. Hence, ProQuest is considered for tracking the trend 
of publications involving PPT research. 
 
Before 1984, there were few reports involving PPT even though pain threshold studies 
involving applied pressure could be traced back to 1897. Hardy et al (1940) for example had 
mentioned that studies by von Frey (1897) and Eddy (1932) did involve production of pain by 
pressure. Since 1984, pain studies reporting PPT as a measure have been increasing. These 
studies often reported methodological features such as test retest interval, size of tip of 
algometer, rate of application of pressure, type of algometer, relevant diseases, operator training, 
as well as reliability and validity as listed in Table 2.1. However, only 16 studies involved age 
group (C1) and 36 mentioned body mass index (C2). In the present research using the PPT 
studies at UTS, analysis of regional PPT by age group or body mass index on healthy adults will 
be possible owing to the large set of database collected based on eight studies. 
 
The search revealed various publication titles which shows that reports of PPT and algometry 
studies are dominating in the fields of musculoskeletal (175 titles) and neurology (112 titles), 
followed by orthodontics (39 titles) and other medical sciences. The musculoskeletal titles 
comprise collections from the disciplines of chiropractic, physiotherapy and osteopathy. 
 
2.2 Mechanical and electronic algometry 
Although mechanical algometry (MA) was used for the majority of studies (61%) for 
measurement of PPT (Fischer et al 1986, 1987, 1990; Antonaci et al 1992, 1998; Nussbaum et 
al 1998; Smidt et al 2002; Zaslawski et al 2003; Li et al 2008), the recent trend (39%) has 
shown an increase in the use of electronic algometry (EA) (Kosek et al 1993 and 1999; Isselée 





rate graph on the screen as reference for the examiner during measurement phase (Kosek et al 
1993 and 1999; Isselée et al 1997; Ogimoto et al 2002; Tanaka et al 2004). However the EA 
was cumbersome as compared to MA when a series of different sites in the one session was to 
be measured as it involved physically connecting the algometer with a control pedal linked to a 
computer monitor at all times. 
 
While more preparation time is required for the EA compared to MA, EA facilitates the 
incremental guidance of the applied rate (a 1kg/cm2/s guide line usually displayed on a 
computer screen) thus attempting to ensure a controlled pressure application required for 
experimental purposes (Isselée et al 1997). The EA PPT scores were also in many cases “subject 
controlled” in that the data acquisition system recorded the PPT score following the subject’s 
pressing a hold switch rather than relying on verbal response of the subject, on sensing the PPT 
and subsequent withdrawal of the algometer by the researcher (Ogimoto et al 2002; Tanaka et al 
2004). No studies were located that compared the reliability of PPT values obtained using 
electronic and mechanical instruments. However, Bernhardt et al (2007) conducted a reliability 
and validity comparison between a commercial Somedic digital algometer with a self-designed 
fingertip-shaped pressure algometer for palpation (PAP) for assessing PPT at 16 sites located in 
the temporomandibular joint, masticatory muscles and the frontalis muscle of 30 subjects. The 
concurrent validity was demonstrated by statistically significant correlations between the two 
devices at all 16 sites (14 highly significant and two significant) with values ranging between 
0.38 and 0.66. The intraexaminer reliability analysis of repeated PPT measurements were 
excellent with ICC>0.75 for 12 sites and ICC≥0.73 for remaining four sites. 
 
Appendix 1 gives a summary of mechanical and electronic algometers used in studies in 
ascending order of the tip size. There were 43% of the EA studies reported the display of 
applied rates and the availability of a control switch for subjects to operate once PPT was sensed. 
 
2.3 Size of algometer tip 
The tip sizes reported were either in terms of area or in diameter. Appendix 1 shows that the 
most frequently employed tip size was a 1cm2 (47%) rubber circular surface (Fischer et al 1987; 
Nordahl et al 2003; Rolke et al 2006; Ge et al 2008; Kinser et al 2009), followed by a 1cm (23%) 
in diameter (Kosek et al 1993; Cairns et al 2006; Frank et al 2013), then 0.5cm2 (Ohrbach et al  






The tip sizes varied from 1mm (Möller et al, 1998; Takahashi et al 2005) in diameter to 2cm2 
(Tunks et al 1988; Defrin et al 2003; Walsh et al 2009) or even 4cm2 in a specific study in 
comparing tip sizes and rates of force application conducted by Xiong et al (2011). All PPT 
studies at UTS (Yuan 2002, Zaslawski et al 2003, Szabo 2007, Li et al 2008) also used a 1 cm2 
circular tip on the plunger. Möller et al (1998) applied a handheld EA with a tip size of only 
1mm diameter for an animal study (rat) while Kosek et al (1999) reported using an EA 
(Somedic Sales AB, Farsta, Sweden) with diameter of 10mm for measurements on the lateral 
epicondyle of the humerus bone. Examples of the variation reported in studies include 
Chesterton et al (2003) who applied a pressure algometer from Salter Abbey Weighing Machine 
Ltd England with circular tip of 11mm in diameter at the first dorsal interosseous muscle and 
Vatine et al (1998) who used an algometer (modified from Model FT 10, Grass Medical 
Instruments, Quincy, MA) with tip size of 0.25cm2 on the sternum. Cathcart et al (2006, 2008) 
used an in-house mechanical algometer of 0.40cm2. While the measuring tips used by the above 
studies were primarily circular in shape, Williams et al (2004) applied a different tip shape with 
measuring tip of 1.5cm straight edge by 1mm in diameter for measuring the PPT at the lunula of 
the nail-bed of 61 healthy subjects at a constant rate of 100g/s. A few studies (Jensen et al 1986; 
Defrin et al 2003; Takahashi et al 2005; Xiong et al 2011) made comparisons on the algometer 
tip-size. 
 
2.4 Rate of application of pressure 
In order to measure PPT, the force is applied via the tip of the algometer at a specific rate. 
Kinser et al (2009) demonstrated the need for the investigator to be well practised in the use of 
the algometer to ensure a consistent rate of force was applied thus enhancing the reliability of 
measurements. Kinser and his associates compared the manually applied pressure on a force 
plate with that applied with a 1cm2 round rubber application surface of a handheld algometer. 
The force-time curves were developed and analysed for the rate of force application. Hence, a 
consistent and appropriate rate of application is critical for the algometry reliability. 
Inconsistency of pressure application may hinder the subject’s recognition of the PPT. As 
summarised in Appendix 1, different studies have used different rates of application of force. 
These rates are expressed in various units such as N/s, kPa/s, kg/s or kg/cm2/s according to the 
calibration of algometer for the specific experiment and the availability of the circular plunger 
tip size. Depending on the aim of the PPT study on the measurement regions (muscles, nerves, 
bone), the anatomical location of the sites, and the sensitivity of the pressure threshold, various 
tip sizes were employed. Hence, standardization of these rates across references were made by 





equivalent to 50kPa. These transformed rates ranged from 0.1kg/cm2/s (Fischer et al 1987) to 
4kg/cm2/s (Vatine et al 1998). The more commonly reported rates were 1kg/cm2/s (Fischer et al 
1987, Nussbaum et al 1998, Zaslawski et al 2003, Cathcart et al 2006, Li et al 2008) and 
0.5kg/cm2/s (Rolke et al 2006, Barlas et al 2006, Vedolin et al 2009). It is to be noted that Fisher 
et al used 1kg/cm2/s in 1986. Antonaci et al (1992) inadvertently reported a rate of 100g/s but 
was amended to 2kg/cm2/s in Antonaci et al (1998). The main reason of having a constant rate 
of application is to enhance reliability (Jensen et al 1986, Kinser et al 2009) and validity of 
algometry (Vaughan et al 2007) since PPT can be quantified but impacted by subjective 
responses of both subject and examiner. For example, too rapid a rate may lead to the examiner 
overshooting the PPT due to reaction times (Jensen et al 1986, Defrin et al 2003) or too slow 
may cause fatigue to examiner for maintaining constant rate (Jensen et al 1986, Defrin et al 
2003) over extended periods of time, especially for repeated measures at multiple sites.  
 
Tunks et al (1988) used 1kg/s of rate application to measure the PPT of ten fibromyalgia and ten 
healthy subjects for the reliability study at ten paired and typical tender points. There was 
significantly lower tenderness thresholds of tender points in fibromyalgia compared to normal 
subjects. Correlation coefficients were calculated and showed high inter-rater (0.85) and test-
retest (0.85) reliability. 
 
2.5 Operator experience and training 
Nussbaum et al (1998) in their PPT study on 35 healthy subjects at biceps brachii muscle (three 
trials, using a protocol of ten seconds between trials, and 20 minutes between examiners, over 
three consecutive days for a total of 18 trials) noted that reliability was enhanced when all 
measurements were taken by one examiner instead of two. The researchers also stressed the 
important of training in operating the algometer. One week prior to the study, the two examiners 
practiced using the Fisher algometer of circular tip size of 1cm2 while being timed so that a 
standard application rate was achieved by increasing the pressure linearly to 5kg/cm2 over five 
seconds  indicating an estimated rate of 1kg/cm2/s. Ten practice trials were performed by each 
examiner. Various combinations of paired measurements with respect to trial-to-trial and day-
to-day between examiners A and B were analysed.  It was reported that examiner A recorded 
higher scores of PPT than those recorded by examiner B in about 70% of the paired 
measurements. However, when mean PPT increased, examiner A tended to score increasingly 
lower than examiner B and as a result the mean difference between examiners (0.14 kg/cm2 in 
Trial 1) was small. Though the order of examiners measured PPT were reversed for 15 subjects, 





scored (p-value = 0.33). With the exception of day one where trial-to-trial reliability was 
significantly higher between Trials 2 and 3 than between Trials 1 and 2 (p<0.05). Furthermore, 
day-to-day reliability for a single measurement of PPT was highest in Trial 3, and day-to-day 
reliability for a measurement derived from the mean of multiple trials was highest for the mean 
of Trials 2 and 3. These results have led to the suggestion that Trial 1 could be excluded in 
deriving the mean PPT. 
 
Training of examiners was undertaken prior to testing (Farasyn et al 2007; Vedolin et al 2009; 
Aldayel et al 2010). Barlas et al (2006) involved a week training to familiarise the examiners 
with algometer and other experimental procedures whist Rolke et al (2006) involved only one 
day of training.  
 
Sayed-Noor et al (2008) suggested the important of examiner’s experience on measuring of PPT 
as it was amenable to bias. In the assessment of 18 subjects reporting pain in the greater 
trochanteric region with matched controls, it was the intra individual body-side PPT differences 
that yielded the most sensitive measurement. Furthermore while large inter individual 
differences across patients might be considerable and could mask pathologic diagnosis findings 
they found good validity for the algometer and suggested the cut-off ratio of 0.8 for PPT of 
affected and non-affected side could be used for diagnostic purposes. 
 
Some reported satisfactory levels of both inter and intra examiner reliability of algometers in 
clinical and/or laboratory practices (Takala et al 1990; Chung et al 1992; Delaney et al 1993; 
Jacobs 1995; Nussbaum et al 1998; Brown et al 2000; Ogimoto et al 2002; Cathcart et al 2006; 
Chesterton et al 2007; Farasyn et al 2008; Kinser et al 2009).  For example, Chesterton et al 
(2007) reported inter-rater reliability on PPT measures at first dorsal interosseous muscle of 13 
healthy adults (21 men, 1 women, mean age = 22) assessed by five trained observers. The 
subjects were blinded from three PPT measures randomly taken by each observer with 15s 
between measurements for a single observer and 10min interval between each observer per 
subject. This study suggested no bias with no significant difference (p=0.094, ICC = 0.91, 95% 
CI) between observers’ mean PPT were found.  The maximum difference among readings were 
1.77kg/cm2. Smidt et al (2002) revealed strong intra-rater reliability (0.91<ICC<0.96) on PPT at 
involved and uninvolved arms of 50 patients with lateral epicondylitis randomly taken by two 
physiotherapists, but received unsatisfactory inter-rater reproducibility (ICC<0.75) at 
uninvolved arms. Delaney et al (1993) measured inter and intra-observer reliability of (MA) 





volunteers (25 men, 25 women, aged 20 to 51 years). The results showed that the pressure 
algometer was highly reliable in measuring myofascial trigger point sensitivity, between and 
within experimenters. The researchers further proposed that PPT measurement could be useful 
in the diagnosis and monitoring of treatment of myofascial pain syndrome. Takala et al (1990) 
reported moderately acceptable intra-rater (ICC from 0.71 to 0.91) and inter-raters (0.68 to 0.79) 
reliabilities for PPT measurements at upper trapezius and levator scapulae muscles of 93 men 
and 70 women.  
 
2.6 Test retest interval 
In Appendix 2, out of 79 groups of researchers, 35 collected three PPT measurements per site 
with a few stated the first reading was discarded (Nussbaum et al 1998; Farasyn et al 2007; 
Meeus et al 2010) whilst many were aware of the possible influence on reliability for rest time 
between repeated trials within an occasion or between occasions (Reeves et al 1986; Fischer et 
al 1987; Ohrbach et al 1989; Takala et al 1990; Wessel et al 1995; Nussbaum et al 1998; 
Ogimoto et al 2002; Persson et al 2004; Potter et al 2006; Jones et al 2007; Vaughan et al 2007; 
Ylinen et al 2007; Gomes et al 2008; Kinser et al 2009; Walsh et al 2009; Xiong et al 2011; 
Lacourt et al 2012; Frank et al 2013). Depending on the objectives of the studies, intervals 
between occasions varied from a few session per day (Kosek et al 1999; Chesterton et al 2003; 
Ayesh et al 2007a, 2007b), several consecutive days (Chung et al 1992; Nussbaum et al 1998; 
Jones et al 2007; Hübscher et al 2008), a week apart (Brennum et al 1989; Reid et al 1994; Plesh 
et al 1998; Ogimoto et al 2002; Sterling et al 2002; Zaslawski et al 2003; Potter et al 2006)  to  a 
year (Taimela et al 2000). For examples, Persson et al (2004) took four consecutive 
measurements at ten minutes intervals on days 1, 3, 28 and 30, Delaney et al (1993) completed 
repeat measurements at five minute intervals, and Zaslawski et al (2003) performed four cycles 
of measurements at ten sites over a ten minute period, resulting in each site being remeasured at 
2-2.5 minute intervals. However, possible comparisons among studies are only applicable if 
same sites on muscles/tissues were examined with similar rest time or interval between 
occasions. 
 
Jones et al (2007) studied the intra and inter day reliability of PPT in the upper extremity and 
torso in 19 healthy women aged between 20 to 39 years. The test-retest reliability of PPT values 
at eight sites with three PPT trials at each session was consistent within the same day across 






Farella et al (2000) examined the PPT of 40 female patients with temporomandibular disorders 
and 40 age-matched female subjects as controls using an EA (tip of circular surface of 1 cm2 at a 
rate of 20kPa/s) at two sites at masseter muscle and two sites at temporalis muscle with 
approximately a five second interval between sites. Four measurements were made at each site 
with a two minute rest interval between trials. The first PPT of a session was discarded and each 
PPT was defined by the mean of the successive three trials.  
 
Ogimoto et al (2002) measured PPT at the buccal and palatal sites of ten subjects (eight males; 
two females) of average age 26.5 years who had suffered pain in the oral mucosa using an 
algometer (tip 2mm in diameter). Three trials were recorded at each measurement site with one 
minute rest time between trials for three occasions with one week apart. 
 
2.7 PPT in disease states 
PPT has frequently been used for temporomandibular disorders (Murphy et al 1992; McMillan 
et al 1994; Reid et al 1994; Brown 2000; Ogimoto et al 2002; Nordahl et al 2003; Visscher et al 
2004; Fernández-de-las-Peñas et al 2006a; Bernhardt et al 2007; Gomes et al 2008). In general, 
algometry was shown to be useful in obtaining PPT measurements for this condition. Other 
disease states that have utilised PPT include chronic neck pain (Taimela et al 2000; Irnich et al 
2001; Sterling et al 2002; Ylinen et al 2007), lateral epicondylitis (Smidt et al 2002; Slater et al 
2005), lateral elbow tendinopathy (Bjordal et al 2008) and myofascial pain (Ohrbach et al 1989; 
Ohrbach et al 1989; McMillan et al 1994; Reid et al 1994; Shen et al 2007; Ge et al 2008; 
Vedolin et al 2009). Appendix 3 provides a more comprehensive overview of disease states in 
various studies. Some studies examined the stability of PPT between the patients and the 
controls in various disease states (McMillan et al 1994; Vatine et al 1998; Farella et al 2000; 
Sterling et al 2002; Shiau et al 2003; Slater et al 2005; Fernández-de-las-Peñas et al 2006a, b, 
2009; Bernhardt et al 2007; Cathcart et al 2008; Vedolin et al 2009). Sand et al (1997) measured 
PPT at 13 cranial sites bilaterally in 30 headache patients and ten healthy controls on three 
different days. Thresholds were reported to be lower significantly at all 13 measurement sites 
when the subjects came directly to algometry without any preceding medical examination. 
However, replication of the study with a larger study group is necessary if general inferences are 
to be made. Chronic neck pain has been studied by two research groups, Sterling et al (2002) 
and Taimela et al (2000). Sterling et al (2002) included 19 healthy subjects and 19 patients 
whilst Taimela et al (2000) used 76 patients (22 men, 54 women) with chronic, nonspecific neck 
pain. Wessel (1995) studied the reliability of PPT in osteoarthritis (OA) of the knee in women 





three occasions were statistically significantly lower in the OA group. Zhang et al (2011) 
designed a randomised controlled model for the study of acupuncture treatment for plantar 
fasciitis. Subjects were randomly assigned to the treatment group (N = 28) or the control group 
(N = 25). The secondary outcome measures included PPT measurement using an electronic 
algometer (Somedic, Sweden) applied by a trained researcher, prior to each treatment session. 
The algometer tip-size was 1cm2. Three successive measurements were made at the medial 
tubercle of the calcaneum of the non-painful foot, and at the most painful site on the painful foot 
(usually the medial tubercle of the calcaneum).  
 
2.8 Characteristics of subjects: gender, age, height and weight 
Takala (1990) studied PPT with a mechanical algometer on the upper trapezius and levator 
scapulae muscles in a working population of 93 men and 70 women. The finding showed that 
women had lower pain threshold values than men, a finding that was consistent with those of 
the UTS studies (Yuan 2002; Zaslawski et al 2003, 2006; Li et al 2005, 2008; Szabo 2007). 
Appendix 4 gives a general view for studies that had concluded that PPT measurements of 
males were statistically significantly higher than that of females in various age groups 
(Buchanan et al 1987; Ohrbach et al 1989; Vanderweeën et al 1996; Plesh et al 1998; Vatine et 
al 1998; Chesterton et al 2003; Christidis et al 2005; Rolke et al 2006). However, Christidis et al 
(2005) further clarified that there was no significant difference in between genders if the change 
in PPT with respect to baseline PPT were considered. Ayesh et al (2007a) found no significant 
difference between genders in their study on younger adults (males of mean age 23.4±0.6, 
female 25.9±0.6), Fischer et al (1987) found 24 males having significantly higher mean PPT 
than 26 females at nine sites except gluteus medius and Isselée et al (1997) concluded that there 
were no significant difference between genders of younger adults (11 males average age 27, 11 
females average age 24) at any study sites except one at the right temporal muscle for their PPT 
study on masseter and temporalis muscles. Whilst some carefully designed matched gender 
groups (Fischer et al 1986, 1987; Buchanan et al 1987; Tunks et al 1988; Brennum et al 1989; 
Delaney et al 1993; Vanderweeën et al 1996; Isselée et al  1997; Plesh et al 1998; Tanaka et al 
2004; Barlas et al 2006; Ayesh et al 2007b ; Anderson et al 2008; Li et al 2008; Walsh et al 
2009) or matched intervention groups (McMillan et al 1994; Wessel et al 1995; Farella et al 
2000; Shiau et al 2003; Slater et al 2005; Bernhardt et al 2007; Cathcart et al 2008; Wasner et al 
2008; Fernández-de-las-Peñas et al 2009; Meeus et al 2010; Xiong et al 2011), a handful of 
others (Murphy et al 1992; Kosek et al 1993, 1999; Farella et al 2000; Waling et al 2001; Shiau 
et al 2003; Persson et al 2004; Jones et al 2007; Ylinen et al 2007; Ge et al 2006, 2008; 





(2006) and Aldayel et al (2010) recruited males only in their studies. Most studies recruited 
unmatched gender groups, for example Zhang et al (2011) recruited 14 males and 29 females for 
study on plantar fascilitis and Taimela et al (2000) involved 22 males and 54 females with 
chronic and non-specific neck pain whereby females were twice more than males. 
 
Appendix 5 gives a summary of the characteristics of subjects involving weights and heights 
when reported. Overall reported mean age for both genders spanned from 20 (Vedolin et al 2009) 
to 76 (Zhang et al 2011) years old, mean weight from 53kg (Shiau et al 2003) to 89kg 
(Nussbaum et al 1998), mean height in between 159cm (Zhang et al 2011) and 180cm 
(Nussbaum et al 1998) and mean BMI in between 20.4 (Xiong et al 2011) to 26 (Ylinen et al 
2007). Anderson et al (2008) recruited younger adults of age in between 22 to 33 with males 
having a BMI range between 20.5–29.3 (mean 24.1) and female 20.4–29 (mean 24.2).  Defrin et 
al (2003) included healthy adults (BMI of 24.6±4 for males and 22.2±3 for females) by using a 
hand-held pressure algometer (Somedic Sales AB, Algometer type II, Sweden) with probe sizes 
0.5, 1 and 2 cm2 for measuring PPT at various sites on hand, painfree back and myofascial 
trigger points (MTPs) in the back of the subjects.  
 
Though reports included age, height, weight and even BMI, no specific comparisons were made 
regarding the PPT by age groups and categories of BMI. To achieve these comparisons, a huge 
database from subjects of various age groups would be required. With its data collection over 
the past 15 years, PPT database recordings from previous studies at UTS together with the 
present extended regional PPT database over a more senior age group of 85 subjects would 
make these comparisons possible.  
 
2.9 Acupuncture sites 
In UTS, Zaslawski et al (2003, 2006) and his associates (Yuan 2002, Li et al 2005, 2008, Szabo 
2007) have conducted extensive PPT measurements on acupuncture sites for clinical trials. 
Barlas et al (2006) applied needling at LI10, TH5, GB34 and ST38 and considered PPT 
measured at bilateral muscle bellies as covariates while interpreting the treatment results. Zhang 
et al (2011) measured PPT at PC7 and LI4 in study of heel pain and found that PC7 showed 







Chapter 3: Methods 
 
I.  Research Study One 
 
3.1 Aim 
To examine the temporal stability of possible relationships between subject variables of gender, 
age and BMI with the regional PPT. 
 
3.2 Design 
Pre-intervention PPT measures from six previous regional PPT studies (Study 1 to Study 6) 
were extracted and combined with the PPT measures obtained from the present extended study 
(Study 7) to expand the comprehensive UTS PPT database.  
 
Unlike Study 1 to Study 6, there was no acupuncture intervention involved in Study 7. All 
studies applied the same pre-intervention protocol with respect to type of algometer, size of 
measuring tip, rate of applied force, number of pre-intervention PPT measurement cycles 
completed and four consecutive data collection occasions scheduled at least one week apart.  
 
Note that two of the previous studies (Study 1 and Study 6) involved more than four data 
collection occasions. However, for the purpose of the present comparisons, only the pre-
intervention PPT measures in the first four occasions (at least one week apart) of three PPT 
readings per occasion have been included. 
 
The previous six studies recruited healthy adults of age between 17 and 70 but with mean (±SD) 
age of 29.9±11.1 years and mean BMI of 22.5±3.5 kg/m2 for 78 females and mean age of 
29.9±9.1 years and mean BMI of 22.9±2.5 kg/m2 for 72 males. 
 
Ethics approval with approval number UTS HREC 2010-367A was obtained on 21 October 
2010 from the Human Research Ethics Committee (HREC) of UTS to recruit staff volunteers. 
Owing to the slow recruitment despite ten advertisements being posted in the online Staff 
Notices and flyers being distributed at various general notice boards, a request was submitted to 
HREC to extend the collection of PPT data to premises outside the UTS Acupuncture Clinic. 





person-in-charge of the premises and the similar environment for measurement and collection of 
data were carried out. At premises outside the UTS Acupuncture Clinic, a portable massage 
table was provided so that subjects would experience a similar measurement environment to  the 
UTS Acupuncture Clinic. 
 
3.3 Subjects 
Recruitment advertisements or notices for the extended PPT study (Study 7) were posted 
electronically via the online Staff Notices in the UTS intranet and also in the form of A4 
Information Posters (Appendix 6) at the general notice boards across different buildings within 
the City Campus of UTS. A total of 139 inquiries were received and an Information Pack that 
consisted of an Information Poster, an Information Sheet (Appendix 7) and a Consent Form 
(Appendix 8) was sent electronically or hand delivered to each potential participant. A total of 
36 male and 49 female volunteers were recruited (Study 7 in Table 3.2). The subjects included 
62 staff volunteers (53 attended at the clinic and nine at Research and Innovative Office in 
Building 1, Main Campus), seven church members and 19 friends and their relatives from two 
private houses. Apart from three discontinuations (attended one or two occasions) by two males 
and one female volunteers due to work commitments, the remaining 85 subjects completed the 
PPT measurements at 17 sites in four occasions. Prior to obtaining consent, all subjects were 
briefed about the study and experienced the PPT measurement procedure at several non-
measurement sites.  
 
For all subjects, age, height and weight were recorded for analyses that involved examination of 
relationship between PPT with age and BMI. The Department of Health, New South Wales has 
classified the BMI (in kg/m2) into four categories: Underweight (BMI<18.50), Healthy Weight 
Range (18.50<BMI<24.99), Overweight (25.00<BMI<29.99) and Obese (BMI≥30) in which 
BMI is calculated as weight (kg) divided by the square of height (m2) (NSW 2014)  
 
Study 7 recruited healthy adults aged between 35 and 65 years with mean age of 50.0±9.3 years 
and mean BMI of 24.5±5.1 kg/m2 for 49 females and mean age of 49.7±9.0 years and mean 
BMI of 25.6±4.1 kg/m2 for 36 males. 
 
The selection criteria for Study 7 were as follows: 
 Aged between 35 and 65; 
 Do not suffer from a chronic musculoskeletal disorder; 





3.4 Regional PPT measurement sites 
All PPT measurement sites were marked with a felt pen to ensure accurate point location 
throughout all sessions. The overall regional PPT measurement sites included 18 acupoints and 
six nonacupoints located variously at the neural segments or dermatomes as shown in Figure 3.1.  
 
Table 3.1 lists the anatomical location of each site by side and by its relation to acupuncture 
channel and/or Western Medical Science (WMS) neuro-segmental region. L and R after the site 
identification number denote the side of the body involved. The acupoints comprised of CV12, 
GB12R, GB20R, KD3L, KD3R, LI10L, LI10R, LI20L, LI20R, LI5L, LI5R, LV5R, PC6L, 
PC6R, SI3R, SP6R, ST36L and ST36R. The nonacupoints were 1L, 1R, 2L, 2R, 3R and 4L. 
The acupoints were separately located in nine channels with one point each from the Conception 
Vessel, Liver, Small Intestine and Spleen channels, two points each in Gall Bladder, Kidney, 
Pericardium, and Stomach channels and six points in Large Intestine channel. A total of 24 
measurement sites were used in Study 1 to Study 6, in which 17 sites (GB12R, KD3R, LI10L, 
LI20L, LI20R, LI5L, LI5R, PC6L, PC6R, SP6R, ST36L, ST36R, 1L, 1R, 2L, 2R and 3R) were 
selected for Study 7. 
 
Each of the six previous studies (Tables 3.2a to 3.2f) used a series of ten measurement sites. The 
17 sites used in Study 7 comprised of sites used in the previous studies (Table 3.2g). Table 3.3 







Figure 3.1: Regional PPT measurement sites used in UTS PPT studies on healthy adults. Figure adapted 









Site Side Anatomical Location Channel / 
segmental 
region 
CV12 Midline On the midline of the abdomen, 4 cun above the umbilicus Channel: 
Conception 
Vessel  
(Zhongwan)   Dermatome: T8 
GB12 Right On the head, in the depression posterior and inferior to the mastoid 
process behind the ear 
Channel: Gall 
Bladder 
(Wangu)   Dermatome: C3 
GB20 Right On the neck, below the occipital bone, 1 cun above the posterior 
hairline, in the depression between the upper ends of the 
stercleidomastoid and trapezius muscles 
Channel: Gall 
Bladder 
(Fengchi)   Dermatome: C3  
KD3 Both Posterior to the medial malleolus, on the midpoint of the line 
connecting the medial malleolus and the Achilles tendon 
Channel: Kidney 
(Taixi)   Dermatome: L4  
LI10 Both On the radial side of the dorsal surface of the forearm, on the line 
connecting LI5 and LI11, 2 cun below LI 11 (Quchi) located at the 
midpoint of the line between the radial end of the cubital crease and 
the external humeral epicondyle 
Channel: Large 
intestine 
(Shousanli)   Dermatome: C5 
LI20 Both At the upper segment of the nasolabial groove of the face, at the level 
of the middle part of the nasal ala, 1 cun superior and lateral to LI19 
(Kouheliao) located on the lateral side of the upper lip, directly below 
the lateral border of the nostril, at the junction of the upper 1/3 and 
middle 1/3 of the upper lip 
Channel: Large 
intestine 
(Yingxiang)   Dermatome: V2 
(maxillary of 
trigeminal) 
LI5 Both At the radial end of the crease of the wrist, in the depression between 




(Yangxi)   Dermatome: C5 
LV5 Right On the medial aspect of the leg, 5 cun above the tip of the medial 
malleolus, in the centre of the medial border of the tibia 
Channel: Liver 
(Ligou)   Dermatome: L4  
PC6 Both On the palmar aspect of the forearm, 2 cun above the transverse crease 
of the wrist, between the tendons of the long palmar muscle and the 
radial flexor muscle of the wrist 
Channel: 
Pericardium 
(Neiguan)   Dermatome: 
border of the C5 
and T1  
SI3 Right On the ulnar side of the hand, posterior to the 5th metacarpophalangeal 
joint, at the end of the distal palmer crease 
Channel: Small 
Intestine 
(Houxi) Dermatome: C8 
SP6 Right On the lower part of the medial side of the leg, 3 cun above the tip of 
the medial malleolus, in the depression posterior to the medial border 
of the tibia 
Channel: Spleen 
(Sanyinjiao)   Dermatome: L4 
ST36 Both 3 cun directly below ST35 (Dubi), in the depression one finger-
breadth lateral to the anterior crest of the tibia. ST35 is located at the 
lower border of the patella, in the depression lateral to the patellar 
ligament, when the knee is flexed 
Channel: 
Stomach 
(Zusanli)   Dermatome: L4  
1R and 1L Both On the arm, 2 cun proximal to the wrist crease on the dorsal surface, 




2R and 2L Both Midway between the wrist joint and the medial epicondyle of the 




3R Right 2 cun distal to the fibula head, posterior to the fibula shaft Channel: Nil 
Nonacupoint 
Dermatone: L5 
4L Left Half way down the lateral planter margin of the left foot, 1 cun from 




Table 3.1: The 24 regional measurement sites at which PPT measures were taken on healthy adults. The 
sites are labelled according to the body side, anatomical location, relation to TCM channel (only 










F = 22; M = 18 
Site 1 LI5R 
Site 2 LI20R 
Site 3 1R 
Site 4 PC6R 
Site 5 2R 
Site 6 ST36R 
Site 7 3R 
Site 8 LI10R 
Site 9 SI3R 




F = 11; M = 9 
Site 1 LI5R 
Site 2 LI20R 
Site 3 1R 
Site 4 2R 
Site 5 ST36R 
Site 6 CV12 
Site 7 3R 
Site 8 LI5L 
Site 9 2L 




F = 11; M = 11 
Site 1 LI5R 
Site 2 LI20R 
Site 3 GB20R 
Site 4 1R 
Site 5 ST36L 
Site 6 KD3L 
Site 7 LI5L 
Site 8 1L 
Site 9 ST36R 




F = 12; M = 12 
Site 1 LI10L 
Site 2 2L 
Site 3 4L 
Site 4 KD3R 
Site 5 SP6R 
Site 6 LI5R 
Site 7 1R 
Site 8 PC6R 
Site 9 LI20L 




F = 10; M = 10 
Site 1 LI10L 
Site 2 1L 
Site 3 ST36L 
Site 4 4L 
Site 5 KD3R 
Site 6 LV5R 
Site 7 LI5R 
Site 8 PC6R 
Site 9 LI20L 




F = 12; M = 12 
Site 1 KD3R 
Site 2 3R 
Site 3 ST36R 
Site 4 LI5L 
Site 5 1L 
Site 6 PC6L 
Site 7 2L 
Site 8 LI10L 
Site 9 LI20R 




F = 49; M = 36 
Site 1 1R 
Site 2 3R 
Site 3 LI5R 
Site 4 ST36R 
Site 5 2R 
Site 6 SP6R 
Site 7 PC6R 
Site 8 KD3R 
Site 9 LI10L 
Site 10 LI20R 
Site 11 1L 
Site 12 LI20L 
Site 13 LI5L 
Site 14 ST36L 
Site 15 2L 
Site 16 GB12R 
Site 17 PC6L 
g 
 















Location of sites Definition of location 
 
 
LI20L or LI20R: At the upper segment of the nasolabial groove of 
the face, at the level of the middle part of the nasal ala  
 
 
GB12R: In the depression posterior and inferior to the mastoid 
process behind the ear 
 
 
2L or 2R: Midway between the wrist joint and the medial epicondyle 
of the elbow on the medial side of the forearm, anterior to the ulna 
shaft 
 
PC6R or PC6L: On the palmar aspect of the forearm, 2 cun above 
the transverse crease of the wrist, between the tendons of the long 
palmar muscle and the radial flexor muscle of the wrist 
 
LI10L: On the radial side of the dorsal surface of the forearm, on the 
line connecting LI5 and the edge of the transverse cubital flexure 
crease, 2 cun distal to the crease 
 
1L or 1R: On the arm, 2 cun proximal to the wrist crease on the 
dorsal surface, just on the medial border of the radius 
 
LI5L or LI5R: At the radial end of the crease of the wrist, in the 
depression between the tendons of the short extensor and long 
extensor muscles of the thumb 
 
 
ST36L or ST36R: 3 cun directly below ST35, in the depression one 
finger-breadth lateral to the anterior crest of the tibia. ST35 is 
located at the lower border of the patella, in the depression lateral to 
the patellar ligament, when the knee is flexed 
 
3R: 2 cun distal to the fibula head, posterior to the fibula shaft 
 
SP6R: On the lower part of the medial side of the leg, 3 cun above 
the tip of the medial malleolus, in the depression posterior to the 
medial border of the tibia 
 
KD3R: Posterior to the medial malleolus, on the midpoint of the line 
connecting the medial malleolus and the Achilles tendon 
Table 3.3: The definition of 17 regional PPT measurement sites used in Research Study One. Note: All 







3.5 Measuring PPT 
 
PPT data collection for the various occasions involved four researchers who were experienced 
in measuring PPT with an algometer and recording PPT measurements. PPT was measured by 
using a mechanical Wagner PainTM Model FPK10 algometer with capacity/graduation of 
10kgfx100gf on a 2¼" dial and rubber tip of 1cm2 attached to the stainless steel plunger as 
shown in Figure 3.2. All PPT readings were taken by applying the rubber tip at the plunger 
perpendicular to the measurement site on the skin with the operator taking the counts by heart 
counting to themselves (1 and 2 and 3 and …in a steady manner) while pressing the site so that 
to achieve  a constant rate of approximately 1kg/s.  This rate was further monitored by the 
researcher recording the measurements to ensure a consistent rate was applied. Throughout the 
PPT measurements, subjects lay supine on the treatment table. PPT measurement sites were 
marked with a felt pen to ensure consistency of measurement locations throughout each  
session. For all studies, in each of the four consecutive visits with at least one week apart in 
between visits, a practice cycle across a series of all measurement sites was conducted before 
actual PPT measures were taken for the subsequent three cycles. The readings from the practice 
cycle were omitted/discarded. Kosek et al (1993) and Nussbaum et al (1998) reported that this 
cycle of first readings appeared to be relatively unreliable compared with readings in subsequent 
cycles as subjects acclimatised to the procedure.  Study 1 to Study 6 required approximately two 
to three minutes to complete a cycle of ten sites whilst Study 7 required approximately four 
minutes to complete a cycle of 17 sites. 
Every subject was briefed to indicate by saying “Yes” or “Now” or “There” when the pressure 
was first perceived as uncomfortable or painful. As soon as the PPT was reached, the operator 
immediately withdrew the algometer. The algometer was then handed to the second researcher 
to read and record the PPT readings. A replacement reading was recorded if and only if the 
subject indicated an advanced or delayed “Yes” or “Now” or “There” in the perception of PPT. 
Throughout the data collection phase of each study, no data were analysed to avoid effects 
stemming from researcher expectations. In addition, the researcher applying the algometer was 










3.6 Statistical analysis 
The baseline PPT data of each subject in each previous study were abstracted from the existing 
databases which were securely kept in the DMMB in the form of original hardcopies and of 
electronic formats in MINITAB and/or EXCEL. For each study the electronic database entries 
were verified against the hardcopies to ensure that the PPT data of each subject were correctly 
and completely transferred and tabulated. The merged and restructured database was then saved 
in IBM SPSS Statistics 22 and MINITAB version 17.0 for data analysis (Tabachnick et al 2007; 
Hills 2011). 
 
The above PPT database comprises the baseline PPT scores collected from six previous UTS 
PPT studies that involved intervention LI4m+21 (A sterile stainless steel disposable needle of 
length 30mm and diameter 0.22mm was inserted into LI4R to a depth of 15 to 20mm, followed 
by a standardised manual rotating of the needle between the fingers through a large angle of 540 
to 720 degree in a bi-directional manner for nine times, each manipulation procedure lasted 
approximately five seconds and was applied every three minutes over a period of 21 minutes) 
while Study 7 (Control group) involved  no intervention.  
 
The analysis of variance (ANOVA) by General Linear Model (GLM) with Sidak’s adjustments 
and Post Hoc Tests was employed for this repeated measures experimental research design. A 
95% confidence interval with Type I Error at  = 0.05 was considered to determine the 
significant difference between the means. Examination of relationships between regional PPT 
and age or BMI included scatterplots, notched boxplots, and Pearson product moment 
correlation coefficient. One-sample t-test with Bonferroni adjustment was used to compare the 





protect the chances of obtaining false-positive results (Type I error) when m tests were 
performed, Bonferroni correction at p= 0.05/m were employed to maintain the familywise error 
rate (Hills, 2011). 
 
II. Research Study Two 
 
3.7 Aim 
To examine the regional PPT measures at LI10 and LI11 between the affected and non-affected 
elbow for subjects with lateral elbow tendinopathy. 
 
3.8 Design 
The PPT data collections were carried out in conjunction with the study conducted by Berle et al 
(2011). This was a double blind (assessor and patient) randomised controlled trial that involved 
PPT measurements (for the present research), pain rating/descriptor questionnaire (Visual 
Analogue Scale and McGill Melzack rating) and a functional self-report disability scale 
(Disabilities of the Arm, Shoulder and Hand questionnaire).   
 
Ethics approval was granted on 21 September 2009 by the HREC of UTS with clearance 
number UTS HREC REF NO. 2009-274A. 
 
3.9 Subjects 
An Information pack that comprised of an Information Letter (Appendix 9), a Trial Entry 
Assessment Form (Appendix 10) and a Consent Form (Appendix 11) was sent to each of the 73 
people who had expressed an interest in entering the trial. While 23 participants met the 
selection criteria only 20 completed the PPT measurements at all four occasions. The subjects 
were randomised with five men and six women in the treatment group and four men and five 
women in the control group.   
 
The inclusion criteria for the participating subjects included: 
 Chronic lateral elbow pain of at least three months duration; 
 And 35 – 55 years of age. 
 
The exclusion criteria included:  





 Radial nerve entrapment; 
 Inflammatory rheumatic diseases; 
 Gout; 
 Radioulnar or radiohumeral osteoarthritis; 
 Earlier episodes of lateral elbow pain treated surgically or with acupuncture; 
 And have a current Work Cover claim. 
 
3.10 Regional PPT measurement sites 
There were four measurement sites with two acupoints located at each arm. These sites were the 
affected LI10 and LI11, and the non-affected LI10 and LI11. The affected arm could be either 
right or left. The locations of the sites are as shown in Figure 3.1. The definition and anatomical 
location of the PPT measurements sites are given in Table 3.4. The sites are labelled according 
to the body side, anatomical location, the relation toacupuncture channel and/or neuro-
segmental region. 
 
Site Side Anatomical Location Channel and/or 
segmental region 
LI10 Both On the radial side of the dorsal surface of 
the forearm, on the line connecting LI5 and 
LI11, 2 cun below LI 11 (Quchi) which is 
located at the midpoint of the line between 
the radial end of the cubital crease and the 
external humeral epicondyle 
Channel: Large intestine 
(Shousanli)   Dermatome: C5 
LI11 Both At the lateral end of the transverse cubital 
crease midway between LU5 (Chi Ze, 
located at the cubital crease on the radial 
side of the biceps brachii tendon) and the 
lateral epicondyle of the humerus. 
Channel: Large intestine 
(Quchi) Dermatome: C5 
Table 3.4: The four regional measurement sites at which PPT measures were taken on adults with lateral 
elbow pain. The sites are labelled according to the body side, anatomical location, the relation to TCM 
channel and/or WMS segmental region. 
 
 
3.11 Measuring PPT 
A computerised hand-held electronic algometer (Tracker Freedom  JTech Medical, Salt Lake 





measurements at experimental sites, the applied rate and tip size of the algometer were as 
introduced in Section 3.5.  
For all PPT measurements, participants were seated comfortably with their shoulder in relax 
manner and the elbow lying on the table with flexion. Pressure was applied perpendicularly to 
each site at a rate of 1kg/cm2/s as shown in Figure 3.3. The examiner was trained to achieve the 
required rate of application via a computerised rate display as shown in Figure 3.4. This was 
further monitored throughout the actual PPT measurement process. 
  
Figure 3.3: Left: Measuring PPT by an electronic algometer at LI10 of the left hand. The subject    
immediately pressed the pedal to record the data into the computerised system (Tracker Software 




Figure 3.4: Display of the application rate as a guide to consistent applied rate and records of 






PPT measurements were obtained in week 0 (one week before commencing the five weeks of 
either verum or sham laser intervention.); in week 1 (initial intervention week); week 5 (final 
intervention week) and week 9 (one month follow-up). On each occasion, two sets of PPT 
measurements were completed at 20 minute intervals. On week 1 and week 5, the 20 minutes 
were used as intervention sessions whereas for week 0 and week 9, no intervention was 
involved. There was a rest time of ten seconds between measures at the two different sites. 
 
3.12 Statistical analysis 
As in Research Study One, a GLM for repeated measures was employed in the data analysis on 
PPT with alpha = 0.05. When subgroups were formed by treatment, gender and occasion, non-
parametric tests such as Friedmann test and Mann-Whitney U test were used to replace the 
parametric GLM for equal and unequal sample groups respectively.  
 
 
III. Research Study Three 
 
3.13 Aim 
To examine the interdevice reliability of two PPT measurement devices: mechanical and 
electronic algometers of same measurement parameters: tip size and application rate.  
 
3.14 Designs 
In this study, subjects were blinded to the measurement procedure with a curtain drawn across 
their neck thereby making them blind to the type of algometer being applied at each site.  
 
Ethics extension for using electronic algometer on 17 subjects from Research Study One at six 
PPT sites for this reliability study was granted on 25 February 2012 by HREC. 
 
3.15 Subjects 
The 17 subjects who volunteered to participate in this reliability testing study had previously 
consented to participate in the extended PPT study (Study 7).  
 
3.16 Regional PPT measurement sites 






3.17 Measuring PPT 
The subject lay on the treatment table in a supine position with all the sites marked by a felt pen. 
A curtain was pulled across the subject’s chest so that they could not see the algometers or the 
PPT measurement process. Sounds associated with the computerised system of electronic 
algometer were muted so that the subject could not differentiate between the two types of 
algometers. 
 
The PPT measurements were carried out in alternate manners between mechanical and 
electronic algometers at different sites located on alternate sides of the body.  
 
3.18 Statistical analysis 
Paired samples t-tests were conducted to examine the consistency of readings between the 








Chapter 4: Results 
 
This chapter reports the results from three independent research studies. 
 
I. Research Study One 
 
Research Study One aimed to examine the temporal stability of possible relationships between 
subject variables of gender, age and BMI with the regional PPT. The temporal period refers to 
the session when three regional PPT measurements were being collected within the same 
occasion and over four consecutive occasions with intervals of at least one week in between 
occasions.  
 
Research Study One included 235 healthy subjects, drawn from seven separate studies. A total 
of 17 PPT measurement sites were used in data analysis. Table 4.1 shows the number of 
subjects in each measurement site by gender by study with total possible number of subjects 
shown in the last row. The number of subjects in measurement site by gender by study which 
was less than the total possible number of subjects in the related gender and study implied that 
some subjects did not complete all four PPT occasions on that site and were excluded from the 
study for that particular site.  It is to be noted that the comparisons of PPT among UTS PPT 
studies were beyond the scope of this thesis. 
 
















F M F M F M F M F M F M F M F M 
LI20L             12 12 10 10     49 36 71 58 
LI20R 22 18 11 9 11 11         12 12 49 36 105 86 
GB12R             12 12 10 10 12 12 49 36 83 70 
2L     11 9     11 8     12 12 49 36 83 65 
2R 20 15 11 9                 49 36 80 60 
PC6L                     12 12 49 36 61 48 
PC6R 22 18         12 12 10 10     49 36 93 76 
LI10L             12 12 10 10 12 12 49 36 83 70 
1L         11 11     10 10 12 12 49 36 82 69 
1R 22 18 11 9 11 11 12 12         49 36 105 86 
LI5L     11 9 11 11         12 12 49 36 83 68 
LI5R 22 18 11 9 11 11 12 12 10 10     49 36 115 96 
ST36L     10 8 11 11     10 10     49 36 80 65 
ST36R 20 14 10 8 11 11         12 12 49 36 102 81 
3R 19 16 11 7             12 12 49 36 91 71 
SP6R             12 12         49 36 61 48 
KD3R         11 11 12 12 10 10 12 12 49 36 94 81 
Total 22 18 11 9 11 11 12 12 10 10 12 12 49 36 127 108 
Table 4.1: The distribution of subjects by gender (F=Female, M=Male) in each measurement site in the 





An overall database of regional PPT was established from pre-intervention PPT measures 
collected in Studies 1 to 6 (involved various interventions inclusive of LI4m+21) and the PPT 
measures in Study 7 (no intervention). A total of three PPT measures being collected per visit 
for four consecutive visits.  
 
The syntax for data analyses performed in the following aims are shown in Appendix 13 by 
sequence of its application. 
 
4.1 Aim One: To display the boxplots of PPT at 17 measurement sites by 
gender 
 
A series of boxplots of PPT measures for 17 measurement sites by gender was generated by 
using R version 3.1.2 to depict the descriptive statistics of PPT at each corresponding site. 
Figure 4.1 displays a series of boxplots for 17 measurement sites by gender, showing the 
interquartiles (Q1 at 25%, Q2 or median at 50%, Q3 at 75%), lower fence (Q1-1.5IQR), upper 
fence (Q3+1.5IQR), mean PPT (red dot) with standard deviation (red double arrows), width of 
box proportional to the square root of the sample size, potential outliers, skewness and the 
notched boxplots which offers evidence of a statistically significant difference between the 
medians of both genders if the notches of two boxes did not overlap (in this case, all 17 sites, 
evidenced by non-parametric Median Test on overall PPT at 95% confidence interval (Q1, Q2, 
Q3 refer to quartiles 1, 2 and 3. IQR=Q3-Q1).  
 
4.2 Aim Two: To examine the overall mean PPT, overall median PPT, PPTmean 
and PPTmedian by genders at each of the 17 PPT measurement sites 
Research questions:  
a) Was there a difference in overall mean PPT between genders?  
b) Was there a difference in overall median PPT between genders? 
c) Was there a difference in mean PPTmean between genders?  
d) Was there a difference in mean PPTmedian between genders? 
 
The influence of gender on PPT of each measurement site was systematically examined from 
different perspectives, namely the overall mean PPT, the overall median PPT, the mean PPTmean 
(PPTmean = mean of three PPT measures within session) and the mean PPTmedian (PPTmedian = 































Figure 4.1: The boxplots of PPT measures at 17 
measurement sites by gender, showing the lower 
and upper fences, interquartiles, outliers, median, 
mean (red dot) with standard deviation (red double 
arrows), width of box proportional to the square 
root of the sample size, skewness and the notched 
boxplots. 
 
As seen in the notched boxplots, the notches of two boxes at each measurement site for both 





overall PPT. The non-parametric median test with alpha=0.05 showed that p=0.000 in all cases. 
For comparing the means of overall PPT, UNIANOVA by GLM on PPT was employed which 
showed that the mean PPT of males was statistically significantly higher than of females (in all 
cases, p=0.000). Table 4.2 gives the overall mean PPT and overall median PPT at all 17 
measurement sites by gender with F-values by GLM shown for comparison of mean PPT 
between genders. The degrees of freedom for PPT in F were large as repeated measures (3 
readings x 4 visits) were not yet taken into consideration. 
 
Comparing the overall mean PPT or median PPT between genders 
Site Overall Mean PPT Overall Median PPT Female Male F-value Female Male 
LI20L 1.66 2.14 F1,1546 = 107.0 1.60 2.00 
LI20R 1.82 2.38 F1,2290 = 221.5 1.80 2.30 
GB12R 2.94 3.54 F1,1834 = 80.0 2.80 3.10 
2L 4.50 5.53 F1,1774 = 108.2 4.20 5.13 
2R 4.72 5.56 F1,1678 = 83.4 4.55 5.40 
PC6L 3.61 4.30 F1,1306 = 85.5 3.40 4.00 
PC6R 3.94 4.85 F1,2026 = 175.1 3.80 4.50 
LI10L 3.23 4.33 F1,1834 = 178.4 3.00 3.65 
1L 3.37 4.43 F1,1810 = 179.4 3.20 3.90 
1R 3.68 4.55 F1,2290 = 163.3 3.40 4.20 
LI5L 3.34 4.09 F1,1810 = 131.9 3.00 3.88 
LI5R 3.46 4.22 F1,2530 = 167.4 3.15 3.85 
ST36L 5.21 6.97 F1,1738 = 256.4 4.95 6.55 
ST36R 5.07 6.60 F1,2194 = 294.6 4.80 6.30 
3R 4.81 5.99 F1,1942 = 164.0 4.55 5.55 
SP6R 4.36 5.33 F1,1306 = 106.2 4.00 5.10 
KD3R 4.28 5.55 F1,2098 = 234.5 4.05 5.35 
Table 4.2: The overall mean PPT and median PPT at each measurement site by gender. 
 
 
For a more robust analysis, repeated measures ANOVA by GLM were performed to examine 
the difference in mean PPTmean (then mean PPTmedian) between genders (Table 4.3). Test of 
normality and homogeneity of variance at each site by gender were tolerable with robust sample 
size of ≥30. The ANOVA revealed statistically that the males had significantly higher mean 
PPTmean (or mean PPTmedian) than for females at each of the 17 measurement sites (in all cases 
p<0.003 except GB12R with p=0.004). Figure 4.2 shows the bar charts for the overall mean 
PPT, overall median PPT, mean PPTmean and mean PPTmedian by site by gender with error bars of 
95% confidence intervals.  
 
In summary, the males had statistically demonstrated significantly higher means of PPT, 
PPTmean, and PPTmedian than for females at all 17 measurement sites, independent of temporal 





Comparing mean PPTmean (or mean PPTmedian) between genders 
Site PPTmean PPTmedian Female Male F-values Female Male F-values 
LI20L 1.66 2.14 F1,127 = 10.8 1.66 2.14 F1,127 = 10.8 
LI20R 1.82 2.38 F1,189 = 22.8 1.82 2.38 F1,189 = 22.7 
GB12R 2.94 3.54 F1,151 = 8.3 2.93 3.54 F1,151 = 8.4 
2L 4.50 5.53 F1,146 = 11.8 4.51 5.51 F1,146 = 11.0 
2R 4.72 5.56 F1,138 = 9.8 4.72 5.56 F1,138 = 9.8 
PC6L 3.61 4.30 F1,107 = 10.2 3.60 4.31 F1,107 = 10.5 
PC6R 3.94 4.85 F1,167 = 20.6 3.94 4.84 F1,167 = 19.6 
LI10L 3.23 4.33 F1,151 = 18.5 3.22 4.33 F1,151 = 19.2 
1L 3.37 4.43 F1,149 = 20.1 3.37 4.44 F1,149 = 19.8 
1R 3.68 4.55 F1,189 = 18.2 3.68 4.57 F1,189 = 18.5 
LI5L 3.34 4.09 F1,149 = 15.0 3.34 4.07 F1,149 = 14.5 
LI5R 3.46 4.22 F1,209 = 19.5 3.45 4.22 F1,209 = 19.0 
ST36L 5.21 6.97 F1,143 = 30.0 5.21 7.00 F1,143 = 30.6 
ST36R 5.07 6.60 F1,181 = 35.6 5.07 6.58 F1,181 = 34.2 
3R 4.81 5.99 F1,160 = 19.2 4.81 5.96 F1,160 = 18.4 
SP6R 4.36 5.33 F1,107 = 11.8 4.34 5.35 F1,107 = 12.6 
KD3R 4.28 5.55 F1,173 = 27.2 4.29 5.54 F1,173 = 26.4 
Table 4.3: The comparison of mean PPTmean (or mean PPTmedian) between genders by repeated measures 








Figure 4.2: The bar graphs of overall mean PPT, overall median PPT, mean PPTmean and mean PPTmedian 





4.3 Aim Three: To examine the mean PPT and median PPT among the three 
PPT readings by regional site by gender, independent of visits 
 
Research question: Independent of visits, how stable were the mean PPT or median PPT among 
the three readings by gender? 
 
Three PPT readings were recorded for all 17 regional sites during each of the four data 
collection visits. Figure 4.3 shows the overall mean PPT for each of the three measurement 
cycles by regional site and gender with error bars for 95% CI. The repeated measures ANOVA 
on PPT among three PPT readings by Post Hoc Tukey’s test revealed that the mean PPT were 
stable across measurement cycles by gender independent of temporal visits, with p>0.05 in all 
cases (Table 4.4).  Similarly for each site by gender, the non-parametric Median Tests on PPT 
by measurement cycles revealed that the median PPT for each of the three measurement cycles 
were generally stable independent of temporal visits with p>0.05 in all cases (Figure 4.4, Table 
4.4). These results generally supported the stability and reproducibility of regional PPT among 


















Site GLM  Median Test  Female Male Female Male 
LI20L 0.794 0.951 0.645 0.928 
LI20R 0.845 0.923 0.580 0.846 
GB12R 0.767 0.963 0.400 0.927 
2L 0.873 0.973 0.841 0.681 
2R 0.866 0.963 0.212 0.689 
PC6L 0.973 0.974 0.844 0.531 
PC6R 0.991 0.977 0.798 0.636 
LI10L 0.874 0.974 0.532 0.648 
1L 0.986 0.978 0.882 0.967 
1R 0.658 0.925 0.384 0.996 
LI5L 0.984 0.814 0.783 0.943 
LI5R 0.783 0.992 0.966 0.650 
ST36L 0.964 0.963 0.850 0.965 
ST36R 0.692 0.979 0.320 0.631 
3R 0.888 0.969 0.671 0.501 
SP6R 0.833 0.900 0.817 0.973 
KD3R 0.790 0.900 0.526 0.688 
Table 4.4: The p-values of repeated measures ANOVA and the Median Test on PPT by reading, 
independent of visits. In all cases, p>0.05. 
 
 
4.4 Aim Four: To examine the temporal stability of the means of PPTmean and 
PPTmedian across four measurement visits at each regional site by gender 
 







Of interest after obtaining the stability of PPT among measurement cycles, exploration was 
undertaken on whether the regional PPT were stable across temporal sessions irrespective of 
measurement cycles. Hence the focus was to examine whether there was a significant difference 
in means of PPTmean and PPTmedian in subsequent visits V2, V3 and V4 with respect to the means 
in V1. As such, the exploration of outcome measures for multiple interactions among four visits 
and three measurement cycles were selective. 
 
Figure 4.5 provides a graphical view of the 95% confidence interval (CI) of the overall mean 
PPT and overall median PPT obtained at four visits (V1, V2, V3, V4) at 17 measurement sites 
by gender.  
 
 
Figure 4.5: The 95% confidence interval (CI) of overall mean PPT and median PPT by regional site and 




Figure 4.6 gives the means of PPTmean and PPTmedian by gender, regional site and visits. The 
repeated measures ANOVA by GLM on PPTmean and PPTmedian by using Post Hoc tests with 





PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 to V3 and V1 to V4. However, 
Bonferroni corrections with p=0.05/17<0.003 largely reduced the significancy into sites marked 
with red arrow. 
 
 
Figure 4.6: The means of PPTmean and PPTmedian (in kg/cm2) by gender, regional site and session. The 
GLM on PPTmean and PPTmedian between visits revealed some significant increases (*) in the means of 
PPTmean and PPTmedian and a decrease (*) in mean PPTmean across temporal intervals of V1 to V2, V3 and 
V4. Bonferroni corrections yielded only sites marked with red arrow. 
 
 
Figure 4.7 provides the percentage of the 17 regional measurement sites that showed statistical 
significant increase in the means of PPTmean and PPTmedian at interval sessions of V1 to V2, V1 to 
V3, and V1 to V4.  Both Figures 4.6 and 4.7 show a similar pattern among sites for both 
genders, with a trend where sites showed a gradual increase in the means of PPTmean and 
PPTmedian over delayed temporal sessions. Statistically significant effects were more frequent for 
males. Several comparisons of the means of regional PPTmean and PPTmedian values as well as its 
consistency over the extended temporal period are evident. However, Bonferroni adjustment 
had largely corrected the number of sites into none for females and at most one (6%) each for 






Figures 4.6 and 4.7 show that there were gender differences evident in the rate of temporal 
change where the means of PPTmean and PPTmedian for males increased significantly (ie p<0.05) 
at more sites than for females. There were no significant changes in the means of PPTmean and 
PPTmedian thresholds for any site for both genders from Visit 1 to Visit 2. For Visit 3, this effect 
involved 23.5% of sites for means of PPTmean and PPTmedian of males compared with 17.6% for 
females in means of PPTmedian. By Visit 4, these effects were evident for high proportions of 
sites for both means of PPTmean and PPTmedian for females (29.4% in both means) and males 
(47.1% and 52.9% respectively). These findings indicate the importance of recognising the 
presence of temporal drift if PPT measures are used in longitudinal clinical or research studies, 
as well as the need to evaluate findings for the genders separately. The means of PPTmean were 
more stable as compared with means of PPTmedian.  
 
  
Figure 4.7: Percentage of the 17 regional measurement sites that showed statistical significant increase in 
the means of PPTmean and PPTmedian (in kg/cm2) at interval sessions of V1 to V2, V1 to V3, and V1 to V4 




4.5 Aim Five: To determine the relationship between regional PPTmean and 
PPTmedian in Visit 1 (pre-intervention) with age or BMI 
 
Research question: Was there a strong effect of age or BMI onto regional PPTmean and PPTmedian 
collected from Visit 1 at each measurement site by gender? 
 
Figure 4.8 shows the distribution of ages and BMI for the subjects. In view of the study 
inclusion criteria that required healthy adults with no medical history of chronic 
musculoskeletal disorder, it would be expected that the group overwhelmingly comprised 
individuals in the designated healthy weight range (70% of subjects) followed by the 
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with standard deviation (SD) of both females and males at each measurement site. Table 4.6 
gives the distribution of BMI in terms of its classification (NSW 2013).  
 
Figure 4.8: Distribution of age and BMI by gender for the study subjects. 
 
 
Site Female Male N age(SD) BMI(SD) N age(SD) BMI(SD) 
LI20L 71 46.3(12.6) 24.3(4.9) 58 43.8(12.8) 24.6(3.9) 
LI20R 105 38.6(14.3) 23.3(4.4) 86 38.2(13.4) 24.2(3.5) 
GB12R 83 43.6(13.5) 23.9(4.6) 70 40.7(13.3) 24.2(3.7) 
2L 83 42.7(13.7) 23.6(4.5) 65 40.7(13.1) 24.3(3.7) 
2R 80 41.7(14.6) 23.6(4.5) 60 42.6(13.0) 24.6(3.9) 
PC6L 61 45.9(12.2) 24.0(4.8) 48 44.1(12.7) 24.9(3.8) 
PC6R 93 42.0(14.6) 23.8(4.5) 76 41.3(13.1) 24.4(3.7) 
LI10L 83 43.6(13.5) 23.9(4.6) 70 40.7(13.3) 24.2(3.7) 
1L 82 41.9(13.6) 23.8(4.8) 69 39.6(14.0) 24.3(3.6) 
1R 105 40.0(14.6) 23.4(4.5) 86 39.4(13.2) 24.3(3.6) 
LI5L 83 41.1(13.7) 23.5(4.7) 68 39.5(13.7) 24.3(3.6) 
LI5R 115 39.1(14.6) 23.5(4.5) 96 38.4(13.4) 24.0(3.5) 
ST36L 80 42.1(13.8) 23.8(5.0) 65 40.5(14.0) 24.3(3.8) 
ST36R 102 39.0(14.2) 23.3(4.4) 81 38.8(13.4) 24.2(3.6) 
3R 91 40.2(14.3) 23.5(4.3) 71 40.4(13.1) 24.3(3.7) 
SP6R 61 48.7(10.8) 24.3(5.0) 48 47.1(10.6) 25.1(4.0) 
KD3R 94 41.8(13.7) 23.7(4.8) 81 39.0(13.6) 24.1(3.5) 
Table 4.5: The distribution of age and BMI by gender in each measurement site. 
 
 
Gender Classification of BMI Percentage 
Female 
Underweight 7.0% 





Healthy Weight 63.4% 
Overweight 28.7% 
Obese 5.9% 





For examining the relationship between regional PPTmean and PPTmedian with age and BMI, the 
PPTmean and PPTmedian in Visit 1 (no intervention) of each subject with known age and BMI was 
used. Figure 4.9 gives the scatterplots of PPTmean and PPTmedian with age and BMI which provide 
evidence of heteroscedasticity in the relationships among the parameters with presence of some 
noise at some PPT measurement sites. 
 
 
Figure 4.9a: The scatterplots of PPTmean and PPTmedian with age. 
 
 








Figure 4.9c: The scatterplots of PPTmean and PPTmedian with BMI (kg/m2). 
 
 
Table 4.7 shows the Pearson correlation coefficients between PPTmean and age, PPTmean and 
BMI, age and BMI whilst Table 4.8 gives the similar details for PPTmedian. There were no strong 
effect of age or BMI onto PPTmean at all measurement sites with the maximum correlation 
coefficients occurred at LI20R (R = -0.259 between PPTmean and age) for en bloc, at PC6L (R = 
0.338 between PPTmean and BMI) for females, and at LI20L (R = -0.333 between PPTmean and 
age) for males. Similarly, there were no strong effect of age or BMI on PPTmedian at all 
measurement sites with the maximum correlation coefficients occurring at LI20R (R = -0.268 
between PPTmedian and age) for en bloc, at PC6L (R = 0.336 between PPTmedian and BMI) for 
females, and at 1L (R = -0.348 between PPTmedian and BMI) for males. 
 
Research question: How was the relationship of PPTmean  or PPTmedian with gender, age and 
BMI? 
 
Table 4.9 gives the stepwise multiple regression established based on the relationship of gender, 










Pearson correlation coefficients between PPTmean and age, PPTmean and BMI, age and BMI 
En Bloc Female Male 
PPTmean & age PPTmean & BMI BMI & age PPTmean & age PPTmean & BMI BMI & age PPTmean & age PPTmean & BMI BMI & age 
LI20L -0.234 -0.021 0.019 -0.114 0.104 -0.124 -0.333 -0.218 0.249 
LI20R -0.259 0.013 0.208 -0.268 0.054 0.174 -0.264 -0.123 0.279 
GB12R -0.089 0.002 0.089 -0.031 0.072 -0.042 -0.124 -0.137 0.303 
2L -0.162 0.066 0.134 -0.120 0.170 0.038 -0.187 -0.125 0.305 
2R -0.106 0.154 0.163 -0.185 0.147 0.105 -0.016 0.125 0.262 
PC6L 0.140 0.239 0.061 0.154 0.338 -0.009 0.150 0.026 0.190 
PC6R 0.025 0.041 0.094 0.099 0.198 0.002 -0.045 -0.224 0.261 
LI10L -0.036 -0.013 0.089 0.103 0.147 -0.042 -0.131 -0.250 0.303 
1L -0.033 -0.059 0.161 0.134 0.129 0.099 -0.135 -0.330 0.278 
1R -0.062 0.027 0.178 0.042 0.107 0.139 -0.195 -0.154 0.258 
LI5L -0.003 0.130 0.200 0.128 0.220 0.161 -0.188 -0.100 0.284 
LI5R 0.088 0.091 0.177 0.104 0.187 0.116 0.092 -0.073 0.294 
ST36L -0.058 0.035 0.182 0.158 0.152 0.118 -0.266 -0.181 0.297 
ST36R 0.070 0.055 0.217 0.166 0.186 0.180 -0.032 -0.207 0.291 
3R 0.033 -0.047 0.178 0.059 -0.014 0.106 -0.010 -0.167 0.303 
SP6R -0.019 -0.075 -0.076 0.043 0.037 -0.159 -0.037 -0.288 0.076 
KD3R 0.092 -0.042 0.144 0.151 0.040 0.067 0.091 -0.192 0.286 
Table 4.7: The Pearson product moment correlation coefficient (R) between the PPTmean and age, PPTmean and BMI, age and BMI. Only PPTmean of Visit 1 were considered. 














Pearson correlation coefficients between PPTmedian and age, PPTmedian and BMI, age and BMI 
En Bloc Female Male 
PPTmedian & age PPTmedian & BMI BMI & age PPTmedian & age PPTmedian & BMI BMI & age PPTmedian & age PPTmedian & BMI BMI & age 
LI20L -0.227 -0.031 0.019 -0.111 0.092 -0.124 -0.319 -0.227 0.249 
LI20R -0.268 0.000 0.208 -0.278 0.051 0.174 -0.271 -0.153 0.279 
GB12R -0.100 0.004 0.089 -0.046 0.077 -0.042 -0.128 -0.138 0.303 
2L -0.155 0.053 0.134 -0.094 0.172 0.038 -0.204 -0.159 0.305 
2R -0.094 0.160 0.163 -0.182 0.132 0.105 0.014 0.160 0.262 
PC6L 0.135 0.247 0.061 0.157 0.336 -0.009 0.134 0.055 0.190 
PC6R 0.022 0.045 0.094 0.092 0.206 0.002 -0.044 -0.217 0.261 
LI10L -0.032 -0.007 0.089 0.101 0.159 -0.042 -0.120 -0.252 0.303 
1L -0.025 -0.070 0.161 0.134 0.121 0.099 -0.118 -0.348 0.278 
1R -0.053 0.026 0.178 0.051 0.099 0.139 -0.187 -0.146 0.258 
LI5L 0.000 0.118 0.200 0.124 0.215 0.161 -0.172 -0.126 0.284 
LI5R 0.079 0.090 0.177 0.112 0.187 0.116 0.063 -0.072 0.294 
ST36L -0.072 0.025 0.182 0.123 0.138 0.118 -0.259 -0.182 0.297 
ST36R 0.071 0.057 0.217 0.167 0.187 0.180 -0.035 -0.203 0.291 
3R 0.013 -0.048 0.178 0.050 -0.004 0.106 -0.054 -0.189 0.303 
SP6R -0.027 -0.081 -0.076 0.050 0.026 -0.159 -0.060 -0.291 0.076 
KD3R 0.083 -0.050 0.144 0.148 0.034 0.067 0.082 -0.203 0.286 
Table 4.8: The Pearson product moment correlation coefficient (R) between the PPTmedian and age, PPTmedian and BMI, age and BMI. Only PPTmedian of Visit 1 were 








Site Stepwise multiple regression models 
LI20L PPTmean = 2.681−0.019(age) PPTmean = 2.428−0.018(age)+0.400(gender) 
LI20R PPTmean = 1.781+0.473(gender) PPTmean = 2.356−0.015(age)+0.461(gender) 
GB12R PPTmean = 2.714+0.433(gender) 
2L PPTmean = 4.189+0.951(gender) 
2R PPTmean = 4.550+0.630(gender) 
PC6L PPTmean = 1.893+0.081(BMI) 
PC6R PPTmean = 3.782+0.759(gender) 
LI10L PPTmean = 3.167+0.869(gender) 
1L PPTmean = 3.278+0.779(gender) 
1R PPTmean = 3.597+0.691(gender) 
LI5L PPTmean = 3.238+0.465(gender) 
LI5R PPTmean = 3.324+0.599(gender) 
ST36L PPTmean = 4.987+1.416(gender) 
ST36R PPTmean = 4.881+1.241(gender) 
3R PPTmean = 4.735+0.803(gender) 
SP6R PPTmean = 4.252+1.022(gender) 
KD3R PPTmean = 4.240+0.893(gender) 
Table 4.9a: The stepwise multiple regression models of PPTmean with age and BMI. 
 
 
Site Stepwise multiple regression models 
LI20L PPTmedian = 2.643−0.019(age) PPTmedian = 2.390−0.017(age)+0.402(gender) 
LI20R PPTmedian = 1.763+0.486(gender) PPTmedian = 2.355−0.015(age)+0.473(gender) 
GB12R PPTmedian = 2.693+0.451(gender) 
2L PPTmedian = 4.169+0.993(gender) 
2R PPTmedian = 4.550+0.630(gender) 
PC6L PPTmedian = 1.782+0.085(BMI) 
PC6R PPTmedian = 3.788+0.716(gender) 
LI10L PPTmedian = 3.162+0.882(gender) 
1L PPTmedian = 3.265+0.780(gender) 
1R PPTmedian = 3.590+0.714(gender) 
LI5L PPTmedian = 3.220+0.464(gender) 
LI5R PPTmedian = 3.317+0.612(gender) 
ST36L PPTmedian = 4.965+1.418(gender) 
ST36R PPTmedian = 4.894+1.181(gender) 
3R PPTmedian = 4.709+0.763(gender) 
SP6R PPTmedian = 4.227+1.058(gender) 
KD3R PPTmedian = 4.191+0.976(gender) 
Table 4.9b: The stepwise multiple regression models of PPTmedian with age and BMI. 
 
 
The stepwise regression revealed that BMI was a significant factor with regression coefficients 





females, R=0.026 for males; PPTmedian: R=0.247 for en bloc, R=0.336 for females, R=0.055 for 
males). Other than PC6L, gender was found to be significant predictors to PPTmean and PPTmedian 
at 16 sites. Two sites (LI20L and LI20R) involved age and gender as significant factors to 




4.6 Aim Six: To examine the temporal stability of the adjusted means of 
PPTmean and PPTmedian with age as covariate across the four measurement visits at 
LI20L and LI20R by gender 
 
Research question: How stable were the adjusted means of the PPTmean and PPTmedian with age 
across the four measurement occasions at LI20L and LI20R? 
 
At LI20L and LI20R (Table 4.9), a repeated measures analysis of covariance (ANCOVA) was 
conducted on PPTmean and PPTmedian by using age as the covariate at α=0.05. The multiple 
comparisons of Sidak for visits revealed no significant differences in the adjusted means of 
PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 to V3 and V1 to V4 (Figure 
4.10). This approach has adjusted the mean PPTmean in V2 and mean PPTmedian in V4 at LI20R of 
females from the presence of significant differences to no significant differences from 
corresponding means in V1. 
 
 
Figure 4.10: The adjusted means of PPTmean and PPTmedian by gender at LI20L and LI20R in four visits 
with age as covariate. The ANCOVA by GLM on PPTmean and PPTmedian between visits revealed no 
































































4.7 Aim Seven: To examine the temporal stability of the adjusted means of 
PPTmean and PPTmedian with BMI as covariate across the four measurement visits at 
PC6L by gender 
 
Research question: How stable were the adjusted means of the PPTmean and PPTmedian at PC6L 
with BMI as covariate across the four measurement occasions? 
 
The PPTmean and PPTmedian of PC6L were analysed with a repeated measures analysis of 
covariance (ANCOVA), using BMI as the covariate at α=0.05. The multiple comparisons of 
Sidak for visits revealed no significant differences in the adjusted means of PPTmean and 
PPTmedian across temporal sessions of V1 to V2, V1 to V3 and V1 to V4. Figure 4.11 gives the 
adjusted means of PPTmean and PPTmedian with BMI as covariate by gender and visit.  
 
 
Figure 4.11: The adjusted means of PPTmean and PPTmedian by gender at PC6L in four visits with BMI as 
covariate. The ANCOVA by GLM on PPTmean and PPTmedian between visits revealed no significant 





































4.8 Aim Eight: To compare the means of PPTmean and PPTmedian between BMI 
groups by gender at Visit 1, then with BMI as covariate 
 
Research question: Was there a difference in the means of regional PPTmean  and PPTmedian 
between BMI groups for each gender in Visit 1 only? Then with BMI as covariate? 
 
At PC6L, the subjects were being categorised according to the BMI classification into four BMI 
groups (Table 4.10). However, due to small sample sizes, data analysis involving Underweight 
for both genders and Obese for males were not carried out.  
 
Site Female Male UW HW OW OB UW HW OW OB 
PC6L 3 40 10 8 1 25 18 4 
UW:Underweight; HW: Healthyweight; OW:Overweight; OB:Obese 
Table 4.10: The number of subjects by BMI-group by gender at PC6L. 
 
 
The one-way ANOVA was employed to compare the means of PPTmean and PPTmedian in Visit 1 
between BMI groups (HW, OW and OB of females, HW and OW of males) for PC6L by gender. 
Table 4.11 provides the means of PPTmean and PPTmedian with associated standard deviations for 
Healthy Weight and Overweight by gender and F-values by ANOVA. Healthy Weight had 
significantly lower means of PPTmean and PPTmedian than the Overweight for females. For Obese 
of females, ANOVA was used in comparing the means of PPTmean  and PPTmedian between Obese 
and Healthy Weight or Overweight. The results revealed that Healthy Weight had significantly 
lower means of PPTmean  and PPTmedian than the Obese at PC6L. 
 
Comparing means of PPTmean and PPTmedian between Healthy and Overweight in Visit 1 
  Healthy weight Overweight F 
Female PPTmean 3.35(1.28) 4.47(1.75) F1,48=5.21* PPTmedian 3.32(1.29) 4.52(1.89) F1,48=5.69* 
Male PPTmean 3.96(1.27) 4.39(1.50) F1,41=1.02 PPTmedian 3.93(1.29) 4.43(1.54) F1,41=1.36 
Table 4.11: The mean (SD) of PPTmean of PC6L in Visit 1 and the results of one-way ANOVA on 
PPTmean and PPTmedian between Healthy Weight and Overweight by gender. The asterisk indicates p<0.05. 
 
 
Table 4.12 provides the adjusted means of PPTmean and PPTmedian associated standard errors for 
Healthy Weight and Overweight by gender and F-values by UNIANOVA on PPTmean and 
PPTmedian with BMI as covariate. The results revealed that there were no significant differences 
(p>0.05 in all comparisons) between the adjusted means of PPTmean and PPTmedian for BMI 





Comparing adjusted means of PPTmean and PPTmedian between Healthy and Overweight in Visit 1 
with BMI as covariate 
  Healthy weight Overweight p 
Female PPTmean 3.56(0.24) 3.63(0.63) F1,47=0.01 PPTmedian 3.54(0.25) 3.64(0.65) F1,47=0.02 
Male PPTmean 3.90(0.40) 4.49(0.52) F1,40=0.52 PPTmedian 3.86(0.41) 4.52(0.53) F1,40=0.63 
Table 4.12: The adjusted mean (SE) of PPTmean of PC6L in Visit 1 and the results of univariate ANOVA 




4.9 Aim Nine: To examine the stability of the means of regional PPTmean and 
PPTmedian of PC6L across visits by BMI-group by gender, then with BMI as 
covariate 
 
Research question: How stable were the means of regional PPTmean and PPTmedian of PC6L 
between follow-up visits and baseline visit by BMI-group by gender? Then with BMI as 
covariate? 
 
The repeated measures ANOVA by GLM using Sidak multiple comparisons for visits by BMI-
group by gender revealed no significant differences (p>0.05 in all cases) in the means of 
PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 to V3 and V1 to V4 (Figure 




Figure 4.12 The bar graphs of mean PPTmean of PC6L across four consecutive visits by selected BMI 







As outlined before Section 4.1, the previous UTS PPT studies (Studies 1 to 6) included various 
types of interventions whilst the current Study 7 was of a non-intervention design. Hence two 
treatment groups were established, namely the Intervention that included pre-intervention 
regional PPT database (Studies 1 to 6), and the Control group with PPT database from the non-
intervention (Study 7).  
 
Sections 4.10 to 4.17 reported the results from data analyses on PPT database grouped 
according to treatment groups. 
 
 
4.10 Aim Ten: To examine, by Intervention and Control groups, the stability of 
the means and medians of overall regional PPT among the three measurement 
cycles by gender 
 
Research question: In general, by treatment groups by gender, how stable were the means or 
medians of regional PPT across three measurement cycles independent of visit? 
 
Figure 4.13 shows the overall mean PPT for each of the three measurement cycles by treatment 
group, site and gender. With treatment by gender, the repeated measures ANOVA on PPT 
among measurement cycles by Post Hoc Tukey’s test revealed that the means of regional PPT 
were stable across measurement cycles independent of temporal visits, with p>0.05 in all cases.  
Similarly, the non-parametric Median Tests on PPT by measurement cycles revealed that the 
medians of regional PPT for each of the three measurement cycles were generally stable with 
p>0.05 in all cases for each site (Figure 4.14). These results were consistent with the results for 
combined group as outlined in Section 4. 
 
 
Figure 4.13: The mean PPT for three measurement cycles at 17 regional sites by treatment group by 





Figure 4.14: The median PPT for three measurement cycles at 17 regional sites by treatment group by 
gender, independent of visit. 
 
 
4.11 Aim 11: To examine, by treatment group by gender, the temporal stability 
of the means of PPTmean and PPTmedian across the four measurement visits at each 
regional site. 
 
Research question: Separately by treatment by gender, how stable were the means of regional 
PPTmean and PPTmedian across the four measurement occasions? 
 
By treatment group by gender, Figures 4.15 and 4.17 give the means of PPTmean and PPTmedian at 
each regional site and visits. The GLM by using Post Hoc tests for visits with Tukey’s multiple 
comparisons by Sidak adjustments revealed some significant increases (*) in the means of 
PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 to V3 and V1 to V4 whilst 
Bonferroni corrections with p=0.05/17<0.003 yielded a more conservative outome with less 
noise. Figures 4.16 and 4.18 provides the percentage of the 17 regional measurement sites that 
showed statistical significant increase in the means of PPTmean and PPTmedian at interval sessions 
of V1 to V2, V1 to V3, and V1 to V4 for Intervention before and after Bonferroni corrections. 
Figures 4.15 to 4.18 show a similar pattern for both Intervention and Control groups, among 
sites by gender, with a trend where sites showed a gradual increase in the means of PPTmean and 
PPTmedian over delayed temporal sessions whilst the Control demonstrated a stable means of 
PPTmean and PPTmedian across temporal sessions. For the Intervention, statistically significant 
effects were more frequent for males. The higher percentages acquired by Intervention at V3 
and V4 would imply the possible remaining of washout effects from other interventions on top 







Figure 4.15: The means of PPTmean by treatment, gender, regional site and session. The GLM on PPTmean 
between visits revealed some significant increases with p<0.05 (denoted by +) in the means of PPTmean 
across temporal intervals of V1 to V2, V3 and V4 whilst Bonferroni correction yielded a more 




Figure 4.16: Percentage of the 17 regional measurement sites that showed statistical significant increase 
in the means of PPTmean at interval sessions of V1 to V2, V1 to V3, and V1 to V4 for females (blue) and 
males (red) for Intervention before and after Bonferroni corrections.  
 
V1 to V2 V1 to V3 V1 to V4 V1 to V2 V1 to V3 V1 to V4
0.003<p<0.05 p<0.003
Female 0.0% 29.4% 64.7% 0.0% 0.0% 41.2%







Percentage of significant increase in means of PPTmean across visits 






Figure 4.17: The mean of PPTmedian by treatment, gender, site and session. The GLM on PPTmedian 
between visits revealed some significant increases with p<0.05 (denoted by +) in the means of PPTmedian 
across temporal intervals of V1 to V2, V3 and V4 whilst Bonferroni correction yielded a more 




Figure 4.18: Percentage of the 17 regional measurement sites that showed statistical significant increase 
in the means of PPTmedian at interval sessions of V1 to V2, V1 to V3, and V1 to V4 for females (blue) and 
males (red) Intervention before and after Bonferroni corrections. 
 
 
4.12 Aim 12: To compare the means of PPTmean and PPTmedian between 
treatment groups by gender in overall visits and in Visit 1 only 
V1 to V2 V1 to V3 V1 to V4 V1 to V2 V1 to V3 V1 to V4
0.003<p<0.05 p<0.003
Female 0.0% 29.4% 64.7% 0.0% 0.0% 41.2%







Percentage of significant increase in means of PPTmedian across visits 





Research question: By gender, was there a difference in the means of regional PPTmean and 
PPTmedian between treatment groups in overall visits and in Visit 1 only? 
 
The repeated measures ANOVA by GLM with Sidak and Bonferroni adjustments was 
employed to compare the means of PPTmean and PPTmedian between treatment groups for all 
measurement sites by gender in overall visits whilst a one-way ANOVA was employed for Visit 
1 only. Table 4.13 provides the means of PPTmean and PPTmedian for overall visits at each 
treatment group of females with its F-values by GLM between treatment groups. The GLM 
results revealed that five sites (LI20L, LI20R, GB12R, 2L, 2R) showed significant increase in 
each of the means of PPTmean or PPTmedian from Control to Intervention whilst three sites (LI20R, 
2L, ST36R for PPTmean; LI20L, LI20R, ST36R for PPTmedian) had shown significant increase in 
Visit 1 in which ST36R did not show significant difference in the respective means in overall 
visits. Table 4.14 provides the means of PPTmean  and PPTmedian for overall visits at each 
treatment group of males with its F-values by GLM between treatment groups. The GLM results 
revealed that ten sites (LI20L, LI20R, GB12R, 2L, LI10L, 1L, 1R, LI5L, ST36L, 3R) showed 
significant increase in each of the mean of PPTmean  or PPTmedian from Control to Intervention in 
which six sites (LI20L, LI20R, GB12R, LI10L, 1L, ST36L) had shown significant increase in 
the means in Visit 1.  
 
Comparing means of PPTmean and PPTmedian between treatment groups of females 
Site 
PPTmean PPTmedian 
Mean GLM Mean GLM 
Control Intervention F Control Intervention F 
LI20L 1.44 2.16 F1,69=20.9* 1.43 2.15 F1,69=20.7*1 
LI20R 1.50 2.11 F1,103=23.3*1 1.49 2.11 F1,103=24.4*1 
GB12R 2.65 3.35 F1,81=9.4* 2.62 3.36 F1,81=10.1* 
2L 3.98 5.24 F1,81=13.6*1 4.00 5.23 F1,81=12.6* 
2R 4.39 5.24 F1,78=6.5+ 4.39 5.22 F1,78=6.1+ 
PC6L 3.69 3.24 F1,59=1.6 3.69 3.22 F1,59=1.6 
PC6R 3.79 4.10 F1,91=1.9 3.78 4.11 F1,91=2.1 
LI10L 3.04 3.51 F1,81=3.2 3.03 3.50 F1,81=3.2 
1L 3.30 3.48 F1,80=0.6 3.28 3.49 F1,80=0.8 
1R 3.45 3.89 F1,103=3.2 3.45 3.88 F1,103=3.0 
LI5L 3.48 3.14 F1,81=1.7 3.47 3.14 F1,81=1.6 
LI5R 3.39 3.50 F1,113=0.3 3.40 3.49 F1,113=0.2 
ST36L 5.38 4.95 F1,78=1.3 5.36 4.97 F1,78=1.2 
ST36R 5.34 4.82 F1,100=2.91 5.35 4.81 F1,100=3.01 
3R 4.88 4.73 F1,89=0.2 4.86 4.75 F1,89=0.1 
SP6R 4.43 4.04 F1,59=0.9 4.42 4.02 F1,59=0.9 
KD3R 4.49 4.05 F1,92=2.6 4.49 4.07 F1,92=2.6 
Table 4.13: Comparisons by GLM on means of PPTmean and PPTmedian between treatment groups of 
females where * indicates p<0.003 (Bonferroni correction) and + for p<0.05 for comparisons in overall 







Comparing means of PPTmean and PPTmedian between treatment groups of males 
Site 
PPTmean PPTmedian 
Mean GLM Mean GLM 
Control Intervention F Control Intervention F 
LI20L 1.76 2.77 F1,56=19.7*1 1.76 2.75 F1,56=18.7*1 
LI20R 1.84 2.77 F1,84=30.1*1 1.83 2.77 F1,84=30.3*1 
GB12R 2.82 4.30 F1,68=22.3*1 2.83 4.28 F1,68=20.9*1 
2L 4.79 6.45 F1,63=13.2* 4.76 6.43 F1,63=13.2* 
2R 5.26 6.01 F1,58=3.0 5.29 5.95 F1,58=2.3 
PC6L 4.35 4.17 F1,46=0.2 4.35 4.19 F1,46=0.2 
PC6R 4.53 5.14 F1,74=3.1 4.52 5.13 F1,74=3.1 
LI10L 3.48 5.24 F1,68=18.0*1 3.48 5.24 F1,68=18.1*1 
1L 3.65 5.29 F1,67=16.5*1 3.65 5.29 F1,67=15.9*1 
1R 3.94 5.00 F1,84=11.0* 3.96 5.01 F1,84=10.4* 
LI5L 3.70 4.53 F1,66=9.4+ 3.68 4.51 F1,66=9.0+ 
LI5R 3.90 4.41 F1,94=3.1 3.89 4.42 F1,94=3.3 
ST36L 6.18 7.96 F1,63=11.5*1 6.19 8.02 F1,63=11.7*1 
ST36R 6.33 6.81 F1,79=1.3 6.33 6.79 F1,79=1.1 
3R 5.47 6.52 F1,69=6.6+ 5.45 6.49 F1,69=6.5+ 
SP6R 5.31 5.41 F1,46=0.0 5.34 5.40 F1,46=0.0 
KD3R 5.37 5.70 F1,79=0.6 5.37 5.68 F1,79=0.5 
Table 4.14: Comparisons by GLM on means of PPTmean and PPTmedian between treatment groups of males 
where * indicates p<0.003 (Bonferroni correction) and + for p<0.05 for comparisons in overall visits and 1 
in Visit 1 only. 
 
 
4.13 Aim 13: To examine, by treatment by gender, the temporal stability of the 
adjusted means of PPTmean and PPTmedian at LI20L and LI20R with age as 
covariate across the four measurement visits 
 
Research question: By treatment by gender, how stable were the adjusted means of the PPTmean 
and PPTmedian with age across the four measurement occasions at LI20L and LI20R? 
 
As derived from stepwise multiple regression equations in Table 4.9, the factor age played a 
significant role in PPTmean and PPTmedian at LI20L and LI20R. Hence, by treatment group and 
gender, a repeated measures analysis of covariance (ANCOVA) was conducted on PPTmean and 
PPTmedian by using age as the covariate at α=0.05. The multiple comparisons of Sidak for visits 
revealed nine significant increases (p<0.05 for + and p<0.025 for * for Bonferroni corrections) 
in the adjusted means of PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 to V3 
and V1 to V4 (Figure 4.19). This attempt has adjusted the means of PPTmean and PPTmedian in V4 
of males and PPTmedian in V3 of females at LI20L from presence of significant differences to no 







Figure 4.19: By treatment group by gender, the adjusted means of PPTmean and PPTmedian by gender at 
LI20L and LI20R in four visits with age as covariate. The ANCOVA by GLM on PPTmean and PPTmedian 
between visits revealed nine significant differences (p<0.05 for + and p<0.025 for *) in the adjusted 




4.14 Aim 14: To examine, by treatment by gender, the temporal stability of the 
adjusted means of PPTmean and PPTmedian with BMI as covariate across the four 
measurement visits at PC6L 
 
Research question: By treatment by gender, how stable were the adjusted means of the PPTmean 
and PPTmedian at PC6L with BMI as covariate across the four measurement occasions? 
 
The stepwise multiple regression equations in Table 4.9 indicated that BMI was a significant 
factor in PPTmean and PPTmedian at PC6L. Hence, by treatment by gender, the PPTmean and 
PPTmedian at PC6L were analysed with a repeated measures analysis of covariance (ANCOVA), 
using BMI as the covariate at α=0.05. The multiple comparisons of Sidak for visits revealed 
four significant increases in the adjusted means of PPTmean and PPTmedian across temporal 
sessions of V1 to V2, V1 to V3 and V1 to V4 (Figure 4.20). This adjustment has reduced the 
number of significant increases from seven to four (excluded V4 of PPTmean and PPTmedian for 








Figure 4.20: By treatment by gender, the Sidak adjusted means of PPTmean and PPTmedian at PC6L in four 
visits with BMI as covariate. The ANCOVA by GLM on PPTmean and PPTmedian between visits revealed 
four significant increases in the adjusted means across temporal intervals of V1 to V2, V3 and V4. 
 
Sections 4.15 to 4.17 focused on PC6L in which BMI was reported as a significant factor in the 
regression models (Table 4.9). Table 4.15 shows the frequency distribution of subjects recruited 
in each BMI-group by treatment group by gender for PC6L. Due to small sample sizes, data 
analyses by non-parametric test were performed on Healthy Weight between treatment groups 
for both genders; on Healthy Weight, Overweight and Obese of females and Healthy Weight 




Intervention Control Intervention Control 
UW HW OW OB UW HW OW OB UW HW OW OB UW HW OW OB 
0 11 1 0 3 29 9 8 0 11 1 0 1 14 17 4 
UW:Underweight; HW: Healthy Weight; OW:Overweight; OB:Obese 
Table 4.15: The frequency distribution of subjects in each BMI group by treatment by gender for PC6L. 
 
 
4.15 Aim 15: To compare, at PC6L of Healthy Weight by gender, the means of 
PPTmean and PPTmedian between treatment groups in overall visits and in Visit 1 
only 
 
Research question: At PC6L of Healthy Weight, was there a difference in the means of regional 
PPTmean  and PPTmedian between treatment groups for each gender in overall visits and in Visit 1 
only? 
 
At PC6L of Healthy Weight by gender, a repeated measures ANOVA by GLM was employed 





a one-way ANOVA was employed for Visit 1 only. Table 4.16 provides the means of PPTmean 
and PPTmedian for overall visits by treatment by gender with F-values by repeated measures 
ANOVA for overall visits and one-way ANOVA for Visit 1 between treatment groups. The 
ANOVA results revealed that no significant differences in the means of PPTmean and PPTmedian 
for overall visits and Visit 1 between Intervention and Control for both genders. 
 
Comparing means of PPTmean and PPTmedian between treatment groups 
Gender 
PPTmean PPTmedian 
Mean ANOVA Mean ANOVA 
Control Intervention Overall Visit 1 Control Intervention Overall Visit 1 
Female 3.37 3.24 F1,38=0.2 F1,38=1.4 3.35 3.22 F1,38=0.2 F1,38=1.4 
Male 4.21 4.29 F1,23=0.0 F1,23=1.1 4.19 4.3 F1,23=0.1 F1,23=0.5 
Table 4.16: Comparisons of means of PPTmean and PPTmedian at PC6L of Healthy Weight between 
treatment groups by gender. The GLM with Sidak adjustment revealed no significant differences (p>0.05) 
in the means between treatment groups in all cases.  
 
 
4.16 Aim 16: To examine, at PC6L of Control, the means of PPTmean and 
PPTmedian between BMI groups by gender at Visit 1, then with BMI as covariate 
 
Research question: At PC6L of Control, was there a difference in the means of regional PPTmean  
and PPTmedian between BMI groups for each gender in Visit 1 only? Then with BMI as covariate? 
 
At PC6L of Control, the univariate ANOVA was employed to compare the means of PPTmean  
and PPTmedian in Visit 1 between BMI groups (HW, OW and OB of females, HW and OW of 
males) by gender. Table 4.17 provides the means of PPTmean and PPTmedian for BMI groups at 
PC6L of Control by gender and F-values by ANOVA whereby Bonferroni correction would 
waive p=0.045 as significant difference between HW and OW of females for PPTmedian.  
 
Comparing the means of PPTmean and PPTmedian between BMI groups in Visit 1 
  Healthy weight Overweight GLM 
Female PPTmean 3.50 4.59 F1,36= 3.968 PPTmedian 3.47 4.66 F1,36= 4.314* 
Male PPTmean 4.20 4.51 F1,29=  0.373 PPTmedian 4.10 4.55 F1,29= 0.761 
 Healthy Weight Obese GLM 
Female PPTmean 3.50 4.65 F1,35= 3.629 PPTmedian 3.47 4.59 F1,35= 3.437 
 Overweight Obese GLM 
Female PPTmean 4.59 4.65 F1,15= 0.003 PPTmedian 4.66 4.59 F1,15= 0.005 
 
Table 4.17: The means of PPTmean and PPTmedian of PC6L of Control in Visit 1 and the results of 
univariate ANOVA on PPTmean and PPTmedian between BMI groups (HW, OW and OB of females, HW 
and OW of males) by gender. The asterisk * indicates p=0.045<0.05. Note that Bonferroni adjustment 







Table 4.18 provides the adjusted means of PPTmean and PPTmedian for BMI groups for both 
genders (HW, OW and OB of females, HW and OW of males) by gender and F-values by 
UNIANOVA on PPTmean and PPTmedian with BMI as covariate (p>0.05 in all cases). The results 
revealed that there were no significant differences (p>0.05 in all comparisons) between the 
adjusted means of PPTmean and PPTmedian for BMI groups for both genders (HW, OW and OB of 
females, HW and OW of males) at PC6L in Visit 1. 
 
Comparing adjusted means of PPTmean and PPTmedian between BMI groups in Visit 1 
 with BMI as covariate 
  Healthy weight Overweight GLM 
Female PPTmean 3.75 3.81 F1,47=0.005 PPTmedian 3.74 3.78 F1,47=0.002 
Male PPTmean 4.33 4.40 F1,40=0.004 PPTmedian 4.28 4.40 F1,40=0.014 
 Healthy Weight Obese GLM 
Female PPTmean 3.48 4.71 F1,34=0.721 PPTmedian 3.49 4.52 F1,34=0.509 
 Overweight Obese GLM 
Female PPTmean 4.37 4.90 F1,14=0.102 PPTmedian 4.46 4.81 F1,14=0.042 
Table 4.18: The adjusted means of PPTmean of PC6L of Control in Visit 1 and the results of univariate 
ANOVA on PPTmean and PPTmedian between BMI groups (HW, OW and OB of females, HW and OW of 





4.17 Aim 17: To examine, at PC6L of Control, the stability of the means of 
regional PPTmean and PPTmedian across visits by BMI-group by gender, then with 
BMI as covariate 
 
Research question: How stable were the means of regional PPTmean and PPTmedian of PC6L of 
Control between follow-up visits and baseline visit by BMI-group by gender? Then with BMI as 
covariate? 
 
The repeated measures ANOVA by GLM using Sidak multiple comparisons for visits by BMI-
group by gender revealed no significant differences (p>0.05 in all cases) in the means of 
PPTmean and PPTmedian at PC6L of Control across temporal sessions of V1 to V2, V1 to V3 and 
V1 to V4 (Figure 4.21). The results remained unchanged (p>0.05 in all cases) with adjusted 







Figure 4.21: The bar graphs of mean PPTmean and mean PPTmedian of PC6L at Control across four 
consecutive visits by selected BMI groups by gender.  
 
For Section 4.18, only the PPT database from the unilateral LI4m+21 (LI4R) intervention was 
established to explore the stability of PPTmean and PPTmedian after intervention. Whilst all 
intervention studies involved LI4m+21, Studies 1, 2, 3 and 6 involved LI4R and Studies 4 and 5 
applied bilateral LI4. As such, there were 15 measurement sites (excluded LI20L and SP6R) 
being included in the data analysis.  
 
4.18 Aim 18: To compare the means of absolute and relative differences of 
PPTmean and PPTmedian respectively between post-intervention and pre-intervention 
during LI4R intervention 
 
Research questions:  
a. Did the intervention LI4R affect the means of absolute difference of PPTmean between 
pre and post interventions? 
b. Did the intervention LI4R affect the means of absolute difference of PPTmedian between 
pre and post interventions? 
c. Did the intervention LI4R affect the means of relative difference of PPTmean between pre 
and post interventions? 
d. Did the intervention LI4R affect the means of relative difference of PPTmedia between pre 
and post interventions? 
A one-sample t-test was conducted to determine whether the means of absolute and relative 
differences of PPTmean and PPTmedian was the same as the test value of zero at alpha level of 0.05. 
Bonferroni correction with p<0.05/15=0.003 was employed to compromise the familywise error 





difference (MD) yielded by t-test at 15 measurement sites by gender. The results in Table 4.19a 
revealed that all sites for both genders except GB12R, 2L, PC6L, LI10L and KD3R for females 
and 2L, PC6R, 1R, ST36L, ST36R and KD3R for males, had displayed significant increase in 
the mean absolute difference of PPTmean from zero whereby the mean differences of absolute 
difference between post and pre PPTmean varied from 0.24kg/cm2 (LI20R) to 0.74kg/cm2 
(ST36R) for females and from 0.37kg/cm2 (ST36R) to 1.01kg/cm2 (2R) for males. The results in 
Table 4.19b revealed that all sites for both genders except seven (GB12R, 2L, PC6L, LI10L, 
LI5L, ST36L, KD3R) for females and seven (2R, PC6L, PC6R, 1R, ST36L, ST36R, KD3R) for 
males, had displayed significant increase in the mean absolute difference of PPTmedian from zero 
in which the mean differences of absolute difference between post and pre PPTmedian varied from 
0.22kg/cm2 (LI20R) to 0.70kg/cm2 (ST36R) for females and from 0.25kg/cm2 (ST36L) to 
1.06kg/cm2 (2R) for males. For relative differences, the results in Table 4.19c revealed that all 
sites for both genders except 2L, PC6L, LI10L, ST36L and KD3R for females and 2L, PC6R, 
1R and ST36L for males, had displayed significant increase in the mean difference of PPTmean 
from zero whereby the mean differences of relative difference between post and pre PPTmean 
varied from 8% (2L) to 20% (PC6R) for females and from 6% (ST36L and ST36R) to 20% 
(LI5R) for males. Table 4.19d revealed that all sites for both genders except four sites (2L, 
PC6L, LI10L, ST36L) for females, and seven sites (PC6L, PC6R, 1R, ST36L, ST36R, KD3R) 
for males, had displayed significant increase in the mean relative difference of PPTmedian from 
zero in which the mean differences of relative difference between post and pre PPTmedian varied 
from 7% (2L, ST36L) to 20% (PC6R, LI10L) for females and from 4% (ST36L) to 21% (2R) 
for males. Figure 4.22 displayed Tables 4.19a-d graphically.  
One sample T-test on absolute difference between POST PPTmean and PRE PPTmean 
Site Female Male t p MD t p MD 
LI20R t55=5.5 0.000 0.24 t49=4.9 0.000 0.38 
GB12R t11=3.3 0.007 0.47 t11=4.5 0.001 0.51 
2L t22=2.8 0.011 0.34 t20=3.0 0.007 0.63 
2R t30=6.3 0.000 0.70 t23=3.6 0.001 1.01 
PC6L t11=2.7 0.022 0.30 t11=4.2 0.002 0.68 
PC6R t21=8.6 0.000 0.72 t17=2.3 0.037 0.46 
LI10L t11=3.1 0.010 0.52 t11=4.7 0.001 0.86 
1L t22=4.0 0.001 0.39 t22=3.9 0.001 0.48 
1R t43=5.5 0.000 0.60 t37=2.7 0.011 0.45 
LI5L t33=3.4 0.002 0.28 t31=3.6 0.001 0.54 
LI5R t43=7.2 0.000 0.58 t37=4.6 0.000 0.73 
ST36L t20=3.7 0.001 0.43 t18=1.8 0.089 0.41 
ST36R t52=6.3 0.000 0.74 t44=2.8 0.008 0.37 
3R t41=3.7 0.001 0.49 t34=4.1 0.000 0.61 
KD3R t22=2.3 0.033 0.28 t22=2.9 0.008 0.62 
Table 4.19a: The results of one-sample t-test on absolute difference between POST PPTmean and PRE 






One sample T-test on absolute difference between POST PPTmedian and PRE PPTmedian 
Site Female Male t p MD t p MD 
LI20R t55=4.6 0.000 0.22 t49=4.9 0.000 0.37 
GB12R t11=3.2 0.008 0.43 t11=4.8 0.001 0.46 
2L t22=1.9 0.073 0.27 t20=3.3 0.003 0.71 
2R t30=5.5 0.000 0.68 t23=3.2 0.004 1.06 
PC6L t11=2.1 0.062 0.27 t11=3.2 0.008 0.66 
PC6R t21=8.2 0.000 0.69 t17=1.4 0.183 0.37 
LI10L t11=2.3 0.039 0.51 t11=4.2 0.002 0.91 
1L t22=3.8 0.001 0.37 t22=3.3 0.003 0.53 
1R t43=4.9 0.000 0.59 t37=3.0 0.005 0.51 
LI5L t33=2.7 0.010 0.27 t31=3.5 0.001 0.54 
LI5R t43=6.5 0.000 0.53 t37=4.0 0.000 0.70 
ST36L t20=2.1 0.051 0.32 t18=1.3 0.207 0.25 
ST36R t52=6.3 0.000 0.70 t44=2.2 0.035 0.33 
3R t41=3.4 0.002 0.50 t34=3.4 0.002 0.58 
KD3R t22=3.0 0.007 0.33 t22=2.6 0.017 0.62 
Table 4.19b: The results of one-sample t-test on absolute difference between POST PPTmedian and PRE 




One sample T-test on relative difference between POST PPTmean and PRE PPTmean 
Site Female Male t p MD t p MD 
LI20R t55=5.6 0.000 0.12 t49=5.2 0.000 0.14 
GB12R t11=4.6 0.001 0.14 t11=5.3 0.000 0.13 
2L t22=2.8 0.011 0.08 t20=2.9 0.008 0.11 
2R t30=6.0 0.000 0.16 t23=3.9 0.001 0.19 
PC6L t11=2.8 0.018 0.10 t11=3.9 0.003 0.15 
PC6R t21=8.4 0.000 0.20 t17=2.5 0.023 0.13 
LI10L t11=3.5 0.005 0.20 t11=6.4 0.000 0.19 
1L t22=4.4 0.000 0.12 t22=4.6 0.000 0.10 
1R t43=6.2 0.000 0.18 t37=2.7 0.011 0.10 
LI5L t33=4.0 0.000 0.11 t31=3.3 0.002 0.12 
LI5R t43=8.1 0.000 0.19 t37=4.7 0.000 0.20 
ST36L t20=3.3 0.004 0.09 t18=1.7 0.108 0.06 
ST36R t52=6.3 0.000 0.15 t44=3.2 0.003 0.06 
3R t41=4.0 0.000 0.12 t34=4.1 0.000 0.10 
KD3R t22=3.1 0.005 0.09 t22=3.4 0.002 0.11 
Table 4.19c: The results of one-sample t-test on relative difference between POST PPTmean and PRE 









One sample T-test on relative difference between POST PPTmedian and PRE PPTmedian 
Site Female Male t p MD t p MD 
LI20R t55=4.9 0.000 0.12 t49=5.3 0.000 0.13 
GB12R t11=4.4 0.001 0.12 t11=5.6 0.000 0.12 
2L t22=2.2 0.039 0.07 t20=3.5 0.002 0.12 
2R t30=5.4 0.000 0.15 t23=3.4 0.003 0.21 
PC6L t11=2.3 0.040 0.10 t11=2.9 0.015 0.14 
PC6R t21=8.2 0.000 0.20 t17=2.0 0.057 0.12 
LI10L t11=2.9 0.015 0.20 t11=4.8 0.001 0.20 
1L t22=4.0 0.001 0.12 t22=3.7 0.001 0.11 
1R t43=5.3 0.000 0.18 t37=3.0 0.005 0.12 
LI5L t33=3.3 0.002 0.10 t31=3.4 0.002 0.12 
LI5R t43=7.2 0.000 0.17 t37=4.3 0.000 0.20 
ST36L t20=2.1 0.048 0.07 t18=1.2 0.247 0.04 
ST36R t52=6.3 0.000 0.15 t44=2.7 0.011 0.06 
3R t41=3.8 0.000 0.11 t34=3.5 0.001 0.09 
KD3R t22=3.7 0.001 0.11 t22=2.8 0.010 0.11 
Table 4.19d: The results of one-sample t-test on relative difference between POST PPTmedian and PRE 





Figure 4.22: The means of absolute differences and the means of relative differences for PPTmean and 
PPTmedian. The marker x indicates no significant differences presence in the mean differences from zero 







4.19 Flow charts summary for Sections 4.1 to 4.17 
 








































II. Research Study Two 
 
Research Study Two aimed to examine the regional PPT measures at LI10 and LI11 between 
the affected and non-affected elbow for subjects with lateral epicondylitis. Three regional PPT 
measurements were being collected in each pre and post sessions of the four occasions at Week 
0, Week 1, Week 5 and Week 9. Week 1 and Week 5 involved intervention of either 
acupuncture or sham laser whilst Week 0 and Week 9 did not involve any intervention. The 
time interval between two sessions at each occasion was 20 minutes with a rest time of 10 
seconds between PPT measurements at one site within same session. Research Study Two 
included 11 females (age=45.8±6.8 years, BMI=23.6±3.1kg/m2) and 9 males (age=46.6±5.7 
years, BMI=24.6±3.1kg/m2) with age ranged from 35 to 55 years for women and 35 to 53 years 
for men. The subjects were randomised with five men and six women in the treatment group 
and four men and five women in the control group.  In particular, caution was paid to 
Bonferroni corrections in protection of Type I error from familywise error whenever multiple 
comparisons were made. 
 
4.20 Aim 19: To compare the regional mean PPT between genders in overall 
occasions 
 
Research question: Was there a difference in regional mean PPT between genders in each 
affected and non-affected site for lateral epicondylitis in overall occasions? 
 
For each of the affected and non-affected measurement site, GLM for repeated measures with 
Sidak comparisons was employed for data analysis on PPT between genders which showed 
significant differences in mean PPT between genders in all cases with p<0.05 (Table 4.20). 
Table 4.20 provides the mean PPT and the associated standard error (SE) of PPT in overall 
occasions at each measurement site with last column shows the F-values from GLM between 
PPT by gender. The statistical significant differences in mean PPT between genders suggested 
subsequent data analyses to be conducted separately by gender.  
 
Site Mean(SE) F p Female Male 
LI10 Non-affected 1.94(0.28) 3.18(0.31) F1,18=8.8 0.008 
LI10 Affected 2.05(0.41) 3.58(0.45) F1,18=6.3 0.022 
LI11 Non-affected 2.59(0.39) 4.16(0.43) F1,18=7.3 0.015 
LI11 Affected 2.66(0.44) 4.42(0.48) F1,18=7.2 0.015 
Table 4.20: The mean (SE) PPT and the F statistics of GLM with Sidak adjustments on PPT between 






4.21 Aim 20: To compare the regional mean PPT between sessions in each 
occasion 
 
Research question: Was there a difference in regional mean PPT between sessions in each 
occasion? 
 
The GLM for repeated measures with Sidak adjustment was employed to compare the mean 
PPT between sessions in each occasion in which Week 0 as practice visit, Week 1 and Week 5 
involved interventions, and Week 9 as one-month follow-up with no intervention. Time interval 
between pre and post sessions was standardized as 20 minutes for each occasion. Table 4.21 
gives the mean (SE) of PPT and the F statistics of GLM on PPT between sessions for each 
affected and non-affected site by session by occasion by gender. The GLM on PPT between 
sessions by occasion by gender revealed that the females had significantly lower mean PPT after 
20 minutes interval in Week 0 for all sites whereas the mean PPT of males did not differ 
statistically between sessions. In Week 1, the mean PPT of the affected LI10 of females 
decreased after the interventions. The females had mean PPT of non-affected LI11 increased 
significantly in Week 5. Figure 4.23 provides the bar graphs of mean PPT at each session by 








0 LI10 Non-affected 2.58(0.33) 2.26(0.29) 0.033 3.56(0.69) 3.28(0.88) 0.303 
LI10 Affected 2.80(0.51) 2.20(0.34) 0.014 3.69(0.73) 3.41(0.88) 0.123 
LI11 Non-affected 3.35(0.44) 2.84(0.35) 0.028 4.14(0.69) 3.93(0.82) 0.228 




1 LI10 Non-affected 1.66(0.13) 1.55(0.15) 0.116 2.72(0.45) 2.54(0.30) 0.378 
LI10 Affected 1.72(0.17) 1.52(0.16) 0.032 3.64(1.07) 3.42(0.99) 0.202 
LI11 Non-affected 2.02(0.27) 2.15(0.33) 0.231 3.94(0.68) 3.91(0.59) 0.843 




5 LI10 Non-affected 1.79(0.19) 1.69(0.16) 0.497 3.46(0.44) 3.07(0.37) 0.070 
LI10 Affected 1.91(0.24) 1.82(0.19) 0.291 3.82(0.55) 3.76(0.54) 0.815 
LI11 Non-affected 2.30(0.38) 2.63(0.44) 0.033 4.23(0.54) 4.40(0.49) 0.490 




9 LI10 Non-affected 2.02(0.18) 1.96(0.23) 0.511 3.42(0.33) 3.40(0.37) 0.920 
LI10 Affected 2.29(0.25) 2.16(0.28) 0.225 3.39(0.36) 3.50(0.38) 0.261 
LI11 Non-affected 2.83(0.47) 2.58(0.34) 0.161 4.29(0.46) 4.47(0.54) 0.318 
LI11 Affected 2.97(0.41) 2.88(0.38) 0.439 4.66(0.56) 4.40(0.61) 0.218 
Table 4.21: The mean (SE) of PPT and the results from GLM with Sidak adjustments on PPT between 











4.22 Aim 21: To compare the regional mean PPT between sessions in each 
occasion by treatment group 
 
Research question: Was there a difference in regional mean PPT between sessions in each 
occasion by treatment group? 
 
As the normality was not met for PPT of small sample sized subgroups (treatment x gender x 
occasion x site) for applying GLM of repeated measures, the alternative non-parametric 
Friedman test was applied to compare the distribution of PPT of two sessions. Tables 4.22 
gives, by treatment group, the mean (SD) of PPT, the p-values from Friedman test on PPT 
between sessions for each affected and non-affected site by occasion by gender with significant 
results marked with *. For Acupuncture group, three sites for each gender (Female: LI10 Non-
affected, LI11 Non-affected and LI11 Affected; Male: LI10 Non-affected, LI10 Affected, LI11 
Affected) had significant decrease in PPT after 20 minutes interval on Week 0, then at LI10 
Affected on Week 1 for females and at LI11 Affected in Week 5 for males. For Sham Laser 
group, the females had PPT at LI10 Affected in Week 0 and LI11 Affected in both Week 0 and 
Week 1 decreased significantly after 20 minutes interval. Figure 4.24 gives a graphical 







Treatment Group: Acupuncture 
Occasion Site Female Male PRE POST p PRE POST p 
Week 0 
LI10 Non-affected 2.96(1.15) 2.51(0.97) 0.005* 2.96(1.21) 2.52(1.11) 0.033* 
LI10 Affected 3.27(2.03) 2.54(1.47) 0.059 2.93(1.03) 2.44(1.17) 0.008* 
LI11 Non-affected 4.01(1.38) 3.33(1.09) 0.008* 3.78(1.61) 3.45(1.74) 0.071 
LI11 Affected 4.07(2.11) 3.27(1.32) 0.029* 3.79(1.80) 3.24(1.51) 0.001* 
Week 1 
LI10 Non-affected 1.76(0.52) 1.61(0.65) 0.225 2.15(0.91) 2.24(0.91) 0.593 
LI10 Affected 1.71(0.44) 1.46(0.51) 0.018* 2.30(0.81) 2.09(0.91) 0.763 
LI11 Non-affected 2.11(0.92) 2.28(1.24) 0.090 3.16(1.64) 3.17(1.35) 0.109 
LI11 Affected 2.24(0.70) 1.95(0.95) 0.225 3.16(1.80) 3.45(2.24) 0.593 
Week 5 
LI10 Non-affected 1.96(0.67) 1.78(0.51) 0.346 3.37(1.30) 3.11(1.13) 0.248 
LI10 Affected 2.13(0.86) 1.98(0.74) 0.808 3.49(1.32) 3.31(1.16) 0.439 
LI11 Non-affected 2.41(1.36) 2.87(1.60) 0.317 4.33(1.78) 4.41(1.31) 0.593 
LI11 Affected 2.77(1.42) 2.76(1.28) 0.637 5.13(2.12) 4.25(1.76) 0.001* 
Week 9 
LI10 Non-affected 2.19(0.65) 2.19(0.87) 0.796 3.29(1.25) 3.24(1.13) 0.782 
LI10 Affected 2.44(0.96) 2.39(0.89) 0.796 2.99(0.82) 3.01(0.72) 0.593 
LI11 Non-affected 3.05(1.84) 2.82(1.33) 0.285 4.43(1.47) 4.79(1.53) 0.166 
LI11 Affected 2.97(1.38) 3.05(1.36) 1.000 4.51(1.34) 4.21(1.47) 0.593 
 (a) 
 
Treatment Group: Sham Laser 
Occasion Site Female Male PRE POST p PRE POST p 
Week 0 
LI10 Non-affected 2.12(0.87) 1.95(0.84) 0.197 4.31(2.84) 4.23(3.56) 0.083 
LI10 Affected 2.24(0.78) 1.78(0.62) 0.013* 4.64(2.87) 4.62(3.36) 0.763 
LI11 Non-affected 2.56(1.20) 2.26(1.02) 0.071 4.60(2.56) 4.53(3.02) 0.248 
LI11 Affected 2.58(1.02) 2.17(1.01) 0.001* 5.12(2.53) 5.35(3.19) 0.564 
Week 1 
LI10 Non-affected 1.55(0.36) 1.47(0.39) 0.405 3.43(1.55) 2.91(0.98) 0.763 
LI10 Affected 1.74(0.71) 1.60(0.56) 0.564 5.33(4.14) 5.09(3.66) 0.527 
LI11 Non-affected 1.93(0.90) 1.99(0.94) 1.000 4.91(2.10) 4.83(1.75) 0.763 
LI11 Affected 2.12(1.03) 1.74(0.76) 0.033* 5.08(3.34) 4.94(2.45) 1.000 
Week 5 
LI10 Non-affected 1.58(0.52) 1.58(0.64) 1.000 3.57(1.39) 3.03(1.12) 0.058 
LI10 Affected 1.64(0.68) 1.63(0.59) 1.000 4.24(1.98) 4.33(2.23) 0.083 
LI11 Non-affected 2.17(1.24) 2.34(1.21) 0.109 4.11(1.52) 4.38(1.78) 1.000 
LI11 Affected 2.34(1.38) 2.60(1.53) 0.197 4.80(1.56) 5.05(1.57) 0.564 
Week 9 
LI10 Non-affected 1.80(0.43) 1.68(0.54) 0.285 3.58(0.71) 3.59(1.32) 0.763 
LI10 Affected 2.10(0.69) 1.87(0.91) 0.052 3.89(1.56) 4.12(1.54) 0.564 
LI11 Non-affected 2.57(1.11) 2.29(0.78) 0.405 4.10(1.44) 4.07(1.77) 0.366 
LI11 Affected 2.97(1.46) 2.68(1.27) 0.564 4.85(2.09) 4.63(2.25) 0.083 
 (b) 
Table 4.22: The mean (SD) of PPT and the p-values of Friedman test on PPT between sessions for (a) 








Figure 4.24: The mean PPT between sessions for each site by treatment by gender in intervention weeks 




4.23 Aim 22: To compare the regional mean PPT between non-affected and 
affected sites in each occasion by treatment group 
 
Research question: Was there a difference in regional mean PPT between affected and non-
affected sites in each occasion by treatment group? 
 
Tables 4.23 and 4.24 listed the p-values (p<0.05 indicates statistical significant change) of 
Friedman test on PPT between the affected and non-affected LI10 and LI11 respectively for 
each occasion by treatment group by gender by session. The results revealed that LI10 Non-
affected had higher PPT than LI10 Affected on Week 1 POST session, and LI11 Affected had 
higher mean PPT than LI11 Non-affected on Week 1 PRE session for females in Acupuncture, 
whereas the non-affected LI10 and LI11 of males demonstrated lower mean PPT at the affected 
sites before and after interventions on Week 5. Figures 4.25 and 4.26 showed the mean PPT 
between non-affected and affected LI10 and LI11 respectively by treatment by gender in each 
occasion with asterisk indicates statistical significant change in mean PPT (* for increase, * for 











Friedman test: Non-affected LI10 versus Affected LI10 
  Acupuncture Sham Laser 
 Occasion Female Male Female Male 
  PRE POST PRE POST PRE POST PRE POST 
Week 0 0.346 0.808 1.000 0.796 0.197 0.109 0.248 0.083 
Week 1 0.346 0.033* 0.782 0.285 0.439 1.000 0.564 0.564 
Week 5 0.593 0.808 0.197 0.071 1.000 0.593 0.001* 0.021* 
Week 9 0.134 0.157 0.197 0.439 0.052 0.285 0.564 0.083 
Table 4.23: The p-values of Friedman test on PPT between LI10 Non-affected and LI10 Affected by 
session by gender for Acupuncture and Sham Laser. The asterisk indicates statistical significant change (* 






Friedman test: Non-affected LI11 versus Affected LI11 
  Acupuncture Sham Laser 
 Occasion Female Male Female Male 
  PRE POST PRE POST PRE POST PRE POST 
Week 0 0.346 0.346 0.593 0.796 0.593 0.052 0.564 0.083 
Week 1 0.046* 0.157 0.439 0.439 0.405 0.366 0.248 0.564 
Week 5 0.090 0.808 0.071 0.796 0.166 0.052 0.021* 0.007* 
Week 9 0.346 0.197 0.796 0.071 0.109 0.197 0.132 0.132 
Table 4.24: The p-values of Friedman test on PPT between LI11 Non-affected and LI11 Affected by 
session by gender for Acupuncture and Sham Laser. The asterisks * indicate statistical significant 








Figure 4.25: The mean PPT between LI10 Non-affected and LI10 Affected by treatment by gender in 
each occasion. The asterisk indicates statistical significant change in mean PPT (* for increase, * for 





Figure 4.26: The mean PPT between LI11 Non-affected and LI11 Affected by treatment by gender in 
each occasion. The asterisk indicates statistical significant change in mean PPT (* for increase, * for 








4.24 Aim 23: To compare the regional mean PPT between treatment groups 
 
Research question: Was there a statistical significant difference in regional mean PPT between 
treatment groups in each occasion by gender? 
 
As the normality was not met for PPT of small sample sized subgroups (treatment x gender x 
occasion x site) for applying GLM of unequal independent groups, the alternative Mann-
Whitney non-parametric test was applied to compare the mean PPT between treatment groups. 
Table 4.25 gives the p-values from Mann-Whitney U test on PPT between treatment groups at 
intervention weeks and the one-month follow-up. The results showed that, in Week 1, the Sham 
Laser had mean PPT higher than the Acupuncture at LI10 Non-affected and LI11 Non-affected 
before intervention and at LI10 Affected and LI11 Non-affected after intervention for males. 
Figures 4.27 and 4.28 presented the bar graphs of mean PPT between the two groups for 
females and males respectively with * indicates significant differences in mean PPT between 




Week 1 Week 5 Week 9 
PRE POST PRE POST PRE POST 
Female 
LI10 Non-affected 0.343 0.735 0.274 0.421 0.100 0.108 
LI10 Affected 0.817 0.532 0.486 0.259 0.381 0.093 
LI11 Non-affected 0.682 0.556 0.682 0.509 1.000 0.630 
LI11 Affected 0.986 0.580 0.307 0.656 0.817 0.580 
Male 
LI10 Non-affected 0.009* 0.083 0.683 0.792 0.516 0.581 
LI10 Affected 0.103 0.047* 0.614 0.399 0.236 0.093 
LI11 Non-affected 0.041* 0.019* 0.719 0.792 0.456 0.183 
LI11 Affected 0.093 0.083 0.867 0.277 0.719 0.581 
Table 4.25: The p-values of Mann-Whitney U test on PPT between treatment groups. The asterisks * 







Figure 4.27: The mean PPT between treatment groups at non-affected and affected LI10 and LI11 for 
females. Mann-Whitney test revealed no statistical significant differences in mean PPT between the two 
groups. 
 
Figure 4.28: The mean PPT between treatment groups at non-affected and affected LI10 and LI11 for 
males. Mann-Whitney test revealed four statistical significant differences (*) in mean PPT between the 





4.25 Aim 24: To evaluate the mean percentage changes of regional PPT from 
baseline mean PPT on Week 1 
 
Research question: Was there a significant change in the mean percentage change of PPT from 
its pre-intervention mean PPT on Week 1? 
 
The percentage change of PPT was computed based on the baseline mean PPT derived from the 
pre-intervention session on Week 1. The one-sample T-test was employed to test whether the 
mean percentage change of PPT at each subsequent session for each treatment group by gender 
at each site was different from zero. Table 4.26 shows the results from T-test with * denote 
significant increase in mean percentage change of PPT and * for significant decrease. The 
results revealed an increase of mean percentage change of PPT at all non-affected and affected 
sites in both sessions of Week 5 and Week 9 for males in Acupuncture group whilst the females 
in Acupuncture had all sites in PRE session and three sites (except LI10 Non-affected) in POST 
session of Week 9 that showed an increase in mean percentage change of PPT. In Sham Laser, 
the females had three sites (except LI10 Affected) in PRE session of Week 9 showed an 
increase in mean percentage change of PPT whilst the males showed a decrease in mean 
percentage change of PPT at LI10 Affected in both sessions of Week 9. Figure 4.29 gives the 
bar graphs of mean percentage changes in PPT at subsequent sessions for each gender. 
 











LI10 Non-affected t17=-0.95 t17=1.30 t17=0.23 t17=2.89* t17=2.11 
LI10 Affected t17=-2.05 t17=2.09 t17=1.58 t17=3.27* t17=3.29* 
LI11 Non-affected t17=0.59 t17=0.95 t17=2.02 t17=2.17* t17=2.27* 







LI10 Non-affected t14=-0.79 t14=0.25 t14=0.20 t14=2.28* t14=0.95 
LI10 Affected t14=-0.98 t14=-0.57 t14=-0.75 t14=2.02 t14=0.57 
LI11 Non-affected t14=0.26 t14=0.77 t14=1.32 t14=2.22* t14=1.82 










LI10 Non-affected t14=0.37 t14=3.64* t14=3.26* t14=3.52* t14=3.73* 
LI10 Affected t14=-0.90 t14=3.47* t14=3.40* t14=3.29* t14=3.79* 
LI11 Non-affected t14=0.02 t14=2.56* t14=3.72* t14=3.35* t14=4.14* 







LI10 Non-affected t11=-1.83 t11=0.35 t11=-1.24 t11=0.77 t11=0.44 
LI10 Affected t11=-0.22 t11=-1.90 t11=-1.56 t11=-3.18* t11=-2.72* 
LI11 Non-affected t11=-0.15 t11=-1.82 t11=-1.02 t11=-1.94 t11=-1.65 
LI11 Affected t11=-0.20 t11=-0.63 t11=-0.07 t11=-0.39 t11=-0.69 
Table 4.26: The results from one-sample T test on percentage change of PPT from baseline mean PPT on 
Week 1. The asterisk * indicates statistical significant increase and * for significant decrease in mean 







Figure 4.29: The mean percentage change in PPT from the baseline mean PPT on Week 1 for each 
gender. The asterisk * indicates statistical significant increase and * for significant decrease in mean 
percentage change in PPT. 
 
 
4.26 Aim 25: To examine the mean percentage changes of regional PPT between 
treatment groups  
 
Research question: Was there a significant difference between treatment groups in mean 
percentage change of PPT at each subsequent session for each measurement site by gender? 
 
The Mann-Whitney U-Test was employed to compare between treatment groups the mean 





revealed statistically that the Acupuncture group for males showed significantly higher mean 
percentage change in PPT over Sham Laser on Week 5 and Week 9 for both PRE and POST 




  Site Week 1 Week 5 Week 9 POST PRE POST PRE POST 
Female 
LI10 Non-affected 0.656 0.789 0.845 0.486 0.442 
LI10 Affected 0.708 0.361 0.166 0.307 0.067 
LI11 Non-affected 0.762 0.957 0.708 0.580 1.000 
LI11 Affected 0.929 0.442 0.817 0.656 0.735 
Male 
LI10 Non-affected 0.256 0.053 0.003* 0.032* 0.019* 
LI10 Affected 0.614 0.001* 0.001* 0.001* 0.000* 
LI11 Non-affected 0.905 0.009* 0.003* 0.004* 0.001* 
LI11 Affected 0.981 0.007* 0.093 0.010* 0.037* 
Table 4.27: The p-values of Mann-Whitney U test on percentage change in PPT from its baseline mean 
between treatment groups. The asterisks * indicate statistical significant difference in mean percentage 




4.27 Aim 26: To compare the mean percentage change in PPT between sessions 
in each occasion by treatment group 
 
Research question: Was there a significant difference in the mean percentage change in PPT 
between sessions in each occasion by treatment group? 
 
A non-parametric Friedman test was applied to compare the mean percentage change in PPT 
between two sessions. Tables 4.28 gives, by treatment group, the p-values from Friedman test 
on percentage change in PPT between sessions for each affected and non-affected site by 
occasion by gender with significant results marked with asterisks. For females, the mean 
percentage change in PPT at LI10 Affected in Acupuncture and LI11 Affected in Sham Laser of 
Week 1 had significantly reduced after intervention. For males, the mean percentage change in 












Occasion Site Female Male Acupuncture Sham Laser Acupuncture Sham Laser 
Week 1 
LI10 Non-affected 0.225 0.405 0.593 0.763 
LI10 Affected 0.018* 0.564 0.763 0.527 
LI11 Non-affected 0.090 1.000 0.109 0.763 
LI11 Affected 0.225 0.033* 0.593 1.000 
Week 5 
LI10 Non-affected 0.346 1.000 0.248 0.058 
LI10 Affected 0.808 1.000 0.439 0.083 
LI11 Non-affected 0.317 0.109 0.593 1.000 
LI11 Affected 0.637 0.197 0.001* 0.564 
Week 9 
LI10 Non-affected 0.796 0.285 0.782 0.763 
LI10 Affected 0.796 0.052 0.593 0.564 
LI11 Non-affected 0.285 0.405 0.166 0.366 
LI11 Affected 1.000 0.564 0.593 0.083 
Table 4.28: The p-values of Friedman test on percentage change in PPT between sessions. The asterisk * 




4.28 Aim 27: To compare the mean percentage change in PPT between non-
affected and affected sites 
 
Research question: Was there a difference in mean percentage change in PPT between affected 
and non-affected sites in each session by treatment group by gender? 
 
Table 4.29 showed the results of Friedman test between the mean percentage change in PPT of 
the affected and non-affected sites of LI10 and LI11 respectively for each occasion by treatment 
group by gender by session. The results revealed that LI10 Non-affected had higher mean 
percentage change in PPT than LI10 Affected at three sessions (Week 5 PRE, Week 9 PRE and 
POST) in Sham Laser of males whilst LI11 Non-affected had higher mean percentage change in 
PPT than LI11 Affected in two sessions (Week 1 POST Acupuncture and Sham Laser) for 
females and LI11 Affected had higher mean percentage change in PPT than LI11 Non-affected 









Friedman test on %Change PPT: Non-affected LI10 versus Affected LI10 
 Occasion 
Female Male 
Acupuncture Sham Laser Acupuncture Sham Laser 
PRE POST PRE POST PRE POST PRE POST 
Week 1 0.346 0.346 0.796 0.197 0.796 0.071 0.248 1.000 
Week 5 0.157 0.637 0.439 0.439 0.439 0.796 0.001* 0.083 
Week 9 0.059 0.157 0.796 0.796 0.197 0.197 0.004* 0.021* 
Friedman test on %Change PPT: Non-affected LI11 versus Affected LI11 
 Occasion 
Female Male 
Acupuncture Sham Laser Acupuncture Sham Laser 
PRE POST PRE POST PRE POST PRE POST 
Week 1 0.157 0.018* 0.439 0.005* 0.439 0.439 0.248 0.564 
Week 5 0.157 0.637 0.796 0.796 0.071 0.796 0.083 0.021* 
Week 9 0.637 1.000 0.439 0.796 0.796 0.071 0.248 0.248 
Table 4.29: The p-values of Friedman test on percentage change in PPT between non-affected and 
affected LI10 and LI11. The asterisk indicates statistical significant change (* for increase, * for decrease) 
in mean percentage change in PPT from non-affected to affected site. 
 
 
III. Research Study Three 
 
Research Study Three aimed to examine the inter-device reliability of two PPT measurement 
devices (mechanical and electronic algometers) of same measurement parameters: 1cm2 flat 
circular tip and force application rate of 1kg/cm2/s.  
 
This study recruited 17 adults (8 females: age=49.4±6.9 years, BMI=25.9±6.4kg/m2; 9 males: 
age=48.4±8.7 years, BMI=27.2±3.8kg/m2) with age ranged from 35 to 58 years for women and 
35 to 65 years for men. Six measurement cycles were performed at six PPT measurement sites 
with two different algometers measuring the PPT scores in alternate order at each site. This 
resulted in three PPT measures per site for each device. All measurements were done in one 
occasion. 
 
4.29 Aim 28: To examine the consistency of PPT measures between two 
algometry devices 
 
Research question: Were the algometers of same measuring tip size and application force rate 
provided the same mean PPT measures? 
 
Paired samples t-tests were conducted to examine the consistency of readings between the 
mechanical and electronic algometers at all six sites. Tables 4.30 and 4.31 show statistically that 





significantly at all sites. The significant correlations between PPT measures obtained by 
different devices ranged from 0.55 to 0.82 independent of measurement cycles.  
 
Paired-samples t-test 
Site t p Mean difference SD Correlation 
1R t50=-1.68 0.099 -0.31 1.32 0.55 
1L t50=0.17 0.866 0.02 1.03 0.72 
LI5R t50=-0.84 0.404 -0.14 1.19 0.63 
LI5L t50=0.13 0.894 0.02 0.99 0.74 
PC6R t50=0.08 0.935 0.01 1.11 0.74 
PC6L t50=-0.20 0.842 -0.03 1.08 0.82 
All t305=-1.11 0.270 -0.07 1.12 0.71 
Table 4.30: The results from paired samples t tests on PPT at six regional PPT measurement sites. 
 
 
Comparisons of PPT between mechanical and electronic algometers 
at each measurement cycle 
Site Cycle t1,17 p 
Mean 
difference SD Correlation 
1R 
1 -0.42 .679 -0.11 1.06 0.66 
2 -0.38 .710 -0.11 1.22 0.73 
3 -1.83 .087 -0.71 1.61 0.39 
1L 
1 -0.05 .957 -0.01 0.89 0.68 
2 -0.22 .827 -0.06 1.09 0.77 
3 0.52 .610 0.14 1.14 0.68 
LI5R 
1 -1.37 .190 -0.49 1.48 0.37 
2 0.82 .423 0.20 0.99 0.77 
3 -0.52 .610 -0.13 1.00 0.76 
LI5L 
1 0.09 .930 0.02 0.95 0.75 
2 -0.90 .379 -0.25 1.13 0.70 
3 1.35 .197 0.28 0.86 0.83 
PC6R 
1 0.13 .901 0.04 1.15 0.75 
2 -0.64 .528 -0.19 1.24 0.73 
3 0.85 .407 0.20 0.95 0.78 
PC6L 
1 -1.10 .288 -0.30 1.14 0.82 
2 0.75 .464 0.21 1.13 0.78 
3 0.02 .981 0.01 0.98 0.87 





4.30 Aim 29: To examine the coefficients of variation of PPT measures within 
and between devices 
 
Research question: What was the extent of variations among PPT readings within and between 





The scale of differences in measurement of PPT within and between devices was examined 
based on the intra and inter-device coefficients of variation (CV). The intra-device CV was 
computed as (standard deviation of the PPT measures within device) / (mean of the PPT 
measures within device) x100%, and the inter-device CV was computed as (standard deviation 
of the PPT measures between devices) / (mean of the PPT measures between devices) x 100%. 
Table 4.32 gives the mean intra-device and mean inter-device coefficients of variation of PPT 
measures at six measurement sites. The mean intra-device coefficients varied from 19.3% 
(PC6R) to 23.1% (1R) for mechanical algometer and 10% (PC6L) to 15.3% (1R) for electronic 
algometer whilst the mean inter-device coefficients of variation varied from 14% (LI5L) to 
16.9% (1R). This showed that the electronic algometer was relatively more precise in PPT 
measurement. 
 
Mean of coefficient of variation 
Site Intra-device Inter-device Mechanical Electronic 
1R 23.1 15.3 16.9 
1L 20.2 12.5 14.2 
LI5R 20.6 11.7 14.9 
LI5L 19.9 14.6 14.0 
PC6R 19.3 11.0 16.4 
PC6L 22.9 10.0 15.5 






Chapter 5: Discussion and conclusion 
 
I. Research Study One 
Sections 5.1 to 5.6 discussed about the results as outlined in Research Study One in Chapter 4. 
  
5.1 Gender based regional PPT comparisons independent of temporal variables 
It was revealed statistically that the males demonstrated significantly higher mean PPT, median PPT,  
mean PPTmean and mean PPTmedian, than the females in all 17 PPT measurement sites (Figures 4.1 
and 4.2, Tables 4.2 and 4.3). These result of significant differences in the means of PPT between 
genders were consistent with and generally reported in various studies (Buchanan et al 1987; 
Fischer et al 1987; Brennum et al 1989; Ohrbach et al 1989; Takala et al 1990; Vanderweeën et al 
1996; Plesh et al 1998; Vatine et al 1998; Chesterton et al 2003; Rolke et al 2006) though at 
different anatomical sites. However, a few studies reported no significant differences in mean PPT 
between genders at certain measurement sites different from the present study (Isselée et al 1997, 
Ayesh et al 2007a). Overall, independent of temporal and regional site variables, the mean PPTmean 
and mean PPTmedian for males was 25% greater than for females and the median difference was 23%. 
Within the same gender for each regional site, since mean PPTmean and mean PPTmedian for overall 
visits were not significantly different, either PPTmean or PPTmedian was similarly appropriate for 
comparisons. 
 
The significant differences in mean PPTmean and mean PPTmedian between genders supported by large 
sample sizes for PPT measurements at all 17 regional sites extended from head to four limbs had 
suggested separate analysis by gender, or restricted to single gender study (Murphy et al 1992; 
Kosek et al 1993; 1999; Farella et al 2000; Waling et al 2001; Shiau et al 2003; Persson et al 2004; 
Cairns et al 2006; Jones et al 2007; Ylinen et al 2007; Ge et al 2006, 2008; Fernández-de-las-Peñas 
et al 2009; Aldayel et al 2010) or alternatively a matched-pair study (Fischer et al 1986, 1987; 
Buchanan et al 1987; Tunks et al 1988; Brennum et al 1989; Delaney et al 1993; Vanderweeën et al 
1996; Isselée et al  1997; Plesh et al 1998; Tanaka et al 2004; Barlas et al 2006; Ayesh et al 2007b; 
Anderson et al 2008; Li et al 2008; Walsh et al 2009).  In whatever settings, unless focus is on 
single gender or the gender is not a factor for matched-pair, comparisons between genders would 
require a doubling up of the sample size ensuring power size was adequate. This would in turn incur 





sufficient power. If only the inclusion of a single gender was undertaken due to cost and time 
constraints, this would leave the outcomes for the other gender unknown.  
 
Pearson correlations were examined for the pattern of overall mean PPT and overall median PPT, 
and the PPTmean and PPTmedian at all 17 sites between genders (Appendix 12, A12.1). The results 
revealed highly significant correlation (p=0.000) for overall mean PPT and overall median PPT 
(r=0.998 for females, r = 0.993 for males), and PPTmean and PPTmedian (r=0.996 for both genders) for 
each gender. Relative difference with respect to females in overall mean PPT, overall median PPT, 
mean PPTmean and mean PPTmedian between genders among sites ranged from 17.8% (2R) to 34.1% 
(LI10L) for overall mean PPT  and PPTmean, from 10.7% (GB12R) to 32.3% (ST36L) for overall 
median , and from 17.8% (2R) to 34.5% (LI10L) for PPTmedian. In general, the lowest PPT group 
comprised of facial sites LI20L and LI20R located at the bony region near the nostrils followed by 
GB12R at occiput behind the earlobe. The medium PPT group mainly represented by the sites at 
forearms (PC6L, PC6R, 1L, 1R, LI5L, LI5R, LI10L). This is consistent with findings from several 
studies that measured PPT on head and neck (Antonacci et al 1992, 1998; Chung et al 1992; Sand et 
al 1997) and reported PPT differences that were lower on the head compared to the arms (Buchanan 
et al 1987; Kosek et al 1993; Christidis et al 2005). The highest PPT sites were ST36L and ST36R 
(located on the tibialis anterior muscle) followed by the non-acupoints sites 3R (located on peroneus 
muscle region on the lateral aspect of the lower limb), 2R and 2L (located on the posterior region of 
the upper limb over the ulna) and then the acupoints KD3R and SP6R (located on the distal region 
of right leg) (Tunks et al 1988; Anderson et al 2008; Lacourt et al 2012). Though these previous 
studies examined sites that were not the exact points as used in the UTS studies, the measurement 
protocols such as models of algometers, size of measurement tip and the force application rate 
across studies were not standardized (Sand et al 1997).  
 
It should be noted that the acupoints LI20L and LI20R were the only measurements sites that the 
subjects could observe PPT measurement. This may have affected the accuracy of the PPT measure. 
In addition, due to the relatively low PPT observed at these sites, the human response delay time, 
which is due to the subject’s signal on perception of PPT with algometer operating at an application 
rate of 1kg/s, may cause further experimental error in addition to the reading error of ±0.05kg on 
the algometer dial scale. Hence, it is suggested that for future studies sites with low PPT, such as 
the acupoint LI20, should not be selected for measurement unless the site is an essential part of a 
clinically oriented assessment.  In this case, it is preferable that the subject be draped directly below 






The current suite of UTS studies also used extensive training of the PPT operator as well as has 
standard verbal instructions for the participants. For reliability of PPT measures, training on the 
operation of algometer in taking PPT measurement has been demonstrated to be essential  (Barlas et 
al 2006; Rolke et al 2006; Farasyn et al 2007; Vedolin et al 2009; Aldayel et al 2010). In addition 
providing standard instruction to subject about perception of PPT is also strongly recommended for 
future PPT studies (Chesterton et al 2007).   
 
 
5.2 Stability of PPT among the measurement cycles  
Another consistent finding was the repeatability or reproducibility of PPT readings within each 
session. For all 17 sites by gender, the mean PPT and median PPT for each of the three 
measurement cycles were stable and independent of temporal visits (Figures 4.3, 4.4, Table 4.4). 
Whilst this implied the practicality of employing PPT measures of either measurement cycle, some 
studies suggest omission of the first reading and averaging the successive readings (Nussbaum et al 
1998; Farella et al 2000; Shiau et al 2003; Farasyn et al 2007; Meeus et al 2010) or taking the 
average of all repeated measures within session. The reproducibility of PPT readings among 
measurement cycles remained consistent even when treatment groups by gender were considered 
for mean PPTmean and mean PPTmedian (Figures 4.13 and 4.14).  This consistency of PPT among 
measurement cycles was generally reported in Chesterton et al (2003) for within session 
measurements though different temporal intervals (an hour for 14 measurements) were used and in 
Jones et al (2007) of three trials at eight sites on same day across four consecutive days. Also, 
Buchanan et al (1987) included 18 subjects (genders were not reported) for assessment on PPT 
readings at five PPT measurement areas measured by same observer and found no significant 
differences in the two readings for the five points, either on the dominant or non-dominant side of 
the body with most sensitive point appearing at the forehead. Brennum et al (1989) recruited 30 
healthy matched-pair adults and reported an intra-individual coefficient of variation (IntraCV) of 
14% on five cycles of PPT measurements with one week interval over 12 locations across fingers 
and toes. Antonacci et al (1998) examined 21 healthy individuals at 14 sites and reported IntraCV 
of 10.9% to 18.6%. Alternatively, Tunk et al (1988) reported high generalization coefficients of 
0.78 to 0.90 in test-retest on PPT at 10 locations for matched-pair of ten. In the present study 
(Appendix 12: A12.2), the average IntraCV of three reading cycles (two to three minutes between 
cycles) across four occasions with at least one week apart ranged from 9.6% (SP6R) to 12.8% 





at SP6R or PC6L was the most stable as compared to LI20L the least stable in intra-individual 
variation. These results supported the stability and reproducibility of PPT among the reading cycles 
and accounted for some variations across longer temporal sessions of more than a week.  The range 
of IntraCV indicated consistent finding from Brennum et al (1989) though this study reported 
different anatomical locations and session intervals. Despite these procedure variations, the UTS 
studies support the reliability and reproducibility of PPT in clinical and experimental research. 
 
Several studies investigated the IntraCV in PPT over different occasions with various degrees of 
consistency. In this present study (Appendix 12: A12.2), the IntraCV among temporal sessions were 
relatively higher than the IntraCV among measurement cycles. For example, the females ranged 
from 18% (PC6R) to 22.4% (LI20L) and the males 15.9% (SP6R) to 21.6% (LI20L). These results 
supported the stability and reproducibility of PPT among the reading cycles and accounted for some 
variations across longer temporal sessions of more than a week which were consistent with other 
studies where different locations were examined (Brennum et al 1989; Takala et al 1990; Antonacci 
et al 1998; Chesterton et al 2003). Takala et al (1990) reported reliable day-to-day repeatability of 
PPT measures and recommended the use of mean scores of several measures to reduce reported 
intra and inter subject variation in PPT. It is unable to make comparisons about IntraCV with the 
other studies due to the different locations used for the PPT measures. 
 
Some studies further examined the inter-individual coefficient of variation (InterCV) for PPT within 
and between occasions and generally reported higher InterCV than the IntraCV (Jensen et al 1986; 
Brennum et al 1989; Antonacci et al 1998). Jensen et al (1986) reported that the InterCV was 
approximately 3 times greater than the IntraCV whilst Brennum et al (1989) reported an InterCV of 
28% for females and 33% for males which was about 2 times greater than the ICV. Antonacci et al 
(1998) reported 13% to 21.4%. In the UTS study (Appendix 12: A12.2), the InterCV among 
measurement cycles ranged from 33.3% (PC6R) to 46.7% (LI20L) for females and from 31.7% 
(PC6L) to 49.3% (LI10L) for males and were consistent with that of among occasions with 33% 
(PC6R) to 46.3% (LI20L) for females and 31.6% (PC6L) to 49.5% (LI20L) for males. This 
demonstrates that in general the PPT at PC6L/R was the most stable and LI20L or LI10L the least 
stable in InterCV.  This higher InterCV could be attributed to various factors such as the 
anthropometric variables (age, BMI, muscle structure), psychosocial and physiological factors 
(break time intervals, learning experience, intervention effects), and psychometric parameters 






However, it should be noted that there were no strong or noticeable effects of age or BMI on 
regional PPT at any of the measurement sites with the coefficients of determination (R2 of Tables 
4.7 and 4.8, Appendix 12: A12.3) for age not exceeding 0.06 (LI20R) for females or 0.12 (LI20L) 
for males, and for BMI no more than 0.08 (PC6L) for females or 0.09 (LI10L) for males. It should 
be noted that these groups comprised of individuals in the designated healthy weight range (70% of 
subjects) followed by the overweight range (18%) (NSW 2013).  
 
 
5.3 Temporal stability of PPT across the four measurement sessions by regional 
site 
While stability of PPT within session and low IntraCV supports reliability and reproducibility of 
PPT at all 17 measurement sites, the consistency of PPT varied by number of sites across different 
extended temporal periods of the four occasions. As shown in Figures 4.6 and 4.7, except one site 
(LI20R, females, Visit 2), there was a gradual increase in means of PPTmean and PPTmedian over 
delayed temporal sessions in which the significant effects were more frequent for males statistically. 
This temporal drift suggested both mean and median were equally representative of PPT in 
longitudinal comparisons. 
 
While there were no significant changes in the means of PPTmean and PPTmedian for any site for both 
genders from Visit 1 to Visit 2, this was not the case in Visit 3 and Visit 4. For Visit 3, this effect 
involved 23.5% of sites for means of PPTmean and PPTmedian of males compared with 17.6% in 
means of PPTmedian for females. By Visit 4, these effects were evident for high proportions of sites 
for both means of PPTmean and PPTmedian for females (29.4% in both means) and males (47.1% and 
52.9% respectively). These findings indicate the importance of recognising the presence of 
temporal drift if PPT measurements are used in longitudinal clinical or research studies (Isselée et al 
1997), as well as the need to evaluate findings for the genders separately. The presence of a 
significant decrease in mean PPTmean for females in Visit 2 for LI20R may represent this situation 
which could be the result of issues discussed regarding low PPT, limitation of scale with reading 
error of ±0.05kg, delayed human response time and gender concerns regarding the use of PPT on a 
tender facial site (afraid of scars and bruise). 
 
Some sites were more likely to show significant temporal changes than others, both within and 
between genders. For males, the number of sites with common significant increases in means of 





seven  (GB12R, 2L, LI5L, LI5R, SL36L, ST36R, KD3R) for Visit 1 to Visit 4. For females, the 
number of sites reduced to four (GB12R, 2L, PC6R, LI5R) for Visit 1 to Visit 4 only. The most 
temporally stable sites were LI20L, LI20R, PC6L, PC6R, LI10L, 1R and SP6R for males, and 
LI20L, PC6L, LI10L, 1L, 1R, LI5L, ST36L, 3R, SP6R and KD3R for females which yielded five 
common sites (LI20L, PC6L, LI10L, 1R and SP6R) for both genders. Of interest are the sites less 
prone to temporal drift for choice as one or several control measurement sites in a different body 
region if, for example, effect of intervention were to be assessed which enable possible comparisons 
on regional PPT between the related intervention and control sites over various temporal sessions. 
In this study, though only the baseline PPT at each of the four occasions were extracted from the 
previous UTS studies that implemented various interventions, there was still potential presence of 
effect from interventions though an assumption was made that a one week “washout period” was 
adequate. This concern was clearly reflected in Figures 4.15 to 4.18 in which the Control had shown 
nil changes in both PPTmean and PPTmedian over temporal sessions whereas the intervention groups 
had significant temporal effect on PPTmean and PPTmedian with males demonstrated more frequent 
significant increase than females with some noise being largely reduced by a more conservative 
approach of Bonferroni corrections. 
 
The higher percentages occurring in the Intervention groups after Visit 3 for both genders for both 
the PPTmean and PPTmedian could be accounted for by the potential effects of complex interventions 
involved in various studies in addition to the LI4 needling. Depending upon the clinical or 
experimental design in pain studies, an increase in PPT may potentially be due to the analgesic 
effects of an intervention such as acupuncture, TENS and medication (Ashton et al 1984; Ayesh et 
al 2007a,b; ) or a decrease in PPT associated with clinically painful conditions (Delaney et al 1993; 
Farella et al 2000; Fernández-de-las-Peñas et al 2006b, 2009; Cathcart et al 2008). All these, in 
whatever ways, supported the gate control theory (Melzack and Wall, 1965, 1988, 1996; Melzack 
1996; Wall 1996; Wolff 1996) and its improved version of neuromatrix theory (Melzack 1999, 
2001; Lee et al 2013).  
 
When PPT between Intervention and Control groups were explored, results from GLM revealed that 
five sites (LI20L, LI20R, GB12R, 2L, 2R) showed significant increase in each of the means of 
PPTmean or PPTmedian from Control to Intervention whilst three sites (LI20R, 2L, ST36R for PPTmean; 
LI20L, LI20R, ST36R for PPTmedian) had shown significant increase in Visit 1 for females. 
Interestingly, ten sites (LI20L, LI20R, GB12R, 2L, LI10L, 1L, 1R, LI5L, ST36L, 3R) showed 





which six sites (LI20L, LI20R, GB12R, LI10L, 1L, ST36L) had shown significant increase in the 
means in Visit 1 for males. The presence of significant increases in Visit 1 implies the potential 
influence of other factors (e.g. psychosocial and physiological factors and psychometric parameters) 
besides age and BMI. 
 
Besides, depending on the clinical and experimental criterion, the statistical significant differences 
in PPT with regard to 95% or 99% CI (α=0.05 or 0.01) may determine the number of regional sites 
to be included. Fischer et al (1987, 1990) reported that the PPT was lower by 1.5kg/cm2 or 2kg/cm2 
than on the opposite normal sites in 97.8% or 87% of hypersensitive trigger points and developed 
an indicator for determining clinically significant tenderness and diagnosis of pathological symptom.  
 
Several studies discussed the variation of PPT involving healthy subjects (Jensen et al 1986; 
Buchanan et al 1987; Fischer et al 1987; Brennum et al 1989; Kosek et al 1993; Antonacci et al 
1998; Chesterton et al 2003, 2007; Jones et al 2007). In the UTS studies, drift values in PPT ranged 
in between -0.01kg/cm2 and 0.95 kg/cm2 and the maximum drift values (increases) were associated 
with sites with the highest difference in PPT values. For females, the maximum temporal drift 
across the four sessions was 0.60 kg/cm2 at 2L (14.2% change from session one mean of 
4.24kg/cm2) and 0.60 kg/cm2 at ST36R (13% change from session one median of 4.60 kg/cm2) for 
comparisons using means and medians respectively. For males, the maximum temporal drift across 
the four sessions was 0.95kg/cm2 at ST36L (14.7% change from session one mean of 6.47kg/cm2) 
and 0.85 kg/cm2 at ST36R (14.7% change from session one median of 5.80 kg/cm2) for 
comparisons using means and medians respectively. However, the percentage change in PPT with 
respect to the session one mean PPT yielded a maximum of 14.2% (2L, mean 4.24kg/cm2) for 
females and 19.2% (LI5L, mean 3.7kg/cm2) for males and that with respect to the session one 
median PPT yielded a maximum of 19.2% (GB12R, median 2.60kg/cm2) for females and 21.7% 
(LI5L, median 3.45kg/cm2) for males. Note that the drift values of decreases were relatively low in 
magnitude with minimum of -0.31kg/cm2 (PC6L, Visit 2, females, -8.4% from session one mean) 
for means and -0.1kg/cm2 (2R, PC6L, LI5R, Visit 2, females, -2.2%, -3%, -3.2% from session one 
median) for medians. This implies practical applications of temporal drifts on increases for 
longitudinal clinical or experimental studies as suggested by several researchers (Fischer et al 1990; 
Chung et al 1992; Isselée et al 1997). 
 
Fischer et al (1990) conducted an extensive study on the clinical application of pressure algometry 





and fibromyalgia tender points and made comparisons with contralateral sites of the patients and 
pain free healthy control subjects. The deduced lower PPT by 1.5 to 2 kg/cm2 at affected sites than 
the non-affected sites were far greater than that of the present study which did not involve pain sites 
and at different locations and temporal intervals.  Both Fischer et al (1990) and Chung et al (1992) 
concluded that the effective application of algometry in experimental and clinical practices such as 
diagnosing the presence of abnormality that requires treatment and providing PPT reports can 
inform patients about the effectiveness of therapy. 
 
 
5.4 Examination of PPT by age and BMI groups 
Reported mean age in studies involving PPT spanned from 20 (Vedolin et al 2009) to 76 (Zhang et 
al 2011) years old for both genders. Some studies however had a mean age in younger group of <35 
years (Buchanan et al 1987; Chung et al 1992; Kosek et al 1993; Isselée et al 1997; Plesh et al 1998; 
Brown et al 2000; Irnich et al 2001; Ogimoto et al 2002; Shiau et al 2003; Cairns et al 2006; 
Cathcart et al 2006; Ayesh et al 2007a,b; Chesterton et al 2007; Anderson et al 2008; Hübscher et al 
2008; Xiong et al 2011) and a few in an elder age group  of ≥35 years (Wessel et al 1995; Tanaka et 
al 2004; Zhang et al 2011). In Research Study One, the majority of subjects in Studies 1 to 6 were 
aged between 17 and 35 (115 for age<35; 35 for age≥35) whilst Study 7 mainly recruited healthy 
adults of age 35 years old and above (n=85). The results from a comparison of these two cohorts 
can be used as a reference though the experimental sites and temporal sessions were different. For 
studies that involved a wider range of age, no study was identified to compare the PPT among age 
groups (Jensen et al 1986; Brennum et al 1989; Antonaci et al 1992, 1998; Delaney et al 1993; 
McMillan et al 1994; Vanderweeën et al 1996; Kosek et al 1999; Smidt et al 2002; Defrin et al 2003; 
Persson et al 2004, 2008; Williams et al 2004; Slater et al 2005; Takahashi et al 2005; Barlas et al 
2006; Fernández-de-las-Peñas et al 2006a,b, 2009 ; Cathcart et al 2008; Farasyn et al 2008; Walsh 
et al 2009; Meeus et al 2010).  
 
In this study, the younger age-group comprised of mainly PPT measures from intervention group 
and the elder group represents PPT from intervention and non-intervention groups. This implies that 
the results from age groups can be derived from the intervention and non-intervention groups. This 
is possible since the relationships of age with PPTmean and PPTmedian separately were not statistically 
significant at all sites except two. These two sites (LI20L and LI20R) for both genders  
demonstrated age as significant factor for PPTmean and PPTmedian as generated by the stepwise 





(Table 4.9). With age as a covariate, the presence of significant decrease of mean PPTmean in V2 and 
significant increase in mean PPTmedian in V4 for LI20R were reduced to nil for the corresponding 
adjusted means. Further exploration by age groups was not conducted at these two sites due to the 
limitations (e.g. very low PPT) arising from these two sites as discussed earlier. 
 
For treatment groups, the attempt to use age as covariate changed the means of PPTmean and 
PPTmedian in V4 of males and PPTmedian in V3 of females at LI20L from significant to no significant 
difference from the corresponding means in V1. However, no effect of adjustments was seen for 
LI20R. As mentioned in Section 5.3, the results implied the influence of other potential factors (e.g. 
psychosocial and physiological factors and psychometric parameters) besides that of age and BMI. 
 
Most studies reported weight and height instead of BMI. The reported mean weight ranged from 
53kg (Shiau et al 2003) to 89kg (Nussbaum et al 1998), mean height in between 159cm (Zhang et al 
2011) and 180cm (Nussbaum et al 1998) and mean BMI ranged between 20.4 (Xiong et al 2011) to 
26 (Ylinen et al 2007). Anderson et al (2008) recruited younger adults (age: 22 to 33) with males 
having a BMI range between 20.5–29.3 (mean 24.1) and female 20.4–29 (mean 24.2).  Defrin et al 
(2003) included healthy adults (BMI of 24.6±4 for males and 22.2±3 for females) by measuring 
PPT at various sites on hand, pain free back region and myofascial trigger points (MTPs) in the 
back of the subjects. However, no study was found to have compared PPT by BMI groups (Defrin 
et al 2003; Jones et al 2007; Anderson et al 2008; Farasyn et al 2008; Xiong et al 2011).  
 
The stepwise regression models (Table 4.9) revealed that BMI was a significant factor for PPT at 
PC6L. With BMI as covariate, the multiple comparisons of Sidak for visits revealed no significant 
differences in the adjusted means of PPTmean and PPTmedian across temporal sessions of V1 to V2, V1 
to V3 and V1 to V4 which were consistent with the results obtained before adjustment. Due to 
sample sizes, means of PPTmean and PPTmedian in Visit 1 were compared to selected BMI groups 
(HW, OW and OB of females, HW and OW of males) of PC6L which revealed that Healthy Weight 
had significantly lower means of PPTmean and PPTmedian than the Overweight and the Obese for 
females which implies the potential effect of fat tissue or thickness of flesh on the sensation of pain. 
However, these effects disappeared for adjusted means of PPTmean and PPTmedian with BMI as 
covariate. No significant differences in the means were found among the above BMI groups for 






For treatment groups, the adjustment using BMI as the covariate at α=0.05 reduced the number of 
significant increases from seven to four (excluded V4 of PPTmean and PPTmedian for females and V4 
of PPTmedian for males) in the Intervention group. However, when comparisons between Intervention 
and Control were made, there were no significant differences in the means of PPTmean and PPTmedian 
at PC6L for overall visits and Visit 1 for both genders (Section 4.15). For comparisons among BMI 
groups by treatment by gender, the Healthy Weight females demonstrated significantly lower mean 
PPTmedian than the Overweight in Visit 1 only in all cases.  
 
 
5.5 Examination of stability of PPT during LI4R intervention 
In previous UTS PPT studies, the significant change in PPT over sessions were frequently assessed 
based on the percentage change of PPT from its baseline mean PPT (Yuan 2002; Li 2005; 
Zaslawski 2006; Szabo 2007; Li et al 2008). However, no study was found to have considered 
PPTmedian in the comparisons. This has always been a concern of the researchers on the effect of 
median PPT on overall results since impact of outliers would be minimised by using median instead 
of mean. In the examination of stability of PPT during LI4R intervention, both PPTmean and 
PPTmedian were considered and the absolute and relative changes based on pre-intervention PPTmean 
and PPTmedian were computed.  
 
In this study, Boneferroni corrections revealed that the effect of LI4R intervention was reflected in 
the significant absolute increase in mean PPTmean from its pre-intervention at ten sites for females 
(except GB12R, 2L, PC6L, LI10L, KD3R) and nine sites (except 2L, PC6R, 1R, ST36L, ST36R, 
KD3R) for males (Table 4.19a) and in mean PPTmedian at eight sites ( LI20R, 2R, PC6R, 1L, 1R, 
LI5R, ST36R, 3R) for females and eight sites (LI20R, GB12R, 2L, LI10L, 1L, LI5L, LI5R, 3R) for 
males (Table 4.19b). This showed that the median approach (as compared with the mean approach) 
had reduced two sites each for both genders that had received positive significant response from 
needling LI4R. The mean absolute difference of PPTmean after intervention varied from 0.24kg/cm2 
(LI20R) to 0.74kg/cm2 (ST36R) for females and from 0.37kg/cm2 (ST36R) to 1.01kg/cm2 (2R) for 
males and that of PPTmedian varied from 0.22kg/cm2 (LI20R) to 0.70kg/cm2 (ST36R) for females and 
from 0.25kg/cm2 (ST36L) to 1.06kg/cm2 (2R) for males in which there were a few swaps in the site 
order for scales of mean differences if compared with that of PPTmean. The above mean differences 
were generally within the range as reported in other studies (Jensen et al 1986; Buchanan et al 1987; 
Fischer et al 1987, 1990; Brennum et al 1989; Kosek et al 1993; Antonacci et al 1998; Chesterton et 






As different sites exhibited different ranges of PPT values, examination on the relative differences 
between post and pre-intervention PPT were important. The one-sample T-test revealed that the 
effect of LI4R intervention was evident by the significant relative increase in mean PPTmean and 
mean PPTmedian from its pre-intervention at 10 sites (except 2L, PC6L, LI10L, ST36L, KD3R) for 
females, and at 11 sites (except 2L, PC6R, 1R, ST36L) in mean PPTmean and at 11 sites (except 2L, 
PC6L, LI10L, ST36L) for females and nine sites (except PC6L, PC6R, 1R, ST36L, ST36R, KD3R) 
in mean PPTmedian for males (Tables 4.19c and 4.19d). This showed that the median approach (as 
compared with the mean approach) had reduced one site (PC6R) for males that had received 
significant positive response from needling LI4R for PPTmean. The mean relative difference of 
PPTmean after intervention varied from 8% (2L) to 20% (PC6R) for females and from 6% (ST36L 
and ST36R) to 20% (LI5R) for males while the PPTmedian varied from 7% (2L, ST36L) to 20% 
(PC6R, LI10L) for females and from 4% (ST36L) to 21% (2R) for males. Again there were a few 
minor swaps in the sites order for scales of mean differences if compared with that of PPTmean. 
Hence, various perspectives, in terms of raw PPT, mean PPT or median PPT, have to be taken into 
consideration in clinical or experimental studies as the extent of stability of PPT would vary slightly 
according to conditions. 
 
5.6 Conclusion  
Research Study One used PPT database from 17 sites of 235 healthy subjects (127 females, 108 
males) collected over four occasions with three measurements per session. The regional sites 
comprised of 14 acupoints on the head, forearms and lower legs, and five non-acupoints on 
forearms and right leg. The reports on these regional PPT data were limited to UTS studies which 
were frequently reported elsewhere. This study analysed the combined data to extend the 
epidemiological profiles that assess the temporal stability of regional PPT and its relationships with 
gender, age and BMI. With large sample size over a wide range of ages and BMI, the results from 
this study should be a good reference for future PPT studies whereby the neuromatrix theory instead 
of the gate control theory or Descarte’s linear causal model. This should be emphasized so as to 
provide a better understanding about human perception of pain. The recruitment of healthy adults 
provides a reliable set of PPT profiles for clinical and experimental studies that involve pain-free or 
disease states interventions or control.  In addition the PPT profile allows quick referencing for the 






In agreement with most studies was the reproducibility of PPT in short term measurements which 
suggested that the first reading need not to be discarded. Genders were also found to have 
significant differences in PPT at all sites which suggested data analysis has to be completed 
separately by gender meaning that the combination of PPT data across both genders is not 
recommended though matched-pair by gender could be a choice depending on the needs of the 
study. However, time and financial costs are incurred for substantial larger sample sizes including  
both genders if comparison between genders is essential for the clinical and experimental studies. 
 
Finally the stability of PPT was found to be consistent for both genders at some sites over certain 
temporal sessions. Whilst both genders showed significant increase in PPT over delayed periods, 
the males showed a higher percentage than the females. The regional PPT was not highly correlated 
with ages and BMI. However, grouping of age and BMI showed that both younger Healthy Weight 
females and males generally demonstrated higher PPT at some sites and the Overweight generally 
had higher PPT than the Healthy Weight. This would provide clinical implications for the analgesia 
dosage for practitioners on pain suffering patients of different genders, age and BMI groups. 
 
The factors behind the differences in PPT for bilateral sites remain unknown as the dexterity of 
subjects (majority of subjects were right-handed) was not a factor of examination in this study. 
Furthermore, the effect of interventions across all previous studies seemed to continue playing a   
role in the stability of PPT. All these contradictions imply the need for a more well designed 
experimental PPT study which includes detailing dexterity, profession, daily activities involving the 




II. Research Study Two 
5.7 Lateral epicondylitis: Acupuncture treatment? 
Research Study Two was a pilot study with limited sample sizes of 11 females (age=45.8±6.8 years, 
BMI=23.6±3.1kg/m2) and 9 males (age=46.6±5.7 years, BMI=24.6±3.1kg/m2). Subgroups of five 
men, six women in the treatment group and four men, five women in the control group were 
randomised. Whilst many studies involved disease states, only two were found involving lateral 
epicondylitis with PPT measurements (Smidt et al 2002; Slater et al 2005) in which the mean ages 





between 18 to 70 years (mean 47±11) with lateral epicondylitis to evaluate the interobserver 
reproducibility of pressure pain threshold at the most sensitive area in common extensor tendon and 
the uninvolved control site in opposite arm. The patients were in sitting position (arm in 30° of 
abduction; elbow in 90° of flexion; forearm, wrist, and hand supported) whereas in this trial study, 
the patients were in supine position. Slater et al (2005) involved 20 patients aged between 34 to 65 
years (mean 48.2) and 20 pain-free subjects aged between 32 to 63 years (mean 47.4). It should be 
noted that compared to the sample sizes reported in the literature, the present trial had a small 
sample size thereby suggesting caution when interpreting the results. However, the results revealed 
some consistencies as found in other clinical PPT studies as described below.  
 
Firstly, the males had displayed significantly higher mean PPT than the females at both affected and 
non-affected measurement sites of LI10 and LI11 (Table 4.20) which is consistent with the findings 
in Research Study One and many other studies as discussed previously in section 5.1. Due to small 
sample sizes, no obvious patterns were found for comparisons between PPT of pre and post 
interventions (Tables 4.21, 4.22), between PPT of affected and non-affected sites (Tables 4.23 and 
4.24) and between PPT of Acupuncture and Sham Laser groups (Table 4.25) during the intervention 
weeks of Week 1, Week 5 and the follow-up in Week 9. Week 0 was a non-intervention occasion 
that showed generally unstable PPT measures for female patients.  
 
Interestingly, when percentage changes from the baseline mean PPT (Week 1) were considered, 
there were some significant increases of PPT at all non-affected and affected sites in both sessions 
of Week 5 and Week 9 for males in Acupuncture group whilst the females in Acupuncture showed 
an increase in PPT at all sites in PRE session and at three sites (except LI10 Non-affected) in POST 
session of Week 9. In Sham Laser, the females showed an increase in PPT at three sites (except 
LI10 Affected) in PRE session of Week 9 whilst the males showed a decrease in PPT at LI10 
(Affected side) in both sessions of Week 9 (Table 4.26, Figure 4.29). Further analysis revealed that 
the Acupuncture group for males showed significantly higher percentage change in PPT compared 
to Sham Laser on Week 5 and Week 9 for both PRE and POST sessions except LI10 Non-affected 
(pre-intervention) and LI11 Affected (post-intervention) on Week 5 (Table 4.27) whilst no obvious 
patterns were shown for comparisons of percentage changes between sessions (Table 4.28) or the 
affected and non-affected sites (Table 4.29). These results supported the potential efficacy of 
acupuncture treatment to lateral elbow pain for both genders while the females displayed positive 
psychological effects and the males had a negative effect from the Sham Laser. Percentage changes 






In conclusion, a larger sample size for improved statistical power is necessary. Caution has to be 
paid for familywise Bonferroni corrections. A practice session for patients is important in addition 
to the training of the examiner operating the algometer. It is also suggested that PPT measurements 
should be measured on every treatment occasion to capture the trends of changes in PPT readings. 
 
III. Research Study Three 
5.8 Electronic algometer versus mechanical algometer 
With the same circular rubber measuring probe of 1cm2 and pressure application rate of 1kg/cm2, 
the algometry results obtained from the electronic and mechanical algometers did not differ 
statistically from each other at all six measurement sites. However, the significant correlations 
between PPT measures obtained by different devices ranged from 0.55 to 0.82 which implies some 
caution in measurement procedures such as training of examiner, practice cycles for subjects, 
positioning of force application. If these procedures are implemented this could improve the 
correlation range. The mean inter-device coefficients of variance varied from 14% (LI5L) to 16.9% 
(1R) and the mean intra-device coefficients varied from 19.3% (PC6R) to 23.1% (1R) for 
mechanical algometer and 10% (PC6L) to 15.3% (1R) for electronic algometer. This demonstrates 
that the electronic algometer was relatively more precise in PPT measurement with the aid of the 
rate display screen which allows the examiner to monitor the rate of application to ensure 
consistency (Kosek et al 1993 and 1999; Isselée et al 1997; Ogimoto et al 2002; Tanaka et al 2004). 
Although no literature was found to have compared types of algometers, Bernhardt et al (2007) 
conducted a reliability and validity comparison between a commercial Somedic digital algometer 
with a self-designed fingertip-shaped pressure algometer for palpation (PAP) for assessing PPT at 
16 sites located in the temporomandibular joint, masticatory muscles and the frontalis muscle of 30 
subjects. The concurrent validity was demonstrated by statistically significant correlations between 
the two devices at all 16 sites (14 highly significant and two significant) with values ranging 
between 0.38 and 0.66 which were lower than the present study.  
 
In conclusion, both electronic and mechanical algometers are equally reliable for clinical and 
experimental studies. Results obtained from either type of algometers can be used for comparisons. 
Combining of PPT measures from these two different algometers is practical though not advisable 







IV. Implications for future research 
While exploring the vast set of PPT in the UTS database, extracting data from the past UTS PPT 
studies with various intervention settings, has prompted some suggestions for future research 
directions especially related to Research Study One. Research Study Two and Research Study 
Three could be seen as an extension of the PPT study if disease states and various models of 
algometers were to be considered. 
 
5.9 Implications derived from Research Study One 
Owing to the amount of data in the PPT database which involves large participant numbers pooled 
from previous UTS PPT studies as well as additional data collected specifically for this current 




a. Scrutinizing the PPT database by Study (i.e. each minor PPT study), narrowing the scope of 
data analysis on PPT measures among studies 
i. for a more convincing representation of baseline/pre-intervention PPT; 
ii. for identifying the effect of interventions on pre-intervention PPT in each study. 
 
b. Examination of the span of wash-out effect of PPT data by Study in terms of the 
interventions involved in each study  
i. if baseline or pre-intervention PPT were to be explored; 
ii. to minimise the complexity of multiple intervention effects in future studies. 
 
c. Examination of the intra- and inter studies variation on PPT 
i. as an inclusion criteria for a more reliable set of PPT for pooling of PPT; 
ii. for identifying the factors that influence PPT as outcome measures. 
 
d. Standardisation of cut-off values for PPT with respect to the capacity of the dial readout 
scale of the algometer used. This implies an alternative of using an algometer of larger 
capacity scale which would accommodate a greater PPT scores when referred to those 






e. Recruit subjects aged below 35 for non-intervention PPT measures at all 17 measurement 
sites across four occasions with three PPT readings per occasion for comparisons with the 
PPT measures of the present non-intervention elder group aged 35 and above. 
 
f. Recruit subjects aged 35 and above for LI4R intervention across four occasions with three 
PPT readings per occasion for comparisons with the PPT measures of the present 
intervention group. 
 
5.10 Implications derived from Research Study Two 
For Research Study Two, the selection of sites could be extended to a hypersensitive Ah Shi site (on 
affected arm) in addition to the acupoints LI10 or LI11. This inclusion of a hypersensitive site could 
provide a reference to the effectiveness of intervention if no clear results were obtained from the 
measures at the adjacent acupoints LI10 and LI11. As the scale of affected site may vary by 
individual, a Likert scale of pain assessment could be administered. A sufficient sample size should 
be considered for adequate statistical power. 
 
5.11 Implications derived from Research Study Three 
For Research Study Three, the inter-device reliability between algometers can be extended to study 
on intra and inter-reliability of PPT measures within and between examiners, with and without 
training in operation of algometer, as well as with crossed application of algometers as designed in 
the present study. Screening for subjects with reliable response to PPT is a key criterion to exclude 
subjects with high intra-individual variation. A selection of one measurement site would be 
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Appendix 1: Characteristics of algometers  
Characteristics of algometers used in various studies 






Fischer et al  
1987 
Pressure threshold meter (Pain Diagnostics and 
Thermography, I7 Wooley Lane East, Great 
Neck, NY 11021, U.S.A.) 
1cm2 100g/s 0.1 
Jones et al  
2007 
Electronic pressure algometer (Somedic, Hörby, 
Sweden) 2cm 30kPa/s 0.1 
Farella et al 
2000 
Electronic algometer (Somadic sales AB, 
Algometer Type II, Sweden) 1cm
2 20kPa/s 0.2 
Walsh et al  
2009 Electronic digital algometer (Somedic AB) 2cm
2 50kPa/s 0.25 
Slater et al  
2005 Algometer (Somedic AB, Sweden) 1cm
2 30kPa/s 0.3 
Ge et al  2006 Electronic pressure algometer (Somedic Algometer type 2, Sollentuna, Sweden) 1cm
2 30kPa/s 0.3 
Bernhardt et 
al 2007 
Fingertip-shaped Pressure algometer for palpation 
& Somedic algometer 1cm
2 30kPa/s 0.3 
Ge et al  2008 Somedic Algometer Type II, Solentuna, Sweden 1cm2 30kPA/s 0.3 
Fernández-de-
las-Peñas et al 
2009 
Electronic pressure algometer (Somedic, Hörby, 
Sweden) 1cm
2 30kPa/s 0.3 
Ayesh et al 
2007b 
Pressure algometer (Somedic Sales AB, Hörby, 
Sweden) 10mm
2 30kPa/s 0.3 
Cairns et al  
2006 Pressure algometer (Somedic, Sweden) 1cm 30kPa/s 0.38 
Ayesh et al 
2007a Pressure algometer (Somedic, Sweden) 1cm 30kPa/s 0.38 
Brennum et al 
1989 
Hand-held electronic pressure algometer 
(Somedic) 0.28cm
2 1.1N/s 0.39 
Sterling et al  
2002 
Electronic digital algometer (Somedic AB, 
Sweden) 1cm
2 40kPa/s 0.4 
Chung et al 
1992 
Pressure algometer-Electronic Algometer Type I, 
Sometic, Stockholm. Sweden. - 40kPa/s 0.4 
Isselée et al  
1997 
Electronic algometer (Somedic, Stockham, 
Sweden) 1.1cm 40kPa/s 0.42 
Persson et al  
2004 
Electronic pressure algometer (Somedic , 
Sweden) 1.1cm 40kPa/s 0.42 
Plesh et al 
1998 Mechanical algometer (Model PTH-AF2) 1cm
2 1lb/cm2/s 0.45 
Murphy et al 
1992 
Pressure threshold meter (Pain Diagnostics and 
Thermography,Great Neck, NY 11023, U.S.A.) 1cm
2 1lb/cm2/s 0.45 
McMillan et 
al  1994 
Model PTH-AF2, Pain disgnostics and 
thermography Corp 1cm 0.5kg/cm
2/s 0.5 
Nordahl et al  
2003 Electronic algometer (Somedic) 1cm
2 50kPa/s 0.5 
Barlas et al  
2006 Type II Somedic algometer (Somedic,Sweden) 1cm
2 50kPa/s 0.5 
Rolke et al  
2006 Algometer (FDN200, Wagner Instruments, USA) 1cm
2 0.5kg/cm
2/s 
or 50kPa/s 0.5 
Gomes et al 
2008 
Mechanical algometer 





Persson et al  
2008 Electronic pressure algometer (Somedic Sweden) 1cm 40kPa/s 0.5 
Vedolin et al 
2009 Electronic algometer (KRATOS) 1cm
2 0.5kg/cm2/s 0.5 
Pfau et al  
2009 Electronic pressure algometer (Somedic, Sweden) 1cm
2 50kPa/s 0.5 
Frank et al 
2013 
Electronic pressure algometer(Somedic 
Algometer Type II,Sweden) 1cm 40kPa/s 0.51 
Chesterton et 
al 2003 
Pressure algometer (Salter Abbey Weighing 
Machine Ltd England) 1.1cm 5N/s 0.53 
Anderson et al  
2008 
Computer-controlled pressure algometer 
(Aalborg University, Aalborg, Denmark) 1cm
2 0.6kg/s 0.6 
Kosek et al  
1993 Electronic( Somedic AB, Farsta, Sweden) 1cm 50-60kPa/s 0.64 
Möller et al  
1998 
Pressure algometer (type 739, SOMEDIC Sales 
AB, Sweden) 1mm 0.05N/s 0.64 
Christidis et al  
2005 
Electronic algometer (Somedic Sales AB, Hörby, 
Sweden) 1cm 50kPa/s 0.64 
Chesterton et 
al  2007 
pressure algometer (Salter Abbey Weighing 
Machines Ltd, England) 1cm 5N/cm
2/s 0.64 
Williams et al 
2004 Nail-bed pressure algometer 
1.5cm 
by 1mm 100g/s 0.67 
Kinser et al  
2009 
Force plate & mechanical algometer(Wagner 
Force One Model FDIX 50TM, Wagner 
Instruments, Greenwich, Conn) 
1cm2 6.8N/s 0.68 
Kosek et al  
1999 Electronic (Somedic Sales AB, Farsta, Sweden) 1cm 50-60kPa/s 0.76 
Isselée et al  
2001 
Electronic algometer Somedic algometer Type II 
(Solentuna,Sweden) 0.5cm
2 40kPa/s 0.8 
Lacourt et al 
2012 Digital algometer (FDX 50; Wagner Instruments) 1cm
2 98kPa/s 0.98 
Fischer et al  
1986, 1990 
Pressure threshold meter (Pain Diagnostics and 
Thermography, Great Neck, NY)  1cm
2  1kg/s 1 
Reeves et al 
1986 
Pressure algometer (Pain Diagnostics and 
Thermography Corporation, Pain Threshold 
Meter, Model PTH-AF2) 
1cm 1 kg/cm2/s 1 
Fernández-de-
las-Peñas et al 
2006a, b 
Pressure threshold meter (Pain Diagnosis and 
Rehabilitation, Great Neck, New York) 1cm 1 kg/cm
2/s 1 
Tunks et al  
1988 Hand held pressure Algometer 2cm
2 1kg/s 1 
Delaney et al  
1993 
Mechanical pressure algometer (Pain Diagnostics 
and Thermography Corporation, Pain Threshold 
Meter, Model PTH-AF2) 
1cm2 1kg/s 1 
Wessel  1995 Dolorimeter (Pain Threshold Meter, Pain Diagnostics and Thermography)  - 1kg/s 1 
Nussbaum et 
al 1998 Fisher algometer 1cm
2 1kg/cm2/s 1 
Waling et al 
2001 
Electronic (Somedic Production AB, Sollentuna, 
Sweden) 10mm
2 10kPa/s 1 
Zaslawski et 
al  2003 
Mechanical algometer (Activator Methods, 
Phoenix, USA) 1cm
2 1kg/s 1 
Potter et al 
2006 
Pain threshold meter, model PTH-AF 2 (Pain 
Diagnostic and Treatment Corporation) 1cm
2 1kg/s 1 
Farasyn et al 
2007 
Fischer pressure algometer (Pain Diagnostics & 
Thermography, Great Neck, NY, USA) 1cm
2 1kg/s 1 
Ylinen et al 
2007 
Hand-held digital pressure algometer (Force 
fiveTM, Wagner Instruments, Box 1217, 
Greenwich, CT 06836) 
1 cm2 10N/s 1 
Farasyn et al 
2008 
Fischer pressure algometer (Pain Diagnostics & 
Thermography, Great Neck, NY, USA) 1cm





Li et al  2008 Mechanical algometer (Activator Methods Phoenix USA) 1cm
2 1kg/s 1 
Meeus et al 
2010 
Fisher algometer (Force Dial model FDK 40, 
Wagner Instruments, Greenwich)  - 1kg/s 1 
Takala et al  
1990 Mechanical algometer (Ametek LN50) 0.95cm
2 10N/s 1.05 
Taimela et al  
2000 Mechanical algometer (Ametek LN50) 0.95cm
2 10N/s 1.05 
Cathcart et al  
2008 Mechanical algometer constructed in-house. 0.4cm
2 0.5kg/s 1.25 
Vanderweeën 
et al  1996 
Pressure algometer (Pain Diagnostics and 
Thermography Corporation, Pain Threshold 
Meter, Model PTH-AF2) 
1cm 1kg/s 1.27 
Hübscher et al 
2008 
Handheld mechanical pressure algometer (pdt, 
Rome, Italy) 1cm 1kg/cm
2/s 1.27 
Ogimoto et al 
2002 Handheld electronic algometer 2mm 50g/s 1.59 
Tanaka et al 
2004 
Electronic controlled pressure algometer for oral 
mucosa 2mm 50g/s 1.59 
Ohrbach et al  
1989, 1998 
Mechanical algometer (Pain Diagnostics and 
Thermography, Great Neck, NY) 0.5cm
2 1kg/cm2/s 2 
Antonaci et al 
1992, 1998 
Mechanical pressure algometer (Pain Diagnostics 
and Thermography Corporation, Pain Threshold 
Meter, Model PTH-AF2) 
1cm2 2kg/cm2/s 2 
Visscher et al  
2004 
Pressure algometer (Pain Diagnostics and 
Thermography) 1cm
2 2kg/cm2/s 2 
Cathcart et al  
2006 
Analogue pressure algometer constructed in-
house 0.39cm
2 1.2kg/s 3.08 
Vatine et al  
1998 
Algometer (Modified: Model FT 10; Grass 




Vaughan et al 
2007 
Electronic pressure algometer (Somedic 
Algometer Type II, Sweden) 1cm
2 10, 20, 30, 40, 50kPa/s 
0.1, 0.2, 0.3, 
0.4, 0.5 
Jensen et al 












Aldayel et al 
2010 
Electronic algometer: Type II, Somedic 
Production AB, Sollentuna, Sweden 1cm
2 50-60kPa/s 0.5-0.6 
Defrin et al 
2003 
Hand-held pressure algometer (Somedic Sales 
AB, Algometer type II, Sweden) 
0.5, 1, 
2cm2 30kPa/s 0.6,0.3,0.15 
Takahashi et 
al 2005 
Electronic pressure algometer (CPU gauge model 





Zhang et al 
2011 Electronic algometer (Somedic, Sweden) 1cm
2  - - 
Buchanan et 
al  1987 Hand-operated Preston dolorimeter  -  -  - 
Smidt et al  
2002 
Algometer (Pain Diagnostics and Thermography, 
17 Wooley Ln E, Great Neck, NY 11021) 1cm
2  -  - 
Shiau et al  
2003 Electronic (Somedic Sales / AB Hörby, Sweden) 6mm   -  - 
Sayed-Noor et 
al  2008 
Hand-held electronic algometer (Somedic, 
Sweden)  - 40-50kPa/s  - 
Xiong et al 
2011 Indentation apparatus 
0.5, 1, 2, 
4 cm2 
0.5, 1, 2, 4 
mm/s  - 
Table A1: Characteristics of algometers used in various studies in ascending order of rates of force. The asterisk * 







Appendix 2: Specificity of measurement cycles and temporal sessions 
Specificity of measurement cycles and temporal sessions in PPT studies 
Reference No. Sites Measures/site Rest time* Occasions 
Aldayel et al 2010 4 3 30s 0, 1, 24, 72, 96 hours 
Anderson et al  2008 7 3   Days 0, 1, 4, 7 and 21 
Antonaci et al 1992 12 3 15min At least 2-days apart 
Antonaci et al 1998 26 3 2-3min 3 
Ayesh et al 2007a 11x2 3 1 min 0, 20, 35 min 
Ayesh et al 2007b 11x2 3   0, 30min, 1hr, 2hr 
Barlas et al  2006 2 
2 (10 - 20s 
between trials) 10 min 0, 10, 20, 30, 40, 50, 60min 
Bernhardt et al 2007 16 6 15 min   
Brennum et al 1989 12 5 5min 2 (one week apart) 
Brown et al  2000 1 3   2 visits: 3-8 days apart 
Buchanan et al  1987 5 areas 2 5 min 1 (12am - 2pm) 
Cairns et al  2006 4   5 min 
10, 15, 20, 25, 30min, 60min, 
1week 
Cathcart et al  2006 3x2 2 10min 5 visits: Mon to Fri 
Cathcart et al  2008   2 10s   
Chesterton et al 2003 
1  10-15s; 10 
min 
1 hour (7 time points) 
Chesterton et al  2007   3 15 min 5  
Christidis et al  2005 5 3 2 min   
Chung et al  1992 13x2 2 5 min 3 consecutive days 
Defrin et al 2003 3 3 45s   
Delaney et al  1993 2 2 5 min 1 
Farasyn et al 2007 5 3 (1st discarded) 10s   
Farasyn et al 2008 both sides 2 10s; 5min 1 
Farella et al  2000 2x2 
4 each site:1st 
discarded 5s; 2 min   
Fernández-de-las-Peñas et 
al 2006a 2 3   2 
Fernández-de-las-Peñas et 
al 2006b 8 3 30s   
Fernández-de-las-Peñas et 
al 2009 12 3 15s; 2.5min   
Fischer et al  1987 9 1   1 (8am-4:30pm) 
Frank et al 2013   3 10s 0,1,2 days 
Ge et al  2006 3 3 
10s between 
measures; 5 
min   
Ge et al  2008 10x2 3 40s   
Gomes et al 2008 6 2 10s   
Hübscher et al 2008 7 3 
10s (2 min 
per cycle) Immediate, 1 day, 2 day, 3 day 
Irnich et al 2001 6 2  6 
Isselée et al  1997     
5 min: 2 
trials per 
session 
A single day and between 2 days, 4 
sessions: Day1: 8am-10am and 
4pm-5pm; Day 3: morning and 
afternoon sessions. 
Isselée et al  2001 10 4 
A few sec; 5 
min 
Females: 3 phases for 10 months 
Men: weekly for 2 mths, then 
fortnight for 10 months 
Jacobs et al  1995 17     2 visits: 1 week apart 
Jensen et al 1986   5   varies 
Jones et al  2007 8 3   4 consecutive days 
Kinser et al  2009 10 sets 5 (per force) 10s (2 min)   
Kosek et al  1993 30 2; 3 3s-10s 






Kosek et al  1999 3 5 1 hr 2 sessions same day 
Lacourt et al 2012 6 3 30-40s   
McMillan et al  1994 10 2 30s   
Meeus et al 2010 7x2 3 (1st discarded) 10s   
Murphy et al  1992 6 2   2: 14 days apart 
Nordahl et al  2003 8 3 
2min per 
cycle   
Nussbaum et al 1998   3 (2 taken) 10s; 20min 3 occasions: 1 day apart 
Ogimoto et al 2002 2 3 1 min 4 occasions: 1 week apart 
Ohrbach et al  1989 4 1   2 




2 (Phase I); 1 
(Phase II) 3-5s   
Persson et al  2004 14 
4 (0, 10, 20, 30 
min) 10 min Days 1, 3, 28, 30 
Persson et al  2008 14 5 10 min   
Plesh et al 1998 3x2     2 pre-exercise sessions: 1 day apart 
Potter et al 2006 8 2 5 min 3 (at least one week apart) 




4 (2 per 
examiner); 
Study 2: 2 (1 for 
each examiner); 
Study 3=Study 
1: + 1 non-
trigger site each 
  2 
Reid et al  1994 4x2 3 30 min 2x2 occasions (one week apart) 
Rolke et al  2006 3 3     
Sayed-Noor et al  2008 4 1   1 
Shen et al  2007 4   30s   
Shiau et al  2003 2x2 4 (1st discarded) 3min   
Slater et al  2005 3 3 30s   
Smidt et al  2002 2 3 20s 2 
Sterling et al  2002 6x2 3   2 visits: 1 week apart 
Taimela et al  2000       Baseline, 3 months, 12 months 
Takahashi et al 2005   3 1 min   
Takala et al  1990     
women: 30 
min; men: 
30-45min one to two days 
Tanaka et al 2004 9 2 3min   
Tunks et al  1988 20   15 min   
Vanderweeën et al  1996 14 2 5 min 1 
Vatine et al  1998 2 
2 but 2nd one 
taken     
Vaughan et al 2007   
30 at 5 discrete 
rates   2 
Vedolin et al 2009 5x2 2  4 min   
Waling et al 2001 2 3   
2 days per week on week 1, week 5, 
week 10 
Walsh et al  2009 6 3 10s   
Wessel  1995 6     3 occasions (5-10 days apart) 
Williams et al 2004 1 2   
Xiong et al 2011 13 2 45s 
2 (plantar surface 1 day, dorsum 
another) 
Ylinen et al 2007 7 1 30s 2 days(1 day apart) 
Zaslawski et al  2003 10 3   8 (at least 2 days between sessions) 
Zhang et al 2011 2 3   
1 day for 10 days in 2 weeks; 1 
month  
Table A2: Specificity of measurement cycles and temporal sessions in PPT studies. Rest time * refers to between 






Appendix 3: Health status and study regions 
Health status and study regions in PPT studies 
 Reference Health status Regions/sites 
Aldayel et al 2010 Healthy Quadriceps femoris muscle: the middle point of the rectus 
femoris, the proximal of rectus femoris, vastus medialis and 
vastus lateralis 
Anderson et al  2008 Healthy Muscle hyperalgesia; tibialis anterior 
Antonaci et al 1992 Healthy (Right-
handed) 
Deltoid; Head 
Antonaci et al 1998 Healthy (Right-
handed) 
Head,neck,deltoid, median finger 
Ayesh et al 2007a, b Healthy Temporomandibular joint 
Barlas et al  2006 Healthy First dorsal interosseous muscle of the dominant and non-
dominant hands; needling at LI10, TH5, GB34, ST38 
Bernhardt et al 2007 Temporomandibular 
disorder; healthy 
Masticatory;temporomandibular;frontalis 
Brennum et al 1989 Healthy Center of the pulpa and center of the dorsal side of the medial 
phalanx of the second and fifth fingers and of the second toe on 
both the right and the left side. 
Brown et al  2000 Healthy Temporomandibular  
Buchanan et al  1987 Healthy a) Medial aspect of calcaneum; b) Medial aspect of upper tibia; 
c) Dorsal surface between thumb and forefinger; d) Lateral 
aspect of midpoint of forearm, and e) Lower forehead.  
Cairns et al  2006 Healthy Masseter muscles and temporalis 
muscle 
Cathcart et al  2006 Healthy (1) The dorsal surface of the middle segment of the 1st phalange; 
(2) the central fibres of the temporalis muscle, identified by 
palpation above the superior margin of the ear; and (3) an 
adjacent parietal location without overlying muscle. 
Cathcart et al  2008 Chronic tension-
type headache 
(CTH) 
Dorsal surface of the medial segment of the first phalange 
Chesterton et al  
2003, 2007 
Healthy First dorsal interosseous muscle 
Christidis et al  2005 Healthy Superficial masseter muscles, anterior temporalis muscles, 
trapezius muscles, and anterior tibialis muscles as well as over 
the muscles over glabella on the forehead 
Chung et al  1992 Healthy Head & neck 
Defrin et al 2003 Healthy Hand, painfree back and myofascial trigger points (MTPs) in the 
back 
Delaney et al  1993 Healthy Trapezius muscles 
Farasyn et al 2007 Healthy Lower thoraco-lumbo-pelvic region 
Farasyn et al 2008 Low back pain Gluteus medius 
Farella et al 2000 Healthy Massete and anterior temporalis muscles 
Fernández-de-las-
Peñas et al 2006a 
Healthy Masseter muscle 
Fernández-de-las-
Peñas et al 2006b 
Nummular 
headache 
Cranial area, temporal muscle, upper trapezius muscle, second 
finger 
Fernández-de-las-
Peñas et al 2009 




Nine points of the temporalis muscle: three points in the anterior, 
medial and posterior parts 
Fischer et al  1986 Healthy pain free Supraspinatus and deltoid, thumb and shin 
Fischer et al  1987 Healthy M. teres major, upper trapezius, levator scapulae, supraspinatus, 
infraspinatus, pectoralis, gluteus medius and paraspinals at the L4 
level, 2 and 4 cm from the midline, middle deltoid 
Fischer et al  1990 Lumbosacral and 
cervical pain 
patients 
M. teres major, upper trapezius, levator scapulae, supraspinatus, 





Frank et al 2013 Asymptomatic Three spinal segments (C6, T6 and L4) 
Ge et al  2006 Chronic unilateral 
myofascial shoulder 
pain 
Infraspinatus; tibialis anterior muscle 
Ge et al  2008 Healthy Infraspinatus 
Gomes et al 2008 Temporomandibular 
disorders (TMD) 
Masseter, temporalis 




Irnich et al 2001 Chronic neck pain levator scapulae, trapezius descendens, paravertebral of the 6th 
cervical spine 
Isselée et al  1997 Symptom free. Masseter and temporalis muscles 
Isselée et al  2001 Symptom free. Masster, temporalis and thumb muscles 
Jacobs et al  1995 Fibromyalgia 
patients 
Interspinous C4-6;, trapezius, costochondral, lateral epicondyle, 
knee, supraspinatus, interspinous L4-S1, buttock, forehead, 
thumbnail 
Jensen et al 1986 Healthy Temporal region 
Jones et al  2007 Healthy (right-
handed) 
Upper extremity; torso 
Kosek et al  1993 Healthy, right-
handed 
Nape, shoulder and lower back 
Kosek et al  1999 Healthy Epicondylus lateralis humeri; at the belly of m exterior carpi 
ulnaris and at m. brachioradialis 
Lacourt et al 2012 Healthy Left and right calf, lower back, and forearm 
Li et al  2008 Healthy Acupoints: GB20R, KD3L, KD3R, LI20R, LI5L, LI5R, ST36L, 
ST36R; nonacupoints: 1L, 1R 
McMillan et al  1994 Jaw muscle pain of 
myogeneous origin 
Masseter, temporal muscles 
Meeus et al 2010 Chronic fatigue 
syndrome (CFS) 
Deltoid, hand, lumbar, calf, thoracal, tibia, forearm 
Murphy et al  1992 Healthy Anterior temporalis muscles, the masseter muscles, and the 
lateral capsules of the temporomandibular joints. 
Nordahl et al  2003 Healthy Temporomandibular  
Nussbaum et al 1998 Healthy Biceps brachii 
Ogimoto et al 2002 Dentulous ; oral 
mucosa 
Bilateral buccal and the palatal sites 
Ohrbach et al  1989 Patients having 
active myofascial 
trigger points 
contributing to head 
and neck pain 
Myogenous temporomandibular disorder 
Ohrbach et al 1998 Facial and temporal 
pain 
  
Persson et al  2004 Healthy Trapezius;deltoid 
Persson et al  2008 Healthy Trapezius muscle; deltoid muscle 
Pfau et al  2009 Masseter muscle, 
trapezius muscle, 
thenar eminence 
Myogenic temporomandibular disorders (TMD) 
Plesh et al 1998 Masseter. Normal 
subjects 
Bilateral masseter 
Potter et al 2006 Healthy Iliocostalis, Multifidus, Gluteus maximus, Trapezius 
Reeves et al 1986 Patients having 
active myofascial 
trigger points 
contributing to head 
and neck pain 
Myofascial trigger points: superficial portion of the masseter, the 
anterior fibers of the temporalis, splenius capitis, trapezius, and 
semispinalis capitis muscles, and a non-myofascial boney point 









Rolke et al  2006 Healthy M. masseter, thenar eminence, instep 




Head bilateral sides 





Shen et al  2007 Chronic myofascial 
pain 
Masseter muscle 
Shiau et al  2003 Healthy Masseter and sternocleidomastoid muscles 
Slater et al  2005 Lateral 
epicondylalgia 
Lateral epicondyle, the belly of the extensor carpi radialis brevis 
muscle, radial head laterally 
Smidt et al  2002 Lateral epicondylitis Lateral epicondylitis 
Sterling et al  2002 Healthy; chronic 
neck pain 
  
Taimela et al  2000 Chronic, non-
specific neck pain 
Upper trapezius and levator scapulas muscles 
Takahashi et al 2005 Healthy   
Takala et al  1990 Working population Upper trapezius; levator scapulae 
Tanaka et al 2004 Denture and 
edentulous patients 
Upper anterior alveolus, upper lateral alveolus, mid palate, lower 
anterior alveolus and lower lateral alveolus 
Tunks et al  1988 Fibromyalgia; 
normal 
Tender & non-tender points 
Vanderweeën et al  
1996 
Shoulder and arm 
pain 
Paravertebral;shoulder;arm 
Vatine et al  1998 Sternum: Reflex 
sympathetic 
dystrophy 
Manubrium of the sternum 




Right masseter, right temporalis (anterior, medium and 
posterior), Achilles’ tendon, left masseter and left temporalis 
(anterior, medium and posterior) 
Visscher et al  2004 Healthy Temporomandibular; masseter;temporalis 
Waling et al 2001 Trapezius myalgia: 
neck-shoulder pain 
Trapezius 
Walsh et al  2009 Low-back related 
leg pain 
Sciatic, tibial peroneal nerves 
Wessel  1995 Osteoarthritis, 
healthy 
Anteromedial and anterolateral joint lines 
Williams et al 2004 Healthy Finger nail: lunula 
Xiong et al 2011 Healthy   
Ylinen et al 2007 Chronic non-
specific neck pain 
Levator scapulae, trapezius muscles, sternum 
Zaslawski et al  2003 Healthy Acupoints: CV12, LI10R, LI20R, LI5R, PC6R. SI3R, ST36R; 
Nonacupoint: 1R, 2R, 3R 
Zhang et al 2011 Plantar fasciitis Medial tubercle of calcaneum: normal foot, affected foot 











Appendix 4: Comparisons of PPT between genders 
 
Reference PPT (M) > PPT (F) M:F Mean (Age range) in years 
Antonaci et al 1992 p>0.12 16:24 36.5±13.9 (20 to 73) 
Ayesh et al 2007a p> 0.162 24:19 M:23.4±0.6 (19 to 31); F: 25.9±0.6 (22 to 32) 
Buchanan et al 1987 p<0.05 95:95 18.3 (17 to 19) 
Chesterton et al 2003 p< 0.0005 (Study 1)  p<0.01 (Study 2). 
120:120 (Study 1) 
15:15 (Study 2) 25 (28 for Study 2) 
Christidis et al 2005 p<0.001   baseline all five sites 10:10 M:37±10; F:36±10 
Fischer et al 1987 p<0.05 nine sites except gluteus medius 24:26 M:35.9(22-63); F:28.6(21-57) 




11:11 M:27(21 to 35); F:24(21 to 34) 
Ohrbach et al 1989 p<0.003 5:40 38.6 
Plesh et al 1998 p < 0·05 7:7 25±3(22 to 28) 
Rolke et al 2006 p < 0.01 70:110 M:37.5±13.0 (17 to 75); F:38.9 ±13.0 (17 to 75) 
Takala et al 1990 p<0.05 93:70 
Vanderweeën et al 1996 p<0.05 30 
Vatine et al 1998 p<0.05 
11:6 (Patients);  
7:6 (Other chronic pain);  
14:10 (Pain-free) 
M:37.3 (11 Patients); 40.0 (7 Other chronic pain); 
40.0 (24 Pain-free);  
F:56.7 (6 Patients); 46.2 (6 Other chronic pain); 
36.9 (10 Pain-free) 
Table A4: Studies that had made comparisons at study sites regarding PPT between genders.  
 
Appendix 5: Characteristics of subjects in terms of age, weight, height and BMI 
Reference Subject M:F Age, Weight (W), Height (H), Body Mass Index (BMI) 
Aldayel et al 2010 9 9:0 Age:31.3±4.7; W:76.3±11.2 kg; H:173.2±4.2cm 
Anderson et al 2008 20 10:10 Age(M):25.6 (22 to 33); Age(F): 25.5 (23 to 27); BMI(M):20.5–29.3 (24.1); BMI(F):20.4–29 (24.2) 
Antonaci et al 1992 40 16:24 Age:36.5±13.9(20 to 73) 
Antonaci et al 1998 21 15:6 Age:29.1±12.4(20 to 67) 
Ayesh et al 2007a 43 24:19 Age(M):23.4±0.6(19 to 31); Age(F):25.9±0.6(22 to 32) 
Ayesh et al 2007b 28 14:14 Age:27.4 ± 6.2 
Barlas et al 2006 48 24:24 Age:23 (18 to 41) 
Bernhardt et al 2007 15 (TMD*); 15 (Control) 
1:14 (TMD);  1:14 
(Control) Age:33±11.3(TMD); 38±10.8(Control) 
Brennum et al 1989 30 15:15 Age: 20 to 40 
Brown et al 2000 65 34:31 Age:25.7±8.3 
Buchanan et al 1987 190 95:95 Age:18.3(17-19) 
Cairns et al 2006 18 18:0 Age:27±1 
Cathcart et al 2006 10 4:6 Age:21±2.6(18 to 25) 
Cathcart et al 2008 16 (CTH*);  15 (Control) 
8:8 (CTH);  
8:7 (Control) Age:18 to 65 
Chesterton et al 2007 13 1:12 Age:22(20-29) 
Chung et al 1992 40 19:21 Age(M):23.8(21 to 27);  Age(F):22.9(20 to 25)  
Defrin et al 2003 26 10:16 Age:31.9(22 to 51); BMI(M):24.6±4; BMI(F):22.2±3 
Delaney et al 1993 50 25:25 Age:20 to 51 
Farasyn et al 2008 42 26:16 Age: 43±16(20 to 75); BMI: 22±3 
Farella et al 2000 40 (TMD);  40 (Control) 
0:40 (TMD);  
0:40 (Control)  
Fernández-de-las-Peñas 




16:9(Control) Age:28±10(Treatment); 27±8(Control) 
Fernández-de-las-Peñas 
et al 2006b 12 (NH) 3:9 Age:21 to 67 
Fernández-de-las-Peñas 





Age(F):36±10 (25 to 59) (Migraine); Age(F):37±6 (26 to 
58) (Control) 





Fischer et al 1987 50 24:26 Age(M):35.9(22-63); Age(F):28.6(21-57) 
Ge et al 2006 21 0:21 Age:45.6±3.16 (24 to 60); W: 63.5±2.31 
Ge et al 2008 21 0:21 Age:46.3±4.2(25 to 63); W: 62.8±3.4 
Hübscher et al 2008 22 10:12 Age:20 to 30 







Age: 52.3±13.3(Acu); 52.7±11.5(Massage); 
52.2±13.2(Sham) 
Isselée et al  1997 22 11:11 Age(M):27(21 to 35); Age(F):24(21 to 34) 
Jensen et al 1986 57 25:32 Age:33(19-69) 
Jones et al 2007 19 0:19 Age:23.9± 5.2(20 to 39); BMI: 23.6±3.5 
Kosek et al 1993 12 0:12 Age:28(15 to 33) 
Kosek et al 1999 15 (10 for both sessions) 
0:15 (10 for both 
sessions) Age(F):36.8 (20 to 54); 50.6 (28 to 63) for separate sessions 
Li et al 2008 22 11:11 Age(M): 28.6±10.8; Age(F): 29.6±8.7 
McMillan et al 1994 20 10 patients; 10 controls Age:21 to 54 
Meeus et al 2010 30 (CFS*);  30 (Control)  Age:18 to 65 
Murphy et al 1992 20 0:20 Age:24.8(18 to 42) 
Nordahl et al 2003 31 10:21 Age(M): 50±15; Age(F): 45±19 
Nussbaum et al 1998 35 5:30 Age(M):36.4; Age(F):29.2; W(M):89kg; W(F):59kg; H(M):180; H(F): 160 ; 
Ogimoto et al 2002 10 8:2 Age:26.5(20 to 29) 
Persson et al 2004 24 0:24 Age:42(24 to 59); H:167(151 to 174); W:65(52 to 90) 
Persson et al 2008 14 Age:47±14.8; H:162±7.2; W:61±12.0 
Pfau et al 2009 23 3:20 Age:46.8±13.1 
Plesh et al 1998 14 7:7 Age: 25±3(22 to 28) 
Rolke et al 2006 180 70:110 Age(M): 37.5±13; Age(F): 38.9±13 
Shen et al 2007 15 1:14 Age(Acupuncture):45.2±12.3; Age(Sham): 41.8±14.9 
Shiau et al 2003  
0:20 (Patient); 
0:20 (Control) 
Age(P):26.5 (20 to 30); Age(C):25.5 (20 to 30); 
H(P):161.2±1.7; W(P): 52.9±1.1; H(C): 160.1±1.1; 
W(C):49.7±1.1 
Slater et al 2005 20 (Patients); 20 (Control)  Age(P):48.2(34 to 65); Age(C):47.4 (32 to 63) 
Smidt et al 2002 50 30:20 Age:47±11(18 to 70) 
Sterling et al 2002 19(CNP*); 19(Control) 
6:13 (CNP);  
7:12 (Control) Age(P):31.6±11.5; Age(C):30.1±11.47 
Taimela et al 2000 76 22:54 
Takahashi et al 2005 34 21:13 Age:22 to 57 
Tanaka et al 2004 35 10:10 (Dentate); 8:7 (Edentulous) 
Age(Dentate):67.8±5.7(60 to 80); 
Age(Edentulous):74.9±9.8(60 to 82) 
Tunks et al 1988 20 10:10 
Vanderweeën et al 1996 30 15:15 Age:15 to 75 
Vatine et al 1998 54 
11:6 (Patients); 
7:6 (Other chronic 
pain); 14:10 
(Pain-free) 
M: 37.3±14.5 (11 Patients); 40.0±17.8 (7 Other chronic 
pain); 40.0±11.2 (14 Pain-free); F: 56.7±14.5 (6 Patients); 
46.2±26.6 (6 Other chronic pain); 36.9±12.7 (10 Pain-free) 
Vedolin et al 2009 45 29 (Patients);  16 (Control) Age(F):19.8 
Visscher et al 2004 250 71:179 Age:34±13.3 (TMJ 118F 30M, 33.8±12.5; Control: 61F, 41M 35.2±14.4) 
Waling et al 2001 24 0:24 Age:40 
Walsh et al 2009 45 22:23 Age: 46±11(26 to 70) 
Wasner et al 2008 20 5:5(A);5:5(B) Age(A): 36.7±15; Age(B): 34±9.4 
Wessel et al 1995 36 18 OA;18 healthy Age: OA: 60.9±7.7; C: 64.3±8.04; H:OA: 160.7±6.08cm; C: 160.4±4.76; W:OA: 78.1±15.4kg; C: 64.4±11.4kg 
Williams et al 2004 61 20:41 Age:29.1 (19 to 50) 
Xiong et al 2011 20 10:10 
Age(M): 21.5±1.43(20 to 24); Age(F): 21.9±1.1(20 to 24); 
W(M): 65.5±8.59kg; BMI(M):22.2±3.02 (18.6 to 27); 
W(F): 54.7±8.8kg; BMI(F):20.4±1.9 (23.8 to 17.7) 
Ylinen et al 2007 20 0:20 Age: 47±5(25 to 53); W:69±13kg; H:163±5kg; BMI:26±5 
Zhang et al 2011 53 (51; 2 withdrew) 
8:20 (PC7); 
6:9(LI4) 
Age(PC7):47±2.2; Age(LI4):50.0±2.0; Age(M): 71.4 
(PC7); 76 (LI4); Age(F): 28.6 (PC7); 24 (LI4); H(PC7): 
161.4±1.8; H(LI4):159.2±2.3; W(PC7):64.8±2.3; 
W(LI4):66.7±2.6 
Table A5: Characteristics of subjects in PPT studies. *CFS = Chronic fatigue syndrome; CNP = Chronic Neck Pain; CTH 


























Appendix 9: Information letter (Research Study Two) 
 
INFORMATION LETTER 
THE EFFECT OF ACUPUNCTURE TREATMENT COMPARED TO LASER 
FOR LATERAL ELBOW PAIN:  A RANDOMISED CONTROLLED PILOT 
STUDY. 
(UTS HREC REF NO. 2009-274A) 
WHO IS DOING THE RESEARCH? 
My name is Christine Berle and I am a research assistant involved in the acupuncture 
study being conducted by Drs Chris, Zaslawski, Peter Meier, Deirdre Cobbin and Sean 
Walsh in the Faculty of Science at UTS. 
WHAT IS THIS RESEARCH ABOUT? 
This research is to find out whether there are any health benefits using acupuncture or 
low level laser for people with lateral elbow pain. 
IF I SAY YES, WHAT WILL IT INVOLVE? 
You will be randomly allocated to one of two groups; either acupuncture or laser 
treatment twice weekly for five weeks (approximately 45 minutes per session) to be 
conducted at the city campus of the University of Technology, Sydney.  The acupuncture 
will involve insertion of sterile single use needles into six acupoints on the affected arm 
and one around the knee.  Those receiving the laser will have low level laser light 
applied to the same acupoints as the acupuncture recipients.  As the laser light is low 
intensity it is a thermal (meaning no heat will be generated) and you may not experience 
any sensory feeling associated with its application. 
An algometer will be used to measure pressure pain 
threshold (PPT) (the first sign of discomfort not how 
much pain you can tolerate) one week prior to 
commencing treatment, pre and post first treatment, 
on completion and at one month follow-up (6 
assessments).  The algometer has a 0.5 cm diameter 
spring loaded rubber plunger which is incrementally 
pressed onto the skin or muscle measuring the 
pressure on the gauge (see photograph).  PPT 
measurements will be taken at two acupoints on the 
forearm twenty minutes after treatment.  The 
algometer does not puncture the skin.                                   
 






Participants will be asked to maintain a diary (monitoring medication, remedial exercise frequency and days off work due 
to the condition) and complete three different questionnaires at specially nominated times (McGill pain questionnaire, 
Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and a sensation scale) during the study and at one 
month follow-up. 
ARE THERE ANY RISKS? 
Yes, there are some minor risks.  If I am randomised into the group receiving 
acupuncture, I am aware that acupuncture involves the insertion of fine needles into the 
skin.  Side effects in acupuncture are infrequent and generally limited to bruising and 
spot bleeding.  On rare occasions patients may feel faint and nauseous.  A 2001 study 
(MacPherson et al, 2001) reported on adverse events and transient reactions associated 
with 34,407 prospective acupuncture treatments.  No serious adverse events were 
reported, where these were defined as requiring hospital admission, prolonging hospital 
stays, permanently disabling, or resulting in death (95% CI: 0 to 1.1 per 10,000 
treatments).  A total of 43 significant minor adverse events were reported, a rate of 1.3 
per 1,000 treatments (95% CI: 0.9 to 1.7).  These included severe nausea and actual 
fainting (12), unexpected, severe and prolonged aggravation of symptoms (7), prolonged 
and unacceptable pain and bruising (5) and psychological and emotional reactions (4).  
There were three avoidable events: two patients had needles left in by mistake, and one 
patient had moxa burns to the skin, also caused by practitioner error.  The acupuncturists 
also recorded 10,920 mild transient reactions occurring in 5136 treatments, 15% (95% 
CI: 14.6 to 15.3) of the 34,407 total. In terms of local reactions, there were reports of 
mild bruising (1.7%), pain (1.2%) and bleeding (0.4%).  The most common mild 
transient reactions to treatment were feeling relaxed (11.9%) and feeling energised 
(6.6%).  To reiterate in this prospective survey of 34,407 treatments, practitioners 
reported no serious adverse events.  In the unlikely event that a serious or minor event 
occurs, the treatment session will be terminated, first aid applied or if necessary medical 
help sought.  No adverse events have been published in the scientific literature 
associated with humans receiving low level laser treatment. 
Reference: MacPherson H, Thomas K, Walters S, Fitter M.(2001) A prospective survey 
of adverse events and treatment reactions following 34,000 consultations with 
professional acupuncturists. Acupuncture in Medicine, 19, 2, p.93-101. 
WHY HAVE I BEEN ASKED? 
You have been asked through a recruitment campaign because you:- 
 Have chronic lateral elbow pain for a period greater than 3 months. 
 The pain occurs on only one side of your body and on the lateral (outside) of 
your elbow 
 You are between 35-55 years of age 
Unfortunately you will be excluded from the research project if you have:- 





 Radial nerve entrapment 
 Inflammatory rheumatic diseases 
 Gout 
 Radioulnar or radiohumeral osteoarthritis 
 Or have experienced a  previous episode of lateral elbow pain that was treated 
surgically or with acupuncture 
DO I HAVE TO SAY YES? 
You don’t have to say yes. 
WHAT WILL HAPPEN IF I SAY NO? 
Nothing.  I will thank you for your time so far and won’t contact you about this research 
again. 
IF I SAY YES, CAN I CHANGE MY MIND LATER? 
You can change your mind at any time and you don’t have to say why.  I will thank you 
for your time so far and won’t contact you about this research again. 
WHAT IF I HAVE CONCERNS OR A COMPLAINT? 
If you have concerns about the research that you think I can help you with, please feel 
free to contact me, Christine Berle on 0418 447 911 email; Christine.Berle@uts.edu.au 
or Chris Zaslawski on (9514 7856). 
If you would like to talk to someone who is not connected with the research, you may 
contact the Research Ethics Officer on 02 9514 9615, and quote this number (UTS 












Appendix 10: Trial entry assessment form (Research Study Two) 
Trial entry assessment form 
                   Yes        No 
Do you have pain on the outside of your elbow (lateral)?         
Have you had this pain over 3 months?       
Do you have the pain only one side of your body?      
Do you perform work which has frequent repetitive motion?    
Do you undertake: 
a) heavy physical work - large expenditure of energy 
(e.g. labourer, bricklayer)      
b) light physical work - medium expenditure of energy 
(e.g. process worker)       
c) sedentary work - minimum expenditure of energy 
(e.g. office worker)       
Please indicate your age: 
Younger than 35 years of age   
Between 35 – 55 years of age   
Older than 55 years of age   
Do you currently have any of the following? 
Neck pain/problems        
Shoulder problems        
Radial nerve entrapment (pinched nerve)     
Inflammatory rheumatic diseases      
Gout          
Arthritis in your wrist or elbow joint      
Have you had any operations on your elbow, wrist or forearm?             
Have you previously had acupuncture for your elbow pain?             

















I _________________________________ agree to participate in the research project “The effect of 
acupuncture treatment compared to laser for lateral elbow pain:  A randomised controlled pilot study” 
(UTS HREC REF NO. 2009-274A) being conducted by Drs Chris Zaslawski, Peter Meier, Deirdre 
Cobbin, Sean Walsh, Christine Berle and PhD student Seong Leang Cheah at the University of 
Technology, Sydney (UTS), Broadway (ph;.0418 447 911).  All researchers do not have a conflict of 
interest.  Funding for this research has been provided by National Institute of Complementary 
Medicine (NICM). 
 
I understand that the purpose of this study is to identify if there are any health benefits using 
acupuncture or laser for people with lateral elbow pain.  I understand that my participation in this 
research will involve me receiving either acupuncture or laser treatment twice weekly for five weeks 
(approximately 45 minutes per session at the city campus of the University of Technology, Sydney).  
An algometer (a device for measuring pressure pain threshold) will be used at two acupoints on the 
forearm pre and post your treatment one week prior to commencing treatment, as well as at first 
treatment, on completion of the intervention phase and at one month follow-up (6 assessments).  
Participants are expected to maintain a diary and complete three different questionnaires at specially 
nominated points in time (pain questionnaire, Disabilities of the Arm, Shoulder and Hand (DASH) and 
a sensation scale). 
 
I am aware that I will be randomised into one of two groups; one group receiving acupuncture and the 
other receiving low level laser acupuncture.  I am aware that acupuncture involves the insertion of fine 
needles into the skin.  Due to the design of the study we cannot give you any information on the 
specific goals of the interventions.  Side effects from acupuncture are infrequent and generally limited 
to bruising and spot bleeding (see information sheet).  On rare occasions patients may feel faint and 
nauseous.  In the unlikely event that this occurs, the treatment session will be terminated, first aid 
applied or medical help sought.  Prior to the first treatment session a brief medical history of overall 
health will be taken (age, gender, duration of elbow condition, occupation and any individual factors 
which may possibly impact on results). 
 
I am aware that I can contact Dr Chris Zaslawski if I have any concerns about the research.  I also 
understand that I am free to withdraw my participation from this research project at any time I wish, 






I agree that Christine Berle has answered all my questions fully and clearly. 
 
I agree that the research data gathered from this project may be published in a form that does not 
identify me in any way. 
________________________________________  ____/____/____ 
Signature (participant) 
________________________________________  ____/____/____ 
Signature (researcher or delegate) 
 
NOTE: 
This study has been approved by the University of Technology, Sydney Human Research Ethics 
Committee.  If you have any complaints or reservations about any aspect of your participation in this 
research which you cannot resolve with the researcher, you may contact the Ethics Committee through 
the Research Ethics Officer (ph: 02 - 9514 9615, Research.Ethics@uts.edu.au), and quote the UTS 
HREC reference number.  Any complaint you make will be treated in confidence and investigated 







Appendix 12: Supplementary results I 
 
This appendix contains materials that were useful and handy in Discussion and for publications in 
the future. These reports are pulled out from Research Study One in Chapter Four so as not to 
impede the smooth flow of the overall presentation and hence to avoid unnecessary confusion. 
 
A12.1: The Pearson correlation coefficients between a) overall mean PPT and overall median 
PPT, and b) between PPTmean and PPTmedian 
 
Pearson Correlation 
Parameters Female Male 
Overall mean & overall median 0.998 0.993 
PPTmean & PPTmedian 0.996 0.996 
Table A12.1: The Pearson correlation coefficients between overall mean PPT and overall median PPT, and 
between PPTmean and PPTmedian by gender. 
 
 
A12.2: The intra- and inter-individual variations of regional PPT 
 
The intra- and inter-individual coefficients of variations were computed based on the percentage of 
the standard deviation (SD) with respect to the mean of PPT values collected by reading cycles (R1, 
R2, R3) and temporal visits (V1, V2, V3, V4) within and between subjects.   That is,  
 
 a.   intra-individual coefficients of variation (IntraCV) across readings 
       = SD of three PPT readings at each visit within individual            x 100% 
           mean of the three PPT readings at each visit within individual  
 
b.   intra-individual coefficients of variation (IntraCV) across visits  
       = SD of four PPT readings across visits by reading cycle within individual            x100% 
          mean of the four PPT readings across visits by reading cycle within individual  
 
c.   inter-individual coefficients of variation (InterCV) across readings 
       = SD of three PPT readings at each visit among subjects             x 100% 
          mean of the three PPT readings at each visit among subjects  
 
d.   inter-individual coefficients of variation (InterCV) across visits  
       = __SD of four PPT readings across visits by reading cycle among subjects       x100% 





The average IntraCV of reading cycles (females: 9.6% to 12.8%; males: 9.2% to 11.5%) were much 
lower than of the temporal sessions (females: 18% to 22.4%; males: 15.9% to 21.6%) for both 
genders (Table A12.5). These results supported the stability and reproducibility of PPT among the 
reading cycles (Figure 4.3) and accounted for some variations across longer temporal sessions of 
more than a week (Figures 4.5 and 4.6). When InterCV were considered (Table A12.8), the ranges 
for reading cycles (females: 33.3% to 46.7%; males: 31.7% to 49.3%) were consistent with that of 
the temporal sessions (females: 33% to 46.3%; males: 31.6% to 49.5%) which indicated the 
presence of some influences that had contributed to PPT measurements. These could include 
various parameters such as age, BMI, break time intervals, learning experience or even the presence 




Intra-individual coefficients of variation across three readings 
IntraCV across readings: Female IntraCV across readings: Male 
V1 V2 V3 V4 Average V1 V2 V3 V4 Average 
LI20L 15.00 12.63 11.42 12.26 12.83 12.38 12.10 11.21 10.19 11.47 
LI20R 12.89 13.82 10.77 10.76 12.06 11.69 9.31 10.08 11.01 10.52 
GB12R 12.32 11.08 10.81 11.55 11.44 10.84 9.50 10.29 10.76 10.35 
2L 13.15 12.64 11.15 11.22 12.04 12.13 11.43 10.48 10.54 11.15 
2R 12.73 12.73 10.43 10.83 11.68 12.19 9.47 9.51 9.02 10.05 
PC6L 12.17 11.42 9.62 10.64 10.96 8.63 9.21 9.47 9.66 9.24 
PC6R 10.23 10.50 10.55 8.99 10.07 10.43 9.29 8.46 8.99 9.29 
LI10L 11.99 12.21 13.61 12.15 12.49 9.99 9.60 8.79 10.73 9.78 
1L 12.35 10.93 11.66 11.94 11.72 11.51 10.44 9.62 11.24 10.70 
1R 11.81 11.55 12.39 12.26 12.00 11.50 11.10 10.13 11.42 11.04 
LI5L 11.19 10.90 12.38 12.06 11.63 11.30 10.28 11.09 9.37 10.51 
LI5R 12.71 11.93 10.24 10.95 11.46 11.73 10.82 10.24 10.40 10.80 
ST36L 11.37 10.15 9.88 8.73 10.04 11.14 9.10 9.42 7.14 9.20 
ST36R 11.51 9.59 9.60 9.77 10.12 10.86 9.58 8.77 8.72 9.48 
3R 11.02 10.15 9.79 9.59 10.14 10.83 10.08 8.78 9.56 9.81 
SP6R 10.09 10.38 9.75 8.00 9.56 10.22 8.79 9.47 8.75 9.31 
KD3R 11.67 11.32 11.48 9.64 11.03 11.19 9.66 9.07 9.81 9.93 













Intra-individual coefficients of Variation across four visits 
IntraCV across visits : Female IntraCV across visits : Male 
R1 R2 R3 Average R1 R2 R3 Average 
LI20L 24.65 21.85 20.85 22.45 22.19 22.03 20.59 21.60 
LI20R 19.62 19.93 19.16 19.57 20.63 20.16 18.68 19.82 
GB12R 19.64 21.28 20.53 20.48 19.82 20.12 20.58 20.17 
2L 21.80 20.46 21.40 21.22 20.61 20.45 21.60 20.89 
2R 20.36 19.83 18.86 19.68 20.32 20.04 20.91 20.42 
PC6L 18.79 18.66 18.57 18.67 17.24 17.55 16.74 17.18 
PC6R 17.78 17.89 18.39 18.02 16.33 18.07 18.47 17.62 
LI10L 22.22 21.28 22.01 21.84 19.47 22.03 20.44 20.64 
1L 20.69 19.90 20.04 20.21 19.67 20.36 19.65 19.89 
1R 20.81 19.10 18.76 19.56 20.76 19.17 18.53 19.49 
LI5L 20.24 20.28 20.11 20.21 19.87 19.07 19.13 19.36 
LI5R 20.34 19.52 19.64 19.83 20.19 20.01 19.09 19.76 
ST36L 20.76 20.80 19.56 20.37 18.85 19.45 18.56 18.95 
ST36R 19.69 20.15 18.75 19.53 19.34 19.22 18.82 19.13 
3R 19.22 20.43 18.57 19.40 19.48 19.00 19.27 19.25 
SP6R 19.12 18.74 17.72 18.52 16.35 16.47 14.96 15.93 
KD3R 20.95 21.33 20.18 20.82 19.16 19.19 19.11 19.15 
Table A12.4: Intra-individual coefficients of variations of PPT readings across four visits. 
 
 
Average Intra-individual coefficient of variation 
Site Female Male R V R V 
LI20L 12.8 22.4 11.5 21.6 
LI20R 12.1 19.6 10.5 19.8 
GB12R 11.4 20.5 10.3 20.2 
2L 12.0 21.2 11.1 20.9 
2R 11.7 19.7 10.0 20.4 
PC6L 11.0 18.7 9.2 17.2 
PC6R 10.1 18.0 9.3 17.6 
LI10L 12.5 21.8 9.8 20.6 
1L 11.7 20.2 10.7 19.9 
1R 12.0 19.6 11.0 19.5 
LI5L 11.6 20.2 10.5 19.4 
LI5R 11.5 19.8 10.8 19.8 
ST36L 10.0 20.4 9.2 19.0 
ST36R 10.1 19.5 9.5 19.1 
3R 10.1 19.4 9.8 19.2 
SP6R 9.6 18.5 9.3 15.9 
KD3R 11.0 20.8 9.9 19.2 
Min 9.6 18.0 9.2 15.9 
Max 12.8 22.4 11.5 21.6 







Inter-individual coefficients of variation across readings 
Female Male 
V1 V2 V3 V4 Average V1 V2 V3 V4 Average 
LI20L 49.1 44.4 44.5 47.3 46.3 45.4 45.7 49.4 53.6 48.50 
LI20R 44.7 41.5 40.0 42.5 42.2 38.9 39.2 44.4 45.1 41.90 
GB12R 46.2 40.1 41.4 40.1 42.0 40.1 42.8 47.2 52.5 45.65 
2L 44.7 40.4 39.1 42.3 41.6 40.3 39.6 40.4 43.0 40.81 
2R 38.0 37.5 34.6 38.2 37.1 36.6 35.2 34.4 37.0 35.78 
PC6L 43.8 33.2 33.9 36.6 36.9 33.6 31.1 30.4 31.3 31.62 
PC6R 33.3 32.5 33.5 32.7 33.0 33.5 35.6 37.2 39.3 36.39 
LI10L 48.4 43.4 40.8 39.7 43.1 47.3 43.7 46.7 56.1 48.45 
1L 40.7 34.2 33.8 37.0 36.4 42.0 43.4 47.4 52.0 46.22 
1R 40.4 38.7 38.9 41.1 39.8 36.1 36.5 40.9 42.3 38.98 
LI5L 45.7 39.6 38.8 37.0 40.3 31.4 32.5 36.5 37.8 34.55 
LI5R 37.9 37.8 38.7 38.3 38.2 38.6 37.8 38.2 40.7 38.82 
ST36L 39.4 36.4 36.0 37.8 37.4 32.9 36.3 38.2 40.5 37.00 
ST36R 38.0 36.0 37.1 37.1 37.0 33.2 34.0 35.7 34.5 34.34 
3R 41.4 38.7 39.1 36.6 38.9 33.0 31.4 37.6 38.3 35.08 
SP6R 33.7 34.5 38.4 34.7 35.3 37.3 35.4 30.2 37.8 35.18 
KD3R 41.3 38.2 35.0 34.9 37.3 39.0 37.3 37.1 42.5 38.98 
Table A12.6: Inter-individual coefficients of variations of three PPT readings in each visit. 
 
 
Inter-individual coefficients of variation across visits 
Female Male 
R1 R2 R3 Average R1 R2 R3 Average 
47.8 46.7 45.4 46.7 48.3 48.7 49.2 48.8 
43.3 42.5 41.9 42.6 41.9 42.4 42.7 42.3 
40.4 42.3 43.7 42.1 46.5 46.5 47.7 46.9 
41.9 41.2 42.9 42.0 40.3 41.6 41.9 41.3 
37.2 36.3 38.2 37.2 35.5 36.5 36.1 36.0 
36.0 37.7 38.7 37.5 31.2 31.9 32.1 31.7 
33.3 33.3 33.1 33.3 35.9 37.7 37.0 36.8 
42.7 42.6 44.2 43.2 48.4 49.1 50.5 49.3 
37.2 36.4 36.1 36.6 44.8 48.6 48.0 47.1 
39.2 39.9 40.6 39.9 39.2 39.5 39.7 39.5 
39.7 39.6 41.6 40.3 33.5 36.3 36.9 35.6 
38.3 38.0 39.2 38.5 38.3 39.0 40.3 39.2 
37.3 38.2 37.1 37.5 36.8 37.5 38.8 37.7 
37.2 37.4 37.2 37.3 34.4 34.2 35.6 34.7 
39.5 39.7 37.7 39.0 36.6 35.6 35.3 35.8 
34.9 35.8 36.1 35.6 36.7 35.6 33.8 35.3 
37.5 37.8 37.0 37.4 39.2 39.2 40.2 39.6 






Average Inter-individual coefficient of variation 
Site Female Male R V R V 
LI20L 46.7 46.3 48.8 49.5 
LI20R 42.6 42.2 42.3 41.9 
GB12R 42.1 42.0 46.9 45.7 
2L 42.0 41.6 41.3 40.8 
2R 37.2 37.1 36.0 35.8 
PC6L 37.5 36.9 31.7 31.6 
PC6R 33.3 33.0 36.8 36.5 
LI10L 43.2 44.2 49.3 48.5 
1L 36.6 36.4 47.1 46.3 
1R 39.9 39.9 39.5 39.1 
LI5L 40.3 41.0 35.6 34.7 
LI5R 38.5 38.4 39.2 38.8 
ST36L 37.5 37.4 37.7 37.0 
ST36R 37.3 37.1 34.7 34.3 
3R 39.0 38.9 35.8 35.4 
SP6R 35.6 35.3 35.3 35.2 
KD3R 37.4 37.4 39.6 39.0 
Min 33.3 33.0 31.7 31.6 
Max 46.7 46.3 49.3 49.5 





A12.3 The coefficients of determination for the relationship between regional PPTmean and 
PPTmedian in Visit 1 (pre-intervention) with age or BMI 
 
Coefficients of determination were often used in discussion in articles. For convenience of 
references in Discussion (Chapter 5), Tables A12.9 and A12.10 calculated the coefficients of 
determination (R2) for the Pearson coefficients (R) as shown in Tables 4.7 and 4.8. However, the 












Coefficients of determination between PPTmean and age, PPTmean and BMI, age and BMI 



















LI20L 5.48% 0.04% 0.04% 1.30% 1.08% 1.54% 11.09% 4.75% 6.20% 
LI20R 6.71% 0.02% 4.33% 7.18% 0.29% 3.03% 6.97% 1.51% 7.78% 
GB12R 0.79% 0.00% 0.79% 0.10% 0.52% 0.18% 1.54% 1.88% 9.18% 
2L 2.62% 0.44% 1.80% 1.44% 2.89% 0.14% 3.50% 1.56% 9.30% 
2R 1.12% 2.37% 2.66% 3.42% 2.16% 1.10% 0.03% 1.56% 6.86% 
PC6L 1.96% 5.71% 0.37% 2.37% 11.42% 0.01% 2.25% 0.07% 3.61% 
PC6R 0.06% 0.17% 0.88% 0.98% 3.92% 0.00% 0.20% 5.02% 6.81% 
LI10L 0.13% 0.02% 0.79% 1.06% 2.16% 0.18% 1.72% 6.25% 9.18% 
1L 0.11% 0.35% 2.59% 1.80% 1.66% 0.98% 1.82% 10.89% 7.73% 
1R 0.38% 0.07% 3.17% 0.18% 1.14% 1.93% 3.80% 2.37% 6.66% 
LI5L 0.00% 1.69% 4.00% 1.64% 4.84% 2.59% 3.53% 1.00% 8.07% 
LI5R 0.77% 0.83% 3.13% 1.08% 3.50% 1.35% 0.85% 0.53% 8.64% 
ST36L 0.34% 0.12% 3.31% 2.50% 2.31% 1.39% 7.08% 3.28% 8.82% 
ST36R 0.49% 0.30% 4.71% 2.76% 3.46% 3.24% 0.10% 4.28% 8.47% 
3R 0.11% 0.22% 3.17% 0.35% 0.02% 1.12% 0.01% 2.79% 9.18% 
SP6R 0.04% 0.56% 0.58% 0.18% 0.14% 2.53% 0.14% 8.29% 0.58% 
KD3R 0.85% 0.18% 2.07% 2.28% 0.16% 0.45% 0.83% 3.69% 8.18% 
Table A12.9: The coefficients of determination (R2) between the PPTmean and age, PPTmean and BMI, age and 




Coefficients of determination between PPTmedian and age, PPTmedian and BMI, age and BMI 



















LI20L 5.15% 0.10% 0.04% 1.23% 0.85% 1.54% 10.18% 5.15% 6.20% 
LI20R 7.18% 0.00% 4.33% 7.73% 0.26% 3.03% 7.34% 2.34% 7.78% 
GB12R 1.00% 0.00% 0.79% 0.21% 0.59% 0.18% 1.64% 1.90% 9.18% 
2L 2.40% 0.28% 1.80% 0.88% 2.96% 0.14% 4.16% 2.53% 9.30% 
2R 0.88% 2.56% 2.66% 3.31% 1.74% 1.10% 0.02% 2.56% 6.86% 
PC6L 1.82% 6.10% 0.37% 2.46% 11.29% 0.01% 1.80% 0.30% 3.61% 
PC6R 0.05% 0.20% 0.88% 0.85% 4.24% 0.00% 0.19% 4.71% 6.81% 
LI10L 0.10% 0.00% 0.79% 1.02% 2.53% 0.18% 1.44% 6.35% 9.18% 
1L 0.06% 0.49% 2.59% 1.80% 1.46% 0.98% 1.39% 12.11% 7.73% 
1R 0.28% 0.07% 3.17% 0.26% 0.98% 1.93% 3.50% 2.13% 6.66% 
LI5L 0.00% 1.39% 4.00% 1.54% 4.62% 2.59% 2.96% 1.59% 8.07% 
LI5R 0.62% 0.81% 3.13% 1.25% 3.50% 1.35% 0.40% 0.52% 8.64% 
ST36L 0.52% 0.06% 3.31% 1.51% 1.90% 1.39% 6.71% 3.31% 8.82% 
ST36R 0.50% 0.32% 4.71% 2.79% 3.50% 3.24% 0.12% 4.12% 8.47% 
3R 0.02% 0.23% 3.17% 0.25% 0.00% 1.12% 0.29% 3.57% 9.18% 
SP6R 0.07% 0.66% 0.58% 0.25% 0.07% 2.53% 0.36% 8.47% 0.58% 
KD3R 0.69% 0.25% 2.07% 2.19% 0.12% 0.45% 0.67% 4.12% 8.18% 
Table A12.10: The coefficients of determination (R2) between the PPTmedian and age, PPTmedian and BMI, age 
and BMI. Only PPTmedian of Visit 1 was considered. Highlighted in red are the coefficients of highest 





A12.4: Descriptive statistics of PPT, PPTmean and PPTmedian  
Descriptive statistics of PPTmean for Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.66 1.57 1.75 1.64 1.60 0.57 0.76 0.15 4.15 4.00 1.07 0.30 -0.18 
LI20R 1.82 1.75 1.90 1.81 1.75 0.57 0.76 0.17 4.53 4.37 1.00 0.27 0.04 
GB12R 2.94 2.81 3.07 2.90 2.83 1.44 1.20 0.50 7.52 7.02 1.65 0.46 0.17 
2L 4.50 4.30 4.70 4.42 4.23 3.36 1.83 1.08 9.68 8.60 2.36 0.66 -0.11 
2R 4.72 4.53 4.91 4.66 4.53 2.86 1.69 1.25 10.23 8.98 2.32 0.51 0.07 
PC6L 3.61 3.44 3.77 3.52 3.43 1.71 1.31 1.40 9.23 7.83 1.67 1.05 1.72 
PC6R 3.94 3.81 4.07 3.90 3.81 1.59 1.26 0.57 7.72 7.15 1.65 0.49 0.12 
LI10L 3.23 3.08 3.38 3.12 2.97 1.93 1.39 0.98 12.15 11.17 1.67 1.66 5.82 
1L 3.37 3.24 3.50 3.32 3.27 1.38 1.17 0.87 7.20 6.33 1.60 0.60 0.11 
1R 3.68 3.55 3.82 3.58 3.41 2.03 1.42 0.70 10.98 10.28 1.91 1.14 2.03 
LI5L 3.34 3.20 3.48 3.23 3.00 1.76 1.33 0.85 8.63 7.78 1.53 1.42 2.56 
LI5R 3.46 3.34 3.57 3.36 3.16 1.64 1.28 0.97 9.17 8.20 1.55 1.23 2.00 
ST36L 5.21 5.00 5.42 5.12 5.00 3.61 1.90 1.48 11.67 10.18 2.32 0.82 0.85 
ST36R 5.07 4.89 5.25 4.96 4.75 3.36 1.83 1.40 12.27 10.87 2.22 0.92 1.31 
3R 4.81 4.62 5.00 4.69 4.51 3.32 1.82 1.38 11.33 9.95 2.20 1.01 1.18 
SP6R 4.36 4.17 4.55 4.28 3.98 2.26 1.50 1.50 9.35 7.85 1.91 0.83 0.67 
KD3R 4.28 4.12 4.44 4.20 4.13 2.39 1.55 1.27 9.78 8.52 1.93 0.74 0.49 
 
Descriptive statistics of PPTmean for Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.14 2.01 2.28 2.08 1.98 1.08 1.04 0.27 6.60 6.33 1.33 1.00 1.77 
LI20R 2.38 2.28 2.48 2.35 2.30 0.96 0.98 0.27 5.52 5.25 1.22 0.49 0.21 
GB12R 3.54 3.35 3.73 3.41 3.03 2.65 1.63 0.92 9.10 8.18 1.89 1.20 1.33 
2L 5.53 5.26 5.80 5.43 5.18 4.90 2.21 1.20 14.13 12.93 2.93 0.73 0.41 
2R 5.56 5.32 5.81 5.50 5.47 3.73 1.93 1.50 12.65 11.15 2.80 0.52 0.42 
PC6L 4.30 4.12 4.49 4.24 4.02 1.72 1.31 2.12 7.85 5.73 1.95 0.72 -0.18 
PC6R 4.85 4.66 5.05 4.70 4.48 3.01 1.73 1.97 12.45 10.48 2.02 1.42 2.53 
LI10L 4.33 4.09 4.58 4.15 3.71 4.40 2.10 1.43 13.37 11.93 2.25 1.52 2.55 
1L 4.43 4.19 4.68 4.25 3.84 4.18 2.05 1.75 11.98 10.23 2.33 1.38 1.73 
1R 4.55 4.37 4.74 4.44 4.23 3.03 1.74 1.22 10.97 9.75 2.17 1.03 0.88 
LI5L 4.09 3.92 4.26 4.00 3.82 1.97 1.41 1.75 9.55 7.80 1.81 0.95 0.92 
LI5R 4.22 4.06 4.38 4.09 3.83 2.55 1.60 1.30 11.57 10.27 1.86 1.30 1.82 
ST36L 6.97 6.66 7.29 6.82 6.53 6.56 2.56 2.73 15.87 13.13 3.46 0.89 0.64 
ST36R 6.60 6.36 6.84 6.51 6.19 4.88 2.21 2.40 13.13 10.73 2.96 0.63 -0.18 
3R 5.99 5.74 6.23 5.84 5.52 4.39 2.10 2.42 15.27 12.85 2.65 1.17 1.98 
SP6R 5.33 5.07 5.60 5.23 5.12 3.36 1.83 2.40 12.27 9.87 2.78 0.79 0.74 







Descriptive statistics of PPTmedian for Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.66 1.57 1.74 1.64 1.60 0.57 0.75 0.15 4.10 3.95 1.09 0.27 -0.23 
LI20R 1.82 1.75 1.89 1.81 1.80 0.59 0.76 0.15 4.50 4.35 1.00 0.25 0.01 
GB12R 2.93 2.80 3.06 2.89 2.80 1.47 1.21 0.45 7.15 6.70 1.63 0.47 0.09 
2L 4.51 4.30 4.71 4.43 4.20 3.45 1.86 0.80 9.60 8.80 2.49 0.63 -0.12 
2R 4.72 4.53 4.90 4.66 4.55 2.96 1.72 1.10 10.50 9.40 2.30 0.52 0.10 
PC6L 3.60 3.43 3.76 3.51 3.45 1.74 1.32 1.20 9.10 7.90 1.68 1.04 1.65 
PC6R 3.94 3.81 4.07 3.90 3.80 1.65 1.28 0.50 7.90 7.40 1.70 0.52 0.22 
LI10L 3.22 3.07 3.37 3.11 3.00 1.92 1.39 0.90 12.05 11.15 1.70 1.60 5.48 
1L 3.37 3.24 3.50 3.31 3.20 1.44 1.20 0.70 7.05 6.35 1.68 0.61 0.21 
1R 3.68 3.54 3.81 3.58 3.43 2.06 1.44 0.70 10.90 10.20 1.90 1.13 1.91 
LI5L 3.34 3.19 3.48 3.22 3.00 1.76 1.33 0.85 8.50 7.65 1.60 1.42 2.53 
LI5R 3.45 3.33 3.57 3.36 3.10 1.69 1.30 0.90 9.50 8.60 1.60 1.23 2.04 
ST36L 5.21 5.00 5.42 5.11 4.98 3.63 1.90 1.40 12.20 10.80 2.39 0.82 0.91 
ST36R 5.07 4.89 5.25 4.96 4.80 3.48 1.87 1.40 12.30 10.90 2.23 0.92 1.23 
3R 4.81 4.62 5.00 4.69 4.50 3.42 1.85 1.35 11.40 10.05 2.24 0.98 1.08 
SP6R 4.34 4.15 4.53 4.26 4.00 2.27 1.51 1.40 9.60 8.20 1.80 0.85 0.84 
KD3R 4.29 4.13 4.45 4.21 4.10 2.42 1.56 1.20 9.90 8.70 2.04 0.73 0.47 
 
Descriptive statistics of PPTmedian for Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.14 2.00 2.27 2.08 2.00 1.08 1.04 0.30 6.80 6.50 1.30 0.97 1.64 
LI20R 2.38 2.27 2.48 2.35 2.30 0.97 0.99 0.20 5.50 5.30 1.25 0.44 0.13 
GB12R 3.54 3.34 3.73 3.41 3.10 2.70 1.64 0.90 9.00 8.10 1.98 1.20 1.31 
2L 5.51 5.23 5.78 5.41 5.10 4.95 2.22 1.30 14.00 12.70 3.08 0.71 0.30 
2R 5.56 5.31 5.81 5.49 5.40 3.86 1.96 1.50 12.70 11.20 2.79 0.58 0.41 
PC6L 4.31 4.12 4.49 4.25 4.00 1.74 1.32 2.00 7.85 5.85 2.00 0.69 -0.28 
PC6R 4.84 4.64 5.04 4.69 4.43 3.11 1.76 1.95 12.90 10.95 1.89 1.50 2.91 
LI10L 4.33 4.09 4.58 4.14 3.68 4.47 2.12 1.35 13.50 12.15 2.20 1.52 2.55 
1L 4.44 4.19 4.68 4.24 3.90 4.32 2.08 1.65 12.05 10.40 2.25 1.41 1.86 
1R 4.57 4.38 4.76 4.44 4.20 3.14 1.77 1.15 10.90 9.75 2.24 1.04 0.88 
LI5L 4.07 3.90 4.24 3.98 3.80 2.01 1.42 1.70 9.50 7.80 1.80 1.03 1.24 
LI5R 4.22 4.06 4.39 4.09 3.85 2.67 1.63 1.40 11.90 10.50 1.95 1.32 1.91 
ST36L 7.00 6.68 7.33 6.84 6.58 6.91 2.63 2.90 16.20 13.30 3.43 0.91 0.65 
ST36R 6.58 6.34 6.83 6.48 6.25 5.04 2.25 2.20 13.20 11.00 3.10 0.63 -0.13 
3R 5.96 5.72 6.21 5.82 5.50 4.47 2.11 2.30 15.60 13.30 2.64 1.20 2.15 
SP6R 5.35 5.09 5.61 5.25 5.20 3.42 1.85 2.20 12.50 10.30 2.60 0.82 0.94 







Descriptive statistics of PPTmean for Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.66 1.48 1.85 1.63 1.60 0.63 0.80 0.15 4.15 4.00 0.92 0.68 1.01 
LI20R 1.81 1.66 1.96 1.78 1.70 0.62 0.79 0.33 4.23 3.90 1.03 0.55 0.26 
GB12R 2.77 2.50 3.04 2.69 2.57 1.55 1.24 0.50 7.52 7.02 1.67 1.01 1.86 
2L 4.24 3.84 4.64 4.15 4.07 3.39 1.84 1.65 9.17 7.52 2.67 0.65 -0.26 
2R 4.56 4.19 4.93 4.51 4.33 2.79 1.67 1.58 8.60 7.02 2.55 0.33 -0.41 
PC6L 3.69 3.29 4.09 3.56 3.38 2.48 1.58 1.58 9.23 7.65 2.08 1.26 2.00 
PC6R 3.77 3.53 4.02 3.73 3.58 1.45 1.21 1.15 7.33 6.18 1.43 0.69 0.48 
LI10L 3.22 2.86 3.57 3.07 2.90 2.61 1.62 0.98 12.15 11.17 2.05 2.36 10.32 
1L 3.34 3.06 3.63 3.24 3.31 1.70 1.30 1.55 7.20 5.65 1.75 1.07 0.94 
1R 3.63 3.35 3.90 3.50 3.40 2.05 1.43 1.33 10.98 9.65 1.67 1.84 6.19 
LI5L 3.23 2.91 3.55 3.08 2.83 2.17 1.47 0.85 8.63 7.78 1.62 1.66 3.05 
LI5R 3.34 3.12 3.57 3.25 3.10 1.47 1.21 1.43 9.07 7.63 1.18 1.48 3.66 
ST36L 5.11 4.68 5.54 5.00 4.79 3.75 1.94 1.48 11.67 10.18 2.31 1.00 1.45 
ST36R 4.87 4.52 5.22 4.75 4.64 3.17 1.78 1.65 11.83 10.18 2.05 1.08 2.17 
3R 4.75 4.35 5.15 4.61 4.33 3.66 1.91 1.48 10.85 9.37 2.72 1.00 1.09 
SP6R 4.21 3.86 4.56 4.17 3.83 1.85 1.36 1.50 8.00 6.50 1.92 0.52 0.01 
KD3R 4.24 3.89 4.59 4.12 3.90 2.88 1.70 1.27 9.78 8.52 1.92 1.12 1.40 
 
Descriptive statistics of PPTmean for Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.55 1.39 1.70 1.54 1.55 0.45 0.67 0.20 2.83 2.63 1.13 0.01 -0.91 
LI20R 1.69 1.56 1.83 1.69 1.63 0.47 0.68 0.23 3.20 2.97 0.90 -0.04 -0.35 
GB12R 2.83 2.58 3.07 2.80 2.70 1.22 1.10 0.53 5.52 4.98 1.50 0.33 -0.32 
2L 4.27 3.90 4.63 4.18 4.18 2.75 1.66 1.45 9.40 7.95 2.22 0.79 0.46 
2R 4.59 4.22 4.95 4.54 4.43 2.72 1.65 1.25 9.40 8.15 2.21 0.52 0.03 
PC6L 3.38 3.10 3.65 3.33 3.28 1.14 1.07 1.40 6.75 5.35 1.21 0.72 0.69 
PC6R 3.83 3.59 4.08 3.81 3.78 1.44 1.20 0.57 7.63 7.07 1.35 0.39 0.65 
LI10L 3.15 2.84 3.45 3.01 2.82 1.93 1.39 1.23 8.97 7.73 1.53 1.84 4.87 
1L 3.27 3.04 3.51 3.22 3.26 1.15 1.07 1.48 6.12 4.63 1.68 0.57 0.25 
1R 3.50 3.25 3.75 3.39 3.30 1.71 1.31 1.23 8.25 7.02 1.72 1.26 2.13 
LI5L 3.29 3.00 3.58 3.17 2.92 1.76 1.33 1.23 8.40 7.17 1.30 1.71 3.67 
LI5R 3.31 3.08 3.53 3.20 2.97 1.48 1.22 0.97 7.78 6.82 1.42 1.39 2.28 
ST36L 5.04 4.64 5.44 4.95 4.79 3.20 1.79 1.78 11.53 9.75 2.03 0.93 1.51 
ST36R 4.90 4.57 5.24 4.81 4.56 2.94 1.71 1.53 10.37 8.83 1.91 0.87 0.94 
3R 4.66 4.29 5.02 4.53 4.40 3.07 1.75 1.65 10.28 8.63 1.87 1.12 1.55 
SP6R 4.19 3.83 4.55 4.11 3.92 1.95 1.40 1.90 8.67 6.77 1.35 0.98 1.23 







Descriptive statistics of PPTmean for Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.68 1.51 1.86 1.67 1.60 0.55 0.74 0.17 3.37 3.20 1.02 0.19 -0.45 
LI20R 1.84 1.70 1.98 1.84 1.88 0.52 0.72 0.17 3.90 3.73 1.05 -0.02 -0.29 
GB12R 3.04 2.78 3.31 3.01 2.95 1.52 1.23 0.55 6.57 6.02 1.68 0.33 0.12 
2L 4.65 4.26 5.04 4.61 4.22 3.14 1.77 1.08 8.68 7.60 2.08 0.56 -0.29 
2R 4.78 4.42 5.13 4.73 4.66 2.54 1.59 1.63 10.00 8.37 2.13 0.43 0.60 
PC6L 3.60 3.30 3.91 3.54 3.50 1.41 1.19 1.72 7.43 5.72 1.69 0.70 0.55 
PC6R 3.95 3.69 4.21 3.90 3.93 1.63 1.28 1.15 7.72 6.57 1.96 0.48 0.13 
LI10L 3.18 2.91 3.45 3.10 2.87 1.53 1.24 1.33 7.13 5.80 1.52 0.98 1.06 
1L 3.41 3.17 3.65 3.40 3.27 1.20 1.09 0.87 5.75 4.88 1.57 0.18 -0.60 
1R 3.74 3.47 4.01 3.67 3.50 1.96 1.40 0.72 8.42 7.70 2.01 0.76 0.78 
LI5L 3.35 3.08 3.63 3.26 3.03 1.57 1.25 1.28 7.65 6.37 1.57 1.19 1.55 
LI5R 3.47 3.23 3.71 3.38 3.23 1.69 1.30 1.02 8.17 7.15 1.48 1.13 1.51 
ST36L 5.25 4.84 5.66 5.18 5.08 3.40 1.84 2.07 9.93 7.87 2.35 0.60 0.10 
ST36R 5.09 4.73 5.45 5.01 4.68 3.38 1.84 1.40 9.97 8.57 2.41 0.66 0.23 
3R 4.81 4.43 5.19 4.70 4.60 3.39 1.84 1.38 11.00 9.62 2.20 0.99 1.10 
SP6R 4.40 3.97 4.82 4.29 3.95 2.76 1.66 1.55 9.35 7.80 2.01 0.97 1.00 
KD3R 4.24 3.95 4.53 4.21 4.13 2.03 1.43 1.72 7.77 6.05 1.90 0.31 -0.41 
 
Descriptive statistics of PPTmean for Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.74 1.55 1.93 1.73 1.67 0.66 0.81 0.28 3.48 3.20 1.37 0.11 -0.83 
LI20R 1.96 1.80 2.11 1.94 1.97 0.66 0.82 0.32 4.53 4.22 1.09 0.28 0.03 
GB12R 3.10 2.84 3.37 3.09 3.05 1.46 1.21 0.60 5.67 5.07 1.87 0.12 -0.64 
2L 4.84 4.40 5.28 4.77 4.55 4.02 2.01 1.08 9.68 8.60 2.85 0.60 -0.27 
2R 4.96 4.55 5.37 4.89 4.73 3.41 1.85 1.73 10.23 8.50 2.40 0.65 -0.01 
PC6L 3.75 3.41 4.09 3.67 3.52 1.79 1.34 1.58 7.95 6.37 1.78 0.88 0.96 
PC6R 4.20 3.92 4.47 4.17 3.97 1.79 1.34 1.02 7.65 6.63 1.90 0.36 -0.33 
LI10L 3.40 3.11 3.68 3.32 3.35 1.69 1.30 1.07 7.18 6.12 1.65 0.78 0.81 
1L 3.47 3.20 3.74 3.44 3.24 1.51 1.23 0.95 6.63 5.68 1.93 0.33 -0.50 
1R 3.86 3.56 4.16 3.78 3.42 2.37 1.54 0.70 8.17 7.47 2.01 0.76 0.11 
LI5L 3.49 3.22 3.76 3.40 3.25 1.56 1.25 1.42 8.52 7.10 1.73 1.15 2.44 
LI5R 3.70 3.45 3.96 3.62 3.42 1.88 1.37 1.03 9.17 8.13 1.92 1.01 1.53 
ST36L 5.45 5.00 5.90 5.34 5.12 4.11 2.03 1.80 11.28 9.48 2.38 0.74 0.72 
ST36R 5.42 5.04 5.81 5.30 5.18 3.85 1.96 1.95 12.27 10.32 2.30 1.03 1.79 
3R 5.02 4.65 5.39 4.91 4.83 3.19 1.79 1.77 11.33 9.57 1.93 1.02 1.54 
SP6R 4.63 4.23 5.03 4.58 4.27 2.47 1.57 1.67 9.12 7.45 2.15 0.70 0.20 







Descriptive statistics of PPTmean for Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.09 1.85 2.33 2.07 1.94 0.86 0.93 0.27 4.10 3.83 1.28 0.43 -0.31 
LI20R 2.30 2.11 2.48 2.29 2.16 0.74 0.86 0.27 4.40 4.13 1.19 0.23 -0.21 
GB12R 3.26 2.96 3.57 3.18 2.78 1.63 1.28 1.28 7.22 5.93 1.72 1.05 0.93 
2L 5.04 4.56 5.53 4.94 4.85 3.83 1.96 2.13 9.73 7.60 2.92 0.65 -0.15 
2R 5.22 4.75 5.69 5.16 5.23 3.31 1.82 1.50 11.57 10.07 2.72 0.64 1.21 
PC6L 4.11 3.72 4.50 4.03 3.69 1.79 1.34 2.13 7.68 5.55 1.90 0.82 0.03 
PC6R 4.60 4.26 4.95 4.48 4.39 2.27 1.51 2.50 9.70 7.20 2.00 1.18 1.75 
LI10L 4.15 3.69 4.61 3.99 3.61 3.74 1.94 1.62 11.87 10.25 2.33 1.41 2.88 
1L 4.11 3.71 4.51 4.01 3.65 2.80 1.67 1.75 8.83 7.08 2.42 0.86 0.00 
1R 4.36 4.04 4.68 4.27 4.12 2.25 1.50 2.25 8.43 6.18 2.31 0.82 0.21 
LI5L 3.70 3.44 3.97 3.67 3.49 1.22 1.11 1.75 6.40 4.65 1.64 0.55 -0.40 
LI5R 4.00 3.70 4.30 3.85 3.65 2.20 1.48 2.17 9.63 7.47 1.80 1.60 3.27 
ST36L 6.47 5.97 6.98 6.38 6.25 4.16 2.04 3.00 12.00 9.00 2.68 0.66 0.25 
ST36R 6.18 5.74 6.61 6.13 5.95 3.85 1.96 2.53 12.00 9.47 2.54 0.48 -0.04 
3R 5.57 5.16 5.98 5.47 5.27 2.97 1.72 2.90 10.30 7.40 2.40 0.80 0.22 
SP6R 5.21 4.66 5.76 5.10 5.03 3.58 1.89 2.40 11.53 9.13 3.05 0.83 1.14 
KD3R 5.14 4.71 5.57 5.06 5.20 3.76 1.94 1.77 10.05 8.28 2.68 0.51 -0.19 
 
Descriptive statistics of PPTmean for Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.11 1.85 2.37 2.06 1.96 0.97 0.99 0.30 6.15 5.85 1.26 1.23 3.72 
LI20R 2.30 2.11 2.49 2.28 2.20 0.79 0.89 0.30 4.68 4.38 1.15 0.46 0.12 
GB12R 3.42 3.08 3.77 3.32 3.03 2.07 1.44 1.12 7.95 6.83 1.68 1.01 1.04 
2L 5.52 4.99 6.04 5.43 5.35 4.49 2.12 1.83 10.77 8.93 2.89 0.66 -0.08 
2R 5.46 4.98 5.94 5.43 5.48 3.48 1.87 1.68 10.10 8.42 3.10 0.20 -0.51 
PC6L 4.33 3.95 4.70 4.26 4.09 1.69 1.30 2.38 7.72 5.33 1.90 0.84 0.09 
PC6R 4.74 4.37 5.11 4.61 4.48 2.60 1.61 1.97 11.30 9.33 1.85 1.42 3.13 
LI10L 4.14 3.72 4.56 3.98 3.62 3.16 1.78 1.87 9.43 7.57 1.58 1.46 1.66 
1L 4.30 3.87 4.74 4.13 3.98 3.33 1.82 2.08 10.70 8.62 2.24 1.37 2.29 
1R 4.42 4.08 4.75 4.34 4.23 2.41 1.55 1.72 9.35 7.63 1.93 0.79 0.39 
LI5L 3.98 3.68 4.28 3.93 3.85 1.52 1.23 1.85 7.30 5.45 1.94 0.55 -0.13 
LI5R 4.08 3.78 4.38 3.95 3.57 2.20 1.48 1.93 9.10 7.17 1.97 1.25 1.38 
ST36L 6.94 6.33 7.55 6.79 6.57 6.05 2.46 3.48 15.47 11.98 3.84 0.86 1.01 
ST36R 6.54 6.07 7.01 6.45 6.47 4.58 2.14 3.25 11.50 8.25 2.82 0.60 -0.34 
3R 5.81 5.40 6.22 5.75 5.63 3.05 1.75 2.95 10.83 7.88 2.57 0.59 -0.21 
SP6R 5.29 4.75 5.82 5.23 5.08 3.38 1.84 2.63 9.93 7.30 3.60 0.38 -0.78 







Descriptive statistics of PPTmean for Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.16 1.88 2.45 2.10 2.15 1.19 1.09 0.57 6.60 6.03 1.46 1.28 3.43 
LI20R 2.44 2.21 2.66 2.40 2.32 1.11 1.05 0.63 5.52 4.88 1.31 0.49 0.03 
GB12R 3.65 3.25 4.06 3.53 3.12 2.89 1.70 1.43 8.65 7.22 2.18 1.10 0.75 
2L 5.80 5.23 6.37 5.73 5.65 5.29 2.30 1.20 12.70 11.50 3.11 0.57 0.18 
2R 5.78 5.28 6.27 5.72 5.60 3.67 1.91 2.40 12.65 10.25 3.06 0.71 1.29 
PC6L 4.30 3.94 4.67 4.23 3.98 1.61 1.27 2.57 7.85 5.28 1.94 0.87 0.18 
PC6R 4.99 4.58 5.41 4.83 4.51 3.33 1.82 2.67 12.45 9.78 1.83 1.65 3.50 
LI10L 4.40 3.92 4.89 4.25 3.72 4.13 2.03 1.70 9.90 8.20 2.38 1.20 0.63 
1L 4.57 4.05 5.09 4.37 3.97 4.63 2.15 2.17 11.98 9.82 2.25 1.55 1.96 
1R 4.62 4.22 5.02 4.49 4.13 3.46 1.86 1.53 10.07 8.53 2.20 1.11 0.70 
LI5L 4.26 3.90 4.63 4.15 3.94 2.28 1.51 1.88 9.55 7.67 1.89 1.17 1.80 
LI5R 4.31 3.99 4.63 4.21 3.92 2.53 1.59 1.30 9.18 7.88 1.98 1.03 0.80 
ST36L 7.06 6.40 7.71 6.93 6.58 6.96 2.64 2.73 14.30 11.57 3.63 0.72 0.11 
ST36R 6.67 6.16 7.18 6.55 6.00 5.37 2.32 2.40 13.13 10.73 3.38 0.78 -0.16 
3R 6.35 5.79 6.92 6.19 5.67 5.62 2.37 2.60 14.20 11.60 3.30 1.15 1.27 
SP6R 5.33 4.88 5.78 5.25 5.15 2.41 1.55 3.08 9.80 6.72 2.35 0.75 0.30 
KD3R 5.67 5.21 6.12 5.59 5.30 4.22 2.06 2.27 10.60 8.33 3.52 0.44 -0.65 
 
Descriptive statistics of PPTmean for Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.20 1.89 2.51 2.13 1.98 1.37 1.17 0.62 5.43 4.82 1.44 0.88 0.36 
LI20R 2.48 2.24 2.71 2.44 2.43 1.20 1.10 0.50 5.52 5.02 1.41 0.49 0.17 
GB12R 3.82 3.35 4.30 3.70 3.37 3.96 1.99 0.92 9.10 8.18 2.35 1.07 0.67 
2L 5.75 5.15 6.35 5.62 5.22 5.85 2.42 1.98 14.13 12.15 3.39 0.86 0.97 
2R 5.79 5.24 6.33 5.71 5.57 4.41 2.10 1.78 11.30 9.52 3.03 0.49 0.02 
PC6L 4.48 4.08 4.87 4.43 4.43 1.83 1.35 2.12 7.58 5.47 2.16 0.49 -0.47 
PC6R 5.07 4.62 5.51 4.93 4.58 3.82 1.95 2.35 11.67 9.32 2.41 1.23 1.36 
LI10L 4.64 4.03 5.26 4.39 3.76 6.58 2.57 1.43 13.37 11.93 2.56 1.56 2.44 
1L 4.75 4.17 5.34 4.57 4.05 5.91 2.43 1.75 11.30 9.55 2.49 1.20 0.79 
1R 4.82 4.39 5.25 4.69 4.29 3.97 1.99 1.22 10.97 9.75 2.50 0.99 0.71 
LI5L 4.41 4.02 4.81 4.35 4.23 2.66 1.63 1.82 8.37 6.55 2.25 0.74 -0.21 
LI5R 4.50 4.14 4.87 4.38 4.11 3.18 1.78 1.90 11.57 9.67 1.99 1.28 1.84 
ST36L 7.42 6.68 8.16 7.26 6.80 8.92 2.99 3.12 15.87 12.75 3.96 0.87 0.16 
ST36R 7.01 6.49 7.53 6.93 6.67 5.54 2.35 2.67 12.82 10.15 3.36 0.49 -0.39 
3R 6.21 5.64 6.77 6.04 5.72 5.71 2.39 2.42 15.27 12.85 2.87 1.24 2.37 
SP6R 5.51 4.91 6.10 5.36 5.28 4.23 2.06 2.58 12.27 9.68 2.60 1.07 1.43 







Descriptive statistics of PPTmedian for Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.64 1.46 1.83 1.61 1.60 0.61 0.78 0.15 4.10 3.95 1.00 0.64 1.02 
LI20R 1.79 1.64 1.95 1.77 1.70 0.64 0.80 0.15 4.15 4.00 1.08 0.47 0.05 
GB12R 2.75 2.48 3.01 2.67 2.50 1.51 1.23 0.45 7.15 6.70 1.80 0.95 1.52 
2L 4.21 3.80 4.62 4.11 4.00 3.48 1.87 1.55 9.20 7.65 2.85 0.63 -0.33 
2R 4.51 4.13 4.90 4.47 4.40 3.02 1.74 1.35 8.65 7.30 2.48 0.31 -0.51 
PC6L 3.67 3.26 4.08 3.55 3.30 2.55 1.60 1.50 9.10 7.60 2.20 1.22 1.79 
PC6R 3.78 3.53 4.03 3.73 3.75 1.48 1.22 1.05 7.15 6.10 1.40 0.67 0.51 
LI10L 3.21 2.86 3.56 3.07 2.85 2.60 1.61 0.90 12.05 11.15 2.00 2.30 9.94 
1L 3.33 3.04 3.62 3.23 3.28 1.79 1.34 1.40 7.05 5.65 1.66 1.06 0.90 
1R 3.61 3.33 3.90 3.49 3.40 2.16 1.47 1.30 10.90 9.60 1.78 1.70 5.12 
LI5L 3.21 2.89 3.53 3.06 2.80 2.15 1.47 0.85 8.50 7.65 1.60 1.62 2.94 
LI5R 3.32 3.09 3.55 3.22 3.10 1.55 1.24 1.30 9.50 8.20 1.30 1.64 4.63 
ST36L 5.10 4.66 5.53 4.98 4.70 3.83 1.96 1.40 12.20 10.80 2.31 1.03 1.65 
ST36R 4.88 4.53 5.24 4.77 4.65 3.29 1.81 1.70 11.60 9.90 2.11 0.98 1.72 
3R 4.73 4.32 5.14 4.60 4.30 3.83 1.96 1.35 10.90 9.55 2.80 0.95 0.88 
SP6R 4.19 3.84 4.54 4.14 3.85 1.88 1.37 1.40 8.90 7.50 1.98 0.74 1.23 
KD3R 4.20 3.86 4.55 4.08 3.90 2.85 1.69 1.20 9.90 8.70 1.95 1.14 1.52 
 
Descriptive statistics of PPTmedian for Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.54 1.38 1.70 1.54 1.50 0.45 0.67 0.20 2.80 2.60 1.15 -0.04 -0.89 
LI20R 1.69 1.56 1.82 1.69 1.65 0.46 0.68 0.20 3.10 2.90 0.93 -0.09 -0.42 
GB12R 2.80 2.56 3.04 2.78 2.70 1.24 1.11 0.50 5.50 5.00 1.55 0.31 -0.35 
2L 4.30 3.93 4.68 4.22 4.20 2.90 1.70 1.35 9.50 8.15 2.25 0.80 0.59 
2R 4.58 4.21 4.95 4.54 4.35 2.74 1.66 1.10 9.20 8.10 2.29 0.49 -0.10 
PC6L 3.34 3.06 3.62 3.30 3.20 1.19 1.09 1.20 7.20 6.00 1.33 0.84 1.58 
PC6R 3.84 3.59 4.09 3.82 3.80 1.50 1.22 0.50 7.70 7.20 1.35 0.35 0.77 
LI10L 3.12 2.83 3.42 3.00 2.85 1.84 1.36 1.10 8.80 7.70 1.65 1.66 3.96 
1L 3.26 3.02 3.49 3.20 3.20 1.13 1.06 1.40 6.15 4.75 1.53 0.56 0.25 
1R 3.50 3.25 3.76 3.39 3.40 1.73 1.31 1.40 8.25 6.85 1.50 1.30 2.13 
LI5L 3.30 3.01 3.59 3.18 2.90 1.77 1.33 1.25 8.40 7.15 1.40 1.72 3.68 
LI5R 3.32 3.08 3.56 3.20 2.90 1.70 1.30 0.90 8.45 7.55 1.40 1.53 2.92 
ST36L 5.04 4.64 5.44 4.95 4.78 3.23 1.80 1.75 11.70 9.95 2.04 0.95 1.69 
ST36R 4.89 4.55 5.24 4.80 4.43 3.09 1.76 1.50 10.70 9.20 2.01 0.92 1.08 
3R 4.65 4.28 5.02 4.52 4.20 3.16 1.78 1.70 10.00 8.30 2.10 1.10 1.40 
SP6R 4.17 3.81 4.53 4.10 3.95 1.97 1.40 1.65 8.60 6.95 1.50 0.92 1.31 







Descriptive statistics of PPTmedian for Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.69 1.52 1.87 1.68 1.60 0.55 0.74 0.20 3.40 3.20 1.05 0.18 -0.49 
LI20R 1.84 1.70 1.99 1.85 1.90 0.54 0.73 0.20 3.80 3.60 1.05 -0.08 -0.36 
GB12R 3.04 2.77 3.32 3.01 3.00 1.55 1.25 0.55 6.80 6.25 1.75 0.41 0.22 
2L 4.66 4.27 5.06 4.62 4.30 3.25 1.80 1.10 8.75 7.65 2.05 0.54 -0.21 
2R 4.78 4.42 5.14 4.73 4.70 2.55 1.60 1.65 10.00 8.35 2.08 0.51 0.73 
PC6L 3.62 3.31 3.94 3.56 3.50 1.48 1.22 1.70 7.50 5.80 1.70 0.71 0.56 
PC6R 3.94 3.67 4.21 3.89 3.90 1.68 1.30 1.35 7.70 6.35 1.83 0.51 0.00 
LI10L 3.16 2.89 3.43 3.08 3.00 1.52 1.23 1.20 7.10 5.90 1.65 0.92 1.04 
1L 3.39 3.15 3.64 3.38 3.23 1.25 1.12 0.70 6.00 5.30 1.58 0.18 -0.51 
1R 3.73 3.46 4.01 3.66 3.50 1.99 1.41 0.80 8.50 7.70 2.05 0.81 0.92 
LI5L 3.35 3.07 3.63 3.25 3.10 1.61 1.27 1.30 7.70 6.40 1.60 1.22 1.75 
LI5R 3.47 3.23 3.71 3.39 3.10 1.69 1.30 0.95 7.40 6.45 1.55 1.01 1.01 
ST36L 5.23 4.83 5.64 5.15 5.10 3.32 1.82 2.00 10.00 8.00 2.31 0.63 0.12 
ST36R 5.11 4.74 5.48 5.01 4.78 3.60 1.90 1.40 10.80 9.40 2.46 0.79 0.56 
3R 4.83 4.45 5.22 4.73 4.70 3.43 1.85 1.35 11.00 9.65 2.45 0.91 0.94 
SP6R 4.37 3.95 4.79 4.27 4.00 2.65 1.63 1.70 9.15 7.45 2.18 0.92 0.75 
KD3R 4.25 3.96 4.54 4.22 4.08 1.97 1.40 1.70 7.70 6.00 2.03 0.31 -0.42 
 
Descriptive statistics of PPTmedian for Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.75 1.55 1.94 1.74 1.60 0.66 0.81 0.25 3.50 3.25 1.40 0.09 -0.86 
LI20R 1.96 1.80 2.12 1.94 2.00 0.69 0.83 0.30 4.50 4.20 1.10 0.33 0.12 
GB12R 3.11 2.85 3.38 3.10 3.05 1.52 1.23 0.60 5.65 5.05 1.85 0.17 -0.64 
2L 4.85 4.41 5.28 4.77 4.60 4.02 2.01 0.80 9.60 8.80 2.70 0.57 -0.28 
2R 4.99 4.57 5.40 4.91 4.70 3.50 1.87 1.75 10.50 8.75 2.38 0.70 0.12 
PC6L 3.74 3.40 4.08 3.66 3.55 1.76 1.33 1.70 7.95 6.25 1.63 0.86 0.91 
PC6R 4.20 3.92 4.48 4.16 4.00 1.87 1.37 1.00 7.90 6.90 2.00 0.47 -0.12 
LI10L 3.38 3.10 3.67 3.31 3.30 1.76 1.33 1.00 7.30 6.30 1.55 0.85 1.06 
1L 3.49 3.21 3.77 3.46 3.20 1.60 1.26 0.80 7.00 6.20 1.88 0.38 -0.25 
1R 3.86 3.56 4.16 3.78 3.50 2.34 1.53 0.70 8.30 7.60 2.18 0.76 0.23 
LI5L 3.48 3.20 3.75 3.39 3.30 1.55 1.24 1.55 8.45 6.90 1.70 1.15 2.36 
LI5R 3.70 3.45 3.94 3.63 3.40 1.78 1.34 1.10 8.80 7.70 1.85 0.93 1.12 
ST36L 5.46 5.00 5.91 5.36 5.13 4.15 2.04 1.80 11.30 9.50 2.48 0.68 0.57 
ST36R 5.38 5.00 5.77 5.26 5.13 3.89 1.97 2.00 12.30 10.30 2.45 0.98 1.63 
3R 5.02 4.64 5.40 4.90 4.85 3.31 1.82 1.70 11.40 9.70 1.90 1.05 1.62 
SP6R 4.63 4.22 5.04 4.58 4.20 2.54 1.59 1.50 9.60 8.10 2.20 0.72 0.49 







Descriptive statistics of PPTmedian for Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.08 1.83 2.32 2.05 1.95 0.85 0.92 0.30 4.10 3.80 1.21 0.51 -0.22 
LI20R 2.29 2.11 2.47 2.29 2.18 0.74 0.86 0.20 4.35 4.15 1.21 0.13 -0.27 
GB12R 3.26 2.95 3.57 3.18 2.83 1.67 1.29 1.25 7.40 6.15 1.65 1.07 1.07 
2L 5.06 4.57 5.56 4.97 4.90 4.06 2.02 2.10 10.00 7.90 3.25 0.53 -0.44 
2R 5.18 4.70 5.67 5.10 4.90 3.52 1.88 1.50 11.70 10.20 2.80 0.75 1.18 
PC6L 4.11 3.71 4.51 4.03 3.68 1.89 1.37 2.20 7.85 5.65 1.95 0.81 -0.01 
PC6R 4.57 4.21 4.92 4.44 4.35 2.39 1.55 2.50 9.80 7.30 1.98 1.24 1.92 
LI10L 4.16 3.70 4.62 4.01 3.63 3.75 1.94 1.60 11.70 10.10 2.23 1.35 2.51 
1L 4.11 3.70 4.52 3.99 3.55 2.97 1.72 1.65 9.20 7.55 2.25 0.97 0.39 
1R 4.38 4.05 4.71 4.27 4.10 2.35 1.53 2.25 8.60 6.35 2.16 0.90 0.36 
LI5L 3.68 3.41 3.95 3.65 3.48 1.23 1.11 1.70 6.30 4.60 1.59 0.47 -0.60 
LI5R 4.00 3.69 4.31 3.84 3.63 2.30 1.52 2.15 9.60 7.45 1.86 1.64 3.18 
ST36L 6.46 5.94 6.97 6.36 6.30 4.33 2.08 2.90 12.00 9.10 2.63 0.69 0.33 
ST36R 6.14 5.70 6.57 6.09 5.90 3.90 1.97 2.50 12.00 9.50 2.48 0.47 -0.02 
3R 5.49 5.11 5.88 5.40 5.30 2.69 1.64 2.90 10.30 7.40 2.20 0.76 0.39 
SP6R 5.24 4.68 5.80 5.14 4.88 3.69 1.92 2.20 12.00 9.80 3.00 0.93 1.66 
KD3R 5.18 4.74 5.61 5.10 5.30 3.90 1.97 1.60 9.75 8.15 2.83 0.45 -0.34 
 
Descriptive statistics of PPTmedian for Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.09 1.84 2.34 2.05 1.95 0.90 0.95 0.30 5.55 5.25 1.25 0.88 1.88 
LI20R 2.30 2.11 2.50 2.28 2.15 0.79 0.89 0.30 4.75 4.45 1.10 0.45 0.14 
GB12R 3.43 3.08 3.77 3.33 3.10 2.04 1.43 1.15 7.80 6.65 1.70 1.01 1.02 
2L 5.46 4.94 5.98 5.37 5.15 4.46 2.11 1.95 10.40 8.45 2.93 0.70 -0.15 
2R 5.44 4.95 5.92 5.40 5.50 3.52 1.88 1.65 9.80 8.15 2.90 0.25 -0.45 
PC6L 4.36 3.99 4.73 4.29 4.05 1.61 1.27 2.55 7.40 4.85 1.76 0.82 -0.10 
PC6R 4.72 4.35 5.08 4.59 4.43 2.52 1.59 1.95 11.40 9.45 1.80 1.48 3.55 
LI10L 4.14 3.72 4.57 3.99 3.60 3.20 1.79 1.90 9.30 7.40 1.73 1.36 1.26 
1L 4.29 3.86 4.73 4.13 4.00 3.31 1.82 2.10 10.50 8.40 2.28 1.32 1.95 
1R 4.41 4.07 4.74 4.32 4.25 2.43 1.56 1.70 9.60 7.90 1.99 0.85 0.69 
LI5L 3.96 3.66 4.25 3.90 3.90 1.48 1.22 1.80 7.30 5.50 1.65 0.66 0.17 
LI5R 4.09 3.78 4.39 3.96 3.63 2.22 1.49 1.90 9.40 7.50 2.00 1.22 1.37 
ST36L 7.01 6.39 7.63 6.86 6.65 6.27 2.50 3.25 15.70 12.45 3.83 0.86 1.03 
ST36R 6.53 6.05 7.02 6.42 6.40 4.85 2.20 3.20 12.50 9.30 2.65 0.67 -0.05 
3R 5.79 5.37 6.22 5.72 5.60 3.24 1.80 2.95 11.20 8.25 2.60 0.64 -0.02 
SP6R 5.31 4.77 5.85 5.25 5.30 3.47 1.86 2.70 10.00 7.30 3.53 0.37 -0.76 







Descriptive statistics of PPTmedian for Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.17 1.87 2.46 2.09 2.18 1.24 1.12 0.60 6.80 6.20 1.40 1.36 3.82 
LI20R 2.43 2.21 2.66 2.40 2.33 1.11 1.05 0.70 5.40 4.70 1.41 0.44 -0.11 
GB12R 3.64 3.23 4.06 3.52 3.23 3.00 1.73 1.30 9.00 7.70 2.06 1.13 0.85 
2L 5.78 5.21 6.35 5.70 5.60 5.27 2.30 1.30 12.80 11.50 3.13 0.59 0.23 
2R 5.83 5.32 6.33 5.75 5.58 3.85 1.96 2.40 12.70 10.30 3.06 0.76 1.09 
PC6L 4.27 3.91 4.64 4.20 4.00 1.57 1.25 2.50 7.60 5.10 2.05 0.80 -0.03 
PC6R 5.02 4.59 5.44 4.83 4.45 3.51 1.87 2.70 12.90 10.20 1.88 1.79 4.11 
LI10L 4.41 3.92 4.90 4.26 3.80 4.24 2.06 1.70 9.90 8.20 2.46 1.22 0.71 
1L 4.58 4.05 5.10 4.37 3.90 4.82 2.19 2.20 12.00 9.80 2.23 1.56 1.93 
1R 4.65 4.24 5.06 4.51 4.05 3.65 1.91 1.50 10.50 9.00 2.21 1.15 0.86 
LI5L 4.27 3.89 4.64 4.14 3.95 2.44 1.56 1.90 9.50 7.60 2.04 1.28 2.22 
LI5R 4.30 3.97 4.63 4.19 3.95 2.63 1.62 1.40 9.45 8.05 1.98 1.07 1.05 
ST36L 7.09 6.42 7.76 6.95 6.60 7.36 2.71 3.00 14.50 11.50 3.78 0.75 0.06 
ST36R 6.63 6.12 7.14 6.52 5.90 5.32 2.31 2.20 13.20 11.00 3.45 0.76 -0.11 
3R 6.37 5.80 6.93 6.21 5.70 5.64 2.38 2.70 14.20 11.50 3.25 1.13 1.18 
SP6R 5.36 4.90 5.82 5.28 5.18 2.46 1.57 3.00 9.70 6.70 2.45 0.64 0.01 
KD3R 5.64 5.19 6.10 5.59 5.30 4.18 2.04 2.20 10.70 8.50 3.43 0.38 -0.76 
 
Descriptive statistics of PPTmedian for Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.21 1.90 2.52 2.14 2.00 1.35 1.16 0.60 5.50 4.90 1.40 0.84 0.24 
LI20R 2.48 2.24 2.72 2.44 2.48 1.24 1.11 0.40 5.50 5.10 1.36 0.43 0.08 
GB12R 3.81 3.34 4.29 3.69 3.33 4.01 2.00 0.90 9.00 8.10 2.24 1.05 0.57 
2L 5.72 5.12 6.32 5.59 5.00 5.92 2.43 1.75 14.00 12.25 3.30 0.83 0.78 
2R 5.79 5.24 6.33 5.71 5.43 4.46 2.11 1.85 11.40 9.55 3.09 0.55 0.08 
PC6L 4.49 4.09 4.89 4.45 4.43 1.90 1.38 2.00 7.55 5.55 2.04 0.49 -0.53 
PC6R 5.07 4.62 5.53 4.91 4.68 3.97 1.99 2.40 11.50 9.10 2.35 1.28 1.50 
LI10L 4.62 4.00 5.24 4.36 3.68 6.75 2.60 1.35 13.50 12.15 2.59 1.61 2.58 
1L 4.77 4.17 5.36 4.56 4.20 6.13 2.47 1.80 12.05 10.25 2.68 1.27 1.07 
1R 4.83 4.40 5.27 4.71 4.38 4.09 2.02 1.15 10.90 9.75 2.73 0.93 0.46 
LI5L 4.38 3.99 4.78 4.32 4.20 2.69 1.64 1.90 8.20 6.30 2.24 0.78 -0.18 
LI5R 4.51 4.13 4.88 4.38 4.03 3.44 1.86 1.90 11.90 10.00 2.18 1.27 1.79 
ST36L 7.46 6.70 8.22 7.28 6.60 9.48 3.08 3.00 16.20 13.20 3.93 0.89 0.17 
ST36R 7.03 6.49 7.57 6.96 6.80 5.89 2.43 2.45 13.00 10.55 3.88 0.46 -0.47 
3R 6.21 5.63 6.79 6.03 5.80 6.01 2.45 2.30 15.60 13.30 2.80 1.27 2.46 
SP6R 5.50 4.90 6.09 5.35 5.23 4.24 2.06 2.60 12.50 9.90 2.38 1.16 1.79 







Descriptive statistics of PPTmean for Control of Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.44 1.33 1.54 1.39 1.35 0.56 0.75 0.15 4.15 4.00 0.88 0.84 0.91 
LI20R 1.50 1.39 1.61 1.47 1.43 0.60 0.78 0.17 4.02 3.85 1.09 0.60 -0.05 
GB12R 2.65 2.47 2.82 2.58 2.48 1.62 1.27 0.50 7.52 7.02 1.75 0.85 0.78 
2L 3.98 3.74 4.22 3.88 3.68 2.87 1.70 1.08 9.17 8.08 2.20 0.88 0.50 
2R 4.39 4.16 4.63 4.33 4.24 2.80 1.67 1.25 9.08 7.83 2.30 0.55 -0.12 
PC6L 3.69 3.50 3.89 3.61 3.50 1.87 1.37 1.40 9.23 7.83 1.76 0.97 1.44 
PC6R 3.79 3.60 3.98 3.74 3.63 1.83 1.35 0.57 7.72 7.15 1.75 0.63 0.51 
LI10L 3.04 2.84 3.24 2.91 2.78 2.07 1.44 0.98 12.15 11.17 1.54 2.23 9.29 
1L 3.30 3.13 3.47 3.24 3.24 1.44 1.20 0.87 7.20 6.33 1.61 0.67 0.47 
1R 3.45 3.25 3.64 3.36 3.27 1.91 1.38 0.70 10.98 10.28 1.73 1.31 3.92 
LI5L 3.48 3.28 3.68 3.38 3.10 1.99 1.41 0.85 8.63 7.78 1.88 1.09 1.34 
LI5R 3.39 3.22 3.57 3.32 3.13 1.55 1.25 0.97 9.07 8.10 1.61 1.16 2.15 
ST36L 5.38 5.09 5.66 5.26 5.01 4.05 2.01 1.48 11.67 10.18 2.33 0.89 0.80 
ST36R 5.34 5.07 5.61 5.23 5.03 3.60 1.90 1.53 12.27 10.73 2.22 1.00 1.67 
3R 4.88 4.61 5.14 4.74 4.53 3.57 1.89 1.48 11.33 9.85 2.25 1.08 1.40 
SP6R 4.43 4.22 4.65 4.36 4.11 2.30 1.52 1.50 9.35 7.85 1.91 0.74 0.58 
KD3R 4.49 4.26 4.73 4.42 4.33 2.79 1.67 1.27 9.78 8.52 2.10 0.63 0.30 
 
Descriptive statistics of PPTmean for Intervention of Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.16 2.05 2.26 2.15 2.14 0.25 0.50 1.13 3.48 2.35 0.78 0.15 -0.54 
LI20R 2.11 2.02 2.19 2.07 2.09 0.38 0.62 1.05 4.53 3.48 0.90 0.72 0.79 
GB12R 3.35 3.19 3.51 3.33 3.36 0.90 0.95 1.45 5.78 4.33 1.31 0.37 -0.24 
2L 5.24 4.94 5.55 5.18 4.85 3.14 1.77 2.20 9.68 7.48 2.70 0.54 -0.45 
2R 5.24 4.96 5.52 5.17 4.95 2.55 1.60 2.15 10.23 8.08 2.09 0.67 0.51 
PC6L 3.24 2.97 3.52 3.18 3.16 0.89 0.94 1.78 6.12 4.33 1.09 0.91 1.08 
PC6R 4.10 3.93 4.27 4.07 3.97 1.29 1.13 2.00 7.25 5.25 1.65 0.44 -0.60 
LI10L 3.51 3.30 3.73 3.43 3.32 1.62 1.27 1.33 7.58 6.25 1.74 0.88 0.74 
1L 3.48 3.28 3.67 3.42 3.27 1.28 1.13 1.83 6.38 4.55 1.71 0.53 -0.43 
1R 3.89 3.70 4.08 3.78 3.57 2.04 1.43 1.75 8.42 6.67 1.86 1.05 0.90 
LI5L 3.14 2.94 3.34 3.02 2.87 1.37 1.17 1.60 8.52 6.92 1.13 2.11 6.34 
LI5R 3.50 3.34 3.66 3.40 3.22 1.71 1.31 1.55 9.17 7.62 1.50 1.27 1.92 
ST36L 4.95 4.66 5.25 4.90 4.98 2.83 1.68 1.78 9.93 8.15 2.28 0.44 0.09 
ST36R 4.82 4.58 5.05 4.72 4.62 3.01 1.74 1.40 10.73 9.33 2.28 0.81 0.66 
3R 4.73 4.47 5.00 4.63 4.48 3.03 1.74 1.38 10.27 8.88 2.17 0.89 0.76 
SP6R 4.04 3.63 4.45 3.94 3.61 2.01 1.42 1.93 8.62 6.68 1.35 1.32 1.86 







Descriptive statistics of PPTmean for Control of Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.76 1.63 1.89 1.73 1.67 0.63 0.80 0.27 3.82 3.55 1.11 0.46 -0.40 
LI20R 1.84 1.70 1.97 1.80 1.75 0.68 0.83 0.27 4.08 3.82 1.07 0.53 -0.06 
GB12R 2.82 2.65 3.00 2.78 2.68 1.13 1.07 0.92 5.93 5.02 1.60 0.69 -0.07 
2L 4.79 4.49 5.08 4.71 4.68 3.20 1.79 1.20 9.73 8.53 2.70 0.50 -0.19 
2R 5.26 4.93 5.59 5.18 5.06 3.99 2.00 1.50 12.65 11.15 2.90 0.75 0.90 
PC6L 4.35 4.14 4.56 4.27 4.08 1.61 1.27 2.53 7.85 5.32 1.90 0.80 -0.07 
PC6R 4.53 4.33 4.73 4.48 4.47 1.45 1.20 2.35 8.55 6.20 1.81 0.64 0.29 
LI10L 3.48 3.29 3.68 3.40 3.21 1.38 1.17 1.43 8.38 6.95 1.35 1.18 2.13 
1L 3.65 3.44 3.87 3.57 3.30 1.71 1.31 1.75 9.57 7.82 1.84 1.20 2.09 
1R 3.94 3.69 4.18 3.83 3.39 2.24 1.50 1.22 10.07 8.85 2.15 1.16 1.51 
LI5L 3.70 3.49 3.90 3.61 3.59 1.53 1.24 1.75 9.55 7.80 1.60 1.28 3.31 
LI5R 3.90 3.70 4.10 3.82 3.76 1.47 1.21 1.93 8.93 7.00 1.58 1.22 2.52 
ST36L 6.18 5.84 6.52 6.03 5.97 4.32 2.08 3.00 14.63 11.63 2.67 1.21 2.41 
ST36R 6.33 5.98 6.68 6.23 5.94 4.56 2.14 2.67 13.13 10.47 3.01 0.73 -0.03 
3R 5.47 5.15 5.78 5.30 5.26 3.66 1.91 2.42 15.27 12.85 2.04 1.89 6.67 
SP6R 5.31 5.02 5.60 5.22 5.16 3.02 1.74 2.40 12.27 9.87 2.40 0.88 1.69 
KD3R 5.37 5.07 5.67 5.28 5.28 3.28 1.81 1.77 11.40 9.63 2.30 0.69 0.63 
 
Descriptive statistics of PPTmean for Intervention of Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.77 2.54 3.00 2.69 2.58 1.20 1.10 1.07 6.60 5.53 1.42 1.07 1.47 
LI20R 2.77 2.65 2.89 2.73 2.65 0.79 0.89 0.98 5.52 4.53 1.18 0.72 0.32 
GB12R 4.30 4.00 4.60 4.19 4.00 3.15 1.77 1.70 9.10 7.40 2.44 0.93 0.08 
2L 6.45 6.01 6.88 6.36 5.89 5.52 2.35 2.52 14.13 11.62 3.47 0.59 -0.06 
2R 6.01 5.66 6.36 5.97 5.99 3.02 1.74 2.40 11.30 8.90 2.38 0.34 0.04 
PC6L 4.17 3.75 4.59 4.11 3.78 2.09 1.45 2.12 7.58 5.47 2.17 0.63 -0.40 
PC6R 5.14 4.82 5.46 4.98 4.53 4.26 2.06 1.97 12.45 10.48 2.62 1.22 1.20 
LI10L 5.24 4.82 5.65 5.08 4.67 6.04 2.46 1.78 13.37 11.58 3.27 0.97 0.58 
1L 5.29 4.88 5.69 5.15 4.68 5.51 2.35 2.03 11.98 9.95 2.93 0.93 0.10 
1R 5.00 4.75 5.25 4.89 4.53 3.13 1.77 1.53 10.97 9.43 2.11 0.98 0.57 
LI5L 4.53 4.28 4.79 4.46 4.38 2.12 1.46 1.88 8.37 6.48 2.08 0.69 -0.16 
LI5R 4.41 4.19 4.64 4.29 3.88 3.10 1.76 1.30 11.57 10.27 2.16 1.15 1.04 
ST36L 7.96 7.45 8.47 7.85 7.72 7.65 2.77 2.73 15.87 13.13 3.81 0.48 -0.15 
ST36R 6.81 6.48 7.15 6.73 6.37 5.06 2.25 2.40 12.82 10.42 3.03 0.55 -0.25 
3R 6.52 6.16 6.88 6.42 5.89 4.61 2.15 2.60 13.20 10.60 3.25 0.69 0.05 
SP6R 5.41 4.80 6.02 5.30 4.83 4.44 2.11 2.87 10.08 7.22 3.58 0.61 -0.83 







Descriptive statistics of PPTmean for Control of Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.54 1.29 1.80 1.49 1.50 0.80 0.90 0.15 4.15 4.00 0.92 1.03 1.10 
LI20R 1.55 1.31 1.79 1.50 1.55 0.71 0.84 0.33 4.02 3.68 1.05 0.91 0.72 
GB12R 2.59 2.19 2.98 2.48 2.37 1.89 1.38 0.50 7.52 7.02 1.81 1.31 2.46 
2L 3.89 3.36 4.41 3.75 3.62 3.33 1.83 1.65 9.17 7.52 2.68 0.91 0.51 
2R 4.30 3.80 4.81 4.23 4.20 3.13 1.77 1.58 8.60 7.02 2.92 0.50 -0.37 
PC6L 3.86 3.39 4.33 3.74 3.45 2.68 1.64 1.58 9.23 7.65 2.22 1.18 1.71 
PC6R 3.76 3.36 4.15 3.71 3.53 1.90 1.38 1.15 7.33 6.18 1.77 0.73 0.18 
LI10L 3.15 2.63 3.67 2.96 2.57 3.31 1.82 0.98 12.15 11.17 2.30 2.68 11.50 
1L 3.35 2.97 3.74 3.25 3.35 1.82 1.35 1.55 7.20 5.65 1.76 1.16 1.36 
1R 3.57 3.10 4.03 3.40 2.97 2.63 1.62 1.33 10.98 9.65 1.83 2.26 8.12 
LI5L 3.46 2.98 3.94 3.32 2.93 2.84 1.68 0.85 8.63 7.78 2.24 1.36 1.77 
LI5R 3.36 2.95 3.77 3.24 3.07 2.03 1.42 1.43 9.07 7.63 1.64 1.76 4.35 
ST36L 5.35 4.76 5.94 5.23 4.88 4.24 2.06 1.48 11.67 10.18 2.09 1.07 1.66 
ST36R 5.31 4.74 5.87 5.17 5.07 3.83 1.96 1.65 11.83 10.18 2.45 1.17 2.25 
3R 4.87 4.29 5.45 4.74 4.42 4.08 2.02 1.48 10.85 9.37 2.46 1.10 1.18 
SP6R 4.31 3.90 4.71 4.27 3.98 1.99 1.41 1.50 8.00 6.50 2.03 0.48 -0.11 
KD3R 4.53 4.00 5.07 4.44 4.33 3.49 1.87 1.27 9.78 8.52 1.85 0.93 0.90 
 
Descriptive statistics of PPTmean for Control of Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.34 1.15 1.52 1.32 1.35 0.42 0.65 0.20 2.83 2.63 0.96 0.39 -0.67 
LI20R 1.38 1.17 1.59 1.35 1.43 0.53 0.73 0.23 3.10 2.87 1.01 0.47 -0.26 
GB12R 2.62 2.28 2.97 2.58 2.48 1.48 1.22 0.53 5.52 4.98 1.75 0.63 -0.11 
2L 3.79 3.36 4.23 3.70 3.33 2.28 1.51 1.45 8.55 7.10 1.94 0.94 0.96 
2R 4.25 3.80 4.71 4.21 4.12 2.53 1.59 1.25 7.82 6.57 1.85 0.59 0.02 
PC6L 3.48 3.17 3.80 3.44 3.42 1.22 1.10 1.40 6.75 5.35 1.29 0.62 0.61 
PC6R 3.75 3.37 4.12 3.72 3.62 1.70 1.30 0.57 7.63 7.07 1.55 0.43 1.12 
LI10L 3.02 2.61 3.43 2.85 2.80 2.04 1.43 1.23 8.97 7.73 1.08 2.39 7.70 
1L 3.27 2.95 3.59 3.22 3.27 1.23 1.11 1.48 6.10 4.62 1.53 0.54 0.35 
1R 3.33 2.97 3.69 3.25 3.38 1.56 1.25 1.23 6.97 5.73 1.62 0.93 0.89 
LI5L 3.46 3.05 3.86 3.36 3.00 1.97 1.40 1.23 8.40 7.17 1.53 1.24 1.90 
LI5R 3.34 2.99 3.70 3.27 3.08 1.54 1.24 0.97 7.33 6.37 1.73 1.01 1.09 
ST36L 5.20 4.65 5.75 5.10 5.02 3.65 1.91 1.95 11.53 9.58 2.19 0.93 1.46 
ST36R 5.21 4.70 5.72 5.14 4.73 3.19 1.78 1.53 10.37 8.83 2.09 0.74 0.79 
3R 4.75 4.24 5.26 4.63 4.22 3.15 1.77 1.65 10.28 8.63 1.87 1.16 1.97 
SP6R 4.31 3.90 4.72 4.24 4.08 2.03 1.43 1.90 8.67 6.77 1.43 0.97 1.19 







Descriptive statistics of PPTmean for Control of Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.45 1.24 1.66 1.42 1.35 0.52 0.72 0.17 3.37 3.20 0.94 0.74 0.57 
LI20R 1.54 1.32 1.76 1.53 1.42 0.60 0.77 0.17 3.00 2.83 1.20 0.32 -0.78 
GB12R 2.73 2.35 3.12 2.66 2.62 1.79 1.34 0.55 6.57 6.02 1.76 0.73 0.50 
2L 4.03 3.57 4.49 3.95 3.75 2.54 1.59 1.08 8.65 7.57 1.53 0.91 1.13 
2R 4.43 3.98 4.88 4.38 4.43 2.49 1.58 1.63 8.52 6.88 2.09 0.39 0.09 
PC6L 3.64 3.29 4.00 3.59 3.70 1.52 1.23 1.72 7.43 5.72 1.73 0.56 0.36 
PC6R 3.78 3.38 4.17 3.71 3.77 1.90 1.38 1.15 7.72 6.57 1.88 0.72 0.84 
LI10L 2.95 2.61 3.30 2.86 2.77 1.45 1.20 1.33 7.13 5.80 1.53 1.18 1.99 
1L 3.34 3.02 3.66 3.34 3.27 1.22 1.11 0.87 5.65 4.78 1.61 0.08 -0.44 
1R 3.51 3.14 3.88 3.49 3.42 1.67 1.29 0.72 6.80 6.08 1.88 0.34 -0.07 
LI5L 3.49 3.12 3.87 3.43 3.28 1.68 1.30 1.28 7.07 5.78 1.78 0.83 0.42 
LI5R 3.39 3.06 3.72 3.33 3.12 1.34 1.16 1.02 6.85 5.83 1.59 0.77 1.06 
ST36L 5.41 4.85 5.97 5.34 5.00 3.80 1.95 2.28 9.83 7.55 2.58 0.53 -0.43 
ST36R 5.21 4.73 5.70 5.15 4.88 2.83 1.68 1.97 9.73 7.77 2.03 0.53 0.29 
3R 4.89 4.34 5.45 4.76 4.65 3.72 1.93 2.05 11.00 8.95 2.78 0.97 1.23 
SP6R 4.46 3.98 4.94 4.37 3.97 2.80 1.67 1.55 9.35 7.80 2.08 0.77 0.79 
KD3R 4.42 4.00 4.84 4.40 4.50 2.10 1.45 1.78 7.77 5.98 2.13 0.11 -0.46 
 
Descriptive statistics of PPTmean for Control of Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.41 1.21 1.62 1.38 1.35 0.50 0.71 0.28 3.40 3.12 0.72 0.62 0.32 
LI20R 1.54 1.32 1.76 1.51 1.50 0.59 0.77 0.32 3.65 3.33 1.13 0.57 -0.18 
GB12R 2.64 2.30 2.98 2.59 2.45 1.41 1.19 0.60 5.45 4.85 1.72 0.63 -0.12 
2L 4.22 3.69 4.75 4.13 3.92 3.42 1.85 1.08 8.83 7.75 2.42 0.78 0.00 
2R 4.58 4.07 5.09 4.50 4.32 3.15 1.78 1.73 9.08 7.35 2.28 0.68 -0.03 
PC6L 3.79 3.37 4.21 3.71 3.52 2.10 1.45 1.58 7.95 6.37 1.85 0.79 0.48 
PC6R 3.89 3.49 4.29 3.83 3.63 1.91 1.38 1.02 7.65 6.63 1.82 0.66 0.48 
LI10L 3.04 2.68 3.40 2.96 2.80 1.57 1.25 1.07 6.97 5.90 1.55 0.97 1.29 
1L 3.24 2.88 3.60 3.20 2.95 1.58 1.26 0.95 6.63 5.68 1.88 0.56 -0.11 
1R 3.38 2.99 3.77 3.31 3.00 1.86 1.36 0.70 6.97 6.27 1.85 0.79 0.35 
LI5L 3.51 3.15 3.87 3.45 3.27 1.59 1.26 1.42 6.83 5.42 1.97 0.60 0.01 
LI5R 3.48 3.14 3.82 3.43 3.22 1.39 1.18 1.03 7.18 6.15 1.58 0.77 0.78 
ST36L 5.55 4.93 6.17 5.42 5.08 4.69 2.17 2.33 11.28 8.95 2.09 0.99 0.83 
ST36R 5.64 5.02 6.26 5.48 5.33 4.66 2.16 1.95 12.27 10.32 2.68 1.17 1.92 
3R 4.99 4.45 5.53 4.85 4.83 3.54 1.88 1.77 11.33 9.57 2.00 1.17 2.12 
SP6R 4.65 4.20 5.10 4.59 4.30 2.44 1.56 1.67 9.12 7.45 2.06 0.70 0.48 







Descriptive statistics of PPTmean for Intervention of Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.93 1.75 2.12 1.93 1.88 0.17 0.42 1.18 2.68 1.50 0.68 0.14 -0.79 
LI20R 2.03 1.85 2.21 2.00 1.92 0.45 0.67 1.05 4.23 3.18 1.06 0.77 0.61 
GB12R 3.04 2.69 3.38 2.98 3.00 0.97 0.98 1.45 5.68 4.23 1.12 0.77 0.86 
2L 4.75 4.13 5.36 4.69 4.27 3.12 1.77 2.20 8.80 6.60 3.05 0.45 -0.76 
2R 4.96 4.43 5.49 4.94 4.83 2.07 1.44 2.15 7.98 5.83 1.60 0.36 -0.16 
PC6L 2.99 2.29 3.69 2.92 2.78 1.21 1.10 1.78 5.57 3.78 1.56 1.16 1.37 
PC6R 3.79 3.49 4.09 3.75 3.74 0.99 0.99 2.00 6.38 4.38 1.22 0.60 0.60 
LI10L 3.32 2.87 3.76 3.22 3.28 1.65 1.29 1.65 6.80 5.15 1.63 1.01 0.88 
1L 3.32 2.88 3.77 3.24 3.27 1.56 1.25 1.92 6.38 4.47 1.66 0.96 0.32 
1R 3.68 3.34 4.01 3.60 3.58 1.57 1.25 1.82 8.00 6.18 1.60 1.10 1.56 
LI5L 2.90 2.54 3.27 2.79 2.70 1.08 1.04 1.73 6.82 5.08 1.05 1.96 5.23 
LI5R 3.33 3.08 3.59 3.28 3.23 1.08 1.04 1.77 6.50 4.73 1.03 0.83 0.38 
ST36L 4.73 4.11 5.35 4.68 4.23 2.85 1.69 2.08 8.60 6.52 2.30 0.57 -0.50 
ST36R 4.46 4.04 4.87 4.38 4.22 2.27 1.51 2.28 8.65 6.37 2.31 0.60 0.03 
3R 4.60 4.04 5.16 4.50 4.29 3.23 1.80 1.80 10.27 8.47 2.90 0.82 0.87 
SP6R 3.80 3.11 4.49 3.80 3.52 1.17 1.08 1.93 5.58 3.65 1.81 0.21 -0.60 
KD3R 3.93 3.49 4.36 3.81 3.47 2.09 1.45 1.97 8.93 6.97 1.93 1.28 2.09 
 
Descriptive statistics of PPTmean for Intervention of Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.01 1.81 2.22 2.02 1.96 0.21 0.46 1.13 2.80 1.67 0.69 0.02 -0.69 
LI20R 1.97 1.83 2.10 1.95 2.05 0.26 0.51 1.17 3.20 2.03 0.78 0.41 -0.39 
GB12R 3.12 2.82 3.41 3.11 2.95 0.72 0.85 1.60 4.68 3.08 1.55 0.26 -0.92 
2L 4.95 4.38 5.52 4.86 4.64 2.69 1.64 2.45 9.40 6.95 2.18 0.79 0.31 
2R 5.11 4.52 5.71 5.06 4.72 2.65 1.63 2.15 9.40 7.25 1.87 0.52 0.31 
PC6L 2.94 2.43 3.46 2.91 2.83 0.66 0.81 1.90 4.63 2.73 1.11 0.89 0.39 
PC6R 3.93 3.60 4.26 3.90 3.86 1.16 1.08 2.25 6.23 3.98 1.31 0.46 -0.44 
LI10L 3.32 2.86 3.79 3.24 3.12 1.77 1.33 1.33 7.58 6.25 1.99 1.06 1.60 
1L 3.27 2.91 3.64 3.22 3.25 1.06 1.03 1.83 6.12 4.28 1.75 0.67 0.27 
1R 3.65 3.29 4.01 3.52 3.28 1.83 1.35 1.92 8.25 6.33 1.71 1.52 2.85 
LI5L 3.05 2.64 3.46 2.90 2.83 1.40 1.18 1.77 8.23 6.47 1.12 2.86 10.85 
LI5R 3.28 2.98 3.57 3.15 2.95 1.45 1.21 1.87 7.78 5.92 1.40 1.73 3.59 
ST36L 4.79 4.21 5.36 4.71 4.53 2.48 1.57 1.78 9.15 7.37 2.07 0.75 1.17 
ST36R 4.62 4.18 5.06 4.52 4.28 2.59 1.61 1.95 9.55 7.60 1.93 1.01 1.45 
3R 4.56 4.01 5.10 4.42 4.43 3.03 1.74 1.93 9.60 7.67 2.07 1.11 1.35 
SP6R 3.69 2.93 4.44 3.63 3.32 1.42 1.19 2.03 6.38 4.35 1.22 0.92 1.33 







Descriptive statistics of PPTmean for Intervention of Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.20 2.00 2.41 2.20 2.26 0.22 0.47 1.35 3.18 1.83 0.56 0.09 -0.31 
LI20R 2.10 1.95 2.25 2.08 2.14 0.31 0.56 1.18 3.90 2.72 0.81 0.51 0.59 
GB12R 3.50 3.18 3.81 3.46 3.38 0.81 0.90 2.08 5.78 3.70 1.22 0.49 0.00 
2L 5.54 4.96 6.12 5.50 5.46 2.73 1.65 3.17 8.68 5.52 2.83 0.36 -1.11 
2R 5.33 4.78 5.87 5.25 5.23 2.19 1.48 2.93 10.00 7.07 1.98 0.85 1.87 
PC6L 3.44 2.79 4.09 3.36 3.36 1.05 1.02 2.17 6.12 3.95 0.94 1.71 4.00 
PC6R 4.14 3.79 4.49 4.11 4.20 1.30 1.14 2.50 6.60 4.10 1.99 0.32 -1.02 
LI10L 3.50 3.08 3.93 3.43 3.40 1.50 1.23 1.78 6.60 4.82 1.62 0.91 0.65 
1L 3.51 3.12 3.89 3.48 3.27 1.17 1.08 1.83 5.75 3.92 1.70 0.36 -0.89 
1R 3.94 3.54 4.33 3.84 3.63 2.16 1.47 1.75 8.42 6.67 2.18 0.96 0.90 
LI5L 3.15 2.74 3.56 3.04 2.83 1.39 1.18 1.60 7.65 6.05 1.18 1.92 5.31 
LI5R 3.53 3.19 3.88 3.43 3.26 1.97 1.40 1.62 8.17 6.55 1.46 1.24 1.46 
ST36L 5.01 4.39 5.62 4.93 5.22 2.77 1.67 2.07 9.93 7.87 2.17 0.65 1.68 
ST36R 4.97 4.43 5.52 4.88 4.67 3.92 1.98 1.40 9.97 8.57 2.58 0.80 0.30 
3R 4.71 4.17 5.26 4.62 4.33 3.07 1.75 1.38 9.27 7.88 1.97 1.02 1.05 
SP6R 4.13 3.08 5.17 3.96 3.58 2.72 1.65 2.63 8.62 5.98 1.10 2.17 5.05 
KD3R 4.05 3.63 4.46 3.99 3.87 1.94 1.39 1.72 7.53 5.82 1.89 0.56 -0.02 
 
Descriptive statistics of PPTmean for Intervention of Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.48 2.26 2.69 2.47 2.56 0.24 0.49 1.70 3.48 1.78 0.84 -0.13 -0.57 
LI20R 2.32 2.14 2.50 2.29 2.22 0.45 0.67 1.13 4.53 3.40 1.00 0.77 0.85 
GB12R 3.77 3.46 4.08 3.75 3.90 0.81 0.90 2.20 5.67 3.47 1.29 0.21 -0.31 
2L 5.75 5.08 6.41 5.68 5.33 3.61 1.90 3.02 9.68 6.67 2.70 0.64 -0.49 
2R 5.56 4.89 6.23 5.47 5.27 3.33 1.82 2.88 10.23 7.35 2.42 0.74 0.09 
PC6L 3.60 3.13 4.07 3.57 3.55 0.55 0.74 2.48 5.17 2.68 0.87 0.65 0.67 
PC6R 4.54 4.18 4.91 4.52 4.44 1.46 1.21 2.70 7.25 4.55 2.24 0.23 -1.07 
LI10L 3.91 3.49 4.33 3.83 3.88 1.47 1.21 2.13 7.18 5.05 1.51 0.96 1.26 
1L 3.80 3.41 4.20 3.79 3.87 1.27 1.13 1.85 6.37 4.52 1.82 0.18 -0.73 
1R 4.28 3.86 4.70 4.20 4.17 2.47 1.57 1.97 8.17 6.20 2.19 0.72 -0.19 
LI5L 3.46 3.02 3.89 3.35 3.17 1.57 1.25 1.72 8.52 6.80 1.25 2.04 7.07 
LI5R 3.87 3.51 4.24 3.78 3.59 2.20 1.48 1.55 9.17 7.62 2.19 1.01 1.39 
ST36L 5.29 4.63 5.96 5.28 5.53 3.29 1.81 1.80 8.93 7.13 2.92 -0.05 -0.38 
ST36R 5.22 4.74 5.71 5.16 5.15 3.09 1.76 2.13 10.73 8.60 2.28 0.65 0.75 
3R 5.06 4.54 5.59 4.98 4.77 2.85 1.69 1.93 9.40 7.47 1.89 0.83 0.82 
SP6R 4.55 3.48 5.62 4.50 4.13 2.81 1.68 2.45 7.50 5.05 2.42 0.79 -0.41 







Descriptive statistics of PPTmean for Control of Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.87 1.57 2.16 1.85 1.74 0.76 0.87 0.27 3.68 3.42 1.27 0.37 -0.50 
LI20R 1.99 1.68 2.31 1.98 1.82 0.86 0.93 0.27 3.90 3.63 1.36 0.46 -0.27 
GB12R 2.92 2.58 3.25 2.89 2.67 1.00 1.00 1.28 5.22 3.93 1.72 0.56 -0.61 
2L 4.65 4.00 5.31 4.52 4.45 3.74 1.93 2.13 9.73 7.60 3.02 0.90 0.45 
2R 5.18 4.47 5.90 5.08 5.08 4.51 2.12 1.50 11.57 10.07 2.96 0.78 0.85 
PC6L 4.29 3.83 4.75 4.21 3.99 1.84 1.36 2.53 7.68 5.15 1.85 0.85 -0.08 
PC6R 4.42 3.99 4.85 4.35 4.35 1.65 1.28 2.67 8.08 5.42 2.11 0.66 0.18 
LI10L 3.58 3.13 4.02 3.52 3.24 1.70 1.30 1.62 6.70 5.08 1.78 0.67 -0.22 
1L 3.72 3.26 4.19 3.66 3.45 1.87 1.37 1.75 7.18 5.43 2.19 0.73 -0.18 
1R 4.08 3.54 4.62 3.97 3.83 2.58 1.61 2.25 7.97 5.72 2.72 0.80 -0.28 
LI5L 3.59 3.19 4.00 3.56 3.14 1.44 1.20 1.75 6.12 4.37 1.80 0.53 -0.68 
LI5R 3.91 3.46 4.37 3.80 3.76 1.80 1.34 2.20 8.93 6.73 2.00 1.49 4.15 
ST36L 5.94 5.40 6.48 5.94 6.10 2.54 1.59 3.00 9.17 6.17 2.65 -0.12 -0.98 
ST36R 6.36 5.63 7.08 6.35 5.93 4.59 2.14 2.75 10.18 7.43 3.00 0.21 -1.02 
3R 5.36 4.77 5.96 5.24 5.03 3.08 1.75 3.10 10.30 7.20 2.51 0.95 0.68 
SP6R 5.32 4.68 5.97 5.20 5.20 3.64 1.91 2.40 11.53 9.13 2.74 0.94 1.86 
KD3R 5.35 4.70 6.01 5.28 5.43 3.77 1.94 1.77 10.05 8.28 2.55 0.49 0.33 
 
Descriptive statistics of PPTmean for Control of Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.78 1.51 2.04 1.75 1.63 0.63 0.79 0.30 3.82 3.52 1.03 0.50 0.12 
LI20R 1.87 1.60 2.15 1.85 1.79 0.65 0.81 0.30 3.92 3.62 1.05 0.50 0.05 
GB12R 2.81 2.46 3.17 2.77 2.73 1.11 1.05 1.12 5.47 4.35 1.69 0.64 -0.09 
2L 4.97 4.34 5.59 4.90 4.81 3.42 1.85 1.83 9.60 7.77 2.73 0.47 -0.28 
2R 5.19 4.53 5.84 5.17 5.20 3.73 1.93 1.68 8.73 7.05 3.36 0.13 -1.04 
PC6L 4.45 4.01 4.89 4.38 4.18 1.68 1.29 2.77 7.72 4.95 1.83 0.84 0.03 
PC6R 4.47 4.09 4.84 4.42 4.49 1.23 1.11 2.80 7.22 4.42 1.65 0.41 -0.20 
LI10L 3.53 3.20 3.86 3.48 3.21 0.95 0.97 2.10 6.50 4.40 1.59 0.92 0.94 
1L 3.70 3.28 4.12 3.65 3.18 1.54 1.24 2.20 6.37 4.17 2.28 0.55 -1.03 
1R 3.95 3.47 4.43 3.89 3.63 2.01 1.42 1.72 7.18 5.47 2.00 0.72 -0.06 
LI5L 3.71 3.31 4.12 3.66 3.68 1.43 1.19 1.85 7.30 5.45 1.90 0.71 0.64 
LI5R 3.86 3.44 4.28 3.78 3.63 1.57 1.25 1.93 7.72 5.78 1.94 0.91 1.02 
ST36L 6.33 5.57 7.08 6.20 6.03 4.93 2.22 3.50 12.80 9.30 3.64 0.89 0.42 
ST36R 6.42 5.66 7.19 6.33 6.18 5.10 2.26 3.25 11.40 8.15 3.13 0.69 -0.46 
3R 5.39 4.85 5.94 5.31 5.25 2.61 1.62 2.95 9.45 6.50 2.18 0.70 0.22 
SP6R 5.33 4.70 5.95 5.27 5.17 3.44 1.85 2.63 9.93 7.30 3.60 0.34 -0.57 







Descriptive statistics of PPTmean for Control of Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.75 1.48 2.03 1.73 1.63 0.64 0.80 0.57 3.50 2.93 1.19 0.49 -0.57 
LI20R 1.78 1.51 2.05 1.74 1.79 0.62 0.79 0.63 4.08 3.45 1.13 0.57 0.56 
GB12R 2.79 2.44 3.14 2.72 2.59 1.07 1.03 1.43 5.58 4.15 1.54 1.00 0.59 
2L 4.93 4.36 5.51 4.92 4.82 2.87 1.69 1.20 8.62 7.42 2.66 0.03 -0.30 
2R 5.49 4.83 6.16 5.34 5.38 3.87 1.97 2.45 12.65 10.20 2.72 1.44 3.60 
PC6L 4.31 3.89 4.73 4.22 3.98 1.55 1.25 2.80 7.85 5.05 1.75 1.09 0.74 
PC6R 4.62 4.21 5.04 4.51 4.25 1.50 1.22 3.22 8.55 5.33 1.58 1.31 2.08 
LI10L 3.48 3.07 3.89 3.37 3.21 1.47 1.21 1.70 8.38 6.68 1.33 1.96 6.60 
1L 3.69 3.23 4.15 3.54 3.34 1.87 1.37 2.17 9.57 7.40 1.48 2.45 8.84 
1R 3.95 3.41 4.49 3.77 3.28 2.54 1.59 2.18 10.07 7.88 1.54 2.03 5.24 
LI5L 3.77 3.33 4.22 3.64 3.68 1.73 1.31 2.08 9.55 7.47 1.42 2.48 9.92 
LI5R 3.88 3.56 4.20 3.82 3.80 0.89 0.94 2.50 6.35 3.85 1.04 0.99 0.82 
ST36L 6.37 5.57 7.17 6.20 5.97 5.57 2.36 3.07 13.93 10.87 2.82 1.25 1.80 
ST36R 6.30 5.56 7.04 6.11 5.60 4.79 2.19 3.95 13.13 9.18 2.79 1.37 1.54 
3R 5.74 5.04 6.45 5.51 5.28 4.34 2.08 3.15 14.20 11.05 2.03 2.24 7.06 
SP6R 5.21 4.78 5.65 5.16 5.08 1.68 1.30 3.27 8.70 5.43 1.91 0.61 0.08 
KD3R 5.36 4.82 5.91 5.25 5.03 2.62 1.62 3.08 10.60 7.52 1.93 1.16 1.93 
 
Descriptive statistics of PPTmean for Control of Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.64 1.39 1.88 1.61 1.53 0.53 0.73 0.62 3.35 2.73 1.03 0.42 -0.58 
LI20R 1.70 1.44 1.97 1.68 1.49 0.60 0.78 0.50 3.47 2.97 1.01 0.51 -0.41 
GB12R 2.78 2.37 3.18 2.72 2.65 1.44 1.20 0.92 5.93 5.02 1.54 0.69 0.11 
2L 4.60 4.02 5.18 4.52 4.62 2.91 1.71 1.98 8.68 6.70 2.60 0.51 -0.24 
2R 5.18 4.50 5.87 5.10 4.72 4.14 2.04 1.78 11.17 9.38 2.83 0.76 0.69 
PC6L 4.34 3.93 4.75 4.28 4.29 1.48 1.22 2.58 7.13 4.55 1.89 0.53 -0.50 
PC6R 4.62 4.21 5.04 4.61 4.54 1.51 1.23 2.35 7.15 4.80 1.77 0.23 -0.63 
LI10L 3.34 2.93 3.75 3.25 3.15 1.48 1.22 1.43 7.28 5.85 1.15 1.31 2.33 
1L 3.49 3.05 3.93 3.40 3.24 1.68 1.29 1.75 7.00 5.25 1.66 1.02 0.66 
1R 3.78 3.30 4.25 3.71 3.29 1.98 1.41 1.22 8.15 6.93 1.99 1.01 1.24 
LI5L 3.70 3.27 4.13 3.60 3.55 1.63 1.28 1.82 7.87 6.05 1.64 1.20 2.24 
LI5R 3.96 3.52 4.41 3.86 3.78 1.74 1.32 1.93 8.17 6.23 1.61 1.29 2.57 
ST36L 6.09 5.37 6.80 5.91 5.77 4.48 2.12 3.12 14.63 11.52 2.32 1.92 6.49 
ST36R 6.25 5.56 6.93 6.15 6.03 4.12 2.03 2.67 11.63 8.97 2.96 0.69 0.41 
3R 5.37 4.63 6.11 5.17 5.16 4.80 2.19 2.42 15.27 12.85 2.18 2.61 11.33 
SP6R 5.38 4.74 6.02 5.24 5.28 3.58 1.89 2.58 12.27 9.68 2.12 1.36 3.72 







Descriptive statistics of PPTmean for Intervention of Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.46 2.05 2.86 2.44 2.27 0.84 0.92 1.07 4.10 3.03 1.02 0.58 -0.53 
LI20R 2.52 2.30 2.73 2.48 2.46 0.55 0.74 1.32 4.40 3.08 0.96 0.56 -0.13 
GB12R 3.63 3.13 4.13 3.54 3.28 2.07 1.44 1.70 7.22 5.52 1.86 0.96 0.24 
2L 5.53 4.80 6.25 5.46 5.25 3.64 1.91 2.60 9.70 7.10 2.94 0.50 -0.28 
2R 5.29 4.75 5.83 5.30 5.38 1.64 1.28 2.78 7.40 4.62 1.79 -0.27 -0.76 
PC6L 3.57 2.82 4.31 3.53 3.32 1.38 1.18 2.13 5.75 3.62 1.95 0.66 -0.65 
PC6R 4.77 4.23 5.31 4.63 4.39 2.83 1.68 2.50 9.70 7.20 1.98 1.28 1.67 
LI10L 4.76 3.96 5.56 4.58 4.32 5.28 2.30 1.78 11.87 10.08 3.25 1.12 1.46 
1L 4.53 3.86 5.20 4.45 3.67 3.56 1.89 2.03 8.83 6.80 2.98 0.68 -0.63 
1R 4.57 4.17 4.97 4.46 4.37 1.96 1.40 2.73 8.43 5.70 1.80 1.06 0.93 
LI5L 3.82 3.47 4.18 3.78 3.50 0.99 0.99 2.32 6.40 4.08 1.23 0.83 0.22 
LI5R 4.06 3.65 4.46 3.90 3.58 2.47 1.57 2.17 9.63 7.47 1.79 1.63 3.00 
ST36L 7.13 6.24 8.03 7.06 6.42 5.51 2.35 3.68 12.00 8.32 3.68 0.59 -0.63 
ST36R 6.03 5.49 6.58 5.97 5.97 3.30 1.82 2.53 12.00 9.47 2.03 0.75 1.55 
3R 5.78 5.20 6.36 5.70 5.35 2.86 1.69 2.90 10.22 7.32 2.32 0.73 0.09 
SP6R 4.87 3.67 6.07 4.81 4.09 3.55 1.89 2.87 7.93 5.07 3.60 0.59 -1.38 
KD3R 4.97 4.39 5.56 4.89 4.43 3.76 1.94 2.18 9.67 7.48 3.04 0.56 -0.45 
 
Descriptive statistics of PPTmean for Intervention of Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.66 2.19 3.12 2.55 2.60 1.09 1.04 1.20 6.15 4.95 1.08 1.79 5.21 
LI20R 2.61 2.38 2.84 2.58 2.46 0.66 0.81 1.12 4.68 3.57 1.09 0.73 0.07 
GB12R 4.07 3.54 4.60 3.97 3.98 2.32 1.52 2.17 7.95 5.78 2.10 0.91 0.30 
2L 6.19 5.33 7.06 6.11 5.78 5.12 2.26 3.20 10.77 7.57 3.27 0.64 -0.60 
2R 5.86 5.14 6.59 5.79 5.58 2.97 1.72 3.18 10.10 6.92 2.05 0.60 0.38 
PC6L 3.95 3.12 4.78 3.87 3.70 1.71 1.31 2.38 6.98 4.60 1.63 1.15 1.43 
PC6R 4.99 4.37 5.61 4.84 4.47 3.77 1.94 1.97 11.30 9.33 2.18 1.26 1.81 
LI10L 4.78 4.02 5.54 4.68 4.09 4.77 2.18 1.87 9.43 7.57 3.28 0.86 -0.44 
1L 4.96 4.21 5.72 4.81 4.38 4.54 2.13 2.08 10.70 8.62 2.18 1.12 0.93 
1R 4.76 4.31 5.20 4.67 4.53 2.46 1.57 2.47 9.35 6.88 2.18 0.86 0.46 
LI5L 4.28 3.83 4.72 4.23 4.26 1.51 1.23 2.37 7.17 4.80 1.78 0.46 -0.56 
LI5R 4.21 3.79 4.62 4.07 3.56 2.57 1.60 2.37 9.10 6.73 2.06 1.27 1.08 
ST36L 7.70 6.73 8.68 7.56 7.90 6.58 2.57 3.48 15.47 11.98 3.78 0.82 1.61 
ST36R 6.63 6.01 7.25 6.55 6.67 4.25 2.06 3.42 11.50 8.08 2.53 0.56 -0.07 
3R 6.24 5.62 6.86 6.16 5.88 3.23 1.80 3.80 10.83 7.03 3.07 0.48 -0.45 
SP6R 5.17 3.99 6.36 5.12 4.35 3.50 1.87 3.08 8.18 5.10 3.58 0.55 -1.40 







Descriptive statistics of PPTmean for Intervention of Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.83 2.31 3.36 2.72 2.65 1.39 1.18 1.30 6.60 5.30 1.30 1.51 3.85 
LI20R 2.91 2.64 3.19 2.88 2.71 0.93 0.96 0.98 5.52 4.53 1.35 0.51 -0.03 
GB12R 4.57 3.94 5.20 4.47 4.21 3.22 1.80 2.35 8.65 6.30 2.72 0.71 -0.38 
2L 6.89 5.93 7.84 6.83 7.15 6.32 2.51 2.52 12.70 10.18 4.53 0.25 -0.57 
2R 6.20 5.44 6.96 6.27 6.48 3.21 1.79 2.40 8.67 6.27 2.77 -0.49 -0.59 
PC6L 4.28 3.39 5.17 4.23 4.33 1.96 1.40 2.57 6.97 4.40 2.20 0.43 -0.85 
PC6R 5.33 4.63 6.03 5.13 4.68 4.81 2.19 2.67 12.45 9.78 2.97 1.34 1.89 
LI10L 5.38 4.59 6.17 5.30 5.07 5.16 2.27 2.42 9.90 7.48 3.85 0.54 -0.86 
1L 5.53 4.66 6.40 5.38 4.73 5.98 2.44 2.52 11.98 9.47 3.29 0.98 0.09 
1R 5.10 4.56 5.64 5.03 4.48 3.62 1.90 1.53 9.93 8.40 2.64 0.77 -0.13 
LI5L 4.82 4.26 5.37 4.77 4.80 2.38 1.54 1.88 8.23 6.35 2.45 0.39 -0.17 
LI5R 4.57 4.09 5.04 4.48 4.02 3.36 1.83 1.30 9.18 7.88 2.97 0.70 -0.17 
ST36L 7.91 6.86 8.96 7.86 7.70 7.59 2.75 2.73 14.30 11.57 3.59 0.24 -0.19 
ST36R 6.97 6.25 7.69 6.91 6.30 5.75 2.40 2.40 12.00 9.60 4.13 0.42 -0.68 
3R 6.98 6.12 7.84 6.91 6.07 6.29 2.51 2.60 13.20 10.60 3.83 0.50 -0.33 
SP6R 5.69 4.31 7.07 5.61 5.43 4.74 2.18 3.08 9.80 6.72 4.01 0.49 -0.75 
KD3R 5.91 5.21 6.61 5.88 5.90 5.46 2.34 2.27 10.58 8.32 4.43 0.08 -1.26 
 
Descriptive statistics of PPTmean for Intervention of Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 3.12 2.60 3.65 3.09 2.85 1.41 1.19 1.50 5.43 3.93 1.89 0.38 -0.90 
LI20R 3.04 2.77 3.31 2.99 2.79 0.89 0.94 1.02 5.52 4.50 1.56 0.76 0.45 
GB12R 4.93 4.21 5.66 4.84 4.23 4.27 2.07 2.40 9.10 6.70 3.38 0.77 -0.68 
2L 7.18 6.25 8.10 7.04 7.27 5.91 2.43 3.82 14.13 10.32 3.59 0.76 0.67 
2R 6.69 5.89 7.49 6.61 6.37 3.60 1.90 3.75 11.30 7.55 2.87 0.54 -0.04 
PC6L 4.88 3.81 5.96 4.89 4.83 2.88 1.70 2.12 7.58 5.47 2.95 0.12 -0.78 
PC6R 5.47 4.71 6.23 5.33 4.67 5.63 2.37 2.45 11.67 9.22 3.40 0.93 -0.09 
LI10L 6.02 5.01 7.03 5.84 5.23 8.39 2.90 2.03 13.37 11.33 4.16 0.98 0.50 
1L 6.13 5.19 7.07 6.06 5.32 6.99 2.64 2.28 11.30 9.02 4.03 0.64 -0.74 
1R 5.57 5.00 6.15 5.46 5.11 4.09 2.02 2.43 10.97 8.53 2.78 0.88 0.13 
LI5L 5.22 4.63 5.80 5.18 4.59 2.65 1.63 2.87 8.37 5.50 2.61 0.38 -1.06 
LI5R 4.83 4.32 5.33 4.70 4.17 3.80 1.95 1.90 11.57 9.67 2.84 1.09 1.12 
ST36L 9.09 7.91 10.27 9.04 8.83 9.63 3.10 3.63 15.87 12.23 5.29 0.11 -0.61 
ST36R 7.62 6.89 8.36 7.60 7.48 5.93 2.44 3.07 12.82 9.75 3.88 0.27 -0.66 
3R 7.07 6.28 7.86 6.98 6.80 5.31 2.30 3.28 12.88 9.60 3.37 0.51 -0.28 
SP6R 5.89 4.28 7.51 5.82 5.30 6.48 2.55 3.00 10.08 7.08 5.02 0.54 -1.25 







Descriptive statistics of PPTmedian for Control of Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.43 1.33 1.54 1.39 1.40 0.56 0.75 0.15 4.10 3.95 0.90 0.79 0.75 
LI20R 1.49 1.38 1.60 1.46 1.40 0.60 0.78 0.15 3.90 3.75 1.10 0.54 -0.18 
GB12R 2.62 2.45 2.80 2.56 2.48 1.60 1.26 0.45 7.15 6.70 1.80 0.84 0.72 
2L 4.00 3.75 4.24 3.90 3.78 3.04 1.74 0.80 9.20 8.40 2.29 0.86 0.51 
2R 4.39 4.16 4.63 4.33 4.23 2.88 1.70 1.10 9.10 8.00 2.28 0.54 -0.12 
PC6L 3.69 3.49 3.88 3.60 3.50 1.92 1.39 1.20 9.10 7.90 1.70 0.96 1.33 
PC6R 3.78 3.59 3.98 3.73 3.68 1.88 1.37 0.50 7.90 7.40 1.60 0.66 0.59 
LI10L 3.03 2.82 3.23 2.90 2.73 2.02 1.42 0.90 12.05 11.15 1.59 2.15 9.11 
1L 3.28 3.11 3.46 3.23 3.15 1.49 1.22 0.70 7.05 6.35 1.64 0.68 0.55 
1R 3.45 3.25 3.64 3.36 3.20 1.95 1.40 0.70 10.90 10.20 1.70 1.30 3.64 
LI5L 3.47 3.27 3.67 3.37 3.10 1.98 1.41 0.85 8.50 7.65 1.70 1.09 1.29 
LI5R 3.40 3.22 3.58 3.32 3.10 1.64 1.28 0.90 9.50 8.60 1.58 1.28 2.84 
ST36L 5.36 5.07 5.64 5.24 4.98 4.09 2.02 1.40 12.20 10.80 2.40 0.90 0.87 
ST36R 5.35 5.08 5.62 5.24 4.98 3.63 1.90 1.50 12.30 10.80 2.29 0.98 1.59 
3R 4.86 4.59 5.13 4.73 4.58 3.61 1.90 1.35 11.40 10.05 2.29 1.04 1.33 
SP6R 4.42 4.20 4.63 4.35 4.08 2.32 1.52 1.40 9.60 8.20 1.88 0.74 0.71 
KD3R 4.49 4.26 4.73 4.43 4.30 2.81 1.68 1.20 9.90 8.70 2.00 0.65 0.34 
 
Descriptive statistics of PPTmedian for Intervention of Female 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.15 2.05 2.26 2.14 2.10 0.24 0.49 1.10 3.50 2.40 0.70 0.15 -0.41 
LI20R 2.11 2.02 2.19 2.07 2.08 0.39 0.63 1.05 4.50 3.45 0.90 0.71 0.72 
GB12R 3.36 3.19 3.53 3.33 3.30 0.96 0.98 1.35 6.00 4.65 1.34 0.40 -0.21 
2L 5.23 4.93 5.54 5.18 4.88 3.16 1.78 2.10 9.60 7.50 2.49 0.52 -0.44 
2R 5.22 4.93 5.51 5.15 4.90 2.68 1.64 2.10 10.50 8.40 2.19 0.69 0.50 
PC6L 3.22 2.95 3.49 3.17 3.13 0.86 0.93 1.70 6.00 4.30 1.25 0.76 0.76 
PC6R 4.11 3.94 4.29 4.08 4.00 1.34 1.16 1.90 7.65 5.75 1.60 0.47 -0.40 
LI10L 3.50 3.28 3.72 3.41 3.33 1.67 1.29 1.40 7.30 5.90 1.88 0.87 0.61 
1L 3.49 3.29 3.69 3.43 3.40 1.34 1.16 1.70 6.65 4.95 1.88 0.56 -0.27 
1R 3.88 3.69 4.07 3.77 3.50 2.08 1.44 1.75 8.50 6.75 2.05 1.05 0.89 
LI5L 3.14 2.94 3.34 3.02 2.88 1.40 1.18 1.60 8.45 6.85 1.24 2.08 6.26 
LI5R 3.49 3.33 3.65 3.39 3.20 1.74 1.32 1.50 8.80 7.30 1.63 1.21 1.57 
ST36L 4.97 4.67 5.27 4.91 4.95 2.83 1.68 1.80 9.80 8.00 2.28 0.44 0.09 
ST36R 4.81 4.56 5.05 4.70 4.63 3.23 1.80 1.40 10.80 9.40 2.30 0.88 0.79 
3R 4.75 4.47 5.02 4.64 4.40 3.22 1.80 1.35 10.10 8.75 2.28 0.89 0.72 
SP6R 4.02 3.61 4.43 3.91 3.60 1.96 1.40 2.00 8.75 6.75 1.38 1.41 2.36 







Descriptive statistics of PPTmedian for Control of Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.76 1.63 1.89 1.73 1.63 0.65 0.80 0.30 3.80 3.50 1.10 0.47 -0.47 
LI20R 1.83 1.69 1.97 1.80 1.78 0.70 0.84 0.20 4.00 3.80 1.20 0.46 -0.29 
GB12R 2.83 2.65 3.02 2.78 2.60 1.22 1.11 0.90 6.10 5.20 1.63 0.76 0.19 
2L 4.76 4.47 5.06 4.69 4.63 3.21 1.79 1.30 9.70 8.40 2.58 0.49 -0.25 
2R 5.29 4.96 5.63 5.20 4.95 4.24 2.06 1.50 12.70 11.20 2.83 0.77 0.77 
PC6L 4.35 4.14 4.56 4.28 4.03 1.63 1.28 2.35 7.85 5.50 1.89 0.78 -0.19 
PC6R 4.52 4.32 4.72 4.46 4.45 1.45 1.21 2.40 8.50 6.10 1.80 0.66 0.46 
LI10L 3.48 3.28 3.68 3.40 3.15 1.44 1.20 1.35 8.40 7.05 1.34 1.18 1.97 
1L 3.65 3.43 3.88 3.56 3.20 1.81 1.34 1.65 9.80 8.15 1.70 1.26 2.29 
1R 3.96 3.70 4.21 3.84 3.43 2.35 1.53 1.15 10.50 9.35 2.08 1.22 1.92 
LI5L 3.68 3.48 3.89 3.61 3.55 1.52 1.23 1.70 9.50 7.80 1.63 1.21 3.09 
LI5R 3.89 3.68 4.09 3.80 3.78 1.52 1.23 1.90 8.85 6.95 1.50 1.15 2.07 
ST36L 6.19 5.84 6.54 6.04 5.98 4.45 2.11 2.90 14.70 11.80 2.64 1.22 2.44 
ST36R 6.33 5.97 6.69 6.22 5.95 4.67 2.16 2.45 13.20 10.75 2.89 0.75 0.14 
3R 5.45 5.13 5.77 5.29 5.28 3.70 1.92 2.30 15.60 13.30 2.19 1.91 7.12 
SP6R 5.34 5.04 5.63 5.25 5.20 3.12 1.77 2.20 12.50 10.30 2.38 0.93 1.98 
KD3R 5.37 5.08 5.67 5.29 5.35 3.27 1.81 1.60 11.20 9.60 2.34 0.59 0.50 
 
Descriptive statistics of PPTmedian for Intervention of Male 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.75 2.52 2.98 2.68 2.55 1.18 1.09 1.05 6.80 5.75 1.48 1.05 1.44 
LI20R 2.77 2.65 2.90 2.73 2.60 0.79 0.89 1.00 5.50 4.50 1.20 0.69 0.25 
GB12R 4.28 3.97 4.58 4.16 3.83 3.19 1.79 1.70 9.00 7.30 2.41 0.96 0.11 
2L 6.43 5.99 6.86 6.35 6.00 5.61 2.37 2.40 14.00 11.60 3.63 0.54 -0.18 
2R 5.95 5.60 6.31 5.90 5.80 3.06 1.75 2.75 11.40 8.65 2.31 0.45 0.05 
PC6L 4.19 3.77 4.60 4.13 3.80 2.07 1.44 2.00 7.55 5.55 2.30 0.57 -0.48 
PC6R 5.13 4.81 5.46 4.96 4.40 4.44 2.11 1.95 12.90 10.95 2.38 1.30 1.43 
LI10L 5.24 4.82 5.66 5.08 4.58 6.12 2.47 1.90 13.50 11.60 3.28 0.98 0.62 
1L 5.29 4.88 5.70 5.14 4.65 5.69 2.39 2.00 12.05 10.05 2.88 0.98 0.22 
1R 5.01 4.76 5.26 4.90 4.48 3.25 1.80 1.50 10.90 9.40 2.15 0.98 0.47 
LI5L 4.51 4.25 4.77 4.42 4.30 2.22 1.49 2.00 9.40 7.40 2.10 0.85 0.27 
LI5R 4.42 4.19 4.65 4.29 3.90 3.26 1.81 1.40 11.90 10.50 2.19 1.17 1.15 
ST36L 8.02 7.49 8.54 7.90 7.90 8.17 2.86 3.00 16.20 13.20 3.90 0.50 -0.18 
ST36R 6.79 6.45 7.12 6.70 6.40 5.27 2.30 2.20 13.00 10.80 3.24 0.55 -0.26 
3R 6.49 6.13 6.86 6.39 5.83 4.73 2.18 2.70 13.20 10.50 2.98 0.74 0.05 
SP6R 5.40 4.79 6.01 5.29 4.50 4.40 2.10 2.90 10.05 7.15 3.49 0.60 -0.84 







Descriptive statistics of PPTmedian for Control of Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.52 1.27 1.77 1.46 1.50 0.76 0.87 0.15 4.10 3.95 0.88 1.01 1.18 
LI20R 1.52 1.28 1.76 1.47 1.50 0.69 0.83 0.15 3.90 3.75 1.03 0.78 0.41 
GB12R 2.55 2.17 2.94 2.46 2.30 1.78 1.33 0.45 7.15 6.70 1.83 1.20 2.02 
2L 3.89 3.34 4.44 3.75 3.60 3.63 1.91 1.55 9.20 7.65 2.90 0.94 0.44 
2R 4.27 3.74 4.79 4.19 4.10 3.36 1.83 1.35 8.65 7.30 3.00 0.43 -0.58 
PC6L 3.85 3.37 4.33 3.72 3.30 2.77 1.67 1.50 9.10 7.60 2.20 1.12 1.43 
PC6R 3.76 3.36 4.16 3.71 3.60 1.95 1.40 1.05 7.15 6.10 1.55 0.72 0.23 
LI10L 3.14 2.63 3.66 2.97 2.70 3.23 1.80 0.90 12.05 11.15 2.25 2.66 11.58 
1L 3.32 2.93 3.72 3.22 3.15 1.88 1.37 1.40 7.05 5.65 1.68 1.11 1.22 
1R 3.56 3.08 4.05 3.40 3.20 2.84 1.69 1.30 10.90 9.60 1.93 2.01 6.38 
LI5L 3.42 2.94 3.90 3.28 2.90 2.80 1.67 0.85 8.50 7.65 2.13 1.36 1.73 
LI5R 3.36 2.93 3.78 3.22 3.00 2.17 1.47 1.30 9.50 8.20 1.55 1.93 5.36 
ST36L 5.30 4.70 5.90 5.18 5.00 4.33 2.08 1.40 12.20 10.80 2.20 1.11 1.92 
ST36R 5.36 4.79 5.93 5.24 5.10 3.91 1.98 1.70 11.60 9.90 2.30 1.01 1.77 
3R 4.83 4.24 5.41 4.69 4.30 4.10 2.02 1.35 10.90 9.55 2.60 1.06 1.17 
SP6R 4.27 3.86 4.69 4.22 4.00 2.05 1.43 1.40 8.90 7.50 1.95 0.71 1.10 
KD3R 4.49 3.96 5.02 4.40 4.10 3.47 1.86 1.20 9.90 8.70 1.90 0.95 1.06 
 
Descriptive statistics of PPTmedian for Control of Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.33 1.14 1.52 1.31 1.40 0.43 0.65 0.20 2.80 2.60 0.98 0.33 -0.72 
LI20R 1.37 1.17 1.58 1.35 1.40 0.51 0.72 0.20 3.00 2.80 1.03 0.40 -0.41 
GB12R 2.58 2.23 2.93 2.53 2.50 1.47 1.21 0.50 5.50 5.00 1.83 0.60 -0.10 
2L 3.82 3.37 4.27 3.74 3.55 2.42 1.55 1.35 8.85 7.50 1.75 0.91 1.10 
2R 4.27 3.80 4.73 4.23 4.00 2.62 1.62 1.10 7.75 6.65 1.95 0.56 -0.09 
PC6L 3.45 3.13 3.78 3.41 3.45 1.29 1.14 1.20 7.20 6.00 1.30 0.74 1.37 
PC6R 3.74 3.36 4.12 3.72 3.65 1.76 1.33 0.50 7.70 7.20 1.55 0.34 1.19 
LI10L 3.00 2.60 3.40 2.84 2.80 1.91 1.38 1.10 8.80 7.70 1.00 2.24 6.95 
1L 3.24 2.92 3.55 3.19 3.15 1.20 1.09 1.40 6.10 4.70 1.50 0.53 0.30 
1R 3.35 2.99 3.71 3.26 3.40 1.57 1.25 1.40 7.20 5.80 1.63 1.00 1.19 
LI5L 3.49 3.09 3.89 3.39 3.15 1.94 1.39 1.25 8.25 7.00 1.48 1.20 1.69 
LI5R 3.37 2.99 3.75 3.28 3.00 1.76 1.32 0.90 7.85 6.95 1.68 1.19 1.76 
ST36L 5.19 4.63 5.75 5.09 4.90 3.77 1.94 1.75 11.70 9.95 2.38 0.95 1.57 
ST36R 5.21 4.68 5.74 5.13 4.75 3.39 1.84 1.50 10.70 9.20 2.28 0.80 1.04 
3R 4.72 4.21 5.22 4.60 4.20 3.10 1.76 1.70 10.00 8.30 2.08 1.06 1.64 
SP6R 4.31 3.89 4.72 4.23 4.00 2.09 1.45 1.65 8.60 6.95 1.43 0.88 1.19 







Descriptive statistics of PPTmedian for Control of Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.46 1.25 1.67 1.43 1.35 0.54 0.73 0.20 3.40 3.20 1.08 0.73 0.40 
LI20R 1.54 1.31 1.77 1.53 1.40 0.64 0.80 0.20 3.05 2.85 1.20 0.31 -0.83 
GB12R 2.73 2.34 3.12 2.66 2.60 1.81 1.34 0.55 6.80 6.25 1.73 0.83 0.82 
2L 4.05 3.58 4.52 3.97 3.95 2.67 1.63 1.10 8.75 7.65 1.58 0.87 1.18 
2R 4.43 3.98 4.87 4.37 4.40 2.40 1.55 1.65 8.70 7.05 2.03 0.45 0.40 
PC6L 3.68 3.31 4.04 3.62 3.80 1.61 1.27 1.70 7.50 5.80 1.75 0.58 0.35 
PC6R 3.75 3.36 4.15 3.68 3.80 1.93 1.39 1.35 7.70 6.35 1.95 0.77 0.72 
LI10L 2.93 2.59 3.27 2.86 2.70 1.41 1.19 1.20 7.10 5.90 1.48 1.07 1.85 
1L 3.33 3.00 3.66 3.32 3.25 1.31 1.14 0.70 6.00 5.30 1.53 0.13 -0.21 
1R 3.50 3.13 3.88 3.47 3.45 1.69 1.30 0.80 6.70 5.90 1.85 0.45 0.04 
LI5L 3.48 3.10 3.86 3.41 3.20 1.72 1.31 1.30 7.20 5.90 1.65 0.91 0.73 
LI5R 3.40 3.06 3.75 3.35 3.10 1.42 1.19 0.95 6.95 6.00 1.63 0.76 1.09 
ST36L 5.39 4.83 5.94 5.31 4.95 3.73 1.93 2.40 10.00 7.60 2.73 0.57 -0.39 
ST36R 5.24 4.76 5.72 5.17 4.95 2.79 1.67 2.00 10.00 8.00 2.05 0.59 0.54 
3R 4.93 4.37 5.50 4.81 4.80 3.85 1.96 2.05 11.00 8.95 2.98 0.91 1.02 
SP6R 4.44 3.98 4.91 4.37 4.10 2.64 1.62 1.70 9.15 7.45 2.20 0.66 0.39 
KD3R 4.43 4.02 4.84 4.41 4.35 2.03 1.42 1.80 7.70 5.90 1.95 0.16 -0.45 
 
Descriptive statistics of PPTmedian for Control of Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.42 1.21 1.63 1.39 1.35 0.51 0.72 0.25 3.40 3.15 0.73 0.62 0.20 
LI20R 1.53 1.31 1.75 1.50 1.50 0.59 0.77 0.30 3.65 3.35 1.05 0.57 -0.02 
GB12R 2.63 2.29 2.98 2.58 2.50 1.42 1.19 0.60 5.65 5.05 1.65 0.68 0.04 
2L 4.24 3.70 4.77 4.15 3.85 3.52 1.88 0.80 8.90 8.10 2.40 0.75 0.01 
2R 4.62 4.10 5.13 4.53 4.40 3.25 1.80 1.75 9.10 7.35 2.23 0.73 0.00 
PC6L 3.77 3.36 4.18 3.69 3.55 2.05 1.43 1.70 7.95 6.25 1.93 0.79 0.50 
PC6R 3.88 3.47 4.28 3.81 3.60 1.99 1.41 1.00 7.90 6.90 1.78 0.80 0.77 
LI10L 3.02 2.66 3.39 2.94 2.80 1.62 1.27 1.00 7.20 6.20 1.63 0.98 1.48 
1L 3.25 2.88 3.62 3.20 2.95 1.66 1.29 0.80 7.00 6.20 1.83 0.64 0.32 
1R 3.37 2.99 3.75 3.31 3.10 1.77 1.33 0.70 6.95 6.25 1.78 0.73 0.43 
LI5L 3.49 3.13 3.85 3.43 3.40 1.57 1.25 1.55 6.70 5.15 1.93 0.65 -0.02 
LI5R 3.48 3.15 3.81 3.44 3.25 1.29 1.14 1.10 7.15 6.05 1.43 0.80 1.10 
ST36L 5.55 4.93 6.17 5.42 5.10 4.70 2.17 2.40 11.30 8.90 2.28 0.93 0.71 
ST36R 5.58 4.97 6.19 5.42 5.20 4.56 2.13 2.10 12.30 10.20 2.73 1.20 2.01 
3R 4.97 4.43 5.51 4.83 4.90 3.56 1.89 1.70 11.40 9.70 1.75 1.21 2.32 
SP6R 4.65 4.19 5.11 4.59 4.20 2.55 1.60 1.50 9.60 8.10 2.18 0.73 0.79 







Descriptive statistics of PPTmedian for Intervention of Female in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.92 1.74 2.11 1.92 1.93 0.17 0.41 1.15 2.65 1.50 0.73 0.06 -0.84 
LI20R 2.03 1.85 2.22 2.00 1.93 0.47 0.69 1.05 4.15 3.10 1.13 0.72 0.25 
GB12R 3.03 2.67 3.38 2.96 3.05 1.03 1.02 1.35 6.00 4.65 1.18 0.93 1.46 
2L 4.67 4.06 5.27 4.62 4.20 3.00 1.73 2.10 8.50 6.40 3.01 0.34 -0.92 
2R 4.91 4.35 5.47 4.88 4.70 2.32 1.52 2.10 8.30 6.20 1.90 0.44 -0.17 
PC6L 2.97 2.29 3.64 2.90 2.78 1.12 1.06 1.80 5.30 3.50 1.49 0.99 0.58 
PC6R 3.79 3.49 4.10 3.76 3.80 0.99 1.00 1.90 6.15 4.25 1.30 0.53 0.43 
LI10L 3.30 2.84 3.76 3.20 3.30 1.75 1.32 1.70 6.70 5.00 1.85 1.03 0.82 
1L 3.34 2.87 3.80 3.24 3.30 1.71 1.31 1.80 6.65 4.85 1.70 1.04 0.64 
1R 3.66 3.32 4.00 3.57 3.53 1.60 1.27 1.80 7.80 6.00 1.69 1.08 1.23 
LI5L 2.91 2.54 3.28 2.81 2.68 1.12 1.06 1.65 6.85 5.20 1.09 1.84 4.87 
LI5R 3.29 3.04 3.55 3.24 3.10 1.11 1.05 1.70 6.55 4.85 1.08 0.86 0.38 
ST36L 4.77 4.14 5.40 4.70 4.40 2.97 1.72 2.15 9.00 6.85 2.60 0.63 -0.21 
ST36R 4.44 4.02 4.86 4.36 4.30 2.36 1.54 2.10 8.65 6.55 2.18 0.62 0.06 
3R 4.61 4.02 5.20 4.49 4.25 3.59 1.89 1.80 10.10 8.30 3.01 0.82 0.57 
SP6R 3.84 3.17 4.51 3.85 3.60 1.11 1.06 2.00 5.55 3.55 1.79 0.19 -0.48 
KD3R 3.89 3.46 4.32 3.77 3.50 2.04 1.43 1.90 8.70 6.80 1.85 1.26 1.97 
 
Descriptive statistics of PPTmedian for Intervention of Female in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.00 1.80 2.20 2.01 2.00 0.21 0.45 1.10 2.80 1.70 0.69 -0.05 -0.54 
LI20R 1.96 1.82 2.10 1.94 2.00 0.26 0.51 1.15 3.10 1.95 0.83 0.33 -0.57 
GB12R 3.11 2.81 3.42 3.10 2.93 0.76 0.87 1.60 4.70 3.10 1.45 0.30 -0.86 
2L 5.00 4.42 5.59 4.90 4.60 2.83 1.68 2.50 9.50 7.00 2.08 0.85 0.37 
2R 5.07 4.48 5.67 5.02 4.90 2.62 1.62 2.30 9.20 6.90 2.00 0.53 0.11 
PC6L 2.88 2.41 3.35 2.88 2.90 0.55 0.74 1.70 4.20 2.50 1.15 0.40 -0.31 
PC6R 3.96 3.62 4.29 3.91 3.85 1.21 1.10 2.30 6.50 4.20 1.45 0.51 -0.22 
LI10L 3.30 2.84 3.76 3.22 3.00 1.74 1.32 1.40 7.20 5.80 2.08 0.89 0.62 
1L 3.28 2.92 3.65 3.23 3.20 1.05 1.03 1.80 6.15 4.35 1.65 0.66 0.37 
1R 3.64 3.27 4.00 3.50 3.30 1.85 1.36 1.95 8.25 6.30 1.75 1.52 2.69 
LI5L 3.04 2.62 3.46 2.88 2.80 1.45 1.21 1.80 8.40 6.60 1.09 2.97 11.57 
LI5R 3.28 2.96 3.60 3.14 2.90 1.68 1.30 1.70 8.45 6.75 1.41 1.84 4.25 
ST36L 4.81 4.24 5.38 4.74 4.60 2.39 1.54 1.85 9.15 7.30 2.05 0.75 1.29 
ST36R 4.60 4.15 5.05 4.50 4.20 2.69 1.64 1.95 9.65 7.70 1.93 1.05 1.40 
3R 4.57 4.01 5.14 4.42 4.30 3.30 1.82 1.90 9.90 8.00 2.05 1.19 1.51 
SP6R 3.63 2.92 4.33 3.58 3.30 1.22 1.10 2.00 6.05 4.05 1.18 0.76 0.98 







Descriptive statistics of PPTmedian for Intervention of Female in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.20 2.00 2.41 2.19 2.15 0.22 0.46 1.35 3.20 1.85 0.50 0.16 -0.20 
LI20R 2.11 1.96 2.26 2.09 2.08 0.31 0.55 1.20 3.80 2.60 0.78 0.44 0.40 
GB12R 3.50 3.17 3.82 3.47 3.35 0.87 0.93 2.00 5.70 3.70 1.30 0.45 -0.24 
2L 5.54 4.95 6.13 5.52 5.30 2.85 1.69 3.00 8.60 5.60 2.86 0.36 -1.04 
2R 5.34 4.78 5.90 5.25 5.10 2.34 1.53 3.00 10.00 7.00 1.90 0.84 1.51 
PC6L 3.42 2.79 4.05 3.34 3.33 0.98 0.99 2.20 6.00 3.80 1.15 1.61 3.81 
PC6R 4.15 3.79 4.50 4.12 4.25 1.36 1.17 2.20 6.50 4.30 2.00 0.30 -0.93 
LI10L 3.48 3.05 3.91 3.40 3.38 1.54 1.24 1.75 6.90 5.15 1.83 0.86 0.69 
1L 3.49 3.10 3.87 3.47 3.20 1.19 1.09 1.80 5.75 3.95 1.88 0.29 -1.03 
1R 3.93 3.53 4.33 3.84 3.60 2.20 1.48 1.75 8.50 6.75 2.23 0.97 1.09 
LI5L 3.16 2.74 3.58 3.05 2.80 1.44 1.20 1.60 7.70 6.10 1.30 1.87 5.08 
LI5R 3.52 3.18 3.86 3.43 3.20 1.91 1.38 1.50 7.40 5.90 1.44 1.10 0.89 
ST36L 4.99 4.39 5.59 4.91 5.10 2.68 1.64 2.00 9.80 7.80 1.75 0.63 1.59 
ST36R 4.99 4.41 5.57 4.87 4.60 4.39 2.10 1.40 10.80 9.40 2.45 0.96 0.62 
3R 4.72 4.18 5.26 4.63 4.43 3.00 1.73 1.35 9.30 7.95 2.21 0.89 0.86 
SP6R 4.06 2.99 5.13 3.87 3.45 2.83 1.68 2.80 8.75 5.95 1.21 2.31 5.77 
KD3R 4.05 3.64 4.46 4.01 3.80 1.88 1.37 1.70 7.60 5.90 2.05 0.49 -0.13 
 
Descriptive statistics of PPTmedian for Intervention of Female in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.48 2.26 2.69 2.46 2.50 0.23 0.48 1.70 3.50 1.80 0.79 -0.09 -0.40 
LI20R 2.33 2.14 2.52 2.30 2.25 0.49 0.70 1.10 4.50 3.40 1.04 0.80 0.77 
GB12R 3.81 3.48 4.13 3.80 3.90 0.87 0.93 2.10 5.60 3.50 1.25 0.17 -0.34 
2L 5.73 5.07 6.38 5.66 5.38 3.52 1.88 3.00 9.60 6.60 2.58 0.63 -0.48 
2R 5.57 4.89 6.25 5.48 5.30 3.43 1.85 2.85 10.50 7.65 2.60 0.81 0.39 
PC6L 3.62 3.12 4.11 3.60 3.58 0.61 0.78 2.35 5.10 2.75 1.10 0.40 0.02 
PC6R 4.56 4.18 4.94 4.53 4.40 1.54 1.24 2.65 7.65 5.00 2.06 0.32 -0.68 
LI10L 3.90 3.47 4.34 3.81 3.65 1.54 1.24 2.20 7.30 5.10 1.45 1.12 1.48 
1L 3.85 3.45 4.26 3.84 3.90 1.33 1.15 1.70 6.50 4.80 1.85 0.19 -0.58 
1R 4.29 3.86 4.71 4.20 4.18 2.49 1.58 1.85 8.30 6.45 2.25 0.71 -0.12 
LI5L 3.46 3.02 3.89 3.34 3.25 1.56 1.25 1.70 8.45 6.75 1.23 1.96 6.73 
LI5R 3.86 3.50 4.22 3.78 3.60 2.11 1.45 1.60 8.80 7.20 2.23 0.87 0.80 
ST36L 5.31 4.63 5.98 5.29 5.60 3.38 1.84 1.80 9.10 7.30 2.80 -0.06 -0.44 
ST36R 5.20 4.70 5.70 5.13 4.90 3.28 1.81 2.00 10.70 8.70 2.35 0.58 0.53 
3R 5.08 4.53 5.62 5.00 4.83 3.09 1.76 2.00 9.50 7.50 1.86 0.88 0.95 
SP6R 4.55 3.50 5.60 4.51 4.10 2.73 1.65 2.35 7.50 5.15 2.21 0.79 -0.24 







Descriptive statistics of PPTmedian for Control of Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.85 1.56 2.14 1.83 1.70 0.74 0.86 0.30 3.65 3.35 1.33 0.41 -0.44 
LI20R 1.98 1.66 2.29 1.97 1.85 0.87 0.93 0.20 3.75 3.55 1.44 0.31 -0.51 
GB12R 2.92 2.57 3.28 2.89 2.63 1.10 1.05 1.25 5.50 4.25 1.71 0.62 -0.41 
2L 4.63 3.96 5.30 4.51 4.45 3.88 1.97 2.10 9.70 7.60 3.28 0.76 0.03 
2R 5.20 4.46 5.94 5.10 4.90 4.77 2.18 1.50 11.70 10.20 3.19 0.77 0.71 
PC6L 4.28 3.80 4.75 4.20 3.93 1.95 1.40 2.35 7.85 5.50 2.03 0.84 -0.09 
PC6R 4.37 3.93 4.81 4.30 4.38 1.67 1.29 2.55 8.35 5.80 1.98 0.77 0.92 
LI10L 3.60 3.15 4.05 3.54 3.23 1.78 1.33 1.60 6.75 5.15 1.75 0.71 -0.11 
1L 3.72 3.25 4.19 3.66 3.30 1.93 1.39 1.65 6.80 5.15 2.01 0.73 -0.31 
1R 4.08 3.54 4.62 3.96 3.80 2.54 1.59 2.25 8.30 6.05 2.63 0.89 0.11 
LI5L 3.59 3.17 4.00 3.56 3.30 1.49 1.22 1.70 6.00 4.30 1.93 0.42 -0.96 
LI5R 3.89 3.44 4.35 3.78 3.73 1.83 1.35 2.20 8.85 6.65 2.05 1.43 3.66 
ST36L 5.95 5.41 6.49 5.95 6.13 2.54 1.59 2.90 9.50 6.60 2.61 -0.14 -0.71 
ST36R 6.31 5.59 7.03 6.29 5.90 4.56 2.13 2.65 10.20 7.55 3.06 0.19 -0.98 
3R 5.27 4.70 5.83 5.17 4.93 2.79 1.67 2.90 10.30 7.40 2.53 0.82 0.70 
SP6R 5.33 4.67 5.99 5.21 5.05 3.81 1.95 2.20 12.00 9.80 2.71 1.06 2.47 
KD3R 5.37 4.72 6.02 5.32 5.58 3.71 1.93 1.60 9.75 8.15 2.56 0.32 0.20 
 
Descriptive statistics of PPTmedian for Control of Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.78 1.50 2.05 1.75 1.65 0.65 0.81 0.30 3.80 3.50 1.24 0.48 -0.13 
LI20R 1.87 1.59 2.14 1.85 1.75 0.66 0.81 0.30 3.90 3.60 1.18 0.48 0.00 
GB12R 2.85 2.48 3.22 2.78 2.70 1.20 1.10 1.15 6.10 4.95 1.65 0.88 0.89 
2L 4.95 4.32 5.57 4.87 4.55 3.39 1.84 1.95 9.50 7.55 2.53 0.58 -0.18 
2R 5.17 4.50 5.84 5.13 5.23 3.93 1.98 1.65 9.20 7.55 3.30 0.26 -0.79 
PC6L 4.48 4.04 4.91 4.40 4.15 1.65 1.28 2.90 7.40 4.50 1.89 0.81 -0.19 
PC6R 4.47 4.09 4.85 4.41 4.48 1.25 1.12 2.80 7.35 4.55 1.80 0.51 0.10 
LI10L 3.51 3.16 3.85 3.45 3.18 1.03 1.02 2.10 6.65 4.55 1.63 0.95 0.95 
1L 3.69 3.27 4.12 3.63 3.18 1.57 1.25 2.15 6.60 4.45 2.16 0.60 -0.82 
1R 3.95 3.46 4.44 3.87 3.78 2.10 1.45 1.70 7.60 5.90 2.00 0.80 0.19 
LI5L 3.74 3.34 4.14 3.69 3.80 1.38 1.18 1.80 7.30 5.50 1.65 0.70 0.83 
LI5R 3.87 3.44 4.29 3.80 3.65 1.58 1.26 1.90 7.45 5.55 2.00 0.79 0.34 
ST36L 6.38 5.61 7.14 6.24 5.98 5.08 2.25 3.50 12.90 9.40 3.61 0.92 0.43 
ST36R 6.48 5.67 7.28 6.35 6.28 5.59 2.37 3.30 12.50 9.20 3.20 0.77 -0.12 
3R 5.40 4.84 5.96 5.33 5.13 2.77 1.66 2.95 9.30 6.35 2.33 0.64 0.02 
SP6R 5.35 4.71 5.99 5.29 5.40 3.53 1.88 2.70 10.00 7.30 3.60 0.32 -0.58 







Descriptive statistics of PPTmedian for Control of Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.76 1.48 2.04 1.74 1.50 0.68 0.83 0.60 3.40 2.80 1.19 0.49 -0.70 
LI20R 1.78 1.51 2.04 1.73 1.80 0.62 0.79 0.70 4.00 3.30 1.13 0.51 0.28 
GB12R 2.78 2.42 3.15 2.71 2.48 1.18 1.08 1.30 5.90 4.60 1.46 1.10 1.08 
2L 4.89 4.33 5.46 4.88 4.75 2.77 1.66 1.30 8.70 7.40 2.58 0.08 -0.19 
2R 5.59 4.89 6.30 5.43 5.40 4.34 2.08 2.40 12.70 10.30 3.01 1.34 2.56 
PC6L 4.28 3.86 4.69 4.19 4.00 1.51 1.23 2.55 7.60 5.05 1.90 1.01 0.48 
PC6R 4.63 4.21 5.04 4.52 4.25 1.49 1.22 3.15 8.50 5.35 1.48 1.32 2.00 
LI10L 3.48 3.07 3.89 3.37 3.13 1.46 1.21 1.70 8.40 6.70 1.18 1.98 6.84 
1L 3.68 3.20 4.16 3.53 3.30 2.00 1.41 2.20 9.80 7.60 1.45 2.50 9.20 
1R 3.98 3.43 4.54 3.81 3.30 2.73 1.65 2.10 10.50 8.40 1.63 2.09 5.90 
LI5L 3.76 3.31 4.21 3.63 3.55 1.77 1.33 1.90 9.50 7.60 1.48 2.33 9.05 
LI5R 3.86 3.53 4.18 3.80 3.80 0.92 0.96 2.20 6.40 4.20 1.18 0.86 0.75 
ST36L 6.36 5.55 7.18 6.18 5.88 5.81 2.41 3.20 14.10 10.90 3.01 1.28 1.84 
ST36R 6.32 5.58 7.06 6.14 5.58 4.76 2.18 3.90 13.20 9.30 2.70 1.35 1.57 
3R 5.77 5.07 6.48 5.54 5.38 4.39 2.09 3.15 14.20 11.05 2.09 2.17 6.73 
SP6R 5.28 4.83 5.73 5.23 5.10 1.76 1.33 3.30 8.70 5.40 2.19 0.57 -0.21 
KD3R 5.35 4.79 5.91 5.25 5.08 2.72 1.65 2.80 10.70 7.90 2.00 1.07 1.86 
 
Descriptive statistics of PPTmedian for Control of Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 1.65 1.40 1.91 1.62 1.60 0.55 0.74 0.60 3.40 2.80 1.05 0.47 -0.48 
LI20R 1.70 1.42 1.98 1.67 1.50 0.68 0.82 0.40 3.50 3.10 1.09 0.53 -0.48 
GB12R 2.78 2.36 3.19 2.73 2.55 1.51 1.23 0.90 6.00 5.10 1.81 0.65 -0.06 
2L 4.58 4.00 5.16 4.51 4.53 2.97 1.72 1.75 8.70 6.95 2.80 0.49 -0.32 
2R 5.22 4.52 5.91 5.12 4.75 4.17 2.04 1.85 11.20 9.35 2.90 0.77 0.67 
PC6L 4.36 3.94 4.78 4.30 4.20 1.54 1.24 2.60 7.10 4.50 1.84 0.57 -0.50 
PC6R 4.61 4.20 5.02 4.60 4.60 1.48 1.22 2.40 7.00 4.60 1.96 0.15 -0.81 
LI10L 3.34 2.92 3.77 3.26 3.10 1.59 1.26 1.35 7.20 5.85 1.09 1.26 1.81 
1L 3.52 3.06 3.98 3.41 3.15 1.86 1.36 1.80 7.15 5.35 1.74 1.12 0.82 
1R 3.81 3.31 4.31 3.74 3.25 2.20 1.48 1.15 8.40 7.25 2.35 0.97 1.09 
LI5L 3.65 3.23 4.08 3.56 3.50 1.55 1.25 1.90 7.70 5.80 1.54 1.17 2.11 
LI5R 3.92 3.46 4.38 3.81 3.68 1.86 1.36 1.95 8.15 6.20 1.49 1.25 2.15 
ST36L 6.07 5.34 6.79 5.89 5.80 4.59 2.14 3.00 14.70 11.70 2.41 1.88 6.40 
ST36R 6.21 5.52 6.90 6.11 6.20 4.15 2.04 2.45 11.50 9.05 3.03 0.67 0.47 
3R 5.36 4.61 6.12 5.16 5.20 5.03 2.24 2.30 15.60 13.30 2.46 2.67 11.87 
SP6R 5.39 4.74 6.03 5.25 5.23 3.63 1.91 2.60 12.50 9.90 2.21 1.47 4.30 







Descriptive statistics of PPTmedian for Intervention of Male in Visit 1 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.44 2.03 2.85 2.43 2.28 0.86 0.93 1.05 4.10 3.05 1.08 0.66 -0.53 
LI20R 2.52 2.31 2.72 2.49 2.48 0.54 0.74 1.30 4.35 3.05 1.03 0.51 -0.28 
GB12R 3.62 3.11 4.12 3.52 3.20 2.07 1.44 1.70 7.40 5.70 1.93 1.05 0.56 
2L 5.61 4.85 6.36 5.54 5.20 3.90 1.97 2.65 10.00 7.35 3.13 0.38 -0.57 
2R 5.15 4.59 5.71 5.14 5.00 1.76 1.33 2.80 7.80 5.00 1.66 0.24 -0.37 
PC6L 3.60 2.83 4.37 3.56 3.25 1.47 1.21 2.20 5.70 3.50 2.18 0.58 -1.03 
PC6R 4.75 4.19 5.30 4.60 4.35 3.04 1.74 2.50 9.80 7.30 1.78 1.28 1.56 
LI10L 4.76 3.96 5.56 4.58 4.30 5.23 2.29 1.90 11.70 9.80 3.41 1.06 1.22 
1L 4.53 3.84 5.23 4.43 3.60 3.85 1.96 2.00 9.20 7.20 2.88 0.82 -0.24 
1R 4.60 4.18 5.02 4.49 4.23 2.15 1.47 2.70 8.60 5.90 1.74 1.09 0.80 
LI5L 3.79 3.44 4.14 3.75 3.50 0.96 0.98 2.30 6.30 4.00 1.28 0.78 0.12 
LI5R 4.06 3.64 4.48 3.89 3.60 2.61 1.62 2.15 9.60 7.45 1.56 1.69 2.95 
ST36L 7.08 6.15 8.01 7.01 6.50 5.99 2.45 3.60 12.00 8.40 3.60 0.58 -0.66 
ST36R 6.00 5.44 6.55 5.93 5.90 3.42 1.85 2.50 12.00 9.50 2.03 0.76 1.47 
3R 5.73 5.18 6.28 5.65 5.35 2.56 1.60 3.05 9.95 6.90 2.55 0.83 0.36 
SP6R 4.97 3.77 6.17 4.92 4.23 3.55 1.88 3.00 7.90 4.90 3.78 0.50 -1.54 
KD3R 5.02 4.42 5.63 4.93 4.30 4.08 2.02 2.25 9.70 7.45 3.00 0.58 -0.51 
 
Descriptive statistics of PPTmedian for Intervention of Male in Visit 2 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.61 2.18 3.03 2.53 2.60 0.92 0.96 1.20 5.55 4.35 0.98 1.39 3.21 
LI20R 2.62 2.39 2.85 2.58 2.48 0.66 0.81 1.15 4.75 3.60 1.13 0.77 0.10 
GB12R 4.04 3.51 4.56 3.94 3.93 2.24 1.50 2.00 7.80 5.80 2.06 0.92 0.41 
2L 6.10 5.23 6.96 6.03 5.50 5.19 2.28 2.90 10.40 7.50 3.40 0.61 -0.67 
2R 5.83 5.13 6.54 5.76 5.75 2.77 1.66 3.35 9.80 6.45 1.81 0.59 0.37 
PC6L 4.00 3.23 4.76 3.93 3.75 1.45 1.21 2.55 6.65 4.10 1.65 0.97 0.68 
PC6R 4.94 4.33 5.54 4.79 4.40 3.62 1.90 1.95 11.40 9.45 2.08 1.36 2.33 
LI10L 4.82 4.06 5.57 4.73 4.23 4.70 2.17 1.90 9.30 7.40 3.25 0.78 -0.62 
1L 4.95 4.20 5.70 4.82 4.30 4.47 2.11 2.10 10.50 8.40 2.24 1.06 0.66 
1R 4.74 4.30 5.19 4.65 4.40 2.44 1.56 2.45 9.60 7.15 2.06 0.94 0.94 
LI5L 4.20 3.76 4.65 4.14 3.98 1.52 1.23 2.50 7.20 4.70 1.64 0.68 -0.30 
LI5R 4.22 3.80 4.63 4.08 3.63 2.60 1.61 2.40 9.40 7.00 2.04 1.26 1.19 
ST36L 7.81 6.81 8.80 7.66 8.00 6.81 2.61 3.25 15.70 12.45 3.70 0.81 1.69 
ST36R 6.58 5.95 7.21 6.48 6.60 4.36 2.09 3.20 12.00 8.80 2.30 0.60 0.16 
3R 6.20 5.56 6.84 6.11 5.85 3.48 1.87 3.55 11.20 7.65 3.05 0.61 -0.13 
SP6R 5.19 3.99 6.39 5.13 4.40 3.55 1.89 3.05 8.40 5.35 3.44 0.58 -1.24 







Descriptive statistics of PPTmedian for Intervention of Male in Visit 3 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 2.83 2.29 3.37 2.71 2.55 1.50 1.22 1.30 6.80 5.50 1.34 1.63 4.21 
LI20R 2.91 2.63 3.18 2.88 2.75 0.94 0.97 1.00 5.40 4.40 1.36 0.41 -0.20 
GB12R 4.55 3.91 5.19 4.44 4.13 3.37 1.84 2.40 9.00 6.60 2.79 0.77 -0.30 
2L 6.87 5.92 7.83 6.82 7.10 6.33 2.52 2.40 12.80 10.40 4.55 0.23 -0.49 
2R 6.18 5.44 6.91 6.22 6.53 3.05 1.75 2.75 8.75 6.00 2.88 -0.39 -0.76 
PC6L 4.27 3.39 5.15 4.22 4.30 1.92 1.39 2.50 6.90 4.40 2.34 0.39 -0.92 
PC6R 5.37 4.64 6.09 5.15 4.63 5.15 2.27 2.70 12.90 10.20 2.98 1.45 2.25 
LI10L 5.40 4.60 6.21 5.32 5.20 5.35 2.31 2.40 9.90 7.50 3.71 0.55 -0.81 
1L 5.55 4.67 6.43 5.40 4.50 6.17 2.48 2.55 12.00 9.45 3.63 1.00 0.04 
1R 5.13 4.57 5.68 5.05 4.43 3.83 1.96 1.50 10.00 8.50 2.73 0.79 -0.11 
LI5L 4.84 4.26 5.43 4.76 4.73 2.62 1.62 2.00 9.40 7.40 2.34 0.72 0.74 
LI5R 4.56 4.08 5.04 4.47 4.05 3.51 1.87 1.40 9.45 8.05 2.91 0.75 0.03 
ST36L 7.99 6.91 9.07 7.93 8.00 8.04 2.84 3.00 14.50 11.50 3.65 0.27 -0.33 
ST36R 6.88 6.16 7.60 6.82 6.15 5.74 2.40 2.20 12.00 9.80 3.95 0.40 -0.67 
3R 6.97 6.11 7.84 6.91 6.00 6.35 2.52 2.70 13.20 10.50 3.80 0.48 -0.42 
SP6R 5.60 4.21 6.99 5.52 5.63 4.82 2.20 3.00 9.70 6.70 4.08 0.45 -0.81 
KD3R 5.88 5.19 6.57 5.87 5.90 5.31 2.30 2.20 9.70 7.50 4.30 0.03 -1.39 
 
Descriptive statistics of PPTmedian for Intervention of Male in Visit 4 
Site Mean 95% Confidence Interval for Mean 5% Trimmed Mean Median Variance Std. Deviation Minimum Maximum Range Interquartile Range Skewness Kurtosis Lower Bound Upper Bound 
LI20L 3.12 2.60 3.64 3.08 2.85 1.36 1.17 1.40 5.50 4.10 1.99 0.34 -0.85 
LI20R 3.04 2.77 3.31 2.99 2.80 0.90 0.95 1.00 5.50 4.50 1.40 0.73 0.42 
GB12R 4.91 4.18 5.64 4.82 4.35 4.38 2.09 2.40 9.00 6.60 3.48 0.74 -0.77 
2L 7.13 6.20 8.07 6.99 7.30 6.07 2.46 3.90 14.00 10.10 4.05 0.69 0.34 
2R 6.64 5.82 7.47 6.56 6.20 3.82 1.96 3.50 11.40 7.90 2.88 0.60 0.01 
PC6L 4.88 3.78 5.99 4.90 4.88 3.02 1.74 2.00 7.55 5.55 3.16 0.07 -0.85 
PC6R 5.49 4.71 6.27 5.34 4.70 5.93 2.44 2.40 11.50 9.10 3.33 0.96 -0.07 
LI10L 5.97 4.94 7.01 5.77 5.10 8.76 2.96 2.10 13.50 11.40 4.50 1.04 0.52 
1L 6.13 5.17 7.09 6.03 5.20 7.32 2.71 2.30 12.05 9.75 3.93 0.75 -0.47 
1R 5.57 4.98 6.15 5.47 5.00 4.22 2.05 2.40 10.90 8.50 2.81 0.81 -0.12 
LI5L 5.21 4.61 5.80 5.17 4.58 2.74 1.66 2.80 8.20 5.40 2.79 0.40 -1.09 
LI5R 4.86 4.33 5.38 4.73 4.20 4.10 2.03 1.90 11.90 10.00 2.98 1.08 1.10 
ST36L 9.19 7.97 10.41 9.13 9.20 10.34 3.22 3.85 16.20 12.35 5.80 0.14 -0.69 
ST36R 7.68 6.92 8.45 7.66 7.35 6.42 2.53 2.70 13.00 10.30 3.95 0.20 -0.80 
3R 7.07 6.26 7.89 7.00 7.05 5.67 2.38 3.15 12.90 9.75 3.55 0.51 -0.41 
SP6R 5.83 4.22 7.44 5.76 5.08 6.40 2.53 2.90 10.05 7.15 4.70 0.61 -1.20 





Appendix 13: Supplementary results II: Unilateral LI4m+21 (LI4R) session 
 
This section could be incorporated with Section 4.18 to form a standalone comprehensive report 
about the effect of LI4R intervention on regional PPT. Whilst all intervention studies involved 
LI4m+21, Studies 1, 2, 3 and 6 involved LI4R and Studies 4 and 5 applied bilateral LI4. In this 
section, only the PPT database from the unilateral LI4m+21 (LI4R) intervention was established to 
explore the stability of PPT after intervention. Section 4.18 examined the absolute differences of 
PPTmean and PPTmedian between pre- and post-intervention, and the relative differences of each 
parameter with respect to its pre-intervention values.  
 
A13.1: Percentage change of POSTmean from PREmean 
 
For each site by gender, the grand mean PPT were obtained from the overall pre-intervention and 
post-intervention PPT measures and defined as PREmean and POSTmean respectively.  The percentage 
change between PREmean and POSTmean was calculated as %Mean=(POSTmean-PREmean)/PREmean x 
100%. Table A13.1 shows the grand mean PPT before and after interventions (PREmean and 
POSTmean) with the associated %Mean at each measurement site by gender. The percentage increase 
in POSTmean varied from 6.4% (2L) to 19.6% (PC6R) for females and 5.5% (ST36R) to 19.3% 
(LI5R) for males.  
 
Site 
Percentage change of POSTmean from PREmean (%Mean) 
Female Male 
PREmean POSTmean %Mean PREmean POSTmean %Mean 
LI20R 2.10 2.34 11.4% 2.62 3.00 14.5% 
GB12R 3.36 3.83 14.0% 4.20 4.71 12.1% 
2L 5.16 5.49 6.4% 6.12 6.75 10.3% 
2R 5.01 5.71 14.0% 5.39 6.40 18.7% 
PC6L 3.57 3.87 8.4% 4.04 4.72 16.8% 
PC6R 3.62 4.33 19.6% 4.82 5.29 9.8% 
LI10L 3.24 3.76 16.0% 4.49 5.35 19.2% 
1L 3.19 3.57 11.9% 4.88 5.36 9.8% 
1R 3.52 4.12 17.0% 4.86 5.31 9.3% 
LI5L 3.30 3.58 8.5% 4.32 4.86 12.5% 
LI5R 3.03 3.61 19.1% 3.84 4.58 19.3% 
ST36L 4.59 5.02 9.4% 7.33 7.74 5.6% 
ST36R 4.87 5.61 15.2% 6.78 7.15 5.5% 
3R 4.76 5.26 10.5% 6.29 6.90 9.7% 
KD3R 4.00 4.28 7.0% 5.67 6.30 11.1% 






A13.2: Percentage change of POSTmedian from PREmedian 
 
For each site by gender, the grand median PPT were obtained from the overall pre-intervention and 
post-intervention PPT measures and defined as PREmedian and POSTmedian respectively.  The 
percentage change between PREmedian and POSTmedian was calculated as %Median=(POSTmedian-
PREmedian)/PREmedianx100%. Table A13.2 shows the grand median PPT before and after 
interventions (PREmedian and POSTmedian) with the associated %Median at each measurement site by 
gender. The percentage increase in POSTmedian varied from 5.2% (2L) to 19.4% (PC6R) for females 




Percentage change of POSTmedian from PREmedian 
Female Male 
PREmedian POSTmedian %Median PREmedian POSTmedian %Median 
LI20R 2.12 2.34 10.4% 2.63 3.00 14.1% 
GB12R 3.39 3.82 12.7% 4.22 4.68 10.9% 
2L 5.15 5.42 5.2% 6.14 6.85 11.6% 
2R 5.05 5.73 13.5% 5.41 6.47 19.6% 
PC6L 3.63 3.89 7.2% 4.06 4.73 16.5% 
PC6R 3.61 4.31 19.4% 4.83 5.19 7.5% 
LI10L 3.23 3.73 15.5% 4.43 5.35 20.8% 
1L 3.16 3.53 11.7% 4.83 5.36 11.0% 
1R 3.53 4.12 16.7% 4.81 5.31 10.4% 
LI5L 3.28 3.54 7.9% 4.28 4.82 12.6% 
LI5R 3.03 3.56 17.5% 3.87 4.56 17.8% 
ST36L 4.60 4.92 7.0% 7.48 7.73 3.3% 
ST36R 4.90 5.60 14.3% 6.80 7.13 4.9% 
3R 4.76 5.26 10.5% 6.29 6.86 9.1% 
KD3R 3.99 4.32 8.3% 5.72 6.33 10.7% 
Table A13.2: The percentage change between overall grand median PPT in pre and post-interventions. 
 
 
A13.3: Percentage change of PREmedian from PREmean 
 
For each site by gender, the grand mean and grand median were generated from the pre-intervention 
PPT scores (i.e. PREmean and PREmedian) and the percentage change between PREmean and PREmedian 
was calculated as %PRE=(PREmedian-PREmean)/PREmean x100%. Table A13.3 shows the PREmean and 
PREmedian with the associated percentage change %PRE at each measurement site by gender. The 







Percentage change between PREmean and PREmedian 
Female Male 
PREmean PREmedian %PRE PREmean PREmedian %PRE 
LI20R 2.10 2.12 1.0% 2.62 2.63 0.4% 
GB12R 3.36 3.39 0.9% 4.20 4.22 0.5% 
2L 5.16 5.15 -0.2% 6.12 6.14 0.3% 
2R 5.01 5.05 0.8% 5.39 5.41 0.4% 
PC6L 3.57 3.63 1.7% 4.04 4.06 0.5% 
PC6R 3.62 3.61 -0.3% 4.82 4.83 0.2% 
LI10L 3.24 3.23 -0.3% 4.49 4.43 -1.3% 
1L 3.19 3.16 -0.9% 4.88 4.83 -1.0% 
1R 3.52 3.53 0.3% 4.86 4.81 -1.0% 
LI5L 3.30 3.28 -0.6% 4.32 4.28 -0.9% 
LI5R 3.03 3.03 0.0% 3.84 3.87 0.8% 
ST36L 4.59 4.60 0.2% 7.33 7.48 2.0% 
ST36R 4.87 4.90 0.6% 6.78 6.80 0.3% 
3R 4.76 4.76 0.0% 6.29 6.29 0.0% 
KD3R 4.00 3.99 -0.2% 5.67 5.72 0.9% 
Table A13.3: The percentage change between grand mean and median PPT in pre-intervention. 
 
 
A13.4: Percentage change of POSTmedian from POSTmean 
 
For each site by gender, the POSTmean and POSTmedian were generated from the overall post-
intervention PPT scores and the percentage change between POSTmean and POSTmedian was 
calculated as %POST=( POSTmedian - POSTmean)/ POSTmean x100%. Table A13.4 shows the 
POSTmean and POSTmedian with the associated percentage change %POST at each measurement site 

















Percentage change between POSTmean and POSTmedian 
Female Male 
POSTmean POSTmedian %POST POSTmean POSTmedian %POST 
LI20R 2.34 2.34 0.0% 3.00 3.00 0.0% 
GB12R 3.83 3.82 -0.3% 4.71 4.68 -0.6% 
2L 5.49 5.42 -1.3% 6.75 6.85 1.5% 
2R 5.71 5.73 0.4% 6.40 6.47 1.1% 
PC6L 3.87 3.89 0.5% 4.72 4.73 0.2% 
PC6R 4.33 4.31 -0.5% 5.29 5.19 -1.9% 
LI10L 3.76 3.73 -0.8% 5.35 5.35 0.0% 
1L 3.57 3.53 -1.1% 5.36 5.36 0.0% 
1R 4.12 4.12 0.0% 5.31 5.31 0.0% 
LI5L 3.58 3.54 -1.1% 4.86 4.82 -0.8% 
LI5R 3.61 3.56 -1.4% 4.58 4.56 -0.4% 
ST36L 5.02 4.92 -2.0% 7.74 7.73 -0.1% 
ST36R 5.61 5.60 -0.2% 7.15 7.13 -0.3% 
3R 5.26 5.26 0.0% 6.90 6.86 -0.6% 
KD3R 4.28 4.32 0.9% 6.30 6.33 0.5% 
Table A13.4: The percentage change between overall grand mean and median PPT in post-intervention. 
 
 
A13.5: To examine the mean percentage change of regional PPT from its pre-
intervention mean PPT (%PREmean) 
 
Research question: Any significant difference in the mean percentage change of regional PPT from 
its PREmean (%PREmean)? 
 
The percentage change between post-intervention PPT and PREmean was calculated as %PREmean = 
(post PPT-PREmean)/PREmean x 100%. A one-sample t-test was conducted to determine whether the 
mean of %PREmean was the same as the test value of zero at alpha level of 0.05. Table A13.5 shows 
the statistics yielded by t-test and the Cohen’s d for effect size at 15 measurement sites by gender. 
The results revealed that 11 sites (LI20R, GB12R, 2R, PC6R, LI10L, 1L, 1R, LI5L, LI5R, ST36R, 
3R) for females and ten sites (LI20R, 2L, 2R, PC6L, LI10L, 1R, LI5L, LI5R, 3R, KD3R) for males 
had displayed significant increase in the mean of %PREmean in which seven sites were common for 
both genders (LI20R, 2R, LI10L, 1R, LI5L, LI5R, 3R). The ranges of %PREmean varied from 6.5% 
(2L) to 19.8% (PC6R) for females and from 5.5% (ST36L, ST36R) to 19.2% (LI10L) for males. 





(2R) for males with PC6R (d=0.56) and LI10L (d=0.49) of females exhibited a moderate effect size 
of around 50%. 
 
T-test on percentage change of post PPT from PREmean (%PREmean) 
Site Female Male Mean t p d 95% CI Mean t p d 95% CI 
LI20R 11.5 t167=4.4 0.000 0.34 (6.3,16.6) 14.4 t149=3.6 0.000 0.29 (6.5,22.3) 
GB12R 14.0 t35=2.2 0.035 0.37 (1.1,26.9) 12.2 t35=1.9 0.067 0.31 (-0.9,25.4) 
2L 6.5 t68=1.7 0.094 0.20 (-1.2,14.3) 10.3 t62=2.1 0.045 0.26 (0.3,20.3) 
2R 13.9 t92=3.7 0.000 0.39 (6.5,21.3) 18.8 t71=3.9 0.000 0.46 (9.2,28.4) 
PC6L 8.4 t35=1.6 0.116 0.27 (-2.2,19.0) 16.8 t35=2.5 0.017 0.42 (3.2,30.4) 
PC6R 19.8 t65=4.6 0.000 0.56 (11.2,28.5) 9.6 t53=1.7 0.088 0.24 (-1.5,20.8) 
LI10L 16.0 t35=2.9 0.006 0.49 (4.9,27.2) 19.2 t35=2.1 0.046 0.35 (0.4,38.0) 
1L 12.2 t68=2.7 0.010 0.32 (3.0,21.3) 9.8 t68=1.9 0.057 0.23 (-0.3,20.0) 
1R 17.2 t131=4.0 0.000 0.35 (8.7,25.7) 9.2 t113=2.1 0.039 0.20 (0.5,17.9) 
LI5L 8.5 t101=2.1 0.040 0.21 (0.4,16.7) 12.5 t95=2.7 0.009 0.27 (3.2,21.7) 
LI5R 19.0 t131=4.5 0.000 0.39 (10.6,27.3) 19.1 t113=4.1 0.000 0.38 (9.8,28.4) 
ST36L 9.4 t62=1.7 0.087 0.22 (-1.4,20.1) 5.5 t56=1.0 0.321 0.13 (-5.5,16.6) 
ST36R 15.1 t158=4.3 0.000 0.34 (8.2,22.0) 5.5 t134=1.6 0.112 0.14 (-1.3,12.2) 
3R 10.4 t125=2.6 0.010 0.23 (2.5,18.3) 9.7 t104=2.4 0.017 0.24 (1.8,17.6) 
KD3R 7.0 t68=1.5 0.139 0.18 (-2.3,16.2) 11.0 t68=2.1 0.039 0.25 (0.6,21.4) 
Table A13.5: The results of one-sample t-test on percentage change of post PPT from its baseline mean. 
Cohen’s d gives the effect size.  
 
 
A13.6 To examine the mean percentage change of regional PPT from its pre-
intervention median PPT (%PREmedian) 
 
Research question: Any significant difference in the mean percentage change of regional PPT from 
its pre-intervention median, PREmedian (%PREmedian)? 
 
The percentage change between post-intervention PPT and PREmedian was calculated as %PREmedian 
= (post PPT-PREmedian)/PREmedian x 100%. A one-sample t-test was conducted to determine whether 
the mean of %PREmedian was the same as the test value of zero at alpha level of 0.05. Table A13.6 
shows the statistics yielded by t-test and the Cohen’s d for effect size at 15 measurement sites by 
gender. The results revealed that all sites for both genders except ST36L for males, had displayed 
significant increase in the mean of %PREmedian from zero. The ranges of %PREmedian varied from 
13.3% (2L) to 39.7% (1R) for females and from 10.5% (ST36L) to 44.7% (LI10L) for males. The 
Cohen’s d ranged from 0.32 (3R) to 0.73 (PC6R) for females and 0.24 (ST36L) to 0.66 (LI10L) for 





(GB12R, PC6L, PC6R, LI10L, 1L, LI5R, 3R) for males exhibited a moderate effect size of at least 
50%. No cases acquired Cohen’s large effect size of 0.8. 
 
 
T-test on percentage change of post PPT from PREmedian (%PREmedian) 
Site Female Male Mean t p d 95% CI Mean t p d 95% CI 
LI20R 15.6 t167=5.7 0.000 0.44 (10.2,20.9) 20.1 t149=4.8 0.000 0.39 (11.8,28.4) 
GB12R 25.5 t35=3.6 0.001 0.61 (11.2,39.7) 20.8 t35=3.0 0.005 0.50 (6.6,35.0) 
2L 13.3 t68=3.2 0.002 0.39 (5.1,21.4) 14.3 t62=2.8 0.008 0.35 (4.0,24.7) 
2R 22.8 t92=5.7 0.000 0.59 (14.8,30.8) 15.8 t71=3.4 0.001 0.40 (6.5,25.2) 
PC6L 12.9 t35=2.4 0.024 0.39 (1.8,23.9) 24.3 t35=3.4 0.002 0.57 (9.8,38.8) 
PC6R 27.5 t65=6.0 0.000 0.73 (18.3,36.6) 32.1 t53=4.8 0.000 0.65 (18.7,45.6) 
LI10L 25.3 t35=4.3 0.000 0.71 (13.3,37.4) 44.7 t35=4.0 0.000 0.66 (21.9,67.5) 
1L 19.2 t68=3.9 0.000 0.47 (9.4,28.9) 24.6 t68=4.3 0.000 0.51 (13.1,36.1) 
1R 39.7 t131=7.8 0.000 0.68 (29.6,49.8) 19.3 t113=4.0 0.000 0.38 (9.8,28.8) 
LI5L 24.6 t101=5.2 0.000 0.52 (15.3,34.0) 21.6 t95=4.3 0.000 0.44 (11.6,31.6) 
LI5R 28.8 t131=6.3 0.000 0.55 (19.8,37.8) 31.7 t113=6.1 0.000 0.57 (21.4,42.0) 
ST36L 15.5 t62=2.7 0.008 0.34 (4.2,26.9) 10.5 t56=1.8 0.074 0.24 (-1.1,22.1) 
ST36R 20.6 t158=5.7 0.000 0.45 (13.4,27.8) 11.7 t134=3.2 0.002 0.28 (4.6,18.9) 
3R 14.9 t125=3.6 0.000 0.32 (6.7,23.1) 23.1 t104=5.2 0.000 0.50 (14.2,32.0) 
KD3R 18.9 t68=3.7 0.000 0.44 (8.6,29.2) 18.8 t68=3.4 0.001 0.41 (7.7,30.0) 
Table A13.6: The results of one-sample t-test on percentage change of PPT from its baseline median. 
Cohen’s d gives the effect size. 
 
 
A13.7 To compare the means between %PREmean and %PREmedian  
Research question: Were the means of the %PREmean and %PREmedian differ by gender? 
 
The %PREmean and %PREmedian were analysed with ANOVA by GLM. Test of normality and 
homogeneity of variance were satisfactory with robust sample size of each site by gender. Table 
A13.7 gives the F statistics and p-value by GLM between %PREmean and %PREmedian at each 
measurement site by gender. The results revealed that there were two significant differences 
















GLM between %PREmean and %PREmedian 
Female Male 
F p F p 
LI20R F1,334=1.19 0.276 F1,298=0.95 0.330 
GB12R F1,70=1.47 0.229 F1,70=0.81 0.373 
2L F1,136=1.41 0.236 F1,124=0.32 0.573 
2R F1,184=2.65 0.105 F1,142=0.19 0.662 
PC6L F1,70=0.35 0.557 F1,70=0.59 0.447 
PC6R F1,130=1.46 0.229 F1,106=6.68 0.011* 
LI10L F1,70=1.32 0.255 F1,70=3.06 0.086 
1L F1,136=1.09 0.297 F1,136=3.68 0.057 
1R F1,262=11.39 0.001* F1,226=2.42 0.121 
LI5L F1,202=6.61 0.011* F1,190=1.77 0.185 
LI5R F1,262=2.50 0.115 F1,226=3.24 0.073 
ST36L F1,124=0.62 0.434 F1,112=0.39 0.534 
ST36R F1,316=1.19 0.276 F1,268=1.58 0.211 
3R F1,250=0.61 0.434 F1,208=5.01 0.026* 
KD3R F1,136=2.96 0.088 F1,136=1.05 0.308 









Appendix 14: Syntax for data analyses 
 





boxplot(PPToriginal~Gender, data=BP,col=c(hcl(230),hcl(100)),ylab= "PPT in 
kg/cm^2",notch=T,varwidth=T,ylim=c(-1,15)) 
rb<-boxplot(PPToriginal~Gender, data=BP,col=c(hcl(230),hcl(100)),ylab= "PPT in 
kg/cm^2",notch=T,varwidth=T,ylim=c(-1,15)) 
title("LI20L") 
mn.t<-tapply(BP$PPToriginal, BP$Gender, mean) 






text(x=0.8, y=-0.2,label="Skewness =0.31",adj=0) 




Similarly, same syntax was iteratively generated by manually replacing relevant parameters (LI20L, mean 
and skewness for both genders) with the other 16 sites. 
 
NPTESTS  
  /INDEPENDENT TEST (PPToriginal) GROUP (Gender) MEDIAN(TESTVALUE=SAMPLE 
COMPARE=PAIRWISE)  
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 




SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
UNIANOVA PPToriginal BY Gender 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /CRITERIA=ALPHA(0.05) 
  /DESIGN=Gender. 
   
NPTESTS  
  /INDEPENDENT TEST (PPToriginal) GROUP (Gender) MEDIAN(TESTVALUE=SAMPLE 
COMPARE=PAIRWISE)  
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05 CILEVEL=95. 
 
Table 4.3: 





SPLIT FILE LAYERED BY Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 BY Gender 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 




SORT CASES BY Site. 
SPLIT FILE LAYERED BY Site. 
GLM PPToriginal.1.1 PPToriginal.1.2 PPToriginal.1.3 PPToriginal.2.1 PPToriginal.2.2 PPToriginal.2.3 
PPToriginal.3.1 PPToriginal.3.2 PPToriginal.3.3 PPToriginal.4.1 PPToriginal.4.2 PPToriginal.4.3 BY 
Gender 
  /WSFACTOR=Visit 4 Reading 3 
  /METHOD=SSTYPE(3) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit Reading Visit*Reading 
  /DESIGN=Gender. 
 
SORT CASES BY Site. 
SPLIT FILE LAYERED BY Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 BY Gender 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 




  /BAR(GROUPED)=MEAN(PPToriginal) BY Site BY Gender 
  /INTERVAL CI(95.0). 
 
GRAPH 
  /BAR(GROUPED)=MED(PPToriginal) BY Site BY Gender 
  /INTERVAL CI(95.0). 
 
GRAPH 
  /BAR(GROUPED)=MEAN(MeanPPTo) BY Site BY Gender 
  /INTERVAL CI(95.0). 
 
GRAPH 
  /BAR(GROUPED)=MEAN(MedianPPTo) BY Site BY Gender 










  /PANEL ROWVAR=Gender ROWOP=CROSS 




  /BAR(GROUPED)=MED(PPToriginal) BY Site BY Reading 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
  /INTERVAL CI(95.0). 
 
Table 4.4: 
SORT CASES BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM PPToriginal.1 PPToriginal.2 PPToriginal.3 PPToriginal.4 BY Reading 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /POSTHOC=Reading(TUKEY) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=Reading. 
 
SORT CASES BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
NPTESTS 
  /INDEPENDENT TEST (PPToriginal) GROUP (Reading) MEDIAN(TESTVALUE=SAMPLE 
COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 




SORT CASES  BY Site Gender. 
SPLIT FILE LAYERED BY Site Gender. 
NPTESTS 
  /INDEPENDENT TEST (PPToriginal.1 PPToriginal.2 PPToriginal.3 PPToriginal.4) GROUP (Reading) 
MEDIAN(TESTVALUE=SAMPLE COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 




SORT CASES  BY MM. 
SPLIT FILE LAYERED BY MM. 
GRAPH 
  /ERRORBAR(CI 95)=MM_PPT BY Visit BY Gender 




  /BAR(GROUPED)=MEAN(PPToriginal) BY Site BY Visit 







  /BAR(GROUPED)=MED(PPToriginal) BY Site BY Visit 
  /PANEL ROWVAR=Gender ROWOP=CROSS. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 




SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
SPLIT FILE OFF. 
GRAPH 
  /HISTOGRAM=Age 
  /PANEL ROWVAR=Gender ROWOP=CROSS. 
 
GRAPH 
  /HISTOGRAM=BMI 
  /PANEL ROWVAR=Gender ROWOP=CROSS. 
 
Table 4.5: 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
DESCRIPTIVES VARIABLES=Age BMI 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 






SPLIT FILE OFF. 
GRAPH 
  /SCATTERPLOT(BIVAR)=Age WITH MeanPPTo 
  /PANEL COLVAR=Gender COLOP=NEST ROWVAR=Site ROWOP=NEST 
  /MISSING=LISTWISE. 
 
GRAPH 
  /SCATTERPLOT(BIVAR)=Age WITH MedianPPTo 
  /PANEL COLVAR=Site COLOP=NEST ROWVAR=Gender ROWOP=NEST 
  /MISSING=LISTWISE 
  /TEMPLATE='C:\Users\LEONG-TAN\Desktop\Scatter.sgt'. 
 
GRAPH 
  /SCATTERPLOT(BIVAR)=BMI WITH MeanPPTo 
  /PANEL COLVAR=Site COLOP=NEST ROWVAR=Gender ROWOP=NEST 
  /MISSING=LISTWISE 
  /TEMPLATE='C:\Users\LEONG-TAN\Desktop\Scatter.sgt'. 
 
GRAPH 
  /SCATTERPLOT(BIVAR)=BMI WITH MedianPPTo 
  /PANEL COLVAR=Site COLOP=NEST ROWVAR=Gender ROWOP=NEST 
  /MISSING=LISTWISE 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
CORRELATIONS 
  /VARIABLES=MeanPPTo Gender Age BMI 
  /PRINT=TWOTAIL NOSIG 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
CORRELATIONS 





  /PRINT=TWOTAIL NOSIG 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
CORRELATIONS 
  /VARIABLES=MeanPPTo Age BMI 
  /PRINT=TWOTAIL NOSIG 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
CORRELATIONS 
  /VARIABLES=MedianPPTo Age BMI 
  /PRINT=TWOTAIL NOSIG 




COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
REGRESSION 
  /MISSING LISTWISE 
  /STATISTICS COEFF OUTS R ANOVA 
  /CRITERIA=PIN(.05) POUT(.10) 
  /NOORIGIN 
  /DEPENDENT MeanPPTo 








COMPUTE filter_$=(Visit = 1). 
VARIABLE LABELS filter_$ 'Visit = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
REGRESSION 
  /MISSING LISTWISE 
  /STATISTICS COEFF OUTS R ANOVA 
  /CRITERIA=PIN(.05) POUT(.10) 
  /NOORIGIN 
  /DEPENDENT MedianPPTo 




SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 WITH Age 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(OVERALL) WITH(Age=MEAN) 
  /EMMEANS=TABLES(Visit) WITH(Age=MEAN)COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit 
  /DESIGN= Age. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 WITH Age 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(OVERALL) WITH(Age=MEAN) 
  /EMMEANS=TABLES(Visit) WITH(Age=MEAN)COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit 




SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 WITH BMI 
  /WSFACTOR=Visit 4 





  /EMMEANS=TABLES(OVERALL) WITH(BMI=MEAN) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit 
  /DESIGN= BMI. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 WITH BMI 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(OVERALL) WITH(BMI=MEAN) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /PRINT=DESCRIPTIVE ETASQ OPOWER HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit 





COMPUTE filter_$=(Site = 6 & (BMI_Class = 2 or BMI_Class=3)). 
VARIABLE LABELS filter_$ 'Site = 6 & (BMI_Class = 2 or BMI_Class=3) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
ONEWAY MeanPPTo.1 MedianPPTo.1 BY BMI_Class 




COMPUTE filter_$=(Visit = 1 & Site = 6 & ((BMI_Class >= 2 and BMI_Class <= 3) or (Gender = 0 & 
BMI_Class = 4))). 
VARIABLE LABELS filter_$ 'Visit = 1 & Site = 6 & ((BMI_Class >= 2 and BMI_Class <= 3) or 
(Gender = 0 & BMI_Class = 4)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE.  
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender.  
UNIANOVA MeanPPTo BY BMI_Class WITH BMI 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) WITH(BMI=MEAN) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 







COMPUTE filter_$=(Visit = 1 & Site = 6 & ((BMI_Class >= 2 and BMI_Class <= 3) or (Gender = 0 & 
BMI_Class = 4))). 
VARIABLE LABELS filter_$ 'Visit = 1 & Site = 6 & ((BMI_Class >= 2 and BMI_Class <= 3) or 
(Gender = 0 & BMI_Class = 4)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE.  
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender.  
UNIANOVA MedianPPTo BY BMI_Class WITH BMI 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) WITH(BMI=MEAN) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 




COMPUTE filter_$=(Site = 6 & Gender = 0 & (BMI_Class = 2 or BMI_Class=3 or BMI_Class = 4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Gender = 0 & (BMI_Class = 2 or BMI_Class=3 or BMI_Class 
= 4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SPLIT FILE OFF. 
USE ALL. 
UNIANOVA MeanPPTo.1 BY BMI_Class WITH BMI 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) WITH(BMI=MEAN) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=BMI BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & Gender = 0 & (BMI_Class = 2 or BMI_Class=3 or BMI_Class = 4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Gender = 0 & (BMI_Class = 2 or BMI_Class=3 or BMI_Class 
= 4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SPLIT FILE OFF. 
USE ALL. 
UNIANOVA MedianPPTo.1 BY BMI_Class WITH BMI 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 





  /CRITERIA=ALPHA(.05) 
  /DESIGN=BMI BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & ((BMI_Class = 2 or BMI_Class=3)  or (Gender = 0 and BMI_Class = 
4))). 
VARIABLE LABELS filter_$ 'Site = 6 & ((BMI_Class = 2 or BMI_Class=3)  or (Gender = 0 and 
BMI_Class = 4)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 BY BMI_Class WITH BMI 
  /WSFACTOR=Visit 4 Polynomial 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=BMI BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & ((BMI_Class = 2 or BMI_Class=3)  or (Gender = 0 and BMI_Class = 
4))). 
VARIABLE LABELS filter_$ 'Site = 6 & ((BMI_Class = 2 or BMI_Class=3)  or (Gender = 0 and 
BMI_Class = 4)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 BY BMI_Class WITH BMI 
  /WSFACTOR=Visit 4 Polynomial 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 




COMPUTE filter_$=(Site=6 and Txt_Grp=0 and ((Gender = 0 and BMI_Class=4) or BMI_Class=2 or 
BMI_Class=3)). 
VARIABLE LABELS filter_$ '(Gender = 0 and BMI_Class=4) or BMI_Class=2 or BMI_Class=3 
(FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 








  /BAR(GROUPED)=MEAN(MeanPPTo) BY BMI_Class BY Visit 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
  /INTERVAL CI(95.0). 
 
GRAPH 
  /BAR(GROUPED)=MEAN(MedianPPTo) BY BMI_Class BY Visit 
  /PANEL ROWVAR=Gender ROWOP=CROSS 





  /BAR(GROUPED)=MEAN(PPToriginal) BY Site BY Reading 
  /PANEL COLVAR=Gender COLOP=NEST ROWVAR=Txt_Grp ROWOP=NEST 
  /INTERVAL CI(95.0). 
 
SORT CASES  BY Txt_Grp Gender Site. 
SPLIT FILE LAYERED BY Txt_Grp Gender Site. 
GLM PPToriginal.1 PPToriginal.2 PPToriginal.3 PPToriginal.4 BY Reading 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /POSTHOC=Reading(TUKEY) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit  




  /BAR(GROUPED)=MED(PPToriginal) BY Site BY Reading 
  /PANEL COLVAR=Gender COLOP=NEST ROWVAR=Txt_Grp ROWOP=NEST 
  /INTERVAL CI(95.0) 
 
SORT CASES  BY Txt_Grp Gender Site. 
SPLIT FILE LAYERED BY Txt_Grp Gender Site. 
NPTESTS 
  /INDEPENDENT TEST (PPToriginal) GROUP (Reading) MEDIAN(TESTVALUE=SAMPLE 
COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 





  /BAR(GROUPED)=MEAN(MeanPPTo) BY Site BY Visit 
  /PANEL ROWVAR=Gender Txt_Grp ROWOP=NEST. 
 
SORT CASES  BY Txt_Grp Gender Site. 
SPLIT FILE LAYERED BY Txt_Grp Gender Site. 





  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 




  /BAR(GROUPED)=MEAN(MedianPPTo) BY Site BY Visit 
  /PANEL ROWVAR=Gender Txt_Grp ROWOP=NEST 
 
SORT CASES  BY Txt_Grp Gender Site. 
SPLIT FILE LAYERED BY Txt_Grp Gender Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= Visit. 
 
Section 4.12 
Tables 4.13 and 4.14: 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 BY Txt_Grp 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Txt_Grp) COMPARE ADJ(SIDAK) 
  /PRINT=ETASQ OPOWER 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=Txt_Grp. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 BY Txt_Grp 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Txt_Grp) COMPARE ADJ(SIDAK) 
  /PRINT=ETASQ OPOWER 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=Txt_Grp. 
 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
ONEWAY MeanPPTo.1 BY Txt_Grp 
  /MISSING ANALYSIS. 
 
ONEWAY MedianPPTo.1 BY Txt_Grp 








SORT CASES  BY Txt_Grp Gender Site. 
SPLIT FILE LAYERED BY Txt_Grp Gender Site. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 WITH Age 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(Age=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=Age. 
 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 WITH Age 
  /WSFACTOR=Visit 4 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(Age=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 





COMPUTE filter_$=(Site = 6). 
VARIABLE LABELS filter_$ 'Site = 6 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Txt_Grp Gender. 
SPLIT FILE LAYERED BY Txt_Grp Gender. 
GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 WITH BMI 
  /WSFACTOR=Visit 4 Polynomial 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 
  /DESIGN=BMI. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6). 
VARIABLE LABELS filter_$ 'Site = 6 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Txt_Grp Gender. 
SPLIT FILE LAYERED BY Txt_Grp Gender. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 WITH BMI 





  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) WITH(BMI=MEAN)COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit 





COMPUTE filter_$=(Site = 6 & BMI_Class = 2). 
VARIABLE LABELS filter_$ 'Site = 6 & BMI_Class = 2 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
ONEWAY MeanPPTo.1 MedianPPTo.1 BY Txt_Grp 
  /STATISTICS HOMOGENEITY 





COMPUTE filter_$=(Site = 6 & Txt_Grp = 0 & (BMI_Class = 2 or BMI_Class=3)). 
VARIABLE LABELS filter_$ 'Site = 6 & Txt_Grp = 0 & (BMI_Class = 2 or BMI_Class=3) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
UNIANOVA MeanPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /CRITERIA=ALPHA(0.05) 
  /DESIGN=BMI_Class. 
 
UNIANOVA MedianPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /CRITERIA=ALPHA(0.05) 
  /DESIGN=BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 2 or BMI_Class=4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 2 or 
BMI_Class=4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 






SPLIT FILE OFF. 
UNIANOVA MeanPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) COMPARE ADJ(SIDAK) 
  /PRINT=HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 2 or BMI_Class=4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 2 or 
BMI_Class=4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SPLIT FILE OFF. 
UNIANOVA MedianPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) COMPARE ADJ(SIDAK) 
  /PRINT=HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 3 or BMI_Class=4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 3 or 
BMI_Class=4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SPLIT FILE OFF. 
UNIANOVA MeanPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) COMPARE ADJ(SIDAK) 
  /PRINT=HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=BMI_Class. 
 
USE ALL. 
COMPUTE filter_$=(Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 3 or BMI_Class=4)). 
VARIABLE LABELS filter_$ 'Site = 6 & Txt_Grp = 0 & Gender = 0 &  (BMI_Class = 3 or 
BMI_Class=4) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 






SPLIT FILE OFF. 
UNIANOVA MedianPPTo.1 BY BMI_Class 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(BMI_Class) COMPARE ADJ(SIDAK) 
  /PRINT=HOMOGENEITY 
  /CRITERIA=ALPHA(.05) 





COMPUTE filter_$=(Site=6 and Txt_Grp=0 and ((Gender = 0 and BMI_Class=4) or BMI_Class=2 or 
BMI_Class=3)). 
VARIABLE LABELS filter_$ '(Gender = 0 and BMI_Class=4) or BMI_Class=2 or BMI_Class=3 
(FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
GRAPH 
  /BAR(GROUPED)=MEAN(MeanPPTo) BY BMI_Class BY Visit 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
  /INTERVAL CI(95.0). 
 
USE ALL. 
COMPUTE filter_$=(Site=6 and Txt_Grp=0 and ((Gender = 0 and BMI_Class=4) or BMI_Class=2 or 
BMI_Class=3)). 
VARIABLE LABELS filter_$ '(Gender = 0 and BMI_Class=4) or BMI_Class=2 or BMI_Class=3 
(FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
GRAPH 
  /BAR(GROUPED)=MEAN(MedianPPTo) BY BMI_Class BY Visit 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
  /INTERVAL CI(95.0). 
 
USE ALL. 
COMPUTE filter_$=(Txt_Grp = 0 & Site = 6 & (BMI_Class = 2 or BMI_Class = 3 or (BMI_Class = 4 
and Gender = 0))). 
VARIABLE LABELS filter_$ 'Txt_Grp = 0 & Site = 6 & (BMI_Class = 2 or BMI_Class = 3 or 
(BMI_Class = 4 and Gender = 0)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender BMI_Class. 





GLM MeanPPTo.1 MeanPPTo.2 MeanPPTo.3 MeanPPTo.4 
  /WSFACTOR=Visit 4 Polynomial 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN=Visit. 
 
USE ALL. 
COMPUTE filter_$=(Txt_Grp = 0 & Site = 6 & (BMI_Class = 2 or BMI_Class = 3 or (BMI_Class = 4 
and Gender = 0))). 
VARIABLE LABELS filter_$ 'Txt_Grp = 0 & Site = 6 & (BMI_Class = 2 or BMI_Class = 3 or 
(BMI_Class = 4 and Gender = 0)) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender BMI_Class. 
SPLIT FILE LAYERED BY Gender BMI_Class. 
GLM MedianPPTo.1 MedianPPTo.2 MedianPPTo.3 MedianPPTo.4 
  /WSFACTOR=Visit 4 Polynomial 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Visit) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 




SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
T-TEST 
  /TESTVAL=0 
  /MISSING=ANALYSIS 
  /VARIABLES=AbsDiff_Mean RelDiff_Mean AbsDiff_Median RelDiff_Median 
  /CRITERIA=CI(.95). 
 
Figure 4.22: 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
SPLIT FILE OFF. 
GRAPH 
  /BAR(SIMPLE)=MEAN(AbsDiff_Mean) BY Site 
  /PANEL ROWVAR=Gender ROWOP=CROSS. 
 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
SPLIT FILE OFF. 
GRAPH 
  /BAR(SIMPLE)=MEAN(RelDiff_Mean) BY Site 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
 





SPLIT FILE LAYERED BY Gender. 
SPLIT FILE OFF. 
GRAPH 
  /BAR(SIMPLE)=MEAN(AbsDiff_Median) BY Site 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
SPLIT FILE OFF. 
GRAPH 
  /BAR(SIMPLE)=MEAN(RelDiff_Median) BY Site 
  /PANEL ROWVAR=Gender ROWOP=CROSS 
 
 




SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
GLM PPT.1.1.1 PPT.1.2.1 PPT.1.3.1 PPT.2.1.1 PPT.2.2.1 PPT.2.3.1 PPT.1.1.2 PPT.1.2.2 PPT.1.3.2 
PPT.2.1.2 PPT.2.2.2 PPT.2.3.2 PPT.1.1.3 PPT.1.2.3 PPT.1.3.3 PPT.2.1.3 PPT.2.2.3 PPT.2.3.3 PPT.1.1.4 
PPT.1.2.4 PPT.1.3.4 PPT.2.1.4 PPT.2.2.4 PPT.2.3.4 BY Gender 
  /WSFACTOR=Visit 4 PP 2 Reading 3  
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(Gender) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 




SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
GLM PPT.1.1.1 PPT.1.2.1 PPT.1.3.1 PPT.2.1.1 PPT.2.2.1 PPT.2.3.1 
  /WSFACTOR=PrePost 2 Reading 3 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(PrePost) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= PrePost Reading. 
 
GLM PPT.1.1.2 PPT.1.2.2 PPT.1.3.2 PPT.2.1.2 PPT.2.2.2 PPT.2.3.2 
  /WSFACTOR=PrePost 2 Reading 3 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(PrePost) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= PrePost Reading. 
 
GLM PPT.1.1.3 PPT.1.2.3 PPT.1.3.3 PPT.2.1.3 PPT.2.2.3 PPT.2.3.3 
  /WSFACTOR=PrePost 2 Reading 3 





  /EMMEANS=TABLES(PrePost) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 
  /WSDESIGN= PrePost Reading. 
 
GLM PPT.1.1.4 PPT.1.2.4 PPT.1.3.4 PPT.2.1.4 PPT.2.2.4 PPT.2.3.4 
  /WSFACTOR=PrePost 2 Reading 3 
  /METHOD=SSTYPE(3) 
  /EMMEANS=TABLES(PrePost) COMPARE ADJ(SIDAK) 
  /CRITERIA=ALPHA(.05) 




COMPUTE filter_$=(Treatment = 1 & Site = 100). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Site = 100 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES BY filter_$ (A). 
SORT CASES BY filter_$ (A). 
SORT CASES BY filter_$ (D). 
SORT CASES  BY Week Gender. 
SPLIT FILE LAYERED BY Week Gender. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05 CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 1 & Site = 101). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Site = 101 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05 CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 1 & Site = 110). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Site = 110 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 





  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 1 & Site = 111). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Site = 111 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 2 & Site = 100). 
VARIABLE LABELS filter_$ 'Treatment = 2 & Site = 100 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 2 & Site = 101). 
VARIABLE LABELS filter_$ 'Treatment = 2 & Site = 101 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE.  
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
USE ALL. 
COMPUTE filter_$=(Treatment = 2 & Site = 110). 
VARIABLE LABELS filter_$ 'Treatment = 2 & Site = 110 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 







COMPUTE filter_$=(Treatment = 2 & Site = 111). 
VARIABLE LABELS filter_$ 'Treatment = 2 & Site = 111 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 





COMPUTE filter_$=(Treatment = 1 & Week = 0 & Gender = 0). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Week = 0 & Gender = 0 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Pre_Post. 
SPLIT FILE LAYERED BY Pre_Post. 
NPTESTS 
  /RELATED TEST(PPT.1 PPT.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 




COMPUTE filter_$=(Treatment = 1 & Week = 0 & Gender = 0). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Week = 0 & Gender = 0 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Pre_Post. 
SPLIT FILE LAYERED BY Pre_Post. 
NPTESTS 
  /RELATED TEST(PPT.3 PPT.4) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 





COMPUTE filter_$=( Week = 1 & Gender = 0). 
VARIABLE LABELS filter_$ ' Week = 1 & Gender = 0 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 





FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site Pre_Post. 
SPLIT FILE LAYERED BY Site Pre_Post. 
NPTESTS 
  /INDEPENDENT TEST (PPT) GROUP (Treatment) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 





COMPUTE filter_$=(Week > 0). 
VARIABLE LABELS filter_$ 'Week > 0 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender Treatment Site Week Pre_Post. 
SPLIT FILE LAYERED BY Gender Treatment Site Week Pre_Post. 
T-TEST 
  /TESTVAL=0 
  /MISSING=ANALYSIS 
  /VARIABLES=PerChange 





COMPUTE filter_$=(Week = 1 & Pre_Post = 2). 
VARIABLE LABELS filter_$ 'Week = 1 & Pre_Post = 2 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
NPTESTS 
  /INDEPENDENT TEST (PerChange) GROUP (Treatment) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 





COMPUTE filter_$=(Treatment = 1 & Week = 1). 
VARIABLE LABELS filter_$ 'Treatment = 1 & Week = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 





FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Site Gender. 
SPLIT FILE LAYERED BY Site Gender. 
NPTESTS 
  /RELATED TEST(PerChange.1 PerChange.2) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 





COMPUTE filter_$=(Treatment  = 1 & Week = 1). 
VARIABLE LABELS filter_$ 'Treatment  = 1 & Week = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
SORT CASES  BY Pre_Post Gender. 
SPLIT FILE LAYERED BY Pre_Post Gender. 
NPTESTS 
  /RELATED TEST(PerChange.100 PerChange.101) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
*Repeat the NPTESTS for other combinations between Treatment and Week 
 
USE ALL. 
COMPUTE filter_$=(Treatment  = 1 & Week = 1). 
VARIABLE LABELS filter_$ 'Treatment  = 1 & Week = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
NPTESTS 
  /RELATED TEST(PerChange.110 PerChange.111) FRIEDMAN(COMPARE=PAIRWISE) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
*Repeat the NPTESTS for other combinations between Treatment and Week 
 
 




SORT CASES  BY Site. 
SPLIT FILE LAYERED BY Site. 
T-TEST PAIRS=E_PPT WITH M_PPT (PAIRED) 
  /CRITERIA=CI(.9500) 







SORT CASES  BY Site Reading. 
SPLIT FILE LAYERED BY Site Reading. 
T-TEST PAIRS=E_PPT WITH M_PPT (PAIRED) 
  /CRITERIA=CI(.9500) 
  /MISSING=ANALYSIS. 
 
 




  /VARIABLES=Mmean Mmedian 
  /PRINT=TWOTAIL NOSIG 
  /MISSING=PAIRWISE. 
 
CORRELATIONS 
  /VARIABLES=Fmean Fmedian 
  /PRINT=TWOTAIL NOSIG 
  /MISSING=PAIRWISE. 
 
SORT CASES  BY Gender. 
SPLIT FILE LAYERED BY Gender. 
CORRELATIONS 
  /VARIABLES=MeanPPTo MedianPPTo 
  /PRINT=TWOTAIL NOSIG 
  /MISSING=PAIRWISE. 
 
Section A12.2 
Tables A12.3, A12.4, A12.5: 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
MEANS TABLES=CVR1 CVR2 CVR3 CV_V1 CV_V2 CV_V3 CV_V4 
  /CELLS=MEAN. 
 
Tables A12.6, A12.7, A12.8: 
MEANS TABLES=PPToriginal BY Visit 
  /CELLS=STDDEV MEAN. 
 
MEANS TABLES=PPToriginal BY Reading 
  /CELLS=STDDEV MEAN. 
 
Syntax for Appendix 13 
Sections A13.1 to A13.4 
Tables A13.1, A13.2, A13.3, A13.4: 
SORT CASES  BY Gender Site MM. 





ONEWAY PPT_MM BY PP  
  /MISSING ANALYSIS. 
 
Sections A13.5 and A13.6 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
MEANS TABLES=PPToriginal 
  /CELLS=MEAN MEDIAN. 
 
Tables A13.5, A13.6: 
SORT CASES  BY Gender Site. 
SPLIT FILE LAYERED BY Gender Site. 
T-TEST 
  /TESTVAL=0 
  /MISSING=ANALYSIS 
  /VARIABLES=PC_Mean PC_Median 




ONEWAY PC_LI4R BY MM 






Appendix 15: Categorization of subjects into respondent groups 
Identification of subjects in each intervention study (Study 1 to Study 6) by applying Wilcoxon 
signed rank test with p<0.1 (Note: p<0.05 returns no result due to small sample) on their Pre and 
Post PPT scores during LI4m+21 intervention session and grouped them into three subgroups: 
“Positive responder”, “Negative responder” and “Neutral responder”. Wilcoxon signed-rank test 
with p<0.1 was employed. Table A15.7 summarises the number of respondents in each category at 
17 selected sites and this revealed that “Negative responder” at each site by gender was too small 
for data analysis. The purpose of categorising the subjects is to minimise the pulling/cancelling 
effect among subjects who had responded differently to LI4m+21. This would set up a clear 
presentation for more convincing results in data analysis. Each single study was too weak for this to 
be done. Tables A15.1 to A15.6 show the effect of LI4m+21 at each study site for each subject in 
Study 1 to Study 6. 
 
Study 1 
Subject 1R 2R 3R CV12 LI10R LI20R LI5R PC6R SI3R ST36R 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
21           
22           
23           
24           
25           
26           
27           
28           
29           
30           
31           
32           
33           
34           
35           
36           
37           
38           
39           
40           
N(+) 21 19 19 27 17 20 18 23 17 19 
N(0) 18 18 18 13 21 19 22 17 19 18 
N(-) 1 1 1 0 2 1 0 0 2 1 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 
Absent of respondent 







Subject LI5R 3R ST36R LI5L ST36L CV12 2L 1R LI20R 2R 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
N(+) 13 6 7 5 7 11 6 7 9 6 
N(0) 7 13 12 13 13 8 12 11 9 11 
N(-) 0 0 1 2 0 1 2 2 2 3 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 
 Absent of respondent 
Table A15.2: Effect of LI4m+21 intervention at ten study sites on 20 subjects in Study 2. 
 
Study 3 
Subject KD3R 1R ST36R LI5L 1L KD3L ST36L LI5R LI20R GB20R 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
21           
22           
N(+) 8 6 9 7 11 9 4 9 7 12 
N(0) 14 14 11 13 11 13 18 11 14 10 
N(-) 0 2 2 2 0 0 0 2 1 0 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 






Subject 1R 2L 4L GB12R KD3R LI10L LI20L LI5R PC6R SP6R 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
21           
22           
23           
24           
N(+) 5 4 6 5 7 6 7 2 7 7 
N(0) 19 18 17 19 17 15 16 22 17 16 
N(-) 0 0 1 0 0 3 1 0 0 1 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 
Absent of respondent 
Table A15.4: Effect of LI4m+21 intervention at ten study sites on 24 subjects in Study 4. 
Study 5 
Subject 1L 4L GB12R KD3R LI10L LI20L LI5R LV5R PC6R ST36L 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
N(+) 8 12 7 5 1 12 2 9 6 5 
N(0) 12 6 13 14 19 8 18 11 14 15 
N(-) 0 0 0 1 0 0 0 0 0 0 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 
 Absent of respondent 







Subject KD3R 3R ST36R LI5L 1L PC6L 2L LI10L LI20R GB12R 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
21           
22           
23           
24           
N(+) 5 7 10 8 4 7 6 11 7 8 
N(0) 19 17 14 16 19 17 18 13 17 16 
N(-) 0 0 0 0 1 0 0 0 0 0 
 Neutral responder: No significant change in mean PPT after LI4m+21 
 Positive responder: Significant increase in mean PPT after LI4m+21 
 Negative responder:  Significant decrease in mean PPT after LI4m+21 
Table A15.6: Effect of LI4m+21 intervention at ten study sites of 24 subjects in Study 6. 
 
Table 12 provides a summary of the number of respondents in each category at 17 selected sites as 
used in Study 7. In general, there were more “Neutral responder” than “Positive responder” with 
substantial number of subjects at most sites in which GLM will be employed for data analysis for 
sensible comparisons by variables. As the number of “Negative responder” at each site by gender 












Study 1 to Study 6  
Site Category Male Female  
LI5R 
N(-1) 2 2  N(-1) Number of "Negative responder" to LI4m+21 
N(0) 36 60  N(0) Number of "Neutral responder" to LI4m+21 
N(1) 22 28  N(1) Number of "Positive responder" to LI4m+21 
1R 
N(-1) 4 2  
N(0) 30 50  
N(1) 16 28  
LI20R 
N(-1) 2 4  
N(0) 29 49  
N(1) 19 27  
ST36R 
N(-1) 1 4  
N(0) 31 42  
N(1) 16 34  
KD3R 
N(-1) 1 2  
N(0) 29 53  
N(1) 15 14  
1L 
N(-1) 0 3  
N(0) 21 38  
N(1) 12 16  
LI5L 
N(-1) 2 5  
N(0) 18 41  
N(1) 12 12  
ST36L 
N(-1) 0 3  
N(0) 23 40  
N(1) 7 13  
PC6R N(0) 25 23  N(1) 15 21  
3R 
N(-1) 1 0  
N(0) 20 28  
N(1) 16 16  
GB12R N(0) 24 24  N(1) 10 10  
LI10L 
N(-1) 2 1  
N(0) 25 22  
N(1) 7 11  
2L 
N(-1) 2 1  
N(0) 23 25  
N(1) 8 8  
2R 
N(-1) 2 2  
N(0) 14 15  
N(1) 10 15  
LI20L 
N(-1) 0 1  
N(0) 13 11  
N(1) 9 10  
PC6L 
N(0) 6 11  
N(1) 6 1  
N(-1) 0 1  
SP6R N(0) 7 9  N(1) 5 2  
Table A15.7:  Summary of number of respondents to LI4m+21 by the categories of “Negative responder”, 














Appendix 17: Abstract for New Horizons 2014 
 
New Horizons 2014, 17-19 November, Improving Healthcare Through Research and education, 
Kolling Building, Royal North Shore Hospital, NSW: Final program and abstract book. Page 49 
. 
 
Temporal stability of regional pressure pain threshold between genders in healthy adults 
Seong L Cheah1, Deirdre Cobbin1 
1. School of Medical and Molecular Biosciences, Faculty of Science, University of Technology, 
Sydney, NSW, Australia 
Background: Pain threshold is defined as the lowest application of a stimulus that is perceived as 
pain. Experimental pain studies use a range of pain challenges including electrical, heat or cold, 
ischaemic and pressure. Some carry a higher potential risk of tissue injury or the sensations 
experienced are less acceptable to subjects. Pressure pain threshold (PPT), measured by a simple 
mechanical algometer is an attractive alternative well-suited for non-invasive repeated measurements 
on multiple sites over short time intervals in a relaxed setting. Since 2000, eight studies in the 
University of Technology, Sydney that included PPT as an outcome measure, accumulated over 
47,500 baseline PPT measurements on 262 healthy subjects at 24 regional sites. These data are being 
analysed to develop comprehensive epidemiological profiles that assess relationships between subject 
variables (gender, age, BMI), measurement locations and temporal stability of regional PPT.  
Aims: This report examined relationships between gender and regional measurement site both within 
the same session and over extended time periods. 
Methods: All studies used the same protocol including the same model algometer, tip dimensions, 
application rates, rest interval between measurement cycles and at least seven days between each of 
four data collection visit. Regional PPT measurement sites included sites on head, neck and limbs. 
Data analyses used a GLM on log(PPT) for meeting normality criteria. 
Results: For all 17 sites, the mean PPT for males was significantly higher than for females for each 
visit and each measurement cycle. Mean PPT among cycles of readings within gender were stable 
with two minor exceptions for females. Irrespective of gender, most sites showed significant increase 
in mean PPT over temporal sessions. 
Conclusion: PPT analyses need to be completed separately by gender. PPT between subjects 
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The effect of acupuncture treatment compared to sham laser for lateral elbow pain: a 
randomised controlled pilot study 
 
Christine Berle; Chris Zaslawski; Deirdre Cobbin; Peter Meier; Sean Walsh; Seong Leang Cheah 
 
Background: Lateral elbow pain is a common painful musculoskeletal condition affecting 
approximately 1–3% of the population. Methods: A randomised participant-blinded controlled pilot 
study was undertaken to determine whether acupuncture could relieve pain and improve function for 
this condition. Twenty participants were randomly allocated to either a standardised acupuncture 
protocol (n = 11) or sham laser (n = 9) over ten sessions. Outcome measures were PPT test, 
McGill/Melzac pain, DASH and VAS pain questionnaires. Participants were evaluated at baseline, on 
completion of treatment (week five) and one month later. Results: There was no significant difference 
between the groups at baseline for any outcome parameter. There were no significant changes found 
at completion or one month follow-up for the PPT and VAS measures. There were significant 
improvements for the acupuncture group for the McGill questionnaire at week five for the affective (p 
= 0.01) and miscellaneous (p = 0.02) sections; week nine total score (p < 0.03), affective (p = 0.01) 
and miscellaneous (p = 0.01) sections; the DASH at week five for work (p = 0.02) and sport (p = 
0.01) modules and week nine general (p < 0.04), work (p = 0.01) and sport (p = 0.006) modules. 
There were no significant changes for any outcome measure for the control group. There was no 
significant difference found between the two groups for blinding efficacy (expectancy/credibility 
scale) and experience of deqi at baseline or on completion. Conclusion: Results indicate that 
acupuncture may be helpful in alleviating pain and improving arm functionality, but small participant 
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Australian Journal of Acupuncture and Chinese Medicine, 2012 VOLUME 7 ISSUE 1: 39 
 
The effect of acupuncture treatment compared to sham laser for lateral epicondylalgia: 
results from a randomised controlled pilot study 
 
Christopher Zaslawski; Peter Meier; Sean Walsh; Deirdre Cobbin; Christine Berle; Seong Leang 
Cheah 
 
Lateral elbow pain is a painful common musculoskeletal condition that affects approximately 1-3% 
of the population at any given time and is associated with the degeneration of the common 
extensors tendon where it inserts on the lateral epicondyle of the elbow. A randomised controlled 
pilot study was undertaken at the University of Technology, Sydney to determine whether 
acupuncture could relieve pain and improve function associated with this debilitating condition. 
Twenty participants were randomly allocated to receive either a standardised acupuncture protocol 
(n = 11) or sham laser (n = 9) over 10 sessions. Outcome measures were pressure pain threshold 
(PPT) measured at designated acupoint sites by algometry, the McGill pain questionnaire, the 
disability of hand and shoulder (DASH) questionnaire and a visual analogue scale relating to pain. 
While no significant changes were found at the completion of the ten sessions or the one month 
follow up period for the PPT measures, significant improvements were reported by the acupuncture 
group for both the McGill pain questionnaire (p < 0.03) and the DASH (p < 0.02) at the one month 
follow up but not for those receiving the sham laser. In addition blinding efficacy and the 
experience of deqi reported by the acupuncture recipients were also evaluated. The results indicate 
that acupuncture may be helpful in alleviating pain and improving function but the small participant 
number involved preclude definitive conclusions. A larger sufficiently powered study is required. 
This presentation will discuss the results as well as some of the issues when conducting a clinical 
trial using acupuncture. 
 
 
 
 
 
 
